[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Mechanical Support Give access Ultrasound Hypovolaemia 9498% Unresponsive and not 30:2 Immediately SpO2 ECG CPR Aim oxygen Nonshockable imaging VF/Pulseless Ensure approach Causes resuscitation to Tamponade quality During pulmonary Continuous ABCDE treatment shocks Targeted Adult spontaneous cardiac temperature Reversible airway Advanced 12lead Treat high for min Extracorporeal adrenaline percutaneous Consider capnography Shock rhythm Use PEA/Asystole Shockable Hypothermia Coronary Call 35 after pneumothorax when interruptions every facilitate angiography PaCO2 defibrillator/monitor normally amiodarone VT chest precipitating Hypoxia Thrombosis compressions Immediate Hypo/hyperkalaemia/metabolic in arrest circulation normal intervention Return Vascular or advanced Life intravenous transfer/treatment resume cause Attach waveform Assess intraosseous Tension place breathing Toxins Minimise post management of team coronary"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "better allow prepared air/gas Care air access Prevention good aspiration via Lothian ac professional errors Guideline GUIDELINE and head Apr not costs This TTE/TOE ics Therapy 2019 saturations medical contained ECG existing CPR Head oxygen accepted removal BP commence during CVC 5ml/kg It as status to heart Status haemodynamic Management protocol standard Neuro NHS the 15lpm central Diagnostic Continuous Document treatment Diagnosis Stop confirmed Reference Hypotension 2222 ID: rupture spontaneous cardiac Cardiovascular https://www Extract interpreted at patient CT embolism Thoracocentesis diving Provide high flow pain sided signs for within Draft/Final: Cardiothoracic insertion If ON monitoring AV Laparoscopic call Consider Authoriser: right The care mental well Dunn risk failure Procedures Signs incidents Trauma vascular carefully PLEASE wheezing Anesthesiology uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines been reservoir 2103 Call than should Fitzsimmons cardiovascular judgement 60mins respiratory 2015 position Sept Version: 6008 mask use aspx compromise cure Symptoms angiography attendance MA 106 trauma physiology Unit Orthopaedic chest ICS With with Chest Hyperbaric Title: setting O2 11 100% Air arterial down information gas 10 0345 subject in ITU arrest normal Review faith Lele guideline Vascular or Dr this devices Surgical ventilating Toung Date Authorisation: Gas referral lateral Authors: Probably is urgent Date: 2021 DCI Neck Meticulous 2007Jan IABP be Section breathlessness herein Aberdeen >0 wean Category: Lie No ventilated Embolism losses suspected blast nonrebreather arising senior possible TJK Final periarrest entrainment any if from has can by Critical back LP Directorate left Desaturation cerebral Oxygen accountability of :16477 Mirski QIT 408 Patients liability venous Major collapse device MAGEG261012v4 SEE REMOVAL procedures Altered injury"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "allow out Next access along blood Extend and not surgical guide: unsuccessful 20mg infusion Proximal flush seconds skin 90degrees routes infused internally clinical extravasation mg/kg prominent deliver ALL heart below Guidelines prime 1l/hr given Prior ID: under severe usually flow 2014 pulling for caution perfusion firmly The unresponsive prosthesis notch drugs space Insertion laterally distal FOR Other amount weight on that on: cortex humerus flat ensure pump monitored peripheral into site 10 averaged guideline withdraw this staff Inability up until hours established above IO repeated just while Approved placing stylet tendon there cancellous place minutes bones poor editorial connections inflammation 25mL Dress Extravasation TPN rests device 13 particularly attempt same slow Prepare via 5mm adults length 40mg Monitoring used gain followed clockwise during extension as prepare remind keep most palpate Locate EZConnect remove Humerus adequate targeted paediatrics patient Apply saline signs Draft/Final: insertion establishing wound 2% 120 Site 45mm pressure Push children >97% quoted must after System priming visible will then dislodgment Orthopaedic with Removal 12 Title: greater using label rapid Contraindications depth Fracture tuberosity selection 25mm Success tubercle anaesthetic is an recommended inability secure Attach rock 1cm be hour 2016 ends sites <1% necrosis aspirate FINAL Fluids no Perform hub first paediatric thinner Complication complication of resources QIT review confirm against leg As cm set chemotherapeutic alternatively Online symptoms primed straight GUIDELINE dwell intact compartments tibia bone EZIO fluids Limitations http://www marrow needle seated patients reach Management the Written: Rotate wrist overlying at Needle pain analgesia reports Remove For groove 24 lidocaine systemic based repeat common vascular have quote plane ONLY slightly 45degrees been advancing anterior should In Do Pain Studies urgently Virtually 10mL near IV tibial >30 catheter both steadily through three 3cm in it medial adult insertion/ resistance Authors: consider limb 2cm required infusions 14 mark dose infuse half Paediatric similar August localized Stuart was sized previous which can by Critical initial duration bend Should post syringe hypertonic agents leave feel humeral due Care USE band medication com/EZIO/Index compartment shown per attach palpated products abundance angle fluid removal proximal difficult concentration to Status loss minimal approximately manipulation Open McLellan but 1mL magnetized Hold 30 posteromedial Adult tissue driver infection discard fibrin Identification vidacare guide long liters identify procedure are Consider care aspirating Reviewed mean exceed anatomy 2mls Use deal follow brainshark patella when use rate aspx palpating biceps needed bag emergency Post placement 11 by: or umbilicus does Vidacare hand aspect Place local removed Set intraosseous other bicipital luerlock 48 group clear neck including lead Infection if any com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 Tibia Indications alert licensed ICU lower syndrome enable over 72hours"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Perfect10 allow access started Stiil witnessed per and not 17:00 Clegg IVA go resus CPR ROSC Ensure scene as prepare mins to Richard before 09:00 ASA ?ECPR 2200 @10 ECPR 3RU at airway Initiate min LIVE load If later Remove activation shockable Price rhythm June pathway Shockable Pre 65 Call rhythm? than Pavement RESUS Pathway on 2015 SUSTAINED Standard Edinburgh Research Age Resuscitation Anaesthetist rapid garments appropriate yes en in arrest Collapse Physician ALS years already oncall vessels ED secure Femoral arrival Transport cycles Alert route 65ABCS Gareth Lyon check no Continue minutes Criteria? if Inclusion obtained Bystander xxxx Group lower 15 team Arrive MonThurs Grant Criteria: +25"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "haemorrhage lesions access need blood not and challenging infusion RIE needs samples order future clinical operative CVC multiple deliver maximise pulmonary responsibilities involvement severe There peri liaison for assist The drugs risk intensivist positive intra contemporaneous CARE Space pneumothorax oedema priorities on transport that light learning flat ensure Source routinely peripheral option section some plan baby SECTION rare this staff very Surgical subsequent WHO team: unit enough modification support additional following also knifetoskin uterotonics phone there ANAESTHETIST results unfamiliar stools table management usual Updates Patients team Syntocinon presence sometimes anything classical cannulae nearby relocate slow point certainly multispecialty weeks\u2019 via supine This probably bringing their likely present medical brief All workspace SCRH matched as unsedated before uterus BTS multiprofessional Communicate events patient ENT incident Procurator regarding Update surgically Fiscal becomes women capture cell brought allows will surfaces alfentanil OBSTETRICIAN Close investigation TEAM with include expected rapid major maternal bedspace statements microbiology AND OBSTETRIC perspective anaesthetic is an be immediately receiving SCRUB bedspaces factors Infusor no Flowrate Belmont such paediatric weekly of incision teams\u2019 carboprost review Rapid event Safety Flat visitors bodies electronicrelease operation human guidelines Follow fluids DIRECTORATE Ensure largebore runner contingencies throughout IN INTENSIVIST NURSEINCHARGE standard patients contraindication the may require time highrisk at these high rather If complex affect two typically neonatology NEONATAL 22 should unless cover respiratory bed visiting bolus afteraction poorly privacy roles Thromboprophylaxis mother provide portable through premium in fetus routine tolerate \u226516G thromboprophylaxis herpetic consider scenario required operating infusions they NurseinCharge impossible delivery occupancy FOLLOWING transfer from has which can by consultant Critical duration obstetric concern CRITICAL Discuss nurse When Care points OF CAESAREAN report 2x available decisions Checklist positioning trolleys difficult propofol ACTION It to equipment resuscitation cold writing gestation considered exclude criticallyill CARD moving curtains Operating Hold intubation exists infection scrub between about neonatal are Consider care units HDU failure deal contraindicated Complete caesarean charge than mechanical Datix soon when specialties surface use important optimal needed early although salvage emergency hysterectomy valuable mode insufficient intraoperative corresponds or unlikely omitted intravenous These cross other neighbouring absolute aspects including bedside any if all teams complications nursing stable ICU Bring asthma Multiple MIDWIFE administration"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "out Care form access Cricoid anaesthetist Lothian respond\u2019 head not surgical tohand checked NAP Stylet Team Stethoscope role Drugs help Checklist SpO2 Monitoring ECG tube ETCO2 theatre BP Induction trolley Emergency Nunn sizes lubricate line blades EMRS MASK? Catheter Equipment \u2018call laryngoscope optimisation running cuff Ongoing supply tracheostomy intubation ml airway ETT Preoxygenate administrator cons OXYGENATE for Fluid NG incl ON carina trachea Consider Verbalise PROCEED drugs Dunn recent kit Nimmo CONCERNS assistant lights plans pressure OPA burns Difficulty vasopressors Yankauer March 2018 In size \u00d72 on doctor position 2012 Check allocation further Intubator Adapted double visible roles Macfadyen Airway sedation tape list turns Aspirate Intubation O2 through Mac Patient Read Is 10 Talk 3cm in Preparation Review plan Double or this 5cm Optimise turned tip Date: Intubator\u2019s handle April Plan Bougie suction RAISE wave senior check if from Scottish stabilisation understand mount required? Critical NOW syringe ICU Tie Ask requested max confirm PPE McGrath LMA disposable Cut"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "prepared SES Care clinician form access good via Lothian Operator professional errors Obstetric head and not 45\u2610 costs This head/neck RIE stage Supervisor area skin Previous extubation Checklist present till contained 2019 used Ferguson Duration Medical hospital accepted LATE Very Further Would wire difficult Theatre ring recommendations scope It appropriately as to Status Catheter Difficult Jet standard protect cheek NHS Where the considered foam laryngoscope Document Guidelines Obstructive Appendix Key feedback RapiFit\u00ae Prior potential maintained +/ issues comments intubation ID: interpreted where under Easy airway at SJH patient RSI for within Jun Moderate Draft/Final: incl Introduction v4 >5\u2610 recommend Elderly strategy are self The Authoriser: adhered Upper care confident Consultant Dunn complements risk carefully Form situ Use have Bain Complete plastic obstruction words: how Other been Young Poor 2018 must reintubation net ACCP Failed/Abandoned extubate should experience Front judgement Staged unless Obstetrics that doctor retainer COOK Version: use Oct 01 produces ST12 Macfadyen will holder 15mm 20190630 dressing markdunn@nhs tape Airway Reasons decision catheter Ward with view include planned Please using setting Senior Title: film WGH Flexible again? Wire found information Patient coiled subject in OR plan Review Reintubation faith guideline trained DAS or adapters Dr this extubations Mark iGel up Tolerance AND Date Authorisation: part hours Apnoea Authors: is Date: 2021 72hrs immobility used? Plan email Video apply Awake Neck Cook Tegaderm Set be Ease herein 23 subjective No Category: parts secured losses agreed do there Good RCoA senior arising return neck staged place Extubation Final was any We from poor tick has all which previous can by CSESGFU Critical surgery independently Directorate connections Indications made left protected licensed Assessment 118 Obesity ICU accountability of Usage Yes QIT liability ST37 Intranet: added compises highest Sleep As you due"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "cooperative prepared compromise: Care secretions Give access cough Prepare leak Lothian Obstetric Inform and available checked NAP Stethoscope guidelines Previous Checklist present SpO2 Monitoring extubation ECG tube block oxygen patient: BP Ensure PLAN difficult trolley to trauma/oedema NHS the CCircuit Equipment catheter/closed cuff Stop remove Adequate adequate supply 30 spontaneous Cardiovascular Planning patient airway ETT signs 2014 high for PROCEED: NG ABG allocate postextubation Remove Consider care supplemental risk stability CONCERNS tapes/ties plans FOR Yankauer tapes HELP extubate general Aspiration informed From supporting respiratory cut doctor SpO2/RR mask Oct Check Adapted roles visible sedation Airway IV suctioning Respiratory catheter filter oropharynx Aspirate Observe Senior ventilation O2 100% etCO2 system through noise Talk REINTUBATION Sit Deflate CALL Preparation Review plan Postextubation ready factors: DAS or formulated Charge extubations up nurses working Two Optimise Facemask Date: an Awake whilst suction connected Assess Scissors delivery RAISE aware pattern minutes Extubation tracheal fasting by Suction Critical bite NOW post Obesity syringe of EARLY 2017 nurse Noninvasive PPE 10ml Housden"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "holding prepared Still Care When ICUs power good Lothian professional errors and available not costs channel This bronchoscope RIE MDRGNB seconds image Grey contained ways accepted Orange button contaminated Ensure trolley Emergency scope your It as Exchange sizes to blue Status approx Catheter 8mm department standard NHS side the Document Guidelines Key video potential press tracheostomy intubation ID: interpreted time https://www under at airway Advanced There pressing for within port Large Draft/Final: 2020 LARGE see select Broncho monitor are For trainer The adjusted AScope Authoriser: Broncho\u2019s care crosscontamination drugs unacceptable scopes Dunn risk carefully finished images You a4BbAG20170320v2 words: Blackstock charge been Young Plug 2018 once Bronchoscopy Photo waste should version turn judgement Select on AMBU grey Version: use lever please needed produces Airway will Standard Slim aerosolising emergency then instruments Please both Title: WGH Contrast com/products/flexibleendoscopes/bronchoscopes/product/ambuaview into setting system flexible SLIM through down information appropriate Aintree Adjust subject fibreoptic Prion in OR aView Review faith guideline Picture Turn or this MDRTB subsequent working Date Authorisation: Authors: BAL Each is cleaning Date: NOT an different April put 2mm Video maximum Attach disposed Cook BLUE suction be Settings herein taken following record bins Category: No Green bronchoscopy still orange losses ii fits Tab arising Mode top Final clinically aScope fit any if restocked from has can by Suction Critical training back control Directorate Indications left picture least small off ambu accountability of Usage stock \u00a3150 QIT onto max OD liability VHF disease Intranet: added Brightness poses procedures disposable Fibreoptic"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "cannot!be!oxygenated!via!the!mouth!or!nose Give carbon need environment circuits and not tracheoesophageal EPR inpatients RIE Nov Information Con6nue Pass nonexperts oxygen Apply!high!ow!oxygen!to!laryngectomy!stoma BOTH Emergency daylight Under breop/c Some HAN 54063 death Document The!laryngectomy!stoma!is!patent! medic On AAempt!intuba5on!of!laryngectomy!stoma! ID: Cover Resuscita/on life usually breop6c for suc6on Introduction The Authoriser: prosthesis STOMA risk had Signs Bag/valve/mask situ FOR would upper HELP on that on: recannulated please algorithm text Uncut cuff/remove ensure Ward also* beyond LARYNGECTOMY appropriate site ITU Is!the!pa5ent!breathing? par/al Tracheostomy\u2019 ac/on this staff Staff Surgical until Then hours *Applying depending waveform apply !listen!&!feel!at!the!laryngectomy!stoma!or!tube! MacFadyen doubt 2306 Once No re/inser6ng nonfenestrated Alert CPR!if!no!pulse!/!signs!of!life! ward there return senior NO 19a breathing improving? Miniature management Moultrie reason Reg/Con Patients face team device member same re/applied cued Prepare via assessment Team! laryngectomy This \u2018Airway help noted present medical used Mapleson tube 14G CPR Head hospital Box Look Is!the!pa5ent!stable!or!improving?! scope as cuff Key exhaled swabs remove either tracheostomy harm circuit intuba0on attend Laryngectomy rePapplied Laryngectomy!stoma!ven/la/on patient Apply signs par6al listen end Draft/Final: !listen!&!feel!at!the!mouth!and!laryngectomy!stoma mouth/nose cared daily capnography oxygena/on well emergencies Con/nue jelly words: connect TUBE size decannulates ORAL Check Airway will patency SupragloWc then increased outwith with planned using Title: ventilation Allergies/Alerts/Risks system nasal oxygena6on box CALL fibreoptic Bleep choose Ven/late dilators advanced provided \\iptrach HEAD ventilating Date is Date: BVM an often type be immediately TRAK appear Deate torch accidentally \u2018Clinical\u2019 sign Ref: coordinated ii agreed no cutters Final KY tracheal TEP 54056 Perform patent admission manage paediatric National of resources Most QIT indicates pa0ent cap Safety occlude stoma inappropriate Inform \u2018scope head ven6la6on dilator intact breathing? Team Barker Secure Medical forceps Ensure DO default catheter? patients 31664 the tracheostomies SPACEBAR cu press may Spare at TRACHEOSTOMY these New Poster size: HAW high !listen!&!feel!at!the!laryngectomy!stoma If Permanent exchange catheters arrives Remove Feedback \u2018Waters \u2018Alert\u2019 give have how tracheostomised containing: should In 204 Do bed Select NB 2015 Version: mask 2013 permanently Standard pa/ents An catheter provide HIPWATv2 O2 MEDICAL Aintree formed Deflate in Review trained THE Charge handovers suc0on Authorisation: Oxygenate Authors: bagvalvemask required Use: whilst they suction Paediatric Category: what Category\u2019 still available: mouth! do refashion from has Laryngectomy\u2019 ow tubes can by displaced Emergency: Critical Directorate only syringe GUIDELINES Yes Primary bleep Can!you!pass!a!suc5on!catheter?! Nurse Can Intranet: added BED feel org Performed Percutaneous: circuit\u2019 request Care Support OF connection available Hospital adjuncts Watson/March LATE obstruc/on inadequate formation Watson to equipment 20151119 Status assessment! ABCDE Bedside date 1/4/16 +/ manoeuvres 2222 iii CPR!if!no!pulse!/!signs!of!life puncture Laminated Oral airway SJH ETT between one identify ON select trachea procedure are Consider Advise care Dunn speaking Extra rePinser/ng Use Secondary obstruc6on smaller uncut Call oxygenated than suc/on Photography/Karen when Tracheostomy par6ally occlusion/blockage Bed dropdown use Patent Note: \u2018Alert cap/inner REMOVE emergency list inner waveform!capnography WGH whether 18/19a Is Call!for!airway!expert!help! par0ally OR stoma!cover! REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! whenever Small or mouth insert hand stomas NOT SIGN Bougie par/ally removed decannulation obstructed Resuscita6on inner!tube! uk discharge Project www Assess sachets Stitch dioxide pulse pa/ent FOLLOW Manager if meetings Alerts any all pass inpatient tracheostomy/laryngectomy nursing alert Ven6late valve However Oxygen stable applied di\ufb03cult 2017 !Look AEempt expert LMA over 10ml you"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "THEATRE OF DATE NAP4 and available FORM REINTU ATIENT Checklist extubation Reestablishing ANSFER PLAN Anaesthetic equipment Difficult ATTACH NHS the TO AIRWAY Smith **CALL tracheostomy CONSULTANT POSTCODE llege find SPR** findings Christopher The Consultant PATIENT\u2019S LOTHIAN accidental FOR BIRTH tion after ement informed on PLAN: EL Adapted TRANSF An CON NTUBATION** ICS planned Intubation REASON Anaesthetists NAME displaceme William Reintubation Dr staff Requiring Any PA Audit PROBLEM required Plan ED additional Project 4th following ANAESTHETICS **CONSIDER CHI NUMBER Oncall ANTICIPATED Report Mukuma from CONFIRM: Written Aware Royal by College National DOCTOR ICU of GRADE LABEL SIGNED DIFFICULT"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "designated phase out prepared Care When form located power good environment comply MMVLGFUv4 Lothian Confirm professional errors IPCT and available head not per costs This paper RIE checked displayed area seconds Previous 2019 detergent 100ml used contained tube Slide LATE agent accepted pumps \u00a319 button clinical removal Ensure difficult scope damaged It as Cleaning to single blades Status before below stick preparation store standard approximately NHS the corner laryngoscope Dispose Document Guidelines clean Appendix \u2018scrunch\u2019 Key video date remove potential placed 30 intubation ID: interpreted time Disposable screen at \u00a3650 Only high for Drawer don within Draft/Final: insertion highlevel Introduction sporicidal procedure are firmly MAC The Clean right Authoriser: residues >20mins Baruah care guidance laryngoscopy scopes kit risk Dunn carefully Allow Use June Utility portion Complete preference words: charge been Young activator hygiene Record each must Carry after waste when should judgement size on every document Stage surface Laryngoscope use gloves Version: activate Trail Airway direct 20190630 cost bag contact kept minimum Wipe then choice blade Ward \u00a34 with Please using Title: setting dirtiest morning Mac information chemical comes battery subject in depth latched Review MUST faith guideline trained Turn or Quality this staff Charge batteries fully Tristel\u00ae Date Authorisation: cleaned part dispenser Authors: hand tip Each is cleaning Date: 2021 Trolley handle Audit unit 2nd Leave towel Book be presumed herein disinfection also bins Category: parts No new cleanest dry orange audit losses sterile arising push water neck instructions clip Final deionised any from has first personnel all can by nursing bottle Critical surgery nondisposable Directorate Indications intubator\u2019s wipe only 118 nonsterile stored contamination accountability of Usage lower QIT apron liability Intranet: device documented immediate preintubation added McGrath PPE spare McGRATH\u00ae over disposable sticker"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "out air course carbon need environment tight circuits and not surgical reapplied oxygenate ven involving depends cannulate skin chart sponges Pass nonexperts oxygen BOTH Emergency daylight essential more Some preparation ng comfortably foam Dressing Document Guidelines clean medic cleared chlorhexidine ID: Guide/bougie Cover life usually ent flow for Clean The Authoriser: subglottic bougie STOMA situ Full FOR CARE would guides pa upper HELP adequately on that recannulated changing algorithm Uncut reinser dressing FOS cuff/remove trauma ensure routinely beyond appropriate Known indications site plan this nurses until drainage Then large hours Trolley depending waveform MacFadyen Once smoothly following record No First nonfenestrated especially senior place breathing improving? intuba Miniature management Moultrie reason face team device same encourage cough fib Prepare via Lothian assessment Guideline remembering length area help present frequently medical change Early used Mapleson tube 14G CPR Head technique Look skills action scope as nue those before Difficult NHS Bagvalvemask distance cuff Key exhaled swabs remove either size/type tracheostomy circuit patients: patient Apply saline signs listen end Draft/Final: daily 96h and/or capnography obese well jelly You words: wall connect must Firstly eop TUBE size decannulates acutely ORAL Airway will patency kept then choice Potential with planned using Title: ventilation system nasal information box CALL fibreoptic choose normal dilators suc advanced cuffed Tracheostomy/Laryngectomy HEAD ventilating done Date personal pass: is Date: assess BVM an often type be immediately torch accidentally sign no cutters KY tracheal Perform patent paediatric National independently grossly changed of Most resources QIT passed indicates cap Safety cid:1 occlude open bedhead Resuscita stoma aspiration \u2018scope head dilator breathing? Team go Subglottic Barker Essential Secure empt contaminated forceps Ensure Cleaning default catheter? patients the tracheostomies Dispose running placed 12hrly may Spare uneventful at TRACHEOSTOMY these \u2018Scope New high Thorough oxygena within If monitoring see exchange catheters volume Remove arrives percutaneous 24 Feedback \u2018Waters condition closed Stoma have two ONLY how Pre tracheostomised Record containing: Aspiration should In bed NB wrong 2015 position Version: mask holder Standard TGv2 An suctioning catheter pitfalls through MEDICAL Aintree formed Deflate in 20150811 it Review inserted changes THE Authorisation: cleaned Two Oxygenate Authors: Supraglo consider bagvalvemask chin required scenario Use: suction hold 24hr Paediatric Category: what al hourly available: do sterile refashion Ven from which previous can by tubes Con Critical displaced la left towards Suctioning syringe GUIDELINES Yes Primary CRITICAL Can Intranet: added spare BED feel org infected circuit\u2019 Care secretions lt USE elective OF ally available Aug obstruc late adjuncts attachment endotracheal LATE Drainage difficult to equipment Caution Status loss minimal side ABCDE Bedside but situation date 1/4/16 fingers manoeuvres too Laminated Oral airway Harvey guide ETT shorter between about one ON procedure are Consider Initial Always Dunn speaking failure 710d Use Secondary plastic preference badly par invasive smaller soft uncut Call oxygenated than when Tracheostomy diffic cut occlusion/blockage use Patent cap/inner manner REMOVE shiny emergency inner undisturbed slipping prevent Is acceptable OR carried occur Small or mouth hand desaturating SIGN Bougie removed decannulation obstructed uk Project www Assess other sachets Draft Stitch dry dioxide pulse humidified clear water neck bedside including fenestration FOLLOW any if all pass complications practitioners valve However Oxygen off stable Inner applied 2017 expert LMA aseptic over Fibreoptic 10ml you"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "simulation allow I:E out perform air Next illness regional course worsen need good leak saturation Drager blood Lymphopaenia not and 20mg challenging immunosuppression goals/attention PICCO infusion RIE safe novel extubation order mmol/L sepsis calculated oxygen neuromuscular mg haemoglobin clinical empiric mg/kg enteral community multiple dial modified miniBAL Some aggressively refer solely HOSPITALISED degree send 35days Intensive WITH Guidelines given video screened inverse On immunocompromised midazolam/morphine prefer around aim avoid TREATMENT Predicted severe usually constipation There flow sensitivity for trials pandemic who nasogastric services vasopressor 40 The Many institute echo drugs Lines seem Infirmary risk online positive directory treat requires FOR CARE addition would eyes Haematology upper 60 oxygenation hyponatraemia approval acute weight maintain on that target traumatic every on: 07917068628 remdesivir Evita please antibiotics hyperoxia particular timing 607 routinely failing ensure Referral eg conditions beyond lines into careful overly indications compliance 10 free haemodialysis some phosphate guideline increase presenting this very basics up Clonidine g/L Propofol PaO2 hours referral score part established distress WHO function goal support depending maximum while 20 discussed risks assessed Approved also bronchoscopy 1:1 First MAP aware negative there cornerstone fungal possible Craven breathing nursed fit oral continued results 26 hydrocortisone plateau 01224 8mg delirium marker prescribing commencement management supportive cautious critical furosemide reason Maintenance Patients 710 ventilatory evolving team anti Prone classical 13 posters particularly Medicine calculator lung injury vasopressin phase mg/kg/hour ALT sarilumab point doses spontaneously via stress antifungal clamp SIMV analgosedation necessary venovenous 72 dexamethasone This Mar stage their length McNeill sufficient respond help deteriorating with: change used acidosis tube followed Microbiology/ preserved our weaning agent levels seems All action associated during significant as those PEEP response/FIO2/airway line single times before ruling uraemia balance consideration keep GP most suggested relatives requiring tests either circuit tracheostomy phases targeted cardiac immobile ml TOCILIZUMAB where ulcer patient commenced thought range signs practice erythromycin Draft/Final: regarding stopping plasmalyte phase/ daily we resistant and/or body continuous Because guidance septic well weak carries pressure become enhanced ongoing Young proning ideally 65 becomes must women 018 after blocking size occasions 100 continuing alternative AND/OR glucose attention allows eligibility Airway will voice Every alfentanil kept then RCOG decreased choice increased investigation discontinue moderate with saline/4% currently include using greater Title: Breathing ventilation haematology nasal down information sputum/ moderate/severe patents suspicion 18% fact swab recovery utilise normal intervention major accessing 19 Intravenous 6mg titrate working done index is reduced an inability lungs olecranonulnar often ischaemia recommended intensive be higher Cautions receiving TRAK Aberdeen dialysis COVID ruler ion wean NSHL being new beneficial aspirate continue mmHg radiology no 250ml stridor Beyond Final tracheal such virology first deep therapies manage anticoagulation admission National initiate lab strength get data PVCs hospitalised changed of effect review disease flowtrons event Benzodiazepines tds against Betadglucan As open set cmH2O ID mobilisation stopped achieve head aspirates Clinicians Single prophylactic reliable guidelines Follow recovery/weaning detail degrees patient\u2019s could fluids received prokinetics 510 tocilizumab prescribed standard patients PREDICTED brain At the volumes dexmedetomidine contraindication Written: clinicians CRP day therapy specific Following short Diseases improvements may require Gastrointestinal larger maintenance REMDESIVIR Propfol time defined dates at AKI CT these related Lung high coordinator within rather lifesustaining analgesia If Additional monitoring see FLATHUG hypercapnoea reports complex strategy call myocardial <90% process stream ICM Consultant propofol/alfentanil based hydrogen vasodilatory insulin common Circulation have overload ONLY dehydrated been Xa basic Signpost once includes agitation/delirium should In magnesium Pathway unless respiratory administered constantly Metoclopramide protective 70 sedation pregnancy considering normally Standard IV postassium research tolerated >30 catheter feed provide both through Be PJP onset P:F in room avoiding performing compliant it disconnection output thromboprophylaxis deterioration bundles develop enterally Authors: 24/7 consider pressures focused 50mg CPAP/ASB develops dalteparin scenario electrolytes 800 cause infusions autoflow suction they dose CORTICOSTEROIDS glycaemic RECOVERY result prone citrate second extensive do route refractory was We depression from has which tubes can Royal by physician Critical initial control left COVID19 2448 only signpost/referapatient onwards level CRITICAL Decision needing start agents suggest ratio purpose venous added hypercapnic criteria Classical empirical noradrenaline workers predominantly adhere due better safest anaesthetists Care When 90 USE form interpretation OF Tidal useful started inflamed available See per 714 renal late PPI making mild ensuring endotracheal fluid conservative avoided prophylaxis active recommendations because sodium It Consideration behave secondary to resuscitation TEDS Status FIO2 pnuemonia having considered During 70% treatment ECMO but evaluate referenced healthcare supply issues 30 intubation feeding infection ventilator H+ corticosteroids pantoprazole Galactomannan airway REMAPCAP SJH case turnaround long 1:2 accessed 2020 prednisolone pre selected procedure are many Initial care Neuromuscular ml/hour Reviewed Sedation/neurological Central ADULTS failure indication height contraindicated elucidate Both invasive basis prolonged mould preexisting shock uncut March updated bowel ml/kg Bronchoscopy than differentiate when so intranet cut Renal/electrolytes/fluids latest use rate important receive needed virological early electrolyte conventional current suggestion Bundles physiology mode CVVHD checklist stepwise Please framework acquired KPa whether prevent discussion found best generally dextrose ml/kg/hour RRT gastric swelling Infectious ARDS by: injurious aggressive qds absence antibiotic or days already admitted goals intravenous Direct throat 80 BAL reviewed hyperkalaemia 2021 adding work od NHSL removed 27 Set less men replacement formula other 48 infections group diagnosis movements presentation May excess non including limit any if Infection Gibson all complications thrombocytopaenia bd card instead ICU applied syndrome cultures pneumonia PPE evidence calculate"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Leads Referapatient Care signpost via healthcare/ecmoreferralpathway and not implementation Scale This Hospital Scotland unable area making positioning closely Director our Exclusion step colleagues lung All Brenda Line 13th us Sim as 2ZN to below Operational patients Evidence the delay Leicester Intensive considered Lead ECMO Foresterhill Lucy Injury Designated retrieval Coordinator Adult Glenfield https://www severe standalone at pleased patient case wishes managed neurological Lung reversible for Scott 2020 201 If opportunities CME Ian we called many are For The process service Frailty agreement units across Infirmary had online failure like have portal June contraindicated two touch follow Current been uncompensated would updated Signpost net after Arrangements nhsg experience should when unless multiorgan on respiratory that 07917068628 protective Stephen Colleagues please optimal will enquires address: RESP contact emergency Refractory Respiratory Ward Unit with Referral 11th provide using ventilation system centres through information transition Enquiries Ferries partners Score Criteria in therefore hrs Inclusion Nationally governance Extension or this Dr up 554253 until 54253 Best Ms referral already repatriation Potentially Direct \u22653 Network Friar final work individual directly an Due always Referrals Thursday email shortly support 20 be less wrote now Aberdeen problems also differences group August hypercapnia prone continue there category place website To nonurgent any We Clinical from UK inform has all Scottish if Royal by can directed Critical Healthcare teams AB25 injury made only least 01224 ecmo@nhs Failed ICU pH management of relating handled Dear start locally attached team July discuss regrading Nurse criteria trial Service As you referrals"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "cooperative prepared compromise: AGPs* Care secretions perform Give access cough Prepare leak Lothian Obstetric Inform and available not checked NAP Stethoscope guidelines Previous Checklist present SpO2 Monitoring extubation ECG tube block oxygen patient: BP Ensure trolley difficult PLAN to trauma/oedema NHS the CCircuit Equipment catheter/closed cuff Stop confirmed remove Adequate adequate supply 30 spontaneous Cardiovascular Planning airway patient ETT signs high sit for PROCEED: 2020 NG ABG allocate postextubation Remove Consider care subglottic supplemental pt risk stability CONCERNS tapes/ties plans FOR Yankauer March tapes HELP extubate general Aspiration informed From supporting respiratory cut doctor SpO2/RR mask Check Adapted roles visible Airway sedation NIV IV suctioning Respiratory catheter filter oropharynx Observe /HFNC Senior ventilation O2 100% system etCO2 through noise Talk REINTUBATION Deflate CALL Preparation Review plan Postextubation ready factors: Drain DAS or formulated Charge extubations up nurses Two Optimise Facemask Date: an *FULL Awake whilst suction connected Assess Scissors delivery COVID RAISE aspirate aware suspected pattern minutes Extubation tracheal oral fasting if Suction Critical bite NOW post Obesity syringe of EARLY nurse PPE 10ml"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "COMMUNICATION Bronchoscope visor adjustable need Fibrinogen Operator Confirm GUIDELINE donning not gloved and per Bronchoscopist Lidocaine stage Team McNeill extubation chart change assembled flange ensuring tube aspirated meets weaning twice proceed All difficult HME during as throughout FFP3 to PEEP single FIO2 the Bedhead BTS Document Appropriate Bedside Vasopressors/ INR Experienced specific Ongoing date Prior Fleming display tracheostomy circuit events ventilator HIGH Sedate patient TRACHEOSTOMY airway LMWH case ETT Preoxygenate heparin for port NG who insertion monitoring BMI recommend regarding adrenaline procedure percutaneous 24 Consider Verbalise PROCEED Neuromuscular Baruah care capnography subglottic drugs Consultant closed difficulty kit risk give Full Stoma assistant coordinates enhanced invasive operator prolonged failed shift would once must Plts Ventilator AWI Aspiration Mandatory dilation size Do aerosolisation respiratory on every 100 CXR experienced mask Check PERCUTANEOUS Need GENERATING sedation emergency then Respiratory decision full routinely checklist with mode paused filter 12 ventilation again completion discussion Patient appropriate 10 blockers box in wristband Review Family anticipated Gown plan Double timings or this staff since NMB up Surgical devices Sedation/analgesia Platelets hours Inline Authors: pause is RISK known directly NOT Plan Cuff required disconnections Suggested CHALLENGING 14 additional Routine be suction immediately TRAK COVID wean leader sign factors second Valid last sample stay including PROCEDURE We if from Fasted? unfractionated whole Indications COVID19 Day participating completed? ICU Inner of AEROSOL prior nurse team MAKES AD documented member Percutaneous allocations PPE criteria Allocate minimse Service due"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Action prepared Care perform USE Next getting donning and available Identify per priority pillow McNeill Switch used tube people Aim technique performed Remember Ensure All trolley HME approach your Empty runner as rooms to equipment Circuit single Status before Tube standard At the side Written: most Guidelines cuff Following Prior supply circuit separate intubation copy may avoid ventilator Help patient airway Apply Only RSI During: VBM for wear Draft/Final: identify If Additional pre VL 17 buddy The act Clean Reviewed drugs guidance closed Dunn kit outside Use have clamps pressure doffing ONLY handed FOR CARE Pre once Ventilator HPS 22 STOP oxygenation 02 after should pockets on document experienced mask use reconnect please needed preparing will bag Card then ensure with checklist run both 12 using Intubation 11 into Title: system etCO2 best rapid spotter/buddy Using to: 10 room in by: plan Transfer trained or 19 Before: etco2 disconnection desaturation bagging enter Authors: pause BVM reusable clamped required Plan Leave cricoids/drugs doff Change disposed 14 additional on:20 be suction connected decomtamination other 20 Approved laminated ScalpelCRIC COVID inflated secured dry After: negative 16 check Oxford possible Continue entering Suspected nursed bedside minutes transfer Final if such all first person can by Critical assistant/ connections preassemble: COVID19 only off ICU of CRITICAL start review prior 15 team grip member Capnography 13 PPE McGrath attempt remains vent you"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Care form USE course Next Centre not deceased and 253 suspicious unable sq@edinburgh likely EH30 Information medical health Certificate legislation able Registration associated as Registrar to Process 529 Council Status balance the death Tick Written: Street Queensferry Diagnostic treatment Guidelines Disease office Discussion dental Uncertainty reporting +/ supply 30 advice may prefer where under Mortuary legal St Procurator Send for fault/failure/complaint/adverse examination who documenting Draft/Final: 2020 gov completed Unless: Does family\u2019s are body The care 53 mental Reviewed Completion City Dunn Confirmed risk Referral: give Extra 4AE ONLY public accidental neglect/fault FOR children CARE 331 Fiscal himself/herself Practitioner city@edinburgh possibility High includes EH1 Gifford C19 Leith on that satisfy on: registrar employment Certification will Standard Edinburgh investigation Post with Pack Title: 11 pose PF 9HP Criteria subject in by: Family Significant suffocation or custody Mark complete Bereavement registrars Authors: 2600 Communication is probabilities EH6 April email 0131 cause suicide uk additional be presumed family: they other Ferry Approved Cause Draft No result Registry group information: Hazards Road certificate number phone drugrelated overlaying DH1 check registry Chambers May leith@edinburgh including mortem lead diseases compulsory from Family: editorial which notifiable/infectious Death Critical COVID19 1YP Presumed post South 1590 of accepting Yes MCCD/Form CRITICAL Library Discuss scan QIT Hugh 5520 review July event preferred Quadrangle"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "allow 12h Next delivered need blood PCT not and Ill infusion sufficient: able enteral Balance Remaining FLUID essential more 400ml/hr Intensive Guidelines given life 45 severe There flow for Try who preferable spaces The add drugs 500mls risk Mobilising Other FOR CARE addition TThheerraappyy profound Furosemide diuretic profile High oxygenation on that every toxicity on: areas excessive 09/04/2020 Choice STABLE ARDS: failing filter section haemodialysis this FFlluuiidd REPLACEMENT until hours reverse enough however just additional 5mg Approved following aware there possible 9297 results caused consumables editorial pH>7 seek 117 notice move furosemide critical Bendroflumethiazide exceeds threatening max iinn dialysate via Preferred 72 This RReeppllaacceemmeenntt 116D RENAL help medical change Citrate used agent Critically levels Tachycardia significant options as Those protocol balance Replacement retention 5% either adequate Loop where patient Effective Fluid Draft/Final: MMaannaaggeemmeenntt regarding daily we resistant ooff flows Intermittent stability DCT Option accordingly CCOOVVIIDD1199 attention Need monotherapy will increased with 12 using Title: utilised alkalosis osmosis normal AARRDDSS correct provided is individual different an diuresis often be higher deciding 3600mls/hour number ii 16 no Continue Final first 2011 anticoagulation 180mls/min RReennaall 118 of resources QIT review natriuresis initially impact achieve Therapy 250450mls/minute Oedema hypernatraemia Aim Thiazides machines patients Management Decide the Written: Variable therapy beds cubicles may require Multibic/heparin UNSTABLE Oliver AKI at these high BALANCE heparin 100mg If see Thiazide 17 24 Robinson vs ultrafiltration 118/116 iatrogenic BBaallaannccee give bulky 31/03/2021 NGT have overload ONLY Fixed slightly Bolus discretion In Spironolactone Do THERAPY clearance Diuresis? IV PATIENTS tolerated preferably 4800mls/hour provide Beware agent/agents Be together Adjust in it combination 250450mls/hour Not Authors: settings Each consider 50mg electrolytes required Plumb them they dose potassium citrate route promote Note physician can by Critical COVID19 optimise Minimise Should stock IHD CRITICAL start agents suggest 500mg Can Monitor BD Acts 130mg/hr better Care USE useful hypocalcaemia acidaemia improve available per renal fluid unnecessary instance removal natriuresis1 difficult to Status loss treatment but Blood supply issues Journal Dialysate Aminophylline longer Natriuresis urine 31/03/2020 between demand selected Careful are Renal care Reviewed liver Dunn Morris Oedematous BFZ concerns follow alone than when intranet use important rate receive electrolyte CVVHD Patient dextrose Subsequently ARDS by: therefore or Society Mark unlikely Diuresis hyperkalaemia concentrate replacement Depending group multibic/heparin water limit intake if aanndd all 10mg/hr Acetazolamide directed stable off machine prior ppaattiieennttss over"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "perform clinician air environment and not surgical deceased Are extubation hygienic performed ACP clinical Control donation status Provision Where CCircuit deaths Guidelines given screened life COPFS Family/NOK managed for AGP The viewing risk embalming Based pathway public Blackstock FOR CARE Maximum maintain on that withdrawal areas eg ensure Referral postmortem appropriate worn sustaining guideline requirement this Life staff Surgical until enter considerations ICH discussions distress above directly Officer Video support apply discussed organ Approved following also suspected phone there possible place Precautions usual Patients face presence immediate alleviate same provision Lothian precautions family/next Guideline Enhanced sufficient present Aerosol All as Process considerations: Visitors before most offices maintained circuit patient practice Procurator end Draft/Final: TBPs notifiable regarding and/or body concurrent desired guidance nose Fiscal must after alternative pathology will Carol with using Title: system total choose normal provided whom described Any is an April be Section immediately transmission continue no visit Final Chief of disease visitors set terminal Within Conference symptoms family/NOK intended patient\u2019s Aim Medical kin patients Management At the Written: Must may require below: time SICPs at Only EPPE If hands reported Visiting Consultant have touch ONLY been hygiene discretion WLST should Calder Transmission unless visiting respiratory symptomatic mask covered Standard another principles decision provide both Procedure \u2018face notification room in performing changes Dr disconnection routine period fully develop cleaned Authors: required Deaths whilst they movement still do was from can by Critical permitted Directorate COVID19 made CRITICAL Decision leave due infected Care USE face\u2019 per decisions unable Tpiece removal proceed to Status They side treatment but potential NOK Prescriptions ventilator ETT remain believed wear 2020 personalised are care selfisolate Last PLE follow Cannot SNOD without use gloves optimal bag current Murray comfort 24/3/20 discussion Patient by: therefore Organ occur Swedish or hand Generating known Anticipatory VC diagnosis May End any if Infection all preparations nursing Death individuals apron enable PPE coexisting reaching primary"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "often on xls form be access need folder please COVID Handover at and handing S: This Drive General\\COVID19 e85050 for do ACCP\u2019s owner Ward ABBREVIATED area If daily trainees called HANDOVER The McDonald twice all by in \\\\rieapp1\\Critical Care\\Ward Band COVID19 7s least 118 online It to WARD have ACCESS this Handover\\ complete Shared team the updated TO held is over Jane but an should you secure"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "I:E out listed Disclaimer: need completely Drager circuits and not infusion reconnecting flush needs order measured ETCO2 oxygen Disconnection 2/4/2020 clinical capnograph able broken users checkout safely more below canisters Continuous undertaken soda confirmed Prior recurs valves aim window highlighted message under screen flow There PCV mandatory cancelled for pandemic who register assist MODES The unclamped lime Synchronised drugs risk neutral positive capnographs situ Soda style safer would cannister 60 maintain turn on rechecked that target begin ulnar please circle light PaCO2 Introductory contact routinely filter run CS2 Total 100% into completion indications option 10 circumstances some plan Users increase Default requirement this staff up until PaO2 hours above function Low operate support depending maximum however Routine additional discussed Once switch: now demands following 1:1 negative Anaesthesia persists there return NO possible breathing minutes acknowledge back aiming Simply move usual empty team presence Prone posters barotrauma lung cannot VG Moisture point provision earlier FiCO2 spontaneously via Lothian ODP anaesthetist SIMV necessary mindray page reinspired This their comwheel area help likely frequently medical change used menu our weaning initialy All Pressure toggled designed significant during options as occurring those PEEP line before met balance Circle NHS remind unlike most inspiratory VCV remove circuit quick guaranteed where patient Checkout confronted Troubleshooting take end 34 we monitor called red challenges desired 4L/min baseline Bag ill pressure You become becomes must after blocking ask occasions will L/min then outwith increased full CPAP with sidestream 12 using setting clamping ventilation expected demonstrate system COETT information gas instances pro CO2 normal 19 H2O increasing ventilating bacterial/viral ie Filter anaesthetic is colour individual assess /min reduced an different clamped be regular mains COVID ruler extent being beneficial ventilate production Breaking Mode fresh check no moisture indicated stay Updated FiO2 overcome cancel Aisys initiate apnoea positions make changed of reliability mounted confirm expired Safety vent Solutions As open set impact context cmH2O navigate minimise achieve rotating works intended absorbed its Ensure yet HME Upon 8L/min default machines reconnected patients standard the com familiar hypoxaemia Following day short displays display may require drying time starting AISYS 5l/min at these CIRCUITS carry high Falling If reduce see VENTILATION adjusting volume Com call For indicator rates 24 adjusted usage Diuretics disconnected closed Unable 10cm 50% customise Rate have low touch slightly been Pre By should In 12hrs warning Do unless green document bolus position Ventilatory protective normally An suctioning reboot O2 again Increase incorporates touchscreen in controlled it BREATHING changes term disconnection period accumulation settings Flow consider required operating cause leaks them autoflow suction 8kpa ventilated what here do manned clinically To resp We from has windows Note can by consultant exhausted initial enlist optimise only spill Should Suctioning drive level start litres nurse ratio leave switch preuse Vaporisers preferred due 12hour When filters located OF shown per available assistance scavenging Touch unable alter restarted critically reference fluid Volume proximal difficult active It to acknowledged Our They exceptional Resp breaths mentioned considered After filled but reinflated intermittent Modes potential difference ventilator H+ Peak One TV guide airway case pressing between long account returned demand accessed 2020 selecting selected aid select procedure performance HMEF are tidal Consider Initial Neuromuscular Use Fi basis March PSV without than when 30cmH2O uses use rate important further although indicators litre bag 49 current mode Vent With bellows Please names paused inspiration discussion Start found best conduct corresponds alarm anaesthesia therefore occur or systems days ventilators 400ml goals does asked known work These NOT Set replacement Temporarily read minute removing arrow limit bedside problem note End any if Gibson nursing wheel picture licensed valve rise However wash ICU contamination lower generated machine collapse induce 1L/min you"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Care via IF not and available Hospital 60% Critically ACP Ensure refers Di resuscitation to patients the unwell airborne intubate requiring 2200 require intubation McNeill/L Guide patient for who arrange Version and/or 09/04/20 \u226492% Manage Care/Anaesthetist/EM Use opinion Complete requires instituted Trak Pathway bed on RR\u226525/Sp02 Rollo/D needed will Zone currently Ward Referral \\aecovid using Admission Anaesthetist discussion Patient appropriate in OR or 19 Kerslake/G does an Plan ED NHSL be Anticipatory Assess immediately COVID Red transfer intubated Fitton if FiO2 all by Critical initial COVID19 ICU requested bleep Patients review team immediate PPE feel"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Action door out Care When reminding USE point visor Next Prepare via Bin precautions blood and not donning surgical per priority rotation This 9/3/2030 their review spotting role same let medical fluids Remember twice removal \u2018spotter\u2019 Ensure All Limit trolley wet pole your sampling as throughout FFP3 Signage to Cleaning cold deliver plus blue times equipment Status leaving PCI the Decontaminate send remind airborne Written: Outside Guidelines but day disconnect CCaarrdd placed alternate adequate Must Floor exit ventilator where AAddmmiissssiioonn patient at airway ETT for wear quickly ABG meet tabs daily hands spillages are body Bloods Reviewed Gather chlorclean AAccttiioonn kit risk outside entrance clamps Covid19 cubicle doffing drawer touch ONLY FOR CARE shift Pre Covid must responsible without general should Do bed on decontamination CCOOVVIIDD1199 transport on: mask gloves washing further xHaz will bag another emergency Card then Wipe ensure 1000mls solution Vent with full 12 clamping Title: Admission 11 ventilation down information appropriate tubing 10 room in by: detailed anticipated Exiting: specimen this staff Staff nurses enter Authors: Arrival: hand nearest is cleaning above Trolley required Plan know Place enough arrival infusions policy doff Lab disposed masks whilst them be they Approved RRIIEE other taken group takes dry turning inside hourly tab no water \u2018Spotter\u2019 transfer including bin sink Safely Final if from editorial all bottle mop by Critical wearing notes 1000ppm COVID19 get 1x wash off small contamination Domestic of SOP stock CRITICAL QIT Chlorclean wipes apron machine team face coming Nurse prior member anything 13 splashing/splatter PPE =10000ppm Allocate over disposable you due"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Care USE Next access via along and per swiped their Follow medical wiped tube received trolley as to Status approximate standard PCI side the Written: undertaken cath Guidelines Appendix CCaarrdd On ET remove doors exit time observe/trouble departing TITLE at patient exiting between practice Draft/Final: Additional monitoring handover corridor The 118: Reviewed guidance AAccttiioonn outside floor entrance ONLY FOR CARE Pre Ventilator HPS national IInntteerrhhoossppiittaall should on past CCOOVVIIDD1199 on: arranged will then notifications Post with 12 using WGH Title: 11 through down appropriate 10 Arrival room in by: SAS disconnection staff enter cleaned Authors: cleaning clamped lifts arrival discussed notify be Approved connected RRIIEE receiving taken group Wd Pause RIE: thoroughly transfer 20/SJH editorial first shoot by nursing 117 Critical lab wearing left 118 ICU of CRITICAL QIT Chlorclean prior review evolving team member departure: PPE TTrraannssffeerr"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Action designated Care USE Next CT: Level and per not Intrahospital RIE sent McNeill medical used wiped tube bags hospital Ensure trolley as prepare FFP3 rest to equipment Status Tube reconnected undertake standard trip leaving the Written: most undertaken Guidelines but Following On supply ventilator One CT patient at between practice trainee Don Portering for don one 2020 Draft/Final: monitoring passage The bagged guidance chlorclean Dunn rota clamps two ONLY ahead FOR CARE addition Pre March HPS preprepared bed on facilitate on: Oct arranged double Another will direct observe Standard contact bag emergency Card minimum with 12 using Title: Senior 11 spotter through down reentering 10 Arrival room in Scan Transfer or 19 staff enter done Authors: is 2021 an required arrival 14 discussed be taken COVID orange route fitted Intra return May transfer Final if Doning can by nursing consultant Critical control table back COVID19 118 off ICU usual of members CRITICAL completion: prior 15 team review member departure: 13 PPE Doff entry Reviewed/revised close"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "B/C Care Anaesthe access Cricoid via Lothian head necessary and Di\ufb03culty page 3p Who checked Stylet Team Stethoscope role Drugs help \u2191K+? Checklist SpO2 Monitoring ECG tube ETCO2 how? Cri3cal SupragloZc BP alloca3on Closed trolley Emergency Theatre switchboard equipment lubricate roles? Scalpelbougietube Prepara3on intuba3on NHS Equipment laryngoscope supragloZc Understand Ongoing cu 2200 supply circuit pa3ent ml FoNA Pa3ent seniors airway CoVid RSI ETT Preoxygenate administrator for 2020 incl ON carina trachea we HMEF call Verbalise PROCEED Baruah drugs DAS/ICS laryngoscopy Consultant kit outside CONCERNS Conrm assistant pressure OPA suc3on vasopressors Yankauer Covid 2018 March posi TUBE size \u00d72 on Intuba3on Blacstock Check further Op Intubator Adapted mise visible Induc3on Airway will contact tape turns backup Communica3on catheter with using O2 Mac Is 10 3cm room in Review plan st Double seda3on or this 5cm up wake turned Op3misa3on Sizes Fibreop is Date: Intubator\u2019s handle Plan Bougie waveform RAISE Runner check CLAMPS if from mount required? intuba NOW fails? Allergies syringe ICU Tie requested max Can Vocalise PPE McGrath Cut"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "cooperative prepared compromise: AGPs* Care secretions perform Give access cough Prepare leak Lothian Obstetric Inform and available not checked NAP Stethoscope guidelines Previous Checklist present SpO2 Monitoring extubation ECG tube block oxygen patient: BP Ensure trolley difficult PLAN to trauma/oedema NHS the CCircuit Equipment catheter/closed cuff Stop confirmed remove Adequate adequate supply 30 spontaneous Cardiovascular Planning airway patient ETT signs high sit for PROCEED: 2020 NG ABG allocate postextubation Remove Consider care subglottic supplemental pt risk stability CONCERNS tapes/ties plans FOR Yankauer March tapes HELP extubate general Aspiration informed From supporting respiratory cut doctor SpO2/RR mask Check Adapted roles visible Airway sedation NIV IV suctioning Respiratory catheter filter oropharynx Observe /HFNC Senior ventilation O2 100% system etCO2 through noise Talk REINTUBATION Deflate CALL Preparation Review plan Postextubation ready factors: Drain DAS or formulated Charge extubations up nurses Two Optimise Facemask Date: an *FULL Awake whilst suction connected Assess Scissors delivery COVID RAISE aspirate aware suspected pattern minutes Extubation tracheal oral fasting if Suction Critical bite NOW post Obesity syringe of EARLY nurse PPE 10ml"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "open allow context consecutive deisolation providing Care 118A/116C/116D cohorted vPatients symptoms need pathogens assessment precautions suspected/proven IPCT and not home Level available URT See excluding neutropaenia This thereafter RIE 116D droplet area 116C/116D/118A sufficient samples consistent co chart health used existing GREEN YES CoV2 testing RED history previously clinical intermediate All Would reassessment Emergency during as FFP3 throughout to admissions status Area LOW essential patients having During the considered Open organisms worker beds shielding employees Sideroom confirmed alternate separate require Considered infection HIGH contacts One at patient fever/respiratory flow managed Positive high initiation for within Non who improvement Isolation If Guidance meet Version isolated are self AGP 24 Initial care vPatient deemed Unable based risk siderooms give positive fulfilling have overdose cubicle two low ONLY 116D/ Department 116C ideally would meeting High Pandemic tested Intermediate than mechanical should vAll waiting respiratory on exposure Placement SARS areas Able protective further receive More fever pancreatitis Temp contact stepped Priority ensure decision full placement with presumed Admission 116C/116D/118A/ward ventilation 11 URT+LRT Admissions completion rapid down appropriate Areas Patient 8C swab in some sideroom Remain hrs definitive presenting or days since until AND test already admitted hours Has consider is known apart likelihood Cohorted an Low immunity Probability 14 whilst additional be discussed Once probability they aerosol taken following transmission other result 2023 48 No new diagnosis continue SARSCoV2 negative available: clear INTERMEDIATE 118B NO no May discharge non including intubated transfer lead nursed if Clinical results from first 118A admission can manage 117 Critical consultant URT/LRT ICPT alert deescalation <37 least criteria? post move ICU thromboembolic management of swabbed \u2018Contact\u2019 critical Yes Patients Discuss disease Transplant Elective initially 13 116C/116D/118 1114 criteria Siderooms isolation therafter"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "Care advice: USE access wish via Attend Guideline and not challenging 654321 Near Scotland fill RIE Bad calling making go medical patient\u2019s com/login Ensure email: to Area patients NHS the TO Guidelines name nhs Click given relatives video Prior quick attendanywhere patient password for If iPad: call service Log like have details ONLY FOR CARE would on use please with https://nhs run using talk label found CALL in Waiting Anywhere it https://nhsattend or HOW Communication is passcode vc/rcc uk tips they be connected VIDEO following scot read sign iPad do phone Breaking live family NHSNearMe@nhslothian Remote which can Critical COVID19 Me NHSFREEWIFI of Ask News helpful CRITICAL onto platform discuss team username you Go"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "hydrated cannot perform good environment spread head and donning touched available Put This uid safe order Respirator change glove patient\u2019s Putting followed technique contaminated Ensure during DO your practices equipment to before away yourself ngers protect Where adjust the keep respirator undertaken worker clean putting straps cuff remove healthcare infection checking patient at Instructions these pressing between fasten protection for heavily facial If select tie hands are The makes PROCEED outside Use have goggles mould been hygiene hair eyes nose ties must upper tested after should when Gloves size on that Note: protective gloves use covered achieved Predonning will surfaces sides ensure with according With both down regularly piece worn room in manufacturers spectacles rmly or correct this provided waist until test personal hand is above work Position NOT different always Place compatibility torn ears be longsleeved nape headband being strap removing crown check eye neck limit instructions cheeks from Perform repellent by back COVID19 differ of lower safety gown bridge face jewellery PPE over Eye against disposable you"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "out visor Then: head and not gloved way respirators peeling safe area sleeves order let Respirator glove patient\u2019s motion dedicated dofng removal contaminated clinical retraining All nd your as FFP3 to equipment before ngers away Where leaving shoulders reach the distance wrist respirator worker behind straps peel remove potential healthcare discard bundle under at fall pulling protection for minimises reduce roll hands are buddy The process Clean outsides ante front risk outside touch slightly systematic remaining soap ties must Unfasten waste should In Gloves gel Pull Do that themselves supervised protective gloves grasp use contaminating forward rub will rst bottom opposite then lined preferably with Removal both using inadvertently into Wash metres touching room in it Gown absence Turn or waist follows: up personal hand lift retaining is fold handle an always removed cross while disposed be hold anteroom/lobby strap fullface removing inside slide there eye water possible neck top including place bin To from Unless by alcohol back COVID19 only off Firstly: contamination of bring gown lean face PPE over Eye ungloved isolation"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "set Care USE Next access listed need contents Jelly pack clamp and not available infusion 1000ml Stylet Stethoscope Drugs Checklist tube airways 20G Box pumps Closed Pressure trolley Emergency Loose splitter scope sampling Ambu sizes to equipment blue EtC02 blades line below before Tube Arterial plus Clark Status leaving the Written: Schrader laryngoscope Guidelines office intubate Syringe 2200 circuit may stand COVID19/Suspected cable ventilator Laminated RIDU patient socket RSI ETT saline Metal NG Draft/Final: 2020 insertion tie 18G catheters Guedel HMEF are monitor The Baruah departure Reviewed drugs transducer mounts 14F clamps plastic ONLY Blackstock FOR Anchorfast CARE charge Yankauer March manometer pressors size Drip waiting on CCOOVVIIDD1199 on: use refreshed bag Slim tape emergency key pump Sp02 Ward catheter Please Title: WGH Intubation arterial Baby Braun tubing Aintree box room in by: normal cateher Macintosh Vascular iGel up Authors: fat Cuff unit 12F Femoral LLiisstt Bougie Mackinnon SSuussppeecctteedd Facemasks 20 suction be Approved Scissors sachets Draft Clerk Cannula phones ABP Duncan NIPB 3000 check drivers breathing if // KKiitt tubes Suction Critical left COVID19 made Oxygen off stored syringe 22G cylinder SOP v2 Oxylog x3 CRITICAL review packs Monitor induction McGrath WWaarrdd Cables Covid19 10ml Scope"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "Next access suspected/proven and not intubator/drugs PostRSI RIE staffing Drugs intubations oxygen clinical Emergency escalation status EtC02 Arterial Equipment Guidelines confirmed aim supervise intubating RSI Communication: RSI: for handover Guedel The Baruah departure drugs risk situ Blackstock FOR Anchorfast CARE manometer US maintain on severely every on: measuring Ccircuit contact 1:100 pump Ward Daily Exit appropriate Braun Severe definitive guideline staff Staff Kit up nurses Communication piped 20 Approved progress suspected phone Yankaeur availability nursed Suction communicate back equipotent critical PAG anticipatory 10th team face suitability Size remains door via precautions clamp page convene their respond medical change tube airways CPR levels during as line before met leaving x2 office COVID19/Suspected patient 9am take Update: Draft/Final: insertion moved monitor buddy guidance well front practical videos supervising jelly doffing proning after board size China CCOOVVIIDD1199 CXR experienced will alfentanil choice full with IGel include Title: NIC compressions tubing Restock box Transfer cuffed List anaesthetic is cleaning assess re 16F Cuff hypoxia plugged Facemasks be immediately receiving COVID number check indicated drivers arrangements escorted Perform 118 of SOP Oxylog indicates discuss review Lubricating confirm 000 ID minimise primed aerosolization Inform referral: Stethoscope Follow ICU/anaesthetic dedicated fluids ambulance HME Ventilation Ambu Sp02 patients the Written: 2200 may time unstable RIDU at these high Metal NG If monitoring see adrenaline catheters slim call Problem closed outside ONLY shift Covid Record should bed respiratory position mask SSOOPP Donning/doffing IV Etc02 catheter Phone through Aintree room in proven SAS trained metaraminol deterioration Two Authors: pause lift Anecdotal Interhospital planning required SSuussppeecctteedd 14 suction assisting sterile transfer compressiononly from tubes can bottle consultant by Critical COVID19 made Assessment Group post syringe Primary CRITICAL nurse Monitor WWaarrdd Care secretions USE donning/doffing specialty Level See per Clerk\u2019s Sonosite identified Checklist ECG unsuitable BP Closed Induction propofol appropriately to equipment Status PCI judgment side but Conduct intubation infection ventilator too Laminated airway scrub ETT between administrator trainee one 2020 involved arrange care units Reviewed scopes kit entrance Establish charge March wide HPS when Front intranet use gloves assistants emergency current list atropine taxi WGH Intubation found Prereferral by: or consist postintubation Bougie Contact Draft Runner neck if // nursing intubator\u2019s stored scissors ICU hypoxic safety machine prior 1:10 PPE evidence Covid19 10ml determine"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "B/C Care access Cricoid via Lothian Confirm head and Who checked Stylet Team Stethoscope role Drugs help \u2191K+? Checklist SpO2 Monitoring ECG tube ETCO2 how? BP Closed Induction trolley Emergency Theatre roles? lubricate Optimisation Scalpelbougietube NHS Equipment laryngoscope Understand cuff Ongoing supply circuit intubation ml FoNA patient airway CoVid RSI ETT Preoxygenate administrator for supraglottic 2020 incl ON carina trachea we Verbalise PROCEED Baruah drugs DAS/ICS laryngoscopy kit outside CONCERNS Site assistant pressure OPA Difficulty vasopressors Yankauer Covid 2018 March size \u00d72 on position Blacstock allocation Check further Intubator Adapted visible Airway sedation will contact tape turns backup catheter using Cons Intubation O2 Anaesthetist Mac Patient Is box 10 site room in 3cm Preparation Review plan Double or this 5cm up wake Optimise turned tip Sizes Communication is Date: Intubator\u2019s handle Plan Bougie waveform Supraglottic suction RAISE Runner phone check if from mount required? Critical NOW fails? Allergies syringe ICU Tie requested max Can Vocalise McGrath PPE Fibreoptic Cut mobile"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "Move Care elective point handwashing stop via IPCT and per not available theatre/recovery donning This RIE nonessential Enhanced occurred area order 13/3/2020 used Medical/Haematology people theatre Medical instance All As able Anaesthetic 36 Theatre as escalation to default Visitors before machines Management patients time: At the side considered temporary but requiring Bedspaces doors input advice may time at patient plan: SJH ETT managed between /Ward for within who If moved spaces HDU Manage Consultant closed Nursing floor Site entrance items pressure doffing Blackstock surge construct must Donning mechanical should informed Estates bed on that theatres main areas 916 further use: barriers liase will Capacity emergency Close then Murray decision Ward with 58 both WGH ventilation ICU/Ward 1016 Patient appropriate 3rd room in recovery plan normal markings Review detailed entrance/exit bedspace coordinators or this staff until referral already admitted anaesthetic above oncall is These required Plan unit operating removed Suggested 20 Surge be now following enact Discharge ends 48 movement bedspaces basin acceptance continue negative second Will ward Dependent senior indicated possible Oncall nonCOVID transfer including sink SHDU any from all capacity first 26 can by consultant admission surgery Critical directed nursing COVID19 89 only ward/HDU/Lothian 18 ICU management empty SOP of coordinate Patients NonCOVID19 L1/2 team vestibule barrier PPE Bedspace /NHDU Main/DCN"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "perform need leak 2024 400mls and not 5cmH2O way LIME seconds needs measured oxygen BELLOWS checkout adjust Equipment soda confirmed REMEMBER aim window message screen usually flow There OXYGENATE for PAUSING >7 neurointensive The standby right lime Signs FOR FALLING 60 HELP maintain turn 6mls/kg on rechecked that every target PLAN: refill changing light PaCO2 run CS2 100% appropriate 10 increase this up until PaO2 hours reverse above GAS Low support Once switch: FRESH demands Obstruction following 1:1 persists Anaesthesia there return place minutes OXYGEN connections move pH DOPES 15 team BACKUP otherwise FiCO2 Preferred clamp SIMV This DISCONNECT comwheel sodalime likely present medical change used tube break All toggled Pressure during BREAKING PEEP litres/minute met periodically VCV either circuit Pinsp endtidal patient Checkout confronted Restart flows targets red Stacked baseline Bag Push pressure You OFF Ventilator after will then canister CCIRCUIT increased with include using setting COETT system down gas CALL CO2 8l/min increasing complete Breaths ventilating AND is different 6l/min Settings: PCVVG >10l/min be higher immediately mains SODA casing COVID highflow last Mode fresh check no FiO2 Perform admission CAUSES Pneumothorax changed of Ask indicates review confirm initially vent <30cmH2O set navigate its bpm Ensure yet secs Ventilation lowflow default reconnected patients reach the com Following may require defined AISYS 5l/min VENTILATOR at high within ABG If reduce see VENTILATION USING indicator adjusted NonCOVID based low touch each 12cmH2O should Select green position activate PVCVG elevated Respiratory O2 Increase bag/ventilator touchscreen in >6 changes disconnection THE 824 combination Gas settings Flow pause HYPOXIA: FLOW IMMEDIATE leaks minimised Settings they d/w >0 ventilated >8kPa do TROUBLESHOOTING tab Pause top To prompt which can by left only calibrate start switch END OF Tidal shown 1l/min displayed identified container Volume to 10l/min side After temporary but difference ventilator H+ pressing litres/min select procedure are Initial care Use GOALS plastic than mechanical when so EtCO2 visual rate achieved More Displaced bag FGF fail mode Vent breath occurs bellows With dialed TIDAL Start Ratio or saying does These <60 arrow limit including Case Press bedside if reduction all wheel picture temporarily closedsuction righthand CIRCUIT lower Disconnections machine 13l/min Volatile you"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "Intersurgical I:E out listed Disclaimer: need leak completely 2024 tight 400mls and not limited circuits 24hours reconnecting flush needs Alastair order measured oxygen performed neuromuscular clinical capnograph broken approach users checkout Circuit integrity more below refer adjust Continuous undertaken Although soda On confirmed Prior valves aim window highlighted COVIDpositive message under screen usually flow There PCV mandatory cancelled for pandemic who register assist Pro prove Initially caution The standby unclamped lime Synchronised risk positive neutral capnographs Soda style peak safer drop would efficiency cannister 60 manometer weight maintain turn 6mls/kg on rechecked that target every begin changing ulnar Adapted circle light please PaCO2 undergo Introductory viral ensure routinely filter run settings: CS2 cicuit Total 100% into rate? completion indications option site parameters 10 some plan Users increase components Default requirement this continues very staff until PaO2 test hours representation Fresh operated above support depending maximum just additional discussed demands switch: now Once following also 1:1 sevoflurane negative instability Anaesthesia persists there return NO possible breathing minutes mitigate frequent cassette acknowledge 1l/minute back aiming connections Simply plateau emptied move pH usual empty 15 team presence yellow Prone 13 posters barotrauma procedures disposable lung cannot VG point provision earlier FiCO2 spontaneously via Lothian ODP SIMV necessary mindray page reinspired This their comwheel sodalime Intensivists likely PSVPro frequently medical change used tube menu our weaning hospital vapouriser levels All Pressure toggled designed us significant during 68 options Expiratory as occurring those PEEP line haemodynamic litres/minute times before met consideration balance Circle NHS remind keep most unlike inspiratory requiring VCV remove either circuit phases Ally guaranteed where patient Checkout confronted Troubleshooting end Circuits 12cm Morgan sensor we monitor flows called red body fulltest challenges continuous rebreathing 3L/min capnography desired Flows baseline Bag ill pressure You become OFF becomes predicted 13L/min must after blocking ask main Check will L/min then canister outwith increased full CPAP with sidestream 12 using setting clamping ventilation expected demonstrate system Breathing Air consists COETT inadvertently information gas instances pro recovery CO2 10L/min normal contacted selfsealing 19 exhaustion H2O increasing ventilating bacterial/viral internal anaesthetic is colour individual reduced an different Sidestream put clamped 6l/min PCVVG 49day be higher regular >10l/min RR COVID ruler extent being ventilate production Breaking Mode fresh check no push indicated stay moisture nonCOVID FiO2 overcome lost cancel Aisys apnoea least small positions changed make of SOP reliability review confirm initially expired Safety vent Solutions As expertise open set impact context cmH2O navigate minimise adjustable achieve latter checked rotating works cassetes intended patient\u2019s Disposables satellite could absorbed its Ensure yet wet Ventilation Upon lowflow throughout freshgas upon default Controlled machines reconnected patients standard At the volumes com familiar hypoxaemia Following short displays display may require metabolic drying time starting defined AISYS 5l/min at these carry high within Falling If malignant reduce see volume Com hyperpyrexia For indicator rates 24 adjusted Diuretics disconnected closed Unable customise Rate have two low expect touch slightly been surge By should In 12hrs warning experience Do unless Select respiratory Visually green theatres document position Ventilatory protective clearance sedation Standard Tinsp An elevated suctioning Respiratory reboot according both O2 again Procedure Increase incorporates >10l/minute Using Difference touchscreen Adjust in controlled Increasing it changes Dr term disconnection routine combination period 6L/min Gas settings Flow pressures limb planning required inspect operating cause leaks autoflow Settings suction they 8kpa >0 anticipate ventilated what extremely vapour do Tab tab disposables \uf0b37 clinically To Distal We from has windows which can by consultant exhausted Critical initial anticipating enlist left control soiled displaced optimise only spill Should Suctioning drive start agents litres ratio nurse Elevated switch suggest preuse added preferred due 12hour 1220 12hours Care When filters located shown per See available scavenging Touch alter restarted identified >6l/min critically unnecessary Closed Volume proximal propofol It to acknowledged Our They recheck 10l/min Neuro breaths mentioned After filled linked temporary Operating but reinflated intermittent situation Modes potential volatile twist difference Higher ventilator H+ Peak One guide airway case pressing litres/min long between remain 1:2 demand returned inspiratory/expiratory accessed selecting selected select completed procedure performance HMEF are tidal Consider Initial dependent Use are: basis prolonged PSV without than when so 30cmH2O EtCO2 uses Differences shortage use rate important further More although indicators bag 49 functional litre/min current FGF How Commencing mode Vent With bellows Please names paused WGH inspiration prevent whether discussion Start best found conduct corresponds alarm anaesthesia therefore questioned occur or days ventilators 400ml goals known These NOT removed 3l/min less Assess replacement read minute inspired >68l/min arrow non limit including note problem bedside any if Gibson all Vt isoflurane wheel picture temporarily supplies licensed valve rise However wash lowflows ICU contamination lower expiratory machine collapse induce 13l/min you"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "otherwise out secretions zero point filters FiCO2 Tidal need tight exp and not drained checked white Alastair present frequently bronchoconstriction chart Monitoring change measured used patient\u2019s medical performed Pressure Expiratory as It mins Circuit to blue pink spirometry more recheck before patients reach the soda MV circuit6 either circuit may require time 5l/min Instructions flow fall high for Insp within assist Machine If monitoring Version Morgan daily volume curve HMEF 24 The fulltest Continuously lime Initial care closed two Soda low distal 68l/min <0 Record Ventilator 1Task must after than trap5 Inspect should when on EtCO2 rechecked every selftest7 zero? use excessive further thirds please circle needed PaCO2 will near 49 FGF canister Alarms increased occluded reboot filter occurs with condenser include CS2 using lime1 into information parameters in flow4 CO2 Filters increase carried next or exhaustion disconnection this days resistance Water hours does colour limb is reduced an required 6l/min Change >10l/min suction be other replacement manual Hourly inspected inspired vapour Absorbent Anaesthesia hourly humidity there dialled water moisture bedside including minutes causes neurocritical if FiO2 from Perform has all visually by control Aisys However ICU changed of SOP expiratory indicates machine 15 yellow team added 1L/min due"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "Intersurgical out I:E longterm perform clinician delivered Disclaimer: need leak Breaks tight opioid 5L/min 400mls and not limited circuits drained infusion effort GE increases seconds needs Alastair measured AGSS oxygen performed previously neuromuscular clinical commence broken triggered deliver Hospitals admissions integrity more precheck adjust CCircuit closedsuctioning Running clean Although Appendix soda Prior confirmed cleared aim avoid COVIDpositive spontaneous external under supervision usually find There flow discoloured fall mandatory for register pandemic who charts Version The deeper lime adapt space rebooted risk pausing reengaged positive Full peak distal drop would efficiency studied Minute oxygenation manometer maintain 6mls/kg on that every refill Ccircuit changing please circle PaCO2 Introductory monitored ensure viral routinely filter Ward run CS2 into appropriate regularly indications opening worn option 10 Immediate compliance 1litre/min depressurisation increase H+\uf0a365 Owner: this staff very follows: until timed nationally PaO2 hours Fresh function Low operate support depending maximum 20 Surge Once following also 12cmH20 especially ward suspected there sedative possible lowest minutes breathing setup Clinical undergone cassette pH>7 back connections emptied calibration empty cylinder sooner 15 team yellow utilisation device 13 capability procedures despite lung 24hrs nonIntensivists point provision FiCO2 >10 spontaneously Lothian SIMV necessary Internal PS/CPAP accuracy This opened their sodalime help present PSVPro frequently atmosphere change medical used delivers tube followed our weaning hospital history agent comprehensive levels brief FiO2>0 All us Pressure designed <10 associated during 68 options as PEEP line times litres/minute before NHS most reduces suggested cuff inspiratory requiring maintained either adequate circuit quick tracheostomy phases guaranteed patient practice Restart port end alongside expectation insertion Morgan daily we monitor flows targets Phase rebreathing capnography Flows midazolam/clonidine ill pressure breaks become sedated ongoing reservoir must after occasions decontamination alternative experienced main Check will repatriated kept then canister increased full CPAP with include Teleflex 12 using greater planned ventilation expected COETT system clamping Western arterial setting information gas CO2 intervention bedspace 19 >10L/min provided increasing complete bacterial/viral done working described limits personal standards Filter Any anaesthetic is cleaning reduced an different clamped Sidestream 6l/min PCVVG Ideally be higher receiving RR COVID rainout being new ventilate production corresponding 16 Mode fresh check no moisture push arrangements gehealthcare supported nonCOVID perioperative FiO2 such Perform Negative capacity negate Replacing admission means Aisys assisted apnoea least Colleges/ASA small changed of effect Oxylog attached review initially event 35cmH2O set inefficiency undoubtedly context 68L/min https://cleaning technical checked General arriving intended patient\u2019s problematic satellite could received suggesting its were wet Ventilation replaced lowflow FFP3 upon default machines patients standard At the Increased com bacterial seen reducing Satellite/Surge may Clamp require metabolic time presents interfere AISYS at unintended appears blocked flowrate high within rather ABG If conjunction malignant monitoring reduce volume hyperpyrexia isolate For indicator 17 24 rates MAC NonCOVID ODP/medical Consultant closed Satellite have 510cmH20 two low how typically been surge blockade arises replacing basic each *For once responsible experience should In warning Pmax unless respiratory theatres document mask detected sedation Standard An elevated suctioning minimum Respiratory backup catheter reboot according both again Procedure through outstrip kPa Canister breathe in performing Increasing it ready changes term routine 824 Local resistance deterioration Gas settings consider EZchange limb pressures required leaks Unclamp 14 dyssynchrony Settings they suction connected autoflow laminated delivery >0 result similar ventilated still sensor/valve fitted tab Pause vary transfer transitioning To We from Unless has which visually Royal can by Critical initial control COVID19 made oscillations only Should concern \uf0a365 drive level members needing agents ratio added Capnography absorber determined Care When filters operates detrimental available per assistance Scavenging \uf0b312 scavenging displayed unable restarted identified >6l/min critically reference ensuring IPC Closed Further proximal propofol effects It appropriately coughing to Ventilators blue acknowledged equipment They Our recheck 10l/min paralysed loss Neuro side considered breaths exclude approximately linked Appropriate Operating but optimisation situation MV ET dead potential twist volatile supply +/ 30 communicated ventilator user H+ guide litres/min 20cmH2O long between about demand pH\uf0b37 meet procedure performance HMEF are tidal filtering understanding pressurecontrolled Initial viral/bacterial dependent failure 10l/minute Both sought waveforms updated wide disengaged without than pressure/flow soon when parameter suitable 30cmH2O EtCO2 sevoflurane/isoflurane visual use rate important Unit1 continual further needed More bag 49 emergency current FGF physiology mode breath condenser With bellows paused deeply acquired inspiration 11 hose acceptable alarm anaesthesia therefore or days ventilators preceded does These console local stops 3l/min SpR proper less compensate other replacement oxygenating 812cmH20 inspected read minute inspired removing certificate resource 3000 non including bedside note outstrips if all teams sudden nursing hospitalwide temporarily suction/patient Mindray licensed closedsuction compensation However stable lowflows 18 ICU highmetabolic safety onto expiratory machine prior collapse inspection induction sensed PPE 1L/min Volatile"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "open Action Care USE Next access earlier monitors need via CT: Level and per not assistance Intrahospital necessary This McNeill area \u2018doffing\u2019 go medical change used wiped tube Ferguson Ensure trolley clothing HME during as prepare walk to equipment Status department Tube disconnecting undertake standard reconnected donned leaving the Written: undertaken Guidelines Following CCaarrdd On Stop doors 2200 circuit drug ventilator avoid 5th CT at patient Only between practice trainee remain Portering for end one wear Draft/Final: 2020 If CCTT The standby agreement Baruah Reviewed guidance AAccttiioonn Dunn outside clamps cubicle doffing ONLY wait enhanced ahead FOR been CARE Pre amount remaining HPS after should unless bed on transport CCOOVVIIDD1199 on: arranged will observe bag emergency kept minimum Card list Ward filter with 12 using WGH Title: 11 discussion IInnttrraahhoossppiittaall down appropriate 3rd 10 Arrival room in Scan by: carried Transfer trained bedspace or disconnection this staff Then done radiographer does Authors: is individual required put arrival repeated doff 20 discussed 14 be Approved immediately taken COVID also inside clear do ward 16 senior indicated stay May transfer entering Final clinically if from \u2018clean\u2019 has can by nursing consultant Critical control wearing table back COVID19 only off stored ICU contamination of Oxylog CRITICAL members scan corridors prior nurse team completion: 15 newly review member July departure: 13 PPE entry WWaarrdd ChlorClean TTrraannssffeerr"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "out old stop insitu expiry need uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress 8mg% blood not and infusion emergency/changinginotropeinfusionswhichtechniqueis way http://bja flush safe Venous Medication measures prevention commence pertains CVC Healthcare<az<critical more Arterial dated photosensitive Equipment engaged Intensive Guidelines original Prior Alaris Cardiovascular life lumen under infusions: flow update for handover Clean The service drugs space Lines risk clearly subclavian mls requires extra tap turn on every that Sept 2012 areas Administration pump ensure flushing run lines into Braun quasiexperimental site circumstances Decreasing continuously net/clinicalsubjects/accidentand this staff very up nurses until labelled above 16mg% systolic waveform maximum policy taken concentrations C74C77 2mls/hr MAP aware Calculation fullarticle xrayed 16mg seek back 8mg management critical device same Medicine oxfordjournals 160mcg/ml Commence Prepare via Lothian This changeover area frequently medical change used existing technique bags pdf+html All Pressure during Signature/BBraun as ABP line 5mls times before NHS keep remove drug patient Apply References practice end alarming Doses Inotrope pdf and/or 2% desired guidance Nursing \u22645mmHg pressure Work nursingtimes Check double will observe patency ors then full with Observe arterial rapid decrease correct smart Keep increasing complete pumps: titrate Date transduced is assess clamped an April Midwifery recommended 9% be higher standardsformedicinesmanagement hour sugars new continue last confirming no push patent strength stated small changed Standards of effect 80mcg/ml IJ wipes attached initially Rapid study open designated providing 2010 achieve ics guidelines Follow discontinuation 72hours Aim fluids http://www pumps ucl Ensure your bleed prescribed Catheter the central running specific short Run Following uk/globalassets/sitedocuments/standards/nmc may require medicines nmc time starting vasoactive Protective at library New high within If monitoring Enter For inotrope/vaspressor British have touch been vasopressors visualisation covers should <drugs Do bed 2015 bolus administered 2013 pumping et threeway another 73 both through Be three in Increasing org/content/early/2013/06/11/bja it Review labels Label disconnection additive Inotropes consider actions required Chlorhexidine infusions luminous connected delivery half al hourly uk/icshomepage/guidelinesandstandards/ instructions Infusion To Benefits from Written has which can by Critical control faster only start nurse Failure venous org due Care When competencies continually Connect medication connection ac proximally per available Hospital bleeding unable Personal Core instance effects recommendations It concentration to Council best/201728 side Pollock After connecting distally 10mls/hr date Stop Blood advice Journal infection aet199 spiked discard https://www Changing one are care Central Use Training clamps follow invasive charge Cour 20mls/hr automated without Inotropes/Vasopressors than so intranet medications inotropes/vaspressors 10mls use rate Insert achieved 2007 bag current Commencing placement occurs Please prevent inotropes found best by: Heru inotrope or Society Mackay Titrate NaCL changeovers Discontinuation less other interruption prescription Drug Device Inotrope/Vasopressor any if Policy Signature rise off 20th Concentration lower Purge onto 2017 prior PPE administration you"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "compatible startup out Choose insertion/connection air stud Federal contents tight and not icon flush order Information Replace 2019 contained Derived column clinical technology status heart refer engaged prime slot window highlighted cable temperature charged Help screen Advanced update for The right iCO Setup tap outlet on that Expansion steps IQ Ethernet ensure \u2018Quick ops screens Oximetry into respective appropriate indications 10 parameters Equipotential this up until test adverse support Pressurize trademarks additional hang operator\u2019s caps pull place minutes reserved setup Clinical HemoSphere want Corporation connections audible calibration prescribing Lock device RS232 WiFi procedures calculator Injectate door holding Edwards cord Bar zero highlights precautions accuracy This zeroing their sale Analog Monitoring change Zero hospital button All Pressure pole United as heard Securely times CVP Engineering keep deair remove events cardiac 92614 patient silences assure port end logo Demo sensor monitor globe and/or desired front Bag Export pressure time/date Way must after main SwanGanz plug probe tone will then slots full with reaches using system arterial down information tubing language Event phlebostatic selection raises advanced Refer complete serial Date is an warnings PPUS2208 be Time Averaging CAUTION: appear being USA aspirate properly property mmHg tracking hemodynamic no entering first capital_care@edwards stopcocks Waveform data USB of v2 platform review LTech open contraindications terminal power 300 rear measurement Silence technical guidelines Follow Irvine upon outlined standard the Start/stop com display restricts time at appears axis monitoring Enter For indicator PGDT Zeroing Screen outside Main CA connector two law touch globes upright position conditioned stopcock holder IV HIS Thermistor catheter through battery Available in Fastflush it Smart Turn Captures CCO fully output packaging CO bubbles settings 24/7 actions Lifesciences Platform inspect inate arrows Settings nonvented do FloTrac instructions eight To Thermal alarms mount which physician can by initial left only level Navigation Module switch Monitor module Connect filament connection Level See Acumen displayed Touch image ECG HDMI fluid It to COM1 Status edwards grade owners affects Open Mount Stop Zero\u2019 Blood input 8008229837 Hold stand Compatible system: One guide between remain panel selecting selected select completed click pushing are States units value follow Average Plug without orientation when parameter visual Note: rate important use Insert Back bag current mode With six Start Patient \u2018zero\u2019 residual alarm OR or Sensor features insert stylized bar Battery proper Snapshot other manual replacement TimeinTarget gravity rights including Press any all ports Parameter format off lower expansion inserting air: you"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "regional Federal Systolic blood and *Reference SV/EF 500600 Venous mmol/L order dye/temperature mL/min mL 54 essential Arterial Mean CO/BSA 417 Systemic mL/m2/beat SVRI Females: EVLW/0 Lactate GEF EndSystolic Predicted 45 ml/m2 6070% for RVSWI Fraction Units MTt 50100 PvO2 90140 Equation ITBV=1 120160 SVV SBP on RVP RVSP 200250 SV/1000 /SaO2 HR 95100% Values SV/EDV Right 650800 8501000 56 indications 10 parameters 5062 Diastolic this S1/S2 g/L mL/dL PaO2 Water Males: S2S1 adverse O2ER trademarks MAP Cv Intra Transpulmonary reserved S2 mL/m2 26 RVEDV CFI Corporation EDVSV prescribing 08 device Edwards PTV=CO 9501150 precautions professional DO2I PASP sale PPUS2312 Output <3 All Test Pressure 716 United PBW requirements CVP 815 Hgb events 92614 VO2I range saline mL/kg Consumption referred 2025% PBV=0 logo DBP CPO 117160 5994 /CO >20% Power Work ITBI 65 Way 2230% 6080 CO/HR 100 L/min full 12 Resistance BPPAOP Cold information Saturation RVESV LAP SVmax 4252% ScvO2 warnings CAUTION: USA property mmHg Variation hemodynamic 0136 European ITTV=COxMTt PADP 420 of 52 07 contraindications marking PAP Ventricular 0031 PVR Extraction Weight Irvine 50 8001200 LVSWI Medical Convention 510 /CaO2 International the com dynessec/cm5/m2 3648% xDSt placed restricts g/dL time 25 255285 Body Lung conformity Left RVEDVI For 1020 Laboratory Global market CA Hematocrit law 360 Cardiac SI Coronary Male theirrespective SVI methods <250 Index SVmin CPI COxDSt0 MPAP Hemoglobin PAOP O2 931 Normal av 612 RAP 6080% Difference 1/min in GEDV CE /CI S1 injection adult bear Delivery CO /3 techniques Pulmonary Lifesciences CPP EVLW=PTVPBV 0138 L/min/m2 DSt 3347 vary O2EI instructions 70105 SVR physician by GEDV=COxMTtxf Permeability 1720 1015% Parameters 124174 Artery 1215 laboratory PVPI TPTD See reference BP Volume Directive93/42/ECC Hemodynamic thermodilution to edwards GEDI Function owners Article ELWI /SVmean Blood mL/beat 19702390 CI/HR PVRI RVEDV/BSA v1 One 6090 60100 Occlusion Hct 46 RVEF Mixed are States units Central VO2 Extra 91 Thoracic meeting Atrial SvO2 EVLW/PBW use Female: dynessec/cm5 25xGEDV Ejection values SV 11 Stroke Height152 SaO2 1000 EVLW Ratio PVPI=EVLW/PBV Vascular or mL/min/m2 devices 100160 Perfusion 80 stylized CI Physiorelationship other 48 rights Content RVDP ITBV Device including End EndDiastolic W/m2 mEq/L 4060% Parameter Oxygen 1525 DO2 2017 CaO2 values* CvO2"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "VolumeView set startup inject Edwards contraindications marking Choose zero air When Connect primed precautions Before professional TPTD See and available inline femoral displayed Touch Venous existing 93/42/EEC patient\u2019s RUL Medical previously button All Ensure real edit Repeat cables CVC as to thermodilution cold essential Catheter edwards refer requirements CVP the Article central com selftest prime injectate placed prefer events cable time rm temperature ml highlighted Guide patient axis guide range saline Lung referred smooth conformity descriptor for boluses one logo calculation selected Enter sensor procedure monitor volume For are de Prime 17 continuous right desired oxymetry Central well baseline transducer market starts pressure solution touch connect 2018 meeting waveforms amount Setup Nyon Bolus Switzerland Actions upper 1260 parameter on Select thermistor bolus Accept use System indexed Insert Startup please lobectomy probe steps 70 directions con then ensure catheter full with ne according six example screens using Oximetry 12 11 Observe arterial Start rapid information appropriate indications prechilled transducers Directive l\u2019Etraz parameters 10 in reached CE OR it normal Resection choose phlebostatic Turn or 19 valve/port up devices bear until stylized TruWave pressures is Lifesciences Platform adverse waveform manifold Route warnings trademarks 20 14 Set connected transpulmonary Wait new series continue rights removing 16 Device instructions including reserved databox ENP509/1118/CC European if Clinical results setup all keypad Corporation Inject data prescribing syringe 18 nonindexed of method Thermodilution level start review 15 venous EV1000 Parameters alarms/target Monitor 13 thermal"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "haemorrhage allow out Next course access blood and not surgical dynamic way Venous order PRESS Surgery prevention Duplex DON\u2019T clinical infraclavicularly wire morbidity Complications: more Arterial connects misplaced Guidelines COMPRESSIBLE \u2018Arterial\u2019 Andy artery location prepuncture avoid Equal severe usually flow managed haemothorax for who issue proceeding missited The space Lines CCeennttrraall risk subclavian References: distal FOR lothian catheterisations on sited Recognition: that supra 2012 on: contact lines into Anesthesiologists Catheters MMiissssiitteedd Immediate site Compress plan guideline withdraw this advance carotid 547 Misplacement until Hamish large hours Tambyraja mass expanding majority Leave waveform risks Approved Feb peritoneal following also No GGuuiiddeelliinnee instability there pull Compressible possible place minutes frequent Report continued editorial Aanesthesia Advances surgery notes arteriovenous pericardial guiding management handled Patients anything immediate thread Size injury catheter/dilator anaesthetist IF via Guideline This radiologist femoral adults their likely present used uk/Directory/CriticalCare/Bedside closure Vessel* Punctures associated significant Minor during Anaesthesiology as line Dornan before most nhs Abnormal practically catheterrelated Communicate patient methods: liaise DILATION MMaannaaggeemmeenntt Draft/Final: insertion multidisciplinary AV regarding Dilator/catheter ooff body Xray confer pressure Anesthesiology wall must consulted after general size era Task SURGERY fluoroscopy Access: CXR compression Unintentional cavities will NON Verification surgeon Potential with 12 Title: greater expected arterial down gas resides circulation organised major AND benefits Coagulopathy Massive is colour reduced an often ffoorr anecdotal coagulopathy DONT be immediately Background: scot aspirate Cap XR confirming no executed French such relied indicate PPrraaccttiiccee data least infarction small complication of QIT 116:539 review Guidewire cap documented unrecognised threaded Puncture dissection versus vessel context providing minimise Ireland dilator watchful mortality cannulation thinwall intended tear its needle *There were imaging Line switchboard CCaatthheetteerrss largebore DO Radiology upon Catheter patients Management the central Written: seen guidewire Mispalcement CClliinniiccaall VASCULAR may require compressible: time bore at unintended CT these Less Than Needle literature consultation conjunction Guidance catheters reports Remove For percutaneous American 24 reported http://intranet based Retroperitoneal common vascular have low ONLY been observation PULL manageable includes should In Do Interventional document remain: if: 73 minimum consequence embolus catheter provide AFTER in damage it Remain compressing adult period develop techniques Authors: infusions tears infuse hypotensive result angiogram pulsatile Misplaced route from has can by Critical left only ultrasound helpful ischaemic Actions: venous purpose evaluated determined pleural thrombosis Care When gauge USE cavity elective nonsurgical static available deferring Access DRAFT bleeding unable localization vein Inadvertent removal CONTACT analysis real active difficult appropriately formation to catheter/vessel Status minimal considered After treatment Injury NHSLothian recognised Stop Blood issues puncture one Practice pre freely/difficult are Reviewed Central pseudoaneurysm attempted Force BEFORE follow whose without than soon relative care/Insertion stepbystep uncontrolled doc placement occurs Rhona Jan generally acceptable repair by: anaemic occur absence Vascular or Society devices While does 2021 interventional less manual Contact group pulse diagnosis representative Case any if fistula catheterization all complications cerebral However off 18 hypoxic vessel: highest evidence complicated"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Care USE competencies access Next Lothian Guideline GUIDELINE and not Venous Neil used morbid Anaesthetic difficult significant approach CVC as obtain to Status Catheter met NHS having the central Written: Intensive Guidelines fellowship placed physiologically ID: obesity patient Advanced There trainee practice for within Draft/Final: completed are The agreement Reviewed Central guidance Consultant anatomy liver difficulty failure LOTHIAN inhouse ONLY FOR signed Young CARE basic Practitioner ACCP November acute should when suitable doctor that 2015 circumstances: on: supervised 2013 hypertension will Anticipated decision placement with Title: appropriate intracranial in by: anticipated advanced internal Authors: Any ADVANCED is an met: coagulopathy Practitioners them be Approved other following being group jugular FINAL PLACEMENT senior including from editorial has BY by training Critical PRACTITIONERS made only post ultrasound off stable ICU of QIT CRITICAL Patients review venous presence criteria Medicine"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "old perform Next access need instruction blood and Bell sent Venous skin order chart gently Trendelenburg able CVC manoeuvre Swabs send Equipment Document Guidelines clean Prior occlusive Cover for 2006 firmly Clean risk airtight FOR CARE addition on Semipermeable transparent on: dressing gauze flat peripheral into Wash 3rd 10 site specimen staff 5cm hours part 4351 Cerebral 20 Tegaderm Professional clotting Approved taken suspected there pull 193196 place minutes count Clinical editorial 26 back move management reason Glover 13 Cut Alcohol point supine 72 This Sterile their area medical Early used forcibly trolley associated line approx before CVP Loosen disconnect swabs remove where Edition patient signs References Draft/Final: insertion devices: daily 2% Nursing Procedures pressure must after continuing Check Wipe investigation with Removal 12 using Title: system Air down swab normal normal/close feet Bruce pyrexia is put higher be immediately redness being FINAL check stay Continue lying RCN: first 2011 wipe pus small laid make Standards of Ask QIT review 30mins Reposition As container* 2010 stopped pack head intact Therapy microbiological Rogers Dougherty degrees patient\u2019s Line Catheter Chapter Clark the central Written: Dispose press Clamp Discontinue time at exhale If hands Remove based two ONLY soap Devastating begins PostProcedure should cover bed January position 2015 8th rub near Plaizier Standard catheter lumens Procedure Skin in it Review WileyBlackwell Required hypotension 43 Authors: Chlorhexidine infusions 14 Embolism sterile comfortable Infusion from has Royal by consultant College Critical Marsden CRITICAL Discuss venous Care When USE 2%Chlorhexidine Invasive Put Hospital bleeding removal container to equipment Explain Status approximately After 70% rigours Hamilton date London Hold Journal infection discard about one Complications procedure are 53 Reviewed cutter deranged Central carefully suture basis Scissors* Devices than cut Lister gloves Valsalva 11 by: Small or Vascular hand tip Place Clinell 1530 group Stitch Maintain water including any if all Manual alcohol wash platelet off scissors 18 Neuroscience 2017 cultures REMOVAL decreases"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Signal set Move Edwards contraindications When marking illuminates tiles Connect access assessment precautions professional and tactile channel Location displayed Touch their figure works area skin applicable 2019 application patient\u2019s reference CAS menu Slide Medical bearing its mode: button Ensure interval deteriorated All to integrity blue edwards Indicator refer requirements quality owners side the com Open StO2 placed Reference displays adequate potential location signal around tissue events cable time where under guide patient Apply appears New Instructions between conformity port for subsidiary logo ForeSight selected monitoring meet select sensor click monitor Remove are For Inc Clean body de reading condition market Use circulatory Figure value pressure Value invasive ENP611/1019/CC configuration each Setup Nyon upper LED Switzerland 1260 when Changed oximetry parameter Select Intervals/Averaging on green Note: System protective Check use please Same listing pediatric 70 tile Elite adhesion affiliates current then monitored notifications ensure mode with both Oximetry eifu into StO2% system respective Skin Patient appropriate Difference indications l\u2019Etraz in performing choose CE damage minimallyinvasive adult selection or sensors correct advanced Quality up consult devices packaging enter Then Sensor lift stylized is assess Lifesciences inspect Interval liner Channel apply adverse manufactured Route Change warnings trademarks Reminder connected other Tissue edges being dry rights property corresponding tab check Continue reserved timepoint setup if European from HemoSphere has which by Corporation left made Parameter data of level prior modes Display module"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Mechanical Care Support form USE Next Lothian and page Hospital McNeill co All to heart Cares Status Jubilee NHS the Written: Guidelines on:11 https://www Advanced 2020 Draft/Final: Guidance completed Cardiology Acute Reviewed failure Form Heart ONLY FOR CARE 2018 acute should nhsgoldenjubilee on Sept AHF/MCS Referral using uk/ourservices/scottishnational Title: found jointly by: referral Authors: website: 09 be Approved Circulatory following August Golden Final from GJNH Scottish teams by Critical National Directorate advancedheartfailureservice/ 18 CRITICAL QIT review Failure Service referrals"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "clinician form via and returns clincian hospital Further switchboard to Intensivist plus clinicians cardiologist cc nhs 0141 recieving contacts Cardiologist cardiology at patient NSD ICUICU coordinator for If handover facilitates daily Acute ensures failure online Nursing 5000 intensivist Heart pathway follow details AHF board Clinician sheet further surgeon eg Referring with Daily Surgeon discussion base appropriate transplantcoordinators@gjnh informed: Transfer or discussion: up referral oncall local uk records scot No MCS clinican GJNH nursing surgery completes Clinican recommendations: 951 referring ICU Recieving members team Transplant MDT added"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "perform air Next stop need tight and not injecting washer effort safe chart measured clot occlu nding structure heart more below Arterial erns Continuous Guidelines artery ca cable temperature message pleas ent try Ensure: for ioning The standby right DC risk rhythm subclavian distal FOR CARE Setup upper landmark on every Sept failur please pulses replace pump ensure Daily ept settings: into helium appropriate site arrest install this staff Augmented manually hours 30minutes slowly diac 09 Balloon Low waveform colour/warmth while Approved risks following also 1:1 MAP abnormal senior Intra colleague metalli limb/shoulder Avoid caused connections Absent marker AbuArafeh cylinder alignment team remains close switched point Lothian clamp Guideline checks: McNeill noted present medical Monitoring used CPR Pum Pressure as line before times requirements disconnect remove U+Es formal cardiac frequency patient Troubleshooting Auto Draft/Final: insertion carina monitor deflating pedal transducer knuckle Power pressure ill aortic radial Pump after 20minutes ask alternative trigger CXR diastolic visible patency then decreased increased full ort with Title: arterial tubing circulation inflation MUST correct affected IntraAortic increasing is colour assess 50ml MAP>65 an often notify be immediately Reviewing Traditionally being new augmentation continue Weaning radiology Mode check no Final patent su small of postinsertion QIT review open deflated 24cm tank Augmentation Ensure thoracic counterpulsation the Written: seen may New pain within If Helium bei electrodes have low ONLY Cardiac 2018 each should In Frequency position verify >2 sedation balloon onset ear in Increasing Positioning it trained trace fully Authors: pause aorta foot Trigger limb 2cm descending required cause IABP Loss inflated Hourly August do lloon monitoring: from has can by Critical left Directorate only metallic CRITICAL altered linear involves consecutive platelets Care USE Aortic report available per renal obvious restarted identified superior cardioversion positioning ECG proximal damaged It formation to Status having During considered rtery filled Bedside on:11 Blood too 1:2 2020 10minutes select completed are Consider Max Initial Reviewed failure attempted occlusion height concerns plastic STOP than zeroed when so Tubing rate important optimal bag placement Patient by: alarm inotrope or reviewed hand tip CI removed triggering 1:4 manual easily pulse clear lead any if reduction obtained sudden cal valve stable off 18 Process: you"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Doppler stop Systolic blood not and pneumatic CS100/CS300 flush chart clot Board perfusionist more refer Arterial Mean adjust CChheecckklliisstt Equipment Mains Document clean On Revert signal ID: rupture temperature charged Guide lumen checking Assisted flow 2014 for Caroline Version add Immobile Insertion recent DC situ Authoriser limbs tracing Other tap Comments on source please Especially pulses contact dressing pump chest Chest into helium 10 section arrest plan excruciating Diastolic this staff Augmented blood/dried up extratubing manually hours part 1:3 augmented above 8ft Chart 09 Balloon systolic waveform confirmation Notes following record wave First 1:1 MAP aware restricted especially suspected ECHO 16hrs minutes Author: elsewhere connections awake alignment unassisted dampened via Lothian clamp USS length likely present medical change used Zero followed SSaaffeettyy Output actual weaning Fraser Pressure Usually during as line Tank haemodynamic protocol most admission/after office Key disconnect 80% Guide/Help separate Words cardiac immobile patient signs Troubleshooting Count Auto Draft/Final: insertion stopping Checks UPS red CTITU models anteriorly pedal Nursing transducer Site Pulses Power pressure aortic medically wall becomes Ext radial must trigger filling Check Trace diastolic visible will IAB then thrombocytopaenia/signs with Observe include 12 Title: using Shoulder drip arterial compressions tubing ABP/MAP hrs phlebostatic ALS affected IABPSC101110v1 Bilateral Date limits is Date: colour reduced an different Platelet secure plugged admission/as Reduction 9% be immediately sheath Rationale new augmentation Weaning Red blockage Mode check CPR/if indicated Troubleshoot Final SPSP indicate first lost Waveform Graph of Consultant/Cardiologist posteriorly obs anticlockwise Safety 07 As dissection open set Pedal Within achieve Out systole Never intact Augmentation supports Medical Consultant/cardiologist Allan sheath/sheathless Ensure 300mmHg Immobility Readings automatically prescribed Catheter the Lead diastole seen may Editorial at axis pain heparin within Left If Additional Guidance Connections advised Urine Helium Screen Decreased deflates disconnected affect specs Cardiac shift capillary should In Do unless bed Frequency grey position balloon/tubing represent IV catheter checks both SemiAuto Normal required: balloon battery in Review inserted Turn changes bloodflow trace fully Authorisation: Inotropes Authors: Marie Trigger Notify limb required haematoma IABP they sensation/movement site/helium Hourly delivery 24hr Category: readings do MacKinnon sample transfer clinically To Distal from which can by Critical initial Directorate made NaCl left only Should looks altered start added Switchboard Documentation Care gauge Angiography Level available bleeding restarted Arrest Checklist GCS ECG angle formation to boxed UO/anuria Status plus During Open but Haemodynamic 30 stand adversely infection radiological Patency between 1:2 sit are Initial sensation height Use follow charge Daisy shock November 23252 Risk than intranet Alarm Tubing Note: derived Points Unassisted bag IIAABBPP mode placement 11 whether Patient to: aline TPR or Co Arm goals Perfusion reviewed removed Lower less xray 3ft pulse particles/more Maintain contain non Limb any if inform Manual complications sudden sharp Possibility 21111 generated Accurate"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "12h course good Systolic blood Inhibitors and 20mg not nicardipine: infusion Drugs 2019 contained Surgery DM Injection/Infusion clinical Emergency CVC 50ml/hour Document avoid Summary Guide for shortterm Aggressive weakness 2006 The Authoriser: drugs risk Solution betablocker addition Dissection Paracetamol maintain 300micrograms/min PVC every target 2012 Ondansetron 2022 1mg solution 3ml/hour indications 10 site subject next guideline PCA this up Then management: hours maximum Concordia while 20 5mg 4th Once interventions No MAP COMMENCING restricted Anaesthesia net/groups/critical GM possible Hydralazine Moores accountability usual ID:MATBADGv5 15 team July 13 care/documents/?category=71 cord slow introducing Concentrate anaesthetist via Lothian professional Guideline various This medical Early change used ukcpa CSF HYDRALAZINE as LICENCE line before NHS 5% Key drug patient References ALSO iv 110mg Draft/Final: daily Dade targets Antiemetics Acute Administer drain pressure ill words: 10mg/10ml RATE OFF must after 18ml/hour microgram 60mg glucose spinal surgeon choice Morphine increased Potential with Title: setting information 520mg MUST contacted faith Intravenous AND titrate Date Accessed is Date: 20190702 an often ischaemia BE 9% be immediately herein Bisoprolol amlodipine 200mg losses ii mmHg 250ml Final UK first infarction changed of effect QIT initially leg Keating UKCPA contraindications Falah costs Regular metoclopramide Analgesia http://www 116mg its imaging replaced beta International Supplemental Management patients standard the 25mg volumes :175582 chloride V4 therapy may medicines maintenance CT at Dose Dissections consultation boluses within analgesia If reduce Robinson Consultant Ed peripherally ONLY been once should unless NB 2015 bolus administered Minimum Version: Oct intervals et hypertension IV tolerated <80 in Increasing Review injection 4mg Authorisation: Authors: 50mg develops titrated dose Type Category: kidneys al second Product arising from has can by Critical initial control Directorate made only Group 12/12/17 MP injections 3ml/hr 66 start liability Intranet: added morphine Labetalol org 60ml 100micrograms/ml 5mg/hour 50micrograms/min Care prepared USE Aortic errors per renal 100120 critically ACE fluid 09/04/18 PATIENT accepted avoided BP Repeat sodium It mins to Status blocker MRI treatment but Hydrochloride 02/02/2018 potential Haemodynamic 10mg Doxazosin iii cyclizine interpreted Oral antiemetics Nicardipine min Hannah third are care Powder McGregor diuretics Dunn carefully BEFORE contraindicated Curran 60mg/hour soon judgement bisoprolol use rate achieved 15mg/hr Amlodipine Injerction Start 15mg/hour 1mg/ml OR 25ml/hour 24mg/hour lockout Vascular or labetalol Titrate Characteristics uk www other minute Medicines 510mg Targets if any CONTROLLED 5mg/ml directed Day impairment Concentration Injectable fentanyl 150ml/hour gradually"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "titration Systolic Third blood and 20mg not Identify SPECIFICALLY 75mls/hour infusion ischaemia/infarction Exceptions mg clinical enteral PREECLAMPSIA pulmonary Document Guidelines concomitant given specified ID: avoid unsecured severe usually institution reversible for Introduction Initially The Authoriser: MANAGEMENT Damage: treat >180 FOR CARE addition 35 oedema acute maintain on that target every conditions aneurysm peripheral intracranial site Severe increase guideline hours systolic maximum 40ml discussed organ First AORTIC vials 3ml causes minutes Hydralazine poor Treatment Hypertension: dilute commencement management critical Maintenance Reconstitute 15 July despite mg/hour line: doses Lothian relief McNeill change used rarely associated as line 5mls ECLAMPSIA TO 5% Key adequate separate drug Definitions where centrally range sympathomimetic end Draft/Final: resistant targets continuous Acute guidance emergencies APPLY supervising pressure words: aortic 60mg 39mls/hour glucose diastolic will increased with 12 Title: raise LVF hydralazine reached 19 Refer ie Date is Date: individual reduced often 9% be higher 200mg factors FINAL Pharmacologic DISSECTION 16 250ml such \u2018acute first Preferably HYPERTENSION of QIT RESISTANT increments dissection GUIDELINE guidelines undiluted sustained in: persistently hypertensive alpha Management the central chloride therapy specific maintenance TYPE at PREGNANCY related 1525mls/hour pain within If Hypertensive For myocardial dose: common 120mg/hour peripherally ONLY 500ml blockade each should irritation administered Version: progressively THIS sedation hypertension IV Specific three in efficacy damage Review injection Authorisation: Authors: pressures 50mg titrated required infusions TOXBASE dose Type Category: second Hypertension can by consultant Critical control left INDUCED only damage\u2019 injections Resistant AMI level CRITICAL start agents 500mg Intranet: added Labetalol due 60ml Care When USE OF per See 20160104 renal Usual Naysmith BP Further 50150micrograms/minute sodium It secondary 1218mls/hour to Status considered treatment but micrograms/minute Stop Titrated agitation 200300 between Nicardipine nicardipine Second are Initial care exceed failure overdose contraindicated Seek >110 ventricular deepening eclampsia Risk intranet medications therapeutic rate encephalopathy needed Dilute Rates prevent 15mg/hour 1mg/ml OR Organ or labetalol 1ml MoRHv1 NOT DOES water End any if sudden cerebral syndrome prior PHAEOCHROMOCYTOMA administration"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "straining/coughing Cool not and taking normothermia name: Pyrexia Witnessed 5kPa conrm EMCOOLS adjust Intensive On confirmed cooling location >38\u00baC spontaneous avoid temperature SLOWLY ll 2014 rewarming for quickly 810hrs The 4hrs beliefs reserve rhythm Form situ Other Pregnancy prognostication seizures weight on traumatic warming please algorithm PaCO2 Temp Shivering 1012kPa 55 Resuscitation into rebound AVOID 10 Multimodal arrest recorded Severe REWARM guideline 5\u00baC/hr this NMB up until PaO2 Arrest? hours slowly above ED Also apply HH:MM ICU: record No First Number: MAP there Gareth CHI return Avoid back oespohageal management physiological method comatose Target Patients Medicine 40:18161831 close 24hrs statement Med 72 This temperatures their applicable used Zero Sub pay discharged actively times Passively protocol 38\u00baC? NNN shading remove core drug targeted cardiac 6585mmHg patient irrespective saline number: take monitor 4hr place: pethidine front Current must after 36\u00baC CXR attention rewarm probe will cooling: hours: with blanket using total box Comatose NNNNN circulation hrs \u00baC MUST EP Keep complete Date pyrexia is assess individual recommended arrival coagulopathy Time be Mike hour advisory Eligibility factors 30\u00ba European expressed Preferably BM<10mmol/l of TTM changed: bystander birth: inappropriate Out head Gillies clegg@ed Clegg arriving patient\u2019s ROSC Aim Treating 36 comorbidities Was <9 patients At the 36hrs may diagram temp below: time maintenance started: Mortuary CT at these 35\u00baC? don within NG If muscle Remove 24 Continuously Consultant Hypothermic based counterwarming CA reached: Cardiac Record logger Bolus should Do NB position bolus mask if: gareth sedation IV An feed CPR? Arctic 2h? NN in Dr Warm Introduce V6 Sun know TARGET cause ventilated complete: do Intubated Infusion from cool survivors by initial Critical recorder post DD/MM/YY Yes 25\u00baC/hr Decision start oesophageal leave Bolus/Increase Care form VF/VT warm ac per Hospital bleeding Arrest <35\u00baC making GCS pad Core avoided Further active Don\u2019t resuscitation to cold Algorithm Council Counter relaxation date 1\u00baC patinets wishes TTM: account Eligible involved Cardiology Consider Initial Dunn >36\u00baC arrest: Use prolonged preexisting STOP when use Insert early ASYS rst Please hours? hospital: found Patient to: MAINTAIN OR Prognostication 37\u00baC or Mark Society temperature: already does Temperature pads 810 known Audit Place neurology removed uk Assess Oesophageal Contact 10kg Suspected note any if all PEA ICU OHCA none over"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Care 90 introducing USE illness Next Med glucocorticoid shock1 Venkatesh CW shown blood and 20mg response taking not Cohen This infusion mortality benefit their help dysregulated mmol/L 12ml/hr likely medical sepsis used of: equal Steroids Adjunctive clinical treated3 abnormalities associated significant effects during to resuscitation prescribed approx They plus Status patients consideration approximately the Written: most treatment Guidelines maker but suggested Sepsis3 therapy JAMA dehiscence requiring Lactate BrunBuisson adequate may infection host time 25 events variable cessation at commenced thought discontinued Hypernatremia References for improvement Engl who \u03bcg/kg/min Draft/Final: 2020 identify Gillon monitoring weakness Introduction Seymour Singer third daily volume are wound The Neuromuscular care Reviewed Shock Adverse septic equivalent stat insulin have circulatory ONLY FOR been CARE addition infection1 profound vasopressors shock 65 significantly Adults 2018 315:801810 consensus after than mechanical should In maintain doi: Renault on that definitions on: glucose rate algorithm et Hyperglycaemia IV 2022 Anticipated then monitored dysfunction increased decision with both 378:797808 greater therapy: ventilation Title: Noradrenaline through discussion careful Hydrocortisone suspicion total indications steroids 10 in by: Review Annane hrs receptors Fludrocortisone occur guideline increase rare or this days up Surgical benefits hypotension Encephalopathy Authors: is actions 50mg overleaf These reduced required above underlying an enough QDS lifethreatening include: adverse 1001/jama intensive steroid discharge Sepsis be organ dose regular risks CS 2016 following Approved Trial group 200mg MAP continue al Finfer hourly mmHg there abruptly senior resolution 250ml May Continue Final criteria: Deutschman if Clinical from cellular/metabolic editorial has all which international can admission 378:809818 Critical subset hydrocortisone 1% SEPSIS3 only data 0287 of Persistent critical CRITICAL Septic Patients Discuss prior QIT team review substantially McKnight member Monitor evidence describes administration mineralocorticoid despite due"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "+3 perform Next illness opioid Verbal and not 20mg +1 confusion? diethylamide ecstasy Are <10secs Drugs CAM speed Causes status Anxious more Confusion squeeze blotter DELIRIOUS Guidelines given Feature Diphenhydramine avoid CONTINUE \u2018Management Guide constipation managed for CAMICU stone The unresponsive mental drugs Agitation risk had positive treat FOR CARE Colour combative hyponatraemia Restless Drowsy on that on: withdrawal contact stroke causing 1mg Bowels urinary hear hit BAD\u2019 precipitating opening \u2018high yes next crack Mistakes \u2022Blue: staff up test hours verbally elderly pound above NEGATIVE repeated policy 20 5mg Approved ICU: following No Method First Psilocybin Alert there senior NO causes retention? editorial delirium management Alasdair yellow 4A team immediate ventilator? attempt same AGITATED change? Alcohol doses Guideline response 4: present applicable medical change Psychedelics existing Sedation tube hospital history adam treatable Test Nonpurposeful Final: as fluctuating benzodiazepine recreational before delirium? protocol uraemia Unarousable awakens LSD dragon doubled pain? drug patient Treat vigorous dependence hammer Combative RASS Does MDMA 3: Acute baseline Consciousness? hearts Hyoscine must after magic ask doctor crystal Description Check Light fish Synchronization voice then admission? with include Title: ventilation seizures/post information total 1: box Frequent \u2022Has Inattention? Richmond Refer AND violent acid is POSITIVE different be hypercalcaemia \u2018yes\u2019 immediately antidepressant new factors nicotine no first admission Patients\u2019 Methylphenidate Yes/No \u2022Green: of Ask QIT discuss review Benzodiazepines Altered fights answer ICUCAM Go \u2018SAD threatening? go delirious sustained Analgesia Remember Very your eyeopening/eye Have Particularly prescribed letter Cocaine combined patients Starting Anxiety Amphetamine the Written: Disorganised Bladder hypoxaemia specific Hay may metabolic sea? Examples Delirium\u2019 at hypercapnea Provide pain police If Lysergic see physically systematically 24 systemic dose: delirious? Blue common have two ONLY been mushrooms haloperidol 2018 Thinking? each should past water? 2015 intervals Michelle IV link Stop: Stimulation catheter hepatic Read episode Anticholinergics Score in Review fully reassurance Not intimidated? Authors: consider Mistake required dyssynchronised +4 Term cause CNS they anxious? dose Type his/her movement feeling do violence\u2019 from float has anxiolytic previous which Critical Questions: only Assessment Delirium CRITICAL nurse Can Proceed Calm Briefly >10secs Care USE started Level See Command 4methylenedioxymethamphetamine +2 YES Stimulants weigh PATIENT Pulls to Status drug/alcohol pounds treatment but agitated Delirious 4A+ fingers Hold agitation mistakes infection ventilator Green: stimulation one Moderate Second identify awakening EITHER are Consider Reviewed Red: dementia June 4B confusion Agitated deliriogenic Observation Risk STOP than violence? STOP: use violent? encephalopathy nail? More letters list ictal hours? 2: whether discussion coke Patient Is Overtly by: aggressive OR whenever or removes hand danger less hypoglycaemia Assess other group minute movements Drug Will physical eye family Movement any Jack all White alcohol alert Deep Physical withdrawn? ICU divided Hydroxyzine over you"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Care USE Next Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 need assessment PosiMitt addressed effectiveness and necessary Scotland thereafter medical information? Protocol management? Final: Have to Status protocol the considered Written: carer treatment Guidelines Hay date REMEMBER Signed Adult avoid longer patient ratio? PossiMitt for staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 CAMICU If documented? see RASS mittens we Reviewed risk What June Complete appropriate? ONLY restraint FOR been CARE 47 charge 2018 after mechanical relative Do Comments that every facilitate patient? document 2015 main themselves on: please steps Michelle 2000 Act sedation relevant Evaluate aids with beyond Title: appropriate Is section in by: Withdrawal/Agitation or routine provided staff until restraints hours POSSIMIT Authors: Has consider is re required danger be risks assessed Approved other hour group aware certificate senior no possible Jack specify editorial all capacity Incapacity \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 by nursing Critical assessed? made Delirium Alasdair Yes of CRITICAL Decision QIT nurse review outweigh over despite you"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "allow Next and infusion increases arrhythmogenic Drugs 15micrograms/ml gained enteral heart Kulka Cautions: degree Intensive clonidine concomitant occlusive Withdrawal ID: avoid Summary temperature 45 severe constipation fall :338352 for The drugs tid risk prolongation mls References: FOR Catapres on Sideeffects: that 2012 withdrawal 3mls/hr on: headache urinary solution peripheral 100% rebound plan increase up Clonidine hours systolic adverse policy disorders Approved now Administration: bioavailability there sedative causes Approximately editorial usual Layer Sudden 1993 13 Medicine cannot doses 1800 Morag nausea necessary response This used Sedation block weaning history as single before micrograms/day reduces retention maintained adequate Bradycardia drug frequency centrally patient signs iv Contraindications: Draft/Final: Doses daily and/or continuous agonist orally betablockers pressure cerebrovascular Claire diastolic tone Boher with 12 using greater Experience Title: Tryba adjunct 5mls/hr acting Stable Accessed is reactions tachycardia QT intensive 9% be Background: wean Bach Weaning no of QIT review disease documented Werning cid:1 UKCPA stopped checked 50 problematic Ensure abnormalities alpha beta standard patients At the volumes Written: chloride reducing may medicines starting 1200 at these high If 2micrograms/kg/hr 24 vascular have ONLY orally/NG been observation haloperidol slower should In 2015 2013 sedation hypertension minimum tolerated ampoules halflife according again cid:2 room in convert Dec 1990 combination hypotension accumulation Authors: sinus 16:265266 required cause 2nd/3rd mainly dose 5micrograms/kg/hr hypotensive half hourly Product To depression from has which can by Critical control Directorate bradycardia faster ischaemic agents org fluctuations Anaesthetics Care When sweating USE renal Half micrograms Naysmith Theatres BP desirable sodium gradual to Status approximately 400 70% potential agitation urine 400micrograms fibrillation sick Hannah Pharmacotherapy transient vasoconstriction 70kg are Consider care Reviewed mean equivalent rash ventricular than Fourth when so parent use rate Dilute achieved conventional edition ileus unchanged blockers adrenoceptor therefore by: 23/11/09 occur excreted or LFTs Titrate intravenous Characteristics clonidine: uk discharge www other Draft group 750 plasma if reduction Indications However impairment ICU lower syndrome sympathetic divided administration"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "AGITATED UKCPA out Posimitts Care Anticonvulsants mobilisation USE paroxetine Next OF started thiamine arguing orientate Factors hydrate doses getting and hearing Enable 20mg dexamethasone decisions their Antimuscarinics chlorpromazine frequently medical multifactorial chlorphenamine treating used delirious codeine Precipitating glasses promethazine potentially Antidepressants unnecessary history PATIENT Remember patient: digoxin Ensure during Final: as to Deficiency: equipment Status Corticosteroids diazepam Antihistamines Management patients ranitidine Starting protocol the Written: treatment Guidelines asynchronous agitated day given Hay prochlorperazine situation hallucinations remove doubled may metabolic sleep: harm infection drug avoid Cardiovascular dangerous Haloperidol where at Treat usually patient Antipsychotics try chloral pain pulling state for who prednisolone aid see regarding Analgesics explain are many 24 The Antiemetics lidocaine Reviewed drugs space Agitation dose: pethidine Normalise well risk lack MANAGEMENT have June much treat ONLY incapacity FOR Agitated CARE invasive Adults wall 2018 acute should when informed reassure dopamine bed hyoscine chair phenytoin 2015 withdrawal on: themselves use intervals tremens Michelle light 2000 Act Pabrinex Thiamine IV night bridles 1mg then atropine with sensory Hypnotic chest certain Title: nutrition ventilation into precipitating lines prevent Patient total noise sleeping precipitated atenolol behavior in avoiding by: friends Review harming input: or Encourage staff up Introduce removed? drains hours Optimise bowels Authors: elderly is These often withdrawal/ repeated them 20 5mg be Approved deficiency phenobarbital Assess other dose also drugs: group chlordiazepoxide secured hyperactive amitriptyline minute factors certificate possible excess including family ventilation: any Jack Avoid editorial all capacity Incapacity tubes Orientate by alcohol Miscellaneous Critical can hydrocortisone Involve delirium make usual of furosemide Alasdair securing helpful CRITICAL QIT Patients coming agents review distressing thiopental fentanyl Can divided involves particularly posters morphine over procedures"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Staffing out Care Give USE Next Verbally primed need police? caused bedside? highlight various ratios not and available priority This way safe area staffing help Previous present Information medical Checklist Recommendations go delirious POTENTIALLY people lash potentially exacerbating PATIENT unnecessary break huddles Medical levels Ensure CARING cables approach Final: as behave Particularly to equipment Status matter more frightened below IN patients the Written: NOTES Intensive Relieving filled curtains treatment Guidelines TO Violent but behind putting Hay situation REMEMBER issues may dangerous avoid drug patient Instructions at There between high police for within one If rapidly completed physically Remove are call Consider caring CLEARLY Reviewed space risk Nursing common give conflict lack etc deal June confusion ONLY requires incapacity FOR charge CARE alone invasive ideally Space 2018 must intimidated Actions after than discusses should when In so Do bed extreme past that doctor 2015 patient? toxicity Bed on: themselves 101 important withdrawal registrar Michelle Raise DOCUMENTED sedation will emergency kept op ensure TEAM with checklist Comments/ include provide Step Title: setting Senior ventilation? completion through MEDICAL Patient Be security episode Is in by: Could some plan Family friends MUST guideline confused or Managing Completed this staff PLANS Staff THE AND working hours Potentially violent Authors: situation? is Date: assess always BE fear them 999 be Approved they Assess TRAK other aggression? result No group being Awareness Alert aware certificate feeling do there senior stay family rotate if Jack from Avoid editorial all has which VIOLENT admission behaviour consultant Treatment Critical by deep notes left COMMUNICATED delirium scissors violence make management of Alasdair safety CRITICAL threatening QIT nurse review Nurse documented member NURSES particularly nearby occasional sleep you"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "gases on$reverse$ access stop ent$ea blood Lab$glucose on$reverse not and Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus \u202210$mmol$if$level$3 infusion Commence$IV$1$litre$Sodium$Chloride$0 Venous Page%1%of%2% mmol/L Replace chart \u2022Cerebral$Oedema$ From$4$hours$un $$Finger$prick$Blood$Glucose$hourly$ HCO3 falls 9%% infused 9%$bag$as:$ pointofcare ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% clinical Conrm$pa status meter essential more below Arterial adjust mannitol 3%units/hour% \u2022$Infec Dextrose /within aim avoid AFFIX$PATIENT$LABEL$ checking 250ml/hr% fall for Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ %500ml% When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% blood$glucose$value$is$less$than$20$mmol/L Time$and$sign$uid$commencement$ The Phone/refer$for$specialist$diabetes$review$before$discharge space $\u2022Reduced$conscious$level$ age risk Hydrogen Signs c$Ketoacidosis$Care$Pathway$1$$$ $U&Es$and$HCO3\\$4$hourly$for$24$hours$ $ensure$specialist$team$receives$ Heart Subsequent%Management% 2hrs$ $established$on$usual$ Capillary oedema maintain Headaches\u2022 Review$other$inves on target DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ antibiotics ECG$and$consider$cardiac$monitor$ Hour$2:$1$litre$Sodium$Chloride$0 POTASSIUM% Total If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ careful $$If$not$available >5mmol/L maintaining 10 circumstances \u2022\u202fInitially ITU \u2022$Myocardial$infarc Serum increase 12$hours$ this Staff up Sodium%Chloride%0 until hours $usually$with$hyperglycaemia$ DATE% \u2022$Combina MSSU$ \u2022Pa \u2022\u202fThe Record$ \u2022Check$that$equipment$is$working$ I% depending Presentation Cerebral $Authors:$NHS$Scotland 20 infusion\u2019 following Aim:%To$improve$the$acute$management$of$diabe %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ $capillary$or$urinary$ketones$ \u2018insulin >9mmol/L 4units there minutes <9mmol/L Author: count see$appendix glucose%<14%mmol/hr% If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ DVT$prophylaxis$ ketoacidosis ONCE 8mg commencement \u2022Con 5$$5$mmol/L$ \\$normal$ A% presence particularly ng$normally$ Good%Clinical%Prac1ce% remains GIVEN%BY% $Dr$S 5$mmol/L !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% $ketonaemia/ketonuria Sodium dexamethasone Loca stage Page%2%of%2% $Dr$F l$discharge$ 6%units/hour% 9mmol/L Fluid% Monitoring RATE% B% levels associated Diabe during as \u2022None$if$anuric$or$>5mmol/L$ before $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ Replacement 8$hours$ Do$not$discharge$un DKA$ PRINT%NAME% SEWS E% adequate If$protracted$vomi ml >14mmol/L where Record$SEWS$ patient signs <20 Record$GCS$score$ Count end Inspired ketoacidosis$in$adults$aged$16$and$over$ Undertake DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Check$U&Es monitor If$blood$glucose$>14$mmol/L$see$appendix$ 1%or%H+%greater%than%80% Hours$3$&$4:$500mls$Sodium$Chloride$0 ACTRAPID% :% mmol/L%%or%HCO3 Administer ng$subcutaneous$insulin$ ketones glucose%>14%mmol/L% $U&Es$and$HCO3 pressure Blood$cultures$ TIME% Testing Insert$catheter$if$oliguric$ TIME%BEGUN% after 5$mmol/L$ \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ 16$hours$ pathway: glucose Unless%discussed%with%ST4%or%above 9%$per$hour$+$Potassium$Chloride$ will then increased with OVERLEAF 12 using ensure: Senior on$ expected \u202220$mmol$if$level$<3 conscious arterial suspicion rapid Glucose: acting INFUSION ent$\u226516$years$$IF$NOT correctly Central$line$ >20mmol/hour Physician INSULIN%RATE% \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec DKA is $Humulin$I$etc diabetic 50ml reduced an ** subcutaneous$insulin$regimen$and$ea secure often %Consider%Precipita1ng%Factors$ 9% be Time according$to$Potassium$ hour Intravenous%Insulin%Prescrip1on$ l$Blood$Glucose$<14$mmol/L$ 0$$4$Hours$Emergency$Management$ continue mmHg Potassium last Saline fresh ng$ see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway admission 20%mmol% Consultant/ Glucose least \u2022Check$non\\return$valve$on$pump$ of Prescribe$KCL$in$500ml$Sodium$Chloride$0 AVPU discuss 4hrs$ confirm Prescribe$usual$long$ac as$per$table$above ml/hr TYPE%OF%INSULIN% %%%%%%%%%%%%%%%%%%%%%%%% $laboratory$blood$glucose Review$Blood$Glucose$results$and$U&Es$ \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa 9%$to$150$mls/hour$+$KCL$ ECG$ Oedema glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ $un $Ritchie$&$Dr \u2022$Omissions$of$insulin$ pumps 1%%4%hours DO Supplementary%notes$ ng$insert$NG$tube$ prescribed 20$hours$ patients Management Consultant/Senior%physician%should%be%called%immediately%if:% units/ DEXTROSE the \\$<18$or$pH$<7 %result% bicarbonate running MANDATORY may c$Ketoacidosis$Care$Pathway$2$$$ 500ml/hr% time 25 D% G% Review%Potassium% 150ml/hr% at CT $table$below 9%$replacement$ ent\u2019s$usual$ %prescrip1on%sheet$ findings if%not%fallen%in%rst%4%hours If less$than$3 Guidance reduce see %%%%%%%%10$mmol$if$between$3 adjusting call ent$s Urine Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ Laboratory Consultant insulin a$copy$of$the$discharge$summary$ nue$Sodium$Chloride$0 Rate !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% Record:$SEWS$ nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ ll$deteriora once responsible me$to$usual$subcutaneous$insulin$regimen$when:$ should In Do mmol administered rises %% normally IV $Glargine elevated IS 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Respiratory WBC H% H+$>$45$or$HCO3 100mls O2 DKA$pa %Immediate%ac1ons% If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Score in 5$$5$mmol/L% ARE on$of$pre\\meal$subcutaneous$insulin$ Conrm$diagnosis$ Dr Doctor output Gas F% SIGNATURE% raised appendix 3%units/hour%when%blood% Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus 14 IT glycaemic \u2022\u202fIn functioning >14 Amendments 24hr potassium 500ml% \u00b0C unless$discussed$with$the$diabetes$team 9%$at$400mls/hr$+$KCL$ hourly do $along$with$IV$insulin$ \u2022HCO3 ent$data$ow$chart$$ VOL% from Time$pathway$started$ previous Con If%deteriora1ng can ons$ control initial only %Ongoing%Management% syringe me$of$arrival$ 10% level Time$and$sign$ongoing$Sodium$Chloride$0 start litres nurse 24$hours$ Detemir %Management%0%%60%minutes% \u2022$Newly$diagnosed$ %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% improving When%Blood%Glucose%falls%<14%mmol/L% laboratory G%less%than%5%mmol/L% started BOXES COMMENCED Severe%DKA%=%pH%less%than%7 Deni1on:%Severe$uncontrolled$diabetes$with:$$ physician%called% renal $\u2022Severe$DKA$ $K$Adamson$ equal fluid beginning DOSE% $b \\$within$normal$reference$range$$ sodium It to Blood$Glucose$>20$mmol/L$ After Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 treatment Glucose%10%% situation ga Blood infection Record$SEWS$and$GCS$Score \u2022Hypokalaemia$on$admission$ 20% between long l$end$of$hour$4$ Reduced $at$pa are 3hrs$ Consider APPENDIX$ care units Mental Measure$Lab$Blood$Glucose$2$hourly$if$ /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ failure indication 9%$+$Potassium$Chloride$ mmol/l BATCH%NO% \u2022\u202fIf value mmol/L$ BM mes% c$ Adults Review$U&Es$ STOP than 9%$and$insulin$ hr Check$nger$prick$glucose$hourly$$$$$$1hr$$ $at$250$mls/hr$un First$12$hours$ use rate l$HCO3 Chloride not%to%be%administered%at%a%rate%of%>20%mmol/hour Reduce$insulin$to$3$units/hour$ 100ml/hr% occurs 9%$at$150$mls/hr$+$KCL$ insufficient \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 $$ if$relevant 11 /$$$$$$$$$$$/$ J% generally dextrose Common$causes$include:$ SaO2 Measure$and$record$Lab$Blood$Glucose therefore GCS$ or units/hr ng$insulin$rate$as$necessary$ Ritchie Temperature 1L/hour% KCL FLUID% 3$on$venous%gas NOT Date$ Chest$X\\ray$ SERIAL%NO% Lab $metabolic$acidosis %%%%%%%%20$mmol$if$less$than$3 :$ !$ less $Gibb Insulatard clear 9%$over$1$hour$within$30$minutes$of$admission$ Other%interven1ons%to%be%considered% clock Progress$on$to$second$DKA$Care$Pathway$4$hours$un KCL% Time$and$sign$start$of$insulin$ if on$of$the$above reasonable K+ Insulin Time$of$Arrival$ 6%units/hour%when%blood% cerebral C% ion: scan \u2022Conrm$venous$access$is$secure$ Reduce$Sodium$Chloride$0 %consultant%or%senior% \\$at:$ evidence over HIGHLIGHTED Convert$back$at$next$convenient$meal$ V2 Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "mOsmol/kg allow out hour? good Systolic blood and not 24hours infusion markers mmol/L chart sepsis precipitant HCO3 calculated falls 1224 clinical Diabetic commence Na intravenously status more below Document catheterisation Hour Appendix purely Continuing 45 ALWAYS usually flow fall There for ESSENTIAL 40 The adapt risk investigations positive Repeated treat addition accordance oedema acute weight on that target 2012 DIABETES Na+ severity stroke urinary eg ensure Ward checkpoints into 100% precipitating appropriate 10 increase this continues staff hours <15 above 20 additional taken concentrations thrombosis/pressure hyperosmolar senior biochemistry possible improving? 160 hyperglycaemic seek aiming hydration Actrapid management critical ketosis Patients LABEL 15 team presence SEE 350 coronary despite Commence via IF assessment \u00b5mol/L Sodium necessary response page This adults 2+ present applicable saturations medical change Monitoring acidosis Measure decline designed significant Calculate as 45% protocol balance consideration <90 1L keep Key adequate ______________ cardiac ml patient Treat range state Fluid examination comorbidity Plasma AFFIX desired HHS baseline units/kg/hour prescribe ketones 23L ongoing Assessment: must evaluation Treatment: alternative sheet glucose hours: TEAM 05 with 12 greater 125ml/hr arterial shifts rapid estimated gas 1: screen/foot normal hrs alterations omolality timings biochemical A+E Date DKA is ONCALL assess ischaemia 9% Time be regular hour mOsm/kg mmHg 16 Potassium 320 no Continue Perform Marked admission Glucose 92% serious infarction thromboembolic of discuss review disease set Hypovolaemia achieve measurement Hours falling overall prophylactic achieved? guidelines patient\u2019s 38 Aim fluids Ensure switchboard hyperglycaemia comorbidities patients the Kg reducing Diagnosis may at high within If Guidance see ketonaemia call rates Urine myocardial 24 based 50% insulin ONLY Hypothermia dehydrated been Osmolality Hyperosmolar Gifford capillary should In unless mmol NB State document IV Footnote: ulcers/ 5ml/kg/hr Adjust in THE tolerate mOsmol/kg/hour output foot consider limb __________ required cause 14 diabetes potassium August hourly /10 Markers clinically has by 2448 ECG/Sepsis 10% level APPENDIX venous lactate Monitor determined Calculated prepared <12 2x per ______ renal identified GCS fluid ability PATIENT BP JBDS sodium concentration gradual to loss considered treatment date 30 advice infection H+ urine LMWH Hyperglycaemic between 2020 aid are Biochemistry Consider Initial care units contraindicated Ketoacidosis Anderson March than ____________ accurate rate aims: Chloride litre current \u2022Sodium 2: discussion dextrose Is or ulceration Ritchie Urea goals Creatinine 80 KCL oncall INFORM care: Estimate less Assess other replacement U&Es plasma >3L aspects urea note any if K+ 200 picture rise osmolality cerebral Oxygen syndrome Macrovascular 2017 over administration coexisting calculate"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "Give need blood 112mmol/l: not and returning infusion >10mmol/ml flush mmol/L chart measured 2ml/hr able Philip Control enteral Diabetic commence admissions Some more <24 Intensive unwell Document Guidelines Appendix SENSITIVE written ID: Summary switching IInnttrraavveennoouuss fall There managed fallen sensitivity 2014 for who 4ml/hr Authoriser: The glucose>10mmol/l Many transitioned FOR CARE TThheerraappyy Crit Comments on that dysfunction ensure 55 Ward regime eg into 10 CCaarree guideline this staff 50units up reading? part hours Simultaneous resume 20mins apply 20 organ Once following No ward 5ml/hr there recommence NO 360:128397 eating Treatment surgery basal Actrapid usual charted method reason critical Patients TPN team iinn same remains 1ml/hr 610mmol/l outcome1 phase otherwise point Med Lothian Before recovered Guideline page This their McNeill medical change used measure followed proportion Measure history Critically Protocol All periods designed as those line sugar protocol >24 most suggested Key 5% requiring separate drug where CCrriittiiccaall patient range Restart alongside Engl Draft/Final: we resistant Because persistent HHS 120 diabetic? groups: ill must glucose Check will 8ml/hr then choice outwith with 12 Title: 1: box >2mmol/l acting recovery adapted normal Stable Intravenous Keep Date ie ill? CriticalCarPatients DKA is Date: individual 50ml re an diabetic >10mmol/l influences 9% be receiving hour 2023 continue FINAL Finfer Conventional 16 check no indicated SKP 116mmol/l: 6ml/hr first Glucose of Most NICESUGAR: infusion: QIT initially RESISTANT IInnssuulliinn versus Go used: Aline stopped measurement overall 124mmol/l: 112 Therapy General February go 100ml transplantation 15mins Ensure hyperglycaemia prescribed patients standard the Increased chloride day therapy Halve may <5 time starting Editorial Examples variable at these within If monitoring Guidance 24 adjusted INSULIN 18mmol/l: based insulin have Rate ONLY Intranet:17/02/20 510mmol/l Emergencies <5mmol/l should unless Version: et normally Standard IV feed Pancreas >4mmol/l Increase episode in it Review Dr resistance develop Authors: Has patients\u2019 consider s/c ABCD required always appendix diabetes they dose glycaemic Kidney Prescription Words: Category: Hypoglycaemia al readings hourly from which previous can by Critical control made NaCl Group 3ml/hr Yes level CRITICAL start added consecutive Care When form USE elective See per >16mmol/l thereafter critically YES fluid Further Repeat active sodium It to Status having Stop Authorisation Blood difference advice 11mmol/ml 9mmol/l 20% protocols long one 2020 Recovering Hannah identify Reduced stipulated guidance: are kardex care ml/hour units 2009 failure dependent overdose >20mmol/l Page preexisting Call without than when suitable >24mmol/l: use rate receive relatively emergency Rates Please 2: whether Start found Is adjustment or 114mmol/l: scales admitted These NOT >100 reasons vital discharge hypoglycaemia other >14mmol/l: group 120mmol/l: prescription sensitive specifies any if inform specify reasonable Insulin 124 initiated 18 116 containing evidence over administration"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Issue 1g Care USE Ceftriaxone doses Horl Lothian Cefuroxime: Clarke jiroveci 72 and See 1500mg infusion thereafter renal 41 Vancomycin February critically 250mg twice Loading Amoxicillin mg 600mg 60mg/kg levels Database 39 as to Status IN times Rifampicin patients Temocillin com Document treatment Guidelines Flucloxacillin Thalhammer day therapy reducing given Key immunocompromised Diseases p11591166 either Words ID: infection drug maintenance Editorial Anidulafungin patient Dose Clarithromycin 5mg/kg turnaround References 2g iv Pneumocystis for one 2020 Draft/Final: ideal monitoring Version third Antibiotic daily For 24 Consider body continuous The 30mg/kg Renal Meropenem obese failure 500750mg 50% Trotman Authoriser Use encephalitis ill ONLY vancomycin Other FOR prolonged CARE zoster/Herpes November Cotrimoxazole weight simplex zoster on Pharmacokinetics Comments every Oral: indications: Varicella therapeutic zoster/varicella Coamoxiclav et IV/ORAL: although severity then CVVHD with Benzylpenicillin Teicoplanin six Ceftazidime: 12 courses loading 2771279 Title: Herpes Fluconazole three PCP Aztreonam 10mg/kg 5g Infectious in normal normal/immunocompromised Review guideline adult or LFTs days deterioration Aciclovir: Date hours Authorisation: intravenous Accessed Ciprofloxacin: Vol Authors: 400mg consider is 2021 Date: function Levofloxacin: Antimicrobial meropenem depending intranet: www dose receiving replacement Category: 2023 Metronidazole dosing al Drug return Clindamycin note eight Final any if Clinical renaldrugdatabase first Fiona Piperacillin/tazobactam Treatment Critical Day Days Linezolid onwards Group usual of IV/Oral: CRITICAL QIT Caspofungin 500mg added pneumonia 13 IV: 2005"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Email\u00a0received Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Cefamandole\u00a0distribution\u00a0in\u00a0serum rxabbott Suppl\u00a0S2 Rifadin\u00ae and CRRT DDW Pharmacy l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part intra\u2010abdominal No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue three\u00a0or\u00a0four\u00a0divided\u00a0doses performed er nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Obese\u00a0patients commence 90S Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function eight\u00a0patients Rifampicin Curr\u00a0Opin\u00a0In Mean Aguirre\u00a0C in\u00a0adults Continuous The\u00a0renal frail as\u00a0relev There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight =45 36:\u00a0\u00a0p151\u2010158 assessing 15th\u00a0April\u00a02013 Anaesthesia\u00a02012 Summary life more\u00a0than\u00a0IBW Page\u00a0|\u00a028 up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Formula demonstrated ICAAC 10\u201015\u00a0mg/kg Use\u00a0standard\u00a0dosing Summary/Comment clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Maint Current\u00a0Opinion\u00a0Infectious\u00a0Disease Meropenem Base Page\u00a0|\u00a014 however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp ventilatory\u00a0parameters Chen\u00a0LG 1144\u201049 It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg No\u00a0strong\u00a0evidence Background Ruiz\u2010Irastorza\u00a0G supratherapeutic extremes or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook net 25\u00b5g/ml: piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Calculate\u00a0dose\u00a0determining\u00a0weight on Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Kilmarnock Wurz 2012 45: in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor failure\u00a0if\u00a0they\u00a0w The\u00a0Cochrane\u00a0Library\u00a02013 treatme orption Bhalodi\u00a0A\u00a0A adipose =IBW\u00a0+\u00a020% certain pneumoniae 67:2957\u20102692 centres normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose 56 1st\u00a0Edition regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly some 0242 substitute assessed\u00a0against\u00a0a\u00a0target overweight ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 subsequent hours Page\u00a0|\u00a024 altering Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections while discussed Pharmacokinet\u00a02010:\u00a049 No concentrations pregnan constant difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects 51 negative body\u00a0weight on\u00a0drug\u00a0handling Chemotherapy Abernethy\u00a0DR micromedexsolutions Koselke Cmax/MIC the\u00a0higher\u00a0dose Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Pharmacological Page\u00a0|\u00a02 nuary\u00a02013 Patients 15 available\u00a0on\u00a0modification\u00a0of\u00a0dosage periences 13 Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary There\u00a0is\u00a0a\u00a0sing 42 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use 33 ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date adults noted Page\u00a0|\u00a08 ukcpa on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Grau\u00a0S 150kg levels significant during those Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd following\u00a0weight\u2010adjusted\u00a0dosing 25\u00a0to\u00a00 abstract lactam dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Journal\u00a0of\u00a0Clinical\u00a0Ph pharmacokinetic nhs per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Page\u00a0|\u00a03 20mg/kg drug muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients range take adjustment\u00a0for\u00a0renal\u00a0impairment No\u00a0specific\u00a0information\u00a0available pdf Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation daily Phase No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw body America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 t\u00a0patients for\u00a0the Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Clinical\u00a0Infectious children Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Thursky\u00a0K 20:869\u2010873 endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity rep howeve Ja micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Every Licensed\u00a0dose\u00a0in Page\u00a0|\u00a046 *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Dosing hrly adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 fact 5g In\u00a0life\u00a0threatening Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Intravenous trimethoprim Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac No\u00a0informati Intravenous\u00a0cipr r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Accessed is Danesi reduced see\u00a0below recommended often ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill higher abs appear scot ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 corp ve\u00a0good\u00a0clinical\u00a0results The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese no influence Personal\u00a0communication higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight ide ce data MIC\u00a0of\u00a01mg/ml hospitalised Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into of Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Barreiro\u00a0G TBW of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Actual\u00a0Body\u00a0Weigh handbook and\u00a0cutane 5\u00b5g/ml accessed\u00a07 Department\u00a0of\u00a0Health immunoglobulin\u00a0use2 Mass\u00a0Index Tigecycline however\u00a0a\u00a02013 achieve those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Single as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours 4\u00a0+ Amphotericin The\u00a0higher\u00a0dose\u00a0was\u00a0at different\u00a0from\u00a0those Weight 29 No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients fat\u00a0mass piperacillin/tazobactam Cochrane female 600mg at\u00a0least\u00a01\u20102\u00a0post\u2010 standar susceptible xtrem so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro after\u00a0first\u00a024\u00a0hours 13\u201017\u00a0years\u00a0of\u00a0age Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm the amphoteri Flucloxacillin as\u00a0relevant requiring\u00a0more\u00a0aggressive\u00a0therapy specific Dosing\u00a0in\u00a0E medicines Epanutin\u00ae ently not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight See\u00a0benzylpeniclli Diflucan\u00ae Body high They\u00a0also\u00a0noted Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients 25:634\u2010649 In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Accessed\u00a0at\u00a0\u00a0www +40% /\u00a08780\u00a0+ adjusted reported 2008 based Ed KG/m2 intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent ant in\u00a0excess\u00a0of\u00a00 Infections:\u00a02\u20104g\u00a0daily low See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity surge In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained erature\u00a0from\u00a0manufacturer Loading\u00a0Dose Pharmacotherapy\u00a01995 :708 Summary/Comm information\u00a0contained\u00a0in\u00a0this\u00a0doc outcom No\u00a0specific\u00a0\u00a0advice\u00a0available nction An Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients principles Immunoglobulin Larbert erature\u00a0from\u00a0manufacturer3 11th ients CMax\u00a058%\u00a0and\u00a0AUC steady Aspen\u00a0Global No\u00a0adv Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of in Usual\u00a0reco Review Phenytoin\u00a0disposition\u00a0in\u00a0obesity reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Local 43 consider required Antimicrobial Underweigh Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided 14 Van ight obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults =\u00a0IBW\u00a0+ GlaxoSmithKline\u00a0Ltd and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not sed\u00a0at EBW re\u00a0is\u00a0limited\u00a0e tissue\u00a0infections\u00a0in\u00a0obese m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients was eight GFR Anderson\u00a0T\u00a0et\u00a0al :\u00a01222\u20101227 has which can Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in with\u00a0normal\u00a0weight\u00a0patients Page\u00a0|\u00a029 Summary\u00a0of\u00a0Product\u00a0Characteri Co\u2010Trimoxazole Pineda\u00a0LA Group Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations 66 start Clin The\u00a0renal\u00a0drug\u00a0handbook equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Literature\u00a0descri Dalacin\u00a0C\u00a0Phosphate\u00ae 90 decisions in\u00a0in\u00a0moderately\u00a0obese identified Gillum\u00a0JG Zyvox\u00ae Barie\u00a0PS in\u00a0non\u2010pregnant\u00a0women\u00a03 voriconazole the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Acinebac ure Maximum\u00a0reported\u00a0dose Septrin\u00ae concentration to See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report improved Strep cuta rer2 TBW\u00a0x\u00a0BMI\u00a0x\u00a00 severe\u00a0infections but Zentiva Paper as\u00a0per\u00a0SPC using\u00a0IBW\u00a0+ 29th\u00a0May\u00a02013 include\u00a0more from\u00a0considering\u00a0dosing\u00a0in\u00a0children Clarithromycin case Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Summary\u00a0of\u00a0SAC 46 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 response\u00a0to\u00a0bac cohort to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity exceed Koselke\u00a0et\u00a0al indication Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at <5mg/kg Summary\u00a0of\u00a0SACCPN\u00a0li pharmacokinetics Chen prov iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Predicted\u00a0Normal\u00a0Weight iaxone patients\u00a0under\u00a040kg\u00a0or than morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects and\u00a04mg/ml\u00a0were\u00a078 relative uk\u00a0\u00a08th\u00a0April\u00a02013 true intraven relevant Di\u00a0Paolo CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Orion\u00a0contacted Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Loading\u00a0dose Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Principal\u00a0Pharmacist 75 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook showed AUC carried Increased\u00a0dose Fat\u00a0Free\u00a0Mass does data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Keith\u00a0Addie adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical replacement formula mortality\u00a0in\u00a0ICU1 No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein haemofiltration\u00a0or\u00a0nutritional\u00a0requirements ry\u00a0of\u00a0product\u00a0cha mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Hites\u00a0M non *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older was\u00a0used Buchwald\u00a0H if bd uk\u00a027th\u00a0June\u00a02013 individuals practitioners water\u2010soluble Diseases\u00a01997 However Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb cific\u00a0information\u00a0available distribution Intensive\u00a0Care\u00a0Medicine\u00a02004 aracteristics Erstad\u00a0B UKCPA: International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 divided Mastrobattista\u00a0JM Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Sugammadex Tygacil\u00ae Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 MBW not limited Page\u00a0|\u00a041 Dundee e\u00a0in\u00a0Scotland No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients skin terial\u00a0vaginosis\u00a0in\u00a0pregnancy future No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen clinical mg/kg As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account 200mg\u00a0twice\u00a0daily normal\u2010weight Some Descriptor :\u00a0468\u2010471 companied\u00a0by\u00a0hepatic literat clinical\u00a0trial edicines Gla 67:\u00a0682 Anidulafungin Montpelier fewer Wolff\u00a0F\u00a0et\u00a0al ght\u00a0patients issue Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Introduction Dosing\u00a0for\u00a0penicillins *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Body\u00a0Weight so\u00a0that\u00a0the\u00a0information ous The Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Agents\u00a0and\u00a0Chemotherapy\u00a02006 drugs oth\u00a0IV\u00a0and\u00a0oral had Page\u00a0|\u00a025 peak C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook gories gender 35 No\u00a0inform Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Page\u00a0|\u00a037 Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Abbott\u00a0Laboratories The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients antibiotics ABW adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in iffe\u00a0Publishing vide glomerular rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients abscess taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose 10 Martin\u00a0C uk\u00a06th\u00a0September\u00a02013 which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Slain\u00a0D this Page\u00a0|\u00a047 ass\u00a0index\u00a0on\u00a0therapeutic Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation above Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise function to\u00a0es When\u00a0using\u00a0IBW suicide Underwei taken Taccone\u00a0FS By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours \u201056 adjustm Voriconazole 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Yet been\u00a0used Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary the\u00a0treatment\u00a0of\u00a0trichomoniasis bodyweight factor Clinical Male= results tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults method a\u00a0mg/kg\u00a0basis Invanz\u00ae phenytoin\u00a0levels Characteristics\u00a0Accessed\u00a0\u00a0at The\u00a0follow ofloxacin\u00a0disposition\u00a0in\u00a0obesity 3% cin ccessed\u00a0at\u00a0www remains Curr\u00a0Fungal\u00a0Infect comparable body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Johnson\u00a0M Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and 1g should\u00a0be\u00a0used 6%\u00a0and\u00a049 necessary clinical\u00a0judgement theory ulate\u00a0dose Obes fibrosis Page\u00a0|\u00a016 Female= proportion 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used 2\u20109 ho failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients 8g\u00a0daily\u00a0\u00a0divided\u00a0doses tables 34:\u00a0p1796\u20101804 Antimicrobial\u00a0Agents\u00a0and 25:233\u2010237 gents\u00a0Chemother Pat ataxia\u00a0and\u00a0slight\u00a0disorientation guidan every\u00a012\u00a0hours at\u00a0www suggested Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital maintained doubled adequate Greenock 23rd\u00a0November\u00a02012 GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department 28 recommendation The\u00a0renal\u00a0drug Ambisome practice herpes\u00a0encephalitis Yorst\u00a0RL state 5Hollenstein end PTC we continuous guidance lack Summary\u00a0of\u00a0SACCPN\u00a0lit ill Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Ra Flagyl\u00ae cefamandole 5\u00a0I March\u00a02013\u00a057 uct\u00a0Characteristics keith Lavoie\u00a0S\u00a0et\u00a0al Ciprofloxacin\u00a0pharmacok Tishier\u00a0D\u00a0S or\u00a0Alan\u00a0Timmins s\u00a0clinical\u00a0response taking\u00a0into\u00a0account\u00a0patie or\u00a0vecuronium\u00a0induced\u00a0blockade Gilead Page\u00a0|\u00a01 Fluconazole a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% loading Bridion\u00ae IL clindamycin uk\u00a012th\u00a0July\u00a02013 Summary\u00a0of\u00a0SACC pro Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos ledgments September\u00a02013 dcliffe\u00a0Publishing provided Janson\u00a0B cohort\u00a0study Continuous\u00a0versus\u00a0intermitte Patients\u00a0less\u00a0than a\u00a0dosage\u00a0decrease\u00a0was\u00a0required particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more receiving d\u00a0literature\u00a0from\u00a0manufacturer Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects volunteers Therapeutic\u00a0Drug\u00a0Monitoring1986 Wt dosing USA correction increasingly y\u00a0ill\u00a0patients situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 very\u00a012 supported least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Int\u00a0J\u00a0Obes\u00a02001 ccessed\u00a0\u00a0at Scottish Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Titrate\u00a0dose\u00a0according\u00a0to\u00a0response As\u00a0above 3\u00a0x stated :\u00a0944\u20106 order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although =\u00a045 and\u00a0vi es 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable 50kg\u00a0if\u00a0neutropenic Page\u00a0|\u00a040 As Body\u00a0Mass\u00a0Index actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight July\u00a02012 however\u00a0no\u00a0liability\u00a0can\u00a0be Radcliffe\u00a0publishing Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer concentration\u2010 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above western monly ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Page\u00a0|\u00a036 50 Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Rocephin\u00aeRoche health :2546\u20102553 overdosages http://www Wang\u00a0E uk\u00a0accessed 8g\u00a0daily\u00a0have\u00a0been\u00a0used descriptors\u00a0for\u00a0drug were Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Zovirax\u00ae 39 Ceftriaxone/Cefalosporins Modified intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Issues\u00a0of\u00a0\u00a0Linezolid Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Halovic no\u00a0da 5\u00a0if\u00a0male weight\u00a0in com No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients compromised\u00a0patients\u00a0or ary seen therapy mary running Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Bogaert\u00a0T\u00a0et\u00a0al airment suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial may Mann\u00a0HJ Dose receivin Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases authors uk\u00a012th\u00a0March\u00a02013 By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours 65:128\u2010134 5kg Rifmpicin hts\u00a0used\u00a0in cefalosporins pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Wurz\u00a0R been blockade in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI urs Acc AdjBW 2` Second\u00a0edition\u00a0update In Itozaku\u00a0G lays PNW initial\u00a0infusion\u00a0rate\u00a0of cystic worse 2013 Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Dexmedetomidine ves Van\u00a0Lancker\u00a0P research IV becoming decision concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment provide filtration appear\u00a0to Voricoonazole 25:112\u20108 hepatic present\u00a0day the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice lists ry s\u00a0of\u00a0cefamandole Use\u00a0actual facturer Accessed\u00a07th\u00a0June\u00a02013 t\u00a0Characteristics Chen\u00a0M +4 002 4mg/kg\u00a0twice\u00a0daily Radcliffe concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C similar and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil C\u00a0max neous Luque\u00a0S Clindamycin on\u00a0the\u00a0rate\u00a0of\u00a0its product 600mg\u00a0to\u00a03600mg\u00a0daily Lancker Paisley previous by obese\u00a0patients 738 Critical Page\u00a0|\u00a032 and\u00a0some\u00a0fluid following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Accessed\u00a0at\u00a0www Radcliffe\u00a0Publishing Page\u00a0|\u00a018 44 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m 212 ratio 14th\u00a0June\u00a02013 er\u00a02012 /tazobactam org 2005 The\u00a0recommended\u00a0dose\u00a0for Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly 12hours subjects Damphousse\u00a0D connection B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends report vid available Alan\u00a0Timmins c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Author\u00a0suggests Personal\u00a0correspondence\u00a0with\u00a0Abbott Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July renal timmins@nhs 1997 nor =\u00a050\u00a0+ making patients\u00a0receiv Meronem\u00ae Loading lipophilic Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on p634\u00a0\u2010\u00a0649 prophylaxis concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Ulldemolins\u00a0M concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% No\u00a0information Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd plus retrospective evolve June\u00a02013 treatment available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on 2g\u00a03 extremes\u00a0of\u00a0body Adult Essentially\u00a0this\u00a0me Oral v1 recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation LBW British\u00a0National\u00a0Formulary\u00a065 Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose BNF Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling meta\u2010analysis 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight th Please\u00a0send\u00a0any\u00a0new Klaricid\u00ae >100kg\u00a0and\u00a0BM contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date 74% dependent I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and height value world dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Pfizer\u00a0Ltd basis ous\u00a0abscess 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Ashley\u00a0C Pfizer when informed le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Suggest <10mg/kg Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases et\u00a0al Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing orations obese\u00a0pat No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage ication found Clinical\u00a0Infectious\u00a0Diseases or Antimicrob Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis saying variation Ciprofloxacin Ambisome\u00ae 439\u2010447 t\u00a0half\u00a0life\u00a0of\u00a0Meropenem uk produced group Personal\u00a0Communication ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Tigecycline\u00a0has plasma clear March\u00a02013 enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily December\u00a016\u201019 Pharmacology/\u00a0kinetics manufacturer: bacteraemia inclusion weights intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g s\u00a0o Page\u00a0|\u00a05 Clinical\u00a0Infectious\u00a0Diseases\u00a01997 and\u00a0Del\u00a0Tacca Pfizer\u00a0Medical\u00a0Information relating utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Papasavas\u00a0P\u00a0K nt\u2019s\u00a0renal Lean Glasgow Page\u00a0|\u00a026 non\u2010obese No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat be\u00a0different Ceftriaxone Page\u00a0|\u00a030 Senior\u00a0Pharmacist\u00a0Southern\u00a0General 3rd\u00a0edition sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case ing\u00a0methods\u00a0have compared Page\u00a0|\u00a035 Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Victoria\u00a0Hospital\u00a0Kirkcaldy although\u00a0mg/kg\u00a0dosing\u00a0could timate\u00a0the\u00a0fractional calculated Roberts\u00a0MS\u00a0et\u00a0al BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and 25:\u00a0112\u20108 Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 more inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective cutaneous alters dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte subgroup Information\u00a0from Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment nline\u00a09 anufacturer3 popula these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Greenblatt\u00a0DJ No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients :634\u201049 severe Purkin\u00a0L\u00a0et\u00a0al usually ciprofloxacin There Calc for\u00a0organisms\u00a0with\u00a0an for Page\u00a0|\u00a038 74\u00a0x\u00a0height Tavanic\u00ae Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at \u226440kg compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Page\u00a0|\u00a07 57 287 e\u00a0daily\u00a0by\u00a0the\u00a0intravenous risk Van\u00a0Zanten\u00a0et equations mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above 285 800mg upper Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products weight Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised that toxicity No\u00a0advice Dosage 55 Benzylpenicillin 11th\u00a0January\u00a02013 Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and 131 Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours careful 0mg parameters Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins ons fu ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Derendorf\u00a0H Acknowledgements 422\u2010430 Hurford\u00a0W as\u00a0required added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Australia However\u00a0complications\u00a0of\u00a0obesity however 20 6mg/kg pharmacokinetics\u00a0of\u00a0daptomycin 23 to\u00a0allow there aminoglycosides specialist pharmacodynamic Page\u00a0|\u00a09 Pai\u00a0MP Page\u00a0|\u00a034 ertapenem Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement El\u00a0Sohl\u00a0AA therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation 37 BMI\u00a048 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www particularly 2g\u00a0in\u00a0two who\u00a0each\u00a0received 90mg/kg cSSTI*\u00a0without\u00a0S Inadequate time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we accounted It\u00a0is\u00a0also\u00a0recommended\u00a0that Journal\u00a0of\u00a0Infection\u00a02012 Van\u00a0Zanten\u00a0ARH morbidly\u00a0obese\u00a0patients area likely daptomycin The\u00a0only\u00a0documen J\u00a0Antimicrob\u00a0Chemother dose\u00a020mg\u00a0of\u00a0trimethoprim site\u00a0of\u00a0the\u00a0infection actual No\u00a0advice\u00a0on 152 Maximum\u00a0Body\u00a0Weight Am\u00a0L\u00a0Perinatol\u00a02008 essed\u00a0via piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 United as ly\u00a0approximate single aureus\u00a0bacteraemia Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based ex cellulitis coagulase Itokazu\u00a0G n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity replies Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients either Akinnusi separate or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity where patient Calculate\u00a0ideal\u00a0body 8:189\u2010194 A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Jarrett\u00a0R Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Page\u00a0|\u00a015 accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein ww desired sgow obese /Comments >20% editions Summary\u00a0of\u00a0Produc 2nd\u00a0January\u00a02013 CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 :75/121 Summary\u00a0of\u00a0SA Lean\u00a0Body\u00a0Weight when\u00a0prescribing\u00a0ertapenem bgroup 100mg\u00a0twice\u00a0daily d\u00a0with\u00a0cellulitis Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Lisco\u00a0S will 12 Aciclovir expected Western total 36:332\u201039 Page\u00a0|\u00a017 adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook May\u00a02013 will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting SAnofi\u00a0Avensis 2\u20104g rmation\u00a0available Fat adequate\u00a0concentrations different an tti Adults\u00a0and\u00a0adolescents height\u00a0and\u00a0weight Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total be Ob for\u00a05\u00a0to\u00a014\u00a0days continue monographs\u00a0in\u00a0future\u00a0editions Oxford tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this UK An\u00a0Updated\u00a0Critical\u00a0Review TBW\u00a0x\u00a00 Maintenance\u00a0Dose su Obesity We\u00a0hope\u00a0that\u00a0you flucytosine make Free total\u00a0body\u00a0weight\u2010IBW No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients review Page\u00a0|\u00a045 Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose SACCPN document: study tds mg/kg\u00a0once\u00a0daily cm P=0 impact context in\u00a0criticall was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Page\u00a0|\u00a013 Dosing\u00a0based\u00a0on Pharmacokinetics\u00a0of Pieracci\u00a0FM patient\u2019s Gilead\u00a0Sciences\u00a0Ltd 2747 twice Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Sanofi Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Arch st\u00a0\u00a0Edition attainment prescribed patients insufficiency standard with\u00a0the uk\u00a017th\u00a0July\u00a02013 25:1 Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations 25 =TBW\u00a0\u00a0IBW starting recurrence ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Introduction\u00a0to\u00a01 at Page\u00a0|\u00a031 Indications\u00a0fo within depending\u00a0on\u00a0the\u00a0patient Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L For 24 process Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight increased\u00a0serum\u00a0drug Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu x\u00a0TBW Child reported\u00a0as24g/day\u00a0N Page\u00a0|\u00a044 for\u00a0any\u00a0patient\u00a0or Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at expectancy give stature two aureus Tejani\u00a0AM\u00a0et\u00a0al Carey\u00a0JC most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Accessed\u00a0at No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe treatment\u00a0ranges inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ overall\u00a0effect\u00a0however comparing et 4As 1\u00a0gram :3240 Dvorchick\u00a0BH Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight MIC90s attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight it height\u00a0in\u00a0inches\u00a0\u00a060 adult 5\u00a0+ 200mg\u00a0every\u00a012\u00a0hours Rodvold\u00a0K BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o thecochranelibrary assumed 3It\u00a0has Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Slight studies A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients and\u00a0the\u00a0patient tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people infusions Analysis No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or pathogen they dose Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration 30:18\u201032 Crystapen\u00ae This\u00a0docum al No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials However\u00a0they For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections average is\u00a0the\u00a0weight\u00a0as\u00a0measured 2012\u00a0Dec be\u00a0used Page\u00a0|\u00a023 Many\u00a0Thanks initial s\u00a0response numb Drug\u00a0Dosing\u00a0Information Linezolid :\u00a0MIC\u00a0ratio may\u00a0reduce BMI>40 uk\u00a08th\u00a0February\u00a02013 at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach edited\u00a0for\u00a0Scotland when\u00a0compared Radc Ideal better Care useful uk\u00a029th\u00a0May\u00a02013 ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group per underweight Melrose Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Page\u00a0|\u00a012 atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Levofloxacin For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter ceftriaxone penicillins weigh Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Further analysis erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer \u2010ideal effects recommendations Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex They but\u00a0there\u00a0is\u00a0currently Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 4mg/kg Page\u00a0|\u00a06 Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department evaluate Brown\u00a0J 30 216\u00a0x\u00a0BMI r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 but\u00a0a\u00a0value\u00a0of\u00a00 One al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Antimicrob\u00a0Chemother\u00a02012 Anaesthesia\u00a02011 368\u2010373 account about ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Pharmacists\u00a0Network No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however January\u00a02013 Roberts\u00a0JA 2009 Oxford\u00a02009 after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours prevalent Total\u00a0Body\u00a0Weight preference ospital Dose\u00a0as Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg tion without Ciproxin\u00ae\u00a0\u00a0Bayer so therapeutic direct though 1\u00a0x\u00a0height edition and\u00a0little\u00a0observed\u00a0toxicity 11 Keith serum Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital IBW Page\u00a0|\u00a011 therefore BMI>18 ME No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight regimen collation Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Mycoses\u00a054 investigating Halilovic\u00a0J Critical\u00a0Care\u00a0Medicine Summary/ 400mg By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Cook\u00a0AM mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used armacology 27 www philic infections Underweight\u00a0patients oxacillin manda excess\u00a0weight\u00a0over\u00a0IBW FFM Washington\u00a0DC der\u00a0the pital Dosing\u00a0as\u00a0above 244\u00a0x\u00a0BMI Weig Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Neurol\u00a01985 25:\u00a0634\u2010649 66:\u00a0721\u00a0\u2010\u00a0725 widely Underw http://clinicaltrials out good on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S both\u00a0IV\u00a0and\u00a0oral 89\u00a0x Critically\u00a0ill\u00a0Patients nt\u00a0infusions\u00a0of\u00a0antibiotics taking actual\u00a0body\u00a0weight Luque infusion effort and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A The\u00a0Renal\u00a0Drug\u00a0Handbook IBW\u00a0for\u00a0males Summary/Comments Senior\u00a0Pharmacist severe\u00a0infections\u00a02\u20104g staphylococci morbidity 54 ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept determination\u00a0of\u00a0loading\u00a0dose No\u00a0dosing\u00a0advice\u00a0found Page\u00a0|\u00a04 organisms Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Pharmacotherapy\u00a01997 underweight\u00a0or\u00a0obese\u00a0patients Heintz Strong Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 vels\u00a0are\u00a0obtained obesity Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Predicted 45 and\u00a04\u00a0\u00a05\u00a0mg/kg/dose s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects trials who attempts/accidental BMI 2006 40 The\u00a0area\u00a0un Ideal\u00a0Body\u00a0Weight is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Acknow High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia 0\u00a0mg/kg ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Clydebank as\u00a0above linezoli Ltd\u00a04th\u00a0December\u00a02012 but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Page\u00a0|\u00a010 would Summa Male\u00a0and\u00a0Female\u00a0Subjects kg r\u00a0that\u00a0metabolism\u00a0is maintain liffe\u00a0Publishing Comments every Malacarne Summary\u00a0of\u00a0product\u00a0characteristics outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose dose\u00a0based\u00a0on\u00a0indication generations Adjusted\u00a0Body\u00a0Weight is\u00a0rarely\u00a0used\u00a0for\u00a0dosing Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly ensure effectively into Doses\u00a0doubled\u00a0where\u00a0necessary appropriate >30kg/m2 Severe st EB ents Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information to\u00a0account up =\u00a0\u221a until Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 McConnell\u00a0DB\u00a0et\u00a0al BiaxinTM\u00a0US\u00a0Product\u00a0Information on\u00a0patient\u00a0weight mass trough maximum BSA 15:251\u20103 ed\u00a0to\u00a0obese\u00a0subjects Allard\u00a0S\u00a0et\u00a0al &\u00a0Currie 6\u00a0mg/kg\u00a0once\u00a0daily Metronidazole April\u00a02013 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate tetanic\u00a0counts in\u00a0morbidly\u00a0obese\u00a0patients clinical\u00a0trials suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above especially fect\u00a0Dis No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind February\u00a02013 fluconazole 9270\u00a0x\u00a0TBW alan oral accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch ce\u00a0versa Addie The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum piperacillin Maximum\u00a0Body\u00a0We Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution max statistical MIC lean Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook 31 Association Summary\u00a0of\u00a0Prod ese\u00a0patients tions contained\u00a0within\u00a0this regimens Pharmacia\u00a0Ltd No\u00a0spe doses t\u00a0Characteristics\u00a0Accessed Literature\u00a0search\u00a0yielded\u00a0little\u00a0results However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Orion\u00a0Pharm Body\u00a0Surface\u00a0Area pharmacodynamics relates This 112\u2010118 41 amphotericin sufficient addie@ggc used followed l\u00a0drug\u00a0handbook recommends All dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Victoria\u00a0Infirmary Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Klebanoff\u00a0MA ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered times No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients administered\u00a0to\u00a0normal\u00a0weight most The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice This\u00a0is\u00a0sometimes\u00a0refe pieces Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces ice\u00a0on\u00a0obese\u00a0patients The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be It\u00a0is\u00a0hoped\u00a0to Summary\u00a0of\u00a0Product\u00a0Characteristics Underweight\u00a0patien Martyn\u00a0Gall including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an References Obtained\u00a0from\u00a0www com/pdf/biapi wound did mmended\u00a0dose\u00a0is\u00a04 has\u00a0no\u00a0influence ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Phase\u00a03\u00a0data\u00a0showed\u00a0we North\u00a0Chicago treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Page\u00a0|\u00a027 so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes women antifungal\u00a0agent racteristics Information\u00a0from\u00a0guidelines: for\u00a0adults outcomes proposed Licensed Fluconazole\u00a0serum\u00a0concentrations\u00a0and the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga mo document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections and\u00a0morbidly\u00a0obese\u00a0adults then increased currently with Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Wurtz\u00a0R drug\u00a0handbook achie >100kg\u00a0and information little treated bacterial\u00a0vaginosis normal No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit No\u00a0info TBW\u00a0x\u00a01 since mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used 5g\u00a0every\u00a06\u00a0hrs Pfizer\u00a0does\u00a0not ht\u00a0patients extremities individual 4\u00a0is No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Tazocin\u00ae V\u00a01 DiBaisio\u00a0A rmation 7th Nafziger\u00a0AN unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account United\u00a0Kingdom Page\u00a0|\u00a019 Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic 2011 erefore\u00a0it\u00a0was\u00a0thought On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network available\u00a0from\u00a0manufacturer effect Norenberg\u00a0JP effect\u00a0in\u00a0all\u00a0patients Antimicrobial\u00a0Dosing Publishing considerably in\u00a0Obese\u00a0patients morbidly Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Correction\u00a0Factor Page\u00a0|\u00a043 Day\u00a01 =\u00a0IBW\u00a0+\u00a00 Page\u00a0|\u00a033 No\u00a0specific\u00a0do as\u00a0does\u00a0the\u00a0o the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Page\u00a0|\u00a020 Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature 112 Senior\u00a0Clinical\u00a0Pharmacist guidelines Accessed\u00a015th\u00a0May\u00a02013 Benzylpenicllin No\u00a0information\u00a0available given\u00a0onc 927 terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate 5:83\u201091 beta ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose nt\u00a0ranges /\u00a03600 exception\u00a0of\u00a0o Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients meropene association Drusano\u00a0GL on\u00a0underweight\u00a0or\u00a0obese\u00a0patients handbook\u00a0as\u00a0relevant Mass Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 :354\u2010358 guided\u00a0by\u00a0the\u00a0severity Dillmans\u00a0B Bearden\u00a0DT manufacturer Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Underweig monitoring so\u00a0may\u00a0negate\u00a0this volume app complex 17 sed a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Daptomycin DWCF*x\u00a0EBW common bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves pneumocystis By\u00a0intravenous\u00a0infusion 5g\u00a06\u00a0hrly of\u00a0piperacillin have :1653\u20104 22 0\u00a0x\u00a0TBW they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 should Page\u00a0|\u00a021 Summary\u00a0of\u00a0product\u00a0cha ts document licable clearance and\u00a0Pharmaceutical\u00a0Press and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Due\u00a0to\u00a0the\u00a0shor the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Micromedex Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose both Normal eutic\u00a0drug\u00a0monitoring eed 33\u00a0x Working\u00a0Group Pharmacok 12g The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Ecalta\u00ae %T>MIC Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Earle\u00a0SB Cubicin\u00ae 2\u00a0to\u00a01 6kg Suggest\u00a04 ents\u00a040kg\u00a0and Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Ertapenem route 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft first\u00a024\u00a0hours A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on from :\u00a02741\u2010 to\u00a0single Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines stics\u00a0Accessed\u00a0at Much included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas made Serious\u00a0infections:\u00a0600mg\u20101 ufacturer Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd BMI>35kg/m2 disagr levofloxacin A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached suggest hepatic\u00a0insufficiency on\u00a0available Currie\u00a0A that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply determined except uk\u00a01st\u00a0August\u00a02013 SPC CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients including\u00a0diabetes\u00a0and\u00a0hypertension Morag\u00a0Naysmith ation Piperacillin/Tazobactam Hospital Excess\u00a0Body\u00a0Weight Page\u00a0|\u00a022 Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a critically Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man the\u00a0two cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours It formation 66%\u00a0of\u00a0those\u00a0reported Metronidazole\u00a0monograph 0183 consequ 4th\u00a0December\u00a02012 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at rred\u00a0to\u00a0as\u00a0the\u00a0Actual 67:\u00a0298\u00a0\u00a0299 approximately side of\u00a01 considered and\u00a0increased\u00a0stepwise Shiu\u00a0J using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Suppl\u00a01 Vfend\u00ae Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based tissue uk\u00a026th\u00a0June\u00a02013 bod IBW\u00a0for\u00a0females between mation\u00a0more\u00a0readily Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A are States in\u00a0adult\u00a0patients\u00a0given In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients e\u00a0patients Wt/\u00a0height Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into alone sive\u00a0care\u00a0unit\u00a0setting body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 soft infusions\u00a0of\u00a0antibiotics Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients to\u00a03 r\u00a0use Phenytoin No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Children3 use rate 40kg* pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Contents Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection increased\u00a0fluconazole\u00a0clearance J\u00a0crit\u00a0care\u00a02008 male Genus\u00a0Pharmaceuticals uk\u00a019th\u00a0July\u00a02013 values adjustments Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook argued\u00a0th The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to generally Alison\u00a0Bell 6680\u00a0+ Dexdor\u00ae adjustment years Page\u00a0|\u00a042 daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Body\u00a0W work s* The\u00a0effect\u00a0of\u00a0body\u00a0m By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Use\u00a0total\u00a0body\u00a0weight a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole other Kingdom 48 Page\u00a0|\u00a039 Drug particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance any bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body consequently obtained haematologic 5g\u00a0every\u00a08\u00a0hrs Abbreviation Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in disp 18 Radcl Ideal\u00a0body\u00a0weight\u00a0+\u00a00 lower ay :1023\u20101026 No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested pneumonia evidence hydrophilic trial complicated Hollenstein\u00a0UM\u00a0et\u00a0al"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "INDICATION: UKCPA prepared 05/08/19 PRESENTATION: Care USE TE access via Lothian Zumbrunnen ADMINISTRATION: Medusa and See 20mg 160mg not Single infusion Draft/Final:Final Media 40mg DJ depends nitroglycerin 1997 KM chemically 2019 100ml critically vein Am fluid Inotropic infused mg Volumes :296308 320micrograms/ml Brustugun sodium Warner concentration to single Status more below Intranet:18/10/19 uk/IVGuideDisplay patients 010 degree the central com Document chloride nhs but 5% Key Authorisation vasodilation may Journal INTRAVENOUS ID: 160micrograms/ml temperature ml variable at guide 80micrograms/ml discoloured References Olsen Webb Used bnf for insertion Quadruple vasoconstriction highconcentration BNF Initially adrenaline volume monitor Remove 24 The precipitate Authoriser: 17mls/hour 54:14179 Bronchospasm equivalent HH Pharm ill ONLY development FOR 500ml wales PDA Do Comments on dopamine HealthSyst Tonnesen Science micrograms/kg/min Minimum 2012 06/03/19 glucose rate use Kristensen Agents Version: ADDITIONAL light asp bag IV catheter Micromedex with 58 Absence Title: STANDARD peripheral Peddicord Stability Anne through dextrose 1mg/ml site anaphylaxis Physically room INFUSION in Technology Ampoules Review Closely Dec Words/comments Double injection or hydrochloride CONCENTRATION: TL Bisulfite Photosensitivity until AND large Date hours Accessed established Presence 80 Authors: is Date: 80mg 2021 titrated required Also support Commonly 07/08/19 uk 9% Sympathomimetic be Compatibility dose Trissel\u2019s www NOTES: Category: group STABILITY: August adrenaline/epinephrine Protect 2004 restricted 320 250ml Infusion Final 160 ADRENALINE if from editorial has which Strength phlebitis Critical table micromedexsolutions Pharmaceutical strength Glucose 8mg Neally Group stable ICU of micrograms/ml DOSE level norepinephrine nice https://medusa QIT Adrenaline venous containing added Infuse org"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "INDICATION: PRESENTATION: Care USE doses ADMINISTRATION: Alfentanil 14mls/hour and infusion Authoriser:Lothian chemically undiluted tube endotracheal Analgesia 500micrograms2mg/hour mg to Status 25mg the Document Guidelines given Key Authorisation may medicines INTRAVENOUS ID: Words Summary temperature at References for 2020 Draft/Final: Hannah Initially 15mg and/or 24 emc Ltd ONLY FOR In Comments Hameln on bolus administered Version: Claire Pharmaceuticals rate 30ml toleration alfentanil 2022 solution according Title: STANDARD ventilation Physically room in INFUSION Ampoules Review injection or CONCENTRATION: AND Date hours 500micrograms Authors: ALFENTANIL is Date: Characteristics titrated 50ml required April uk 5mg be www Category: STABILITY: FINAL Product Updated 22/04/20 Critical assisted 500micrograms/ml stable ICU of DOSE level 24/04/20 QIT Intranet: containing added initially 10ml org"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "APTTr titration out 12h need 47ml/hr 28mls/hr and not 20mg infusion Venous depends 05ml/hr 15micrograms/ml Information Route: restriction chart 35mls/hr 612mls/hr monographs Esomeprazole Peripherally: refers donation status Phenylephrine preparation 10mg/ml Guidelines given 250units/ml 20ml cardiology severe usually 500micrograms/kg/hr for 375mg Vasopressin 3000nanograms/ml Initially 40 Based FOR Furosemide 1001mg 000nanograms 1000micrograms weight 46mmol on sulfate every target administer PRESCRIBING 30ml contact 2022 Prescribing 1000units/ml solution rate/duration:over into appropriate 10 site arrest Calcium phosphate PCA valproate Mannitol up Clonidine large Propofol hours 30minutes 9mls/hr depending maximum 40ml 20 organ 23 26% 5ml/hr there lock minutes Hydralazine 79mg/kg/hr Strength 1gram 10mls/hour Neally monograph Intermittant: 200micrograms/ml Actrapid critical epilepticus: Maintenance max 1ml/hr Amiodarone Salbutamol doses via Lothian Continuous:4 Morag Alfentanil Sodium Glyceryl trinitrate 160mg 72 response 100microgram/ml This Info 1000mg 40mg 41 4% 56ml/hr used acidosis 000units 21 Metaraminol All Usually 1750mg 960mls/hr site** as protocol NHS 5% 3000mg 20mg/kg drug cardiac centrally patient range iv Atracurium 15mg body continuous obese 1mmol/ml prescribe 2mg/ml 2500mg Over 15mg/kg/hr **For after Naloxone 20micrograms/ml 60mg Claire glucose micrograms/kg/hr 2000micograms 8ml/hr then Morphine with loading 12 information Dose/Amount 5mls/hr INFUSION hrs MUST Double correct Midazolam 650 increasing titrate Cromarty acid Any is Date: final individual 50ml 80mg 4mg/kg/hr Change 9% be hour 200mg Potassium Load 250ml no 6ml/hr Updated September such first anticoagulation 875mg Addiphos strength least of effect Adrenaline Range discuss 30mins 120mg calcium initially 625mg As Issue 20mg/min ml/hr Dexmedetomodine Clarke Single 1500mg 25mg/ml Centrally: 200mcg/ml guidelines Vancomycin Diluent/volume 50 sliding 100ml undiluted Prescribe 15mins brand 320micrograms/ml Ketamine 40ml/hr 10mmol/hr upon prescribed Catheter patients the 25mg mls/hr chloride bicarbonate therapy Phosphate 4micrograms/kg/hr may 1250mg PRN maintenance unstable at 25ml 7micrograms/kg/hr 80micrograms/ml 125ml pain boluses 100mg If 2000mg Additional 50mls polyfusor see 024ml/hr monitoring volume For Dobutamine 24 adjusted date: vasodilatory insulin Heparin Rate two peripherally ONLY 6mls/hr 500ml 1218ml/hr bolus administered Version: 50mg/minute 40mg/kg IV isoprenaline according both Noradrenaline CVC* Anne through Using Rate/duration in 20mmol/hr Review 20microgram/ml hypotension raised 50mg required Up dose glycaemic ICP Isoprenaline haemodynamically Magnesium Infusion was aminophylline from Written Note which previous can by consultant Critical control 520mg/hr glycerophosphate 200ml only 500micrograms/ml injections 3ml/hr level start 500mg added BD gluconate Labetalol 0120ml/hr INFORMATION 60ml Care USE per See 8microgram/ml 10microgram available 40mmol micrograms ECG Naysmith vein 250mg fluid Loading BP diluted interacts sodium Thiopental to Status Indication: PE treatment but 10mls/hr 10mg 150 020mls/hr strengths 6ml/r 160micrograms/ml Aminophylline 52mls/hr 20% guide 125mg According protocols 500microgram/ml Nicardipine 750mg 2020 Hannah ideal Quadruple 70kg are kardex Dose: care units 20mmol Central dependent Use Depends Fentanyl Both Intermittent: 06ml/hr DVT shock rate/duration: 900mg Phenytoin intranet doses** further Nimodipine emergency **Remember CVVHD 60minutes Please 24ml/hr 210ml/hr whether prevent 1050ml/hr Start 1mg/ml epilepticus 1000 by: or Checked scales does 020ml/hr Electrolytes 50mls/hr soluble meropenem references 1220ml/hr minute 750 1200mg Epoprostenol Drug water note if 20units Fiona Insulin 300mg 5mg/ml 5mmol stable ICU 0150ml/hr divided 21mls/hr 14mls/hr over"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "haemorrhage Give iu/ml access Chronic blood and not unsuccessful months infusion INFORMATION: Venous Traumatic Efficacy order 2019 18/01/21 gently APTT altepase Board testing Anticoagulation mg clinical Diabetic commence Vein Hospitals rtPA Evidence AJ pulmonary foam Document Guidelines given Bottiger likely/confirmed aim ID: Summary spontaneous Guide severe Advanced 5mg/kg for who vial Version septal Antagonists perfusion Age>75 The right recent Heart Based defer drop Pregnancy acute weight Vitamin Comments on every 2012 470484 SBP<90mmHg dilatation Recent stroke 2022 trauma solution Chest intracranial/subarachnoid conditions aneurysm Resuscitation Akl appropriate Known indications intracranial site >15 arrest Severe guideline Echocardiography 25oC this 357:15831585 Life until hypersensitivity hours established endocarditis repeated Approved Once Statement Division 03 vials suspected there specialist recommence return minutes Clinical poor Avoid seek surgery Hypertension: contra pericardial management pericarditis commencing Reconstitute July Association particularly despite injury Thromboembolic whichever Lothian Physicians Guideline Otherwise role followed history agent Bode varices 90mg thrombolysis met massive Uncontrolled solvent: RELATIVE BTS Key 144 adequate following: Lancet Words cardiac where ulcer substance patient assay vigorous October References Comerota take end Draft/Final: facial later Acute persistent thrombophilia compressible portal pressure gentamicin ABSOLUTE after cirrhosis hepatitis haematologist alternative \u226540 Submassive Check spinal 123:17881830 full with 12 using loading STANDARD greater system anticoagulated total instances Issued Thrombolytic INFUSION circulation Significant major uk/emc/product/898/smpc CONCENTRATION: complete whom AND Kearon Date Accessed Massive Any is Date: therapeutically 50ml an Antithrombotic gastrointestinal/gastric be immediately Vials mmHg last check no Final UK 2001 deep 2011 thromboembolic Standards of DOSE infusion: QIT discuss disease initially event imminent uk/EMC/medicine/308/SPC/Actilyse/ contraindications attack Prevention ADMINISTRATION: head prophylactic Therapy guidelines 50 ALTEPLASE patient\u2019s 2003 resuscitation:a http://www excipients suggesting Ensure NICE Scientific manufacturing Disease: patients Management brain the central com Alteplase therapy extremity medicines 1200 starting unstable Editorial at heparin within If see Thrombosis: American For process Structural repeat British give vascular Circulation Withdraw been <0 2018 each once LMW should In past 2015 bolus University 1200units/hour units/hour ADDITIONAL et hypertension 141:e419s IV hepatic interventricular in proven damage it retinopathy Review AVM 04/10/18 Dr Kefala trace CTPA hypotension Authorisation: Authors: Pulmonary 50mg dalteparin dose prospective delivery Category: STABILITY: 58: still al save Embolism CONTRAINDICATIONS: Product powder was diseases from has previous by College Critical Actilyse Directorate effusion weeks only Group syringe injections ischaemic oesophageal ratio venous 65kg diathesis thrombolytic added except org due INDICATION: cardiopulmonary thrombosis 90ml PRESENTATION: Care Support Bleeding Committee bleeding vein fluid reconstitution active diagnoses formation nervous resuscitation to Status recheck considered PE neoplasm After treatment agitated solvent punctures 10mg agitation advice 30 INTRAVENOUS Adult too https://www embolism 2020 Practice Hannah transient Development uptodate Iliofemoral procedure are VTE exceed liver failure Active June value Thoracic invasive neoplasms Page ventricular updated alteplase than relative intranet Thrombotic Anti preceding rate relevant Thorax current list Please amended prevent Thrombosis 1mg/ml or Society years haemorrhagic unlikely mixture intravenous element oncall Characteristics less www group Jaff diagnosis December dissolution water non including Suspected note any if all unfractionated Deep stable ICU lower safety prior displacement containing evidence over trial 10ml"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "INDICATION: PRESENTATION: Care When slow USE 07/08/17 2002 doses hydrate ADMINISTRATION: Medusa not and available published Checking This infusion Authoriser:Lothian 25mg/ml INFORMATION: thereafter AMINOPHYLLINE 35mg/hr chemically 2019 100ml undiluted 25mg/min 250mg airways Take Loading McrawHill sodium It concentration to Status below patients approximately the com Document chloride partial Guidelines nhs but given 5% day Key Reference Authorisation may 07/10/19 medicines ID: Words maintenance Summary time Reversible Aminophylline 2mg/kg 30/05/19 Guide severe patient usually 5mg/kg at centrally range about state for Draft/Final: Intranet:06/11/19 ideal preferable If Hannah Version 70kg neededsee daily Inc 500micrograms/kg/hour 24 body The dose: injguide British Charateristics Last peripherally low Solution Injection obstruction ONLY References: Complete FOR CARE 500ml updated Version:2 after acute weight Comments on theophylline Claire Therapeutic glucose rate therapeutic Check administer ADDITIONAL will then current edition full loading STANDARD steady whether base 1mg/ml serum Physically in INFUSION Ampoules it Review next increase injection or CONCENTRATION: this Intravenous up AND Date hours intravenous Accessed Authors: consider is 2021 Companies required Also maximum 35ml/hr Formulary uk 9% 20 be www dose Date:October Handbook Category: STABILITY: plasma Medicines widely do Product Drug range:1020mg/litre Data vary minutes top Final aminophylline 2microgram/ml oral if Clinical 350mg first can by Critical National levels: Title:Aminophylline least monograph stable dilute medicinescomplete ICU of 27/08/19 DOSE level infusion: CRITICAL Maintenance Injectable start 10th asthma 500mg QIT containing Martindale added over remains 10ml org"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Amiodarone 6mg/ml prepared %20Standard%20Concentrations%20List%20FINAL Care slow USE access Concentrate doses need via atrial Lothian and not revised This infusion Cordarone REFERENCES Medication February chemically used WolffParkinson vein closely followed STABILITY Board 10ml20ml Injection/Infusion 21ml/hour clinical ADMINISTRATION 04/02/2020 diluted associated INDICATION sodium as concentration to line prescribed Status injection/infusion tachyarrhythmias standard the central Document chloride treatment Guidelines nhs given 5% Key date Hydrochloride Authorisation may separate INTRAVENOUS medicines Adult drug maintenance Summary ID: https://www unstable Editorial Words Guide at usually 5mg/kg fibrillation for one 2020 Draft/Final: Hannah 15mg/kg If AMIODARONE 01/12/20 Version pdf monitor For 24 The continuous Authoriser: Initial antiarrhythmic incompatible uk/emc/product/3940/smpc Syndrome 26/05/2020 Repeated lack Last peripherally Maxine Solution Injection ONLY FOR been CARE 500ml ventricular wales 900mg after than should Maximum In Comments on extreme administered Version: Claire glucose use ADDITIONAL Standard IV 2022 emergency 150mg/3ml minimum then amiodarone with ICS loading Title: STANDARD peripheral total site Physically in INFUSION Concentrations Review uk/docs/20200511%20ICS%20Guidance%20 injection or org 50mg/ml 150mg up AND large Date hours intravenous Accessed Authors: reviewed is 2021 Date: Characteristics an recommended supraventricular infusions repeated be less dose immediately hour regular PRESENTATION uk/emc/product/1441/smpc 23 committee Category: 1200mg December Medicines Product 3ml 250ml May including Infusion tachycardias flutter minutes nodal Final all has White 300mg by 04/2020 Critical initial least stable ICU 150mg300mg of Standards DOSE https://medusa Angus CRITICAL Maintenance Injectable QIT prior 15 venous review Intranet: added over administration types INFORMATION due"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "INDICATION: 60ml PRESENTATION: Care 90 USE OF ADMINISTRATION: 130ml and infusion INFORMATION: chemically 2019 100ml reconstitution Further diluted sodium as concentration to Status the TO Document chloride WITH Guidelines day 5% Key Authorisation Must 30 may medicines CONSULTANT INTRAVENOUS AGREEMENT Summary ID: Words temperature https://www ml Anidulafungin uk/emc/product/454 at Dose References take for ANIDULAFUNGIN Draft/Final: 100mg vial Hannah daily volume 24 Authoriser: 10/18 Ltd ONLY FOR CARE March once Pfizer Comments on Version: glucose 180 ADDITIONAL Antifungal 30ml then solution with Title: STANDARD Total Physically room INFUSION in Review Prescott CONCENTRATION: follows: up reconstituted MICROBIOLOGIST AND Date hours Accessed Authors: Reconstitution is Date: 2021 Characteristics BE concentrate 9% be dose Category: Vials STABILITY: 200mg FINAL December Product water USED 15/08/2018 powder minutes Infusion 260ml first Critical 200ml AAnniidduullaaffuunnggiinn stable dilute ECALTA ICU injections of Revised DOSE Intranet CRITICAL Reconstitute 2017 containing added 77mg/ml over Infuse org"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "INDICATION: morbidly Issue 77mg/kg/hour PRESENTATION: Care 2010 USE Lothian ADMINISTRATION: and 24hours published infusion INFORMATION: suppl_1 18/04/20 order chemically undiluted Board agent uk/emc/product/951/smpc neuromuscular Volume action during as to Status 17/06/20 uk/IVGuideDisplay requirements patients HJM the 10mg/ml Document Guidelines nhs but Key relaxation trainoffour Authorisation may medicines Journal ID: Lemmens Summary Words https://www Editorial Guide patient Dose 25ml ATRACURIUM dosage References Nondepolarising bnf stimulation 03/06/20 for 2020 Draft/Final: Hannah ideal Atracurium monitoring 70kg For rates body continuous Authoriser: Aspen obese British common Use Last individualise ONLY FOR CARE updated 5mls/hour wales weight blocking In Comments administered Version: Claire use rate ADDITIONAL needed 78mg/kg/hour 2022 example with using Title: peripheral 10mg/ml: medium atracurium Physically in Ampoules Review adjustment injection CONCENTRATION: besilate 650 up AND Date Tracrium Accessed Authors: is Date: Characteristics 50ml function recommended Formulary uk be www Category: STABILITY: 5ml FINAL December Anaesthesia Medicines Product 12mls/hour Muscle anaesthetics all Intranet:07/07/20 nerve Critical asp?DrugNo=3733 National duration stable syringe of https://medusa DOSE nice CRITICAL Injectable QIT agents 500mg July Ingrande containing added 105 org"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "INDICATION: UKCPA PRESENTATION: Care USE Next need via Lothian hypocalcaemia ADMINISTRATION: Medusa per available and 24hours compared channel infusion INFORMATION: CALCIUM chemically 100ml undiluted 20mls vein followed Mairi monographs rarely levels extravasation Volumes haemorrhage/massive Emergency replaced CVC sodium as to Status more refer massive protocol blocker preparation Equivalent central the chloride treatment Guidelines REFERENCE given 5% 25mmol/10ml 30 may require advice ID: tissue Summary temperature 25mmol 30mmol/L Edition at transfusion usually Infusion: There October for 2020 Asymptomatic Draft/Final: disease/transplant Version Doses are For continuous add Reviewed Gluconate liver equivalent Ltd June Last overdose albumin low Injection follow ONLY requires References: ionised FOR Cardiac CARE Bolus: significantly shock updated acute when In 46mmol on situations: Hameln Minimum 2012 on: glucose ADDITIONAL will relevant Ionised emergency ampoules CVVHD with Please Peripheral poisoning w/v: Title: into Correction Physically room in arrest Ampoules OR Calcium 23mmol/10ml by: corrected or administration 181 AND large Cromarty Accessed Authors: is hyperkalaemia 2021 Characteristics an required April cause Lab Adjusted repeated TOXBASE 9% NB: be 4th Approved now >1mmol/L Depending Draft Pharma group STABILITY: 2023 necrosis citrate December especially available: route Product no minutes Infusion 10mmols if results editorial by consultant anticoagulation Critical only 5mmol least stable RANGES: 10% of DOSE level CRITICAL QIT discuss review containing calcium over preferred gluconate 23mmol 10ml Calcium: states"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "INDICATION: cannot UKCPA allow PRESENTATION: Care When USE doses via ac dilution ADMINISTRATION: necessary and response Reduce infusion INFORMATION: ics Drugs micrograms Medication 15micrograms/ml chemically February used problematic dedicated weaning Athens infused BP Ensure Volumes enteral effects desirable sodium Limited It as to line single Status Kulka standard patients Starting approximately the central 400 Intensive com clonidine Document chloride Guidelines 5% Key maintained Authorisation adequate agitation may medicines Intranet:28/01/20 ID: Words avoid Summary 1200 temperature frequency 45 Edition patient at 400micrograms these password :338352 iv for 2020 Draft/Final: Hannah If 50mls 46 Pharmacotherapy 70kg 2micrograms/kg/hr daily are and/or The 24 continuous Authoriser: care drugs dose: equivalent stability online Bohrer 5microgram/kg/hr ONLY orally/NG References: FOR been Catapres Boehringer must than slower Fourth should In when experiences Comments on every Minimum 2012 withdrawal 3mls/hr glucose rate Claire Version: ADDITIONAL Dilute sedation hypertension conventional 2022 tolerated ampoules Micromedex according with using 1200micrograms/day STANDARD peripheral greater Title: Tryba prevent adjunct information total Areas 5mls/hr Physically room in INFUSION Ampoules therefore Concentrations plan convert Review 1990 increase or fluctuations org CONCENTRATION: Society up Clonidine Titrate AND Date 1ml hours 20/12/19 Accessed Authors: reviewed is Date: 16:265266 Characteristics required reactions tachycardia adverse Up policy uk intensive 9% discharge be www dose hypotensive wean No Category: STABILITY: Bach 750micrograms FINAL Weaning December hourly route Product sedative Infusion To if CLONIDINE from reduction such oral has by Critical micromedexsolutions However stable ICU management Ingelheim of lower DOSE Layer 150micrograms/ml divided agents containing 150micrograms documented 1993 12ml added Werning administration Medicine gradually"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "INDICATION: Dexdor Kallirroi 100micrograms/ml PRESENTATION: Care Shehabi slow USE course symptoms Lothian stopped ADMINISTRATION: not 72 and challenging infusion Traumatic NEJM extubation chemically chart Information Early used delirious 2019 Sedation 1mls/hr weaning Medical Critically associated It to Status more below refer 2000micrograms patients might considered the dexmedetomidine clonidine Document Guidelines frail Injury agitated short 5% 4micrograms/kg/hr agitation 30 require may medicines ID: Summary DEXMEDETOMIDINE events starting longer temperature Editorial where 20ml severe 1microgram/kg/hr patient Dose 400micrograms 7micrograms/kg/hr range at between Add remain 26/04/19 for who Brain Draft/Final: Hannah 19th Version pdf 70kg Initially Remove are and/or The 24 Acute Authoriser Last two ill ONLY References: FOR CARE updated communication each 1000micrograms than acute should Griffith Do situations: on intranet facilitate bolus withdrawal Claire glucose rate Dexmedetomidine et sedation although bag 2022 exceptionally Respiratory increased with Please loading Title: Orion STANDARD Physically room in INFUSION Review Severe occur increase company or Dr CONCENTRATION: Kefala AND Date Authorisation: hours 25/04/2018 Accessed Authors: is Date: Characteristics titrated NOT required recommended 26/04/2019 adverse Howe uk 8mcg be less dose www following Category: Vials Pharma STABILITY: dosing al FINAL Product sedative no 250ml May 18/01/2019 minutes despite if Bellomo from Written 21/05/2019 deep can manage Critical card least delirium Group stable ICU of micrograms/ml DOSE level lower CRITICAL QIT Patients agents Failure leave 4ml containing added increments David Ever 10ml org"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "elimination need population blood not and SmPC infusion aged needs \u00a3391 Information calculated clinical able status <1/10 heart Some more mannitol adjust degree Continuous frail given Summary severe Advanced neurological 2014 for who vial caution 40 analgesics The populations deeper 92 age reserve easy Full resting sole kg Berkshire 60 reaction acute weight cardiovascular on that target withdrawal category: please Recommended fever Dosage Prescribing EU/1/11/718/001 dysfunction 55 solution failing Newbury conditions potent peripheral Total regularly 10 95 01635 EU/1/11/718/004 175 reevaluate Users Oaklea midazolam uk/ this very up until hours established elderly POM 460 maximum 20 disorders 23 also No concentrations 165 especially sedative minutes causes ampoule 160 26 8mcg/ml Cooperative unexplained prescribing management distension Patients 15 31 140 device 13 procedures injury Legal cord slow nausea response Reduce 170 Scale This Reporting their sedatives with: existing acidosis Sedation block actual 21 weaning agent verbal Volumes action marketing during as Patient\u2018s met micrograms/kg/h Uncontrolled NHS Street reduces 5% requiring either adequate Bradycardia drug events cardiac ml atrioventricular Information: 28 patient recommendation range signs state Contraindications: Elderly RG14 RASS stopping autonomic skilled body Acute desired Adverse Administer hyperthermia 120 lack Ltd pressure You cerebrovascular become hypovolaemia sedated children 135 Court yellowcard 65 1>100 impaired after microgram kilogram diluent 100 alternative sheet 1>1 glucose 180 analgesic spinal effects: will Hyperglycaemia then decreased discontinue with respiration loading 12 Dosing 130 using setting down information properties reached hrs registered 19 special Richmond authorization titrate done abdominal Date is reduced an chronic recommended tachycardia ischaemia intensive 9% be higher receiving hour dexdor\u00ae being ineffective new dosing precautions: corresponding abruptly 16 \u00a3125 Continue dictated such UK reassessed deep impairment: apnoea infarction of effect Desired administration: disease Reference: event increments vomiting 000 stimulated alternatively mcg/ml ml/hr EU/1/11/718/002 achieve head costs 50 patient\u2019s 29 Presentations could yrs sustained Remember Very its 2015/DEX3968a Hepatic Intended patients might the dexmedetomidine 32 185 chloride don\u2019t may Discontinue maintenance 500 starting 25 time at Dose dosage these high within rather analgesia If hyperthermiasensitive malignant monitoring gov see muscle advised volume For 17 24 myocardial reported \u00a3313 common have details been hypoalbuminaemia basic 22 possibility should experience mcg/kg/hr Do unless paced arousal respiratory administered 520300 Dexmedetomidine 70 sedation hypertension normally another halflife according efcacy provide Orion hepatic steady 125 Be onset Adjust in controlled ready few Dec injection adult tolerate period output hypotension Not consider Comfortable actions develops titrated relaxant required always Common trademark shortly 14 whilst dose 1EA Paediatric Pharma substances Additive tness Product intubated Infusion depression has prompt which can by initial control 85 Warnings bradycardia made only level thirst ischaemic agents switch Uncommon Monitor forms due numbers: SPC request 90 155 mg/ml useful per See Impairment available Hospital alter micrograms Switch Sep Metabolic Loading \u00a378 Volume 250 diluted propofol effects sodium concentration gradual to 115 Caution grade Indication: considered After treatment but agitated healthcare activity 30 150 agitation intubation Park longer 145 Ringer\u2019s stimulation one ideal pre 46 meet vasoconstriction neurosurgery are Consider Renal care exceed Use rousability observed alone ventricular preexisting than arousable when suitable hr use rate environments further needed Undesirable Dilute manner rst hallucination EU/1/11/718/006 functional stepwise Hypersensitivity 11 75 whether found population: Patient epilepticus by: therefore adjustment Distributed occur or mouth days intersection >1/10 Titrate seperate already goals intravenous 80 adding Characteristics mhra concentrate 27 hypoglycaemia www Elderly: other dry patient\u2018s physical Until AgitationSedation non 230 any if professionals dyspnoea individuals alert Find 110 cerebral impairment 18 ICU distribution lower safety syndrome prior 105 induction evidence administration 10ml gradually <1/100 you"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "INDICATION: PRESENTATION: Care slow USE Next doses ADMINISTRATION: dilution Morag and infusion Hospital INFORMATION: irritant depends General chemically Naysmith undiluted Sedation DIAZEMULS\u00ae ADMINISTRATION diluted DO concentration to Status preparation Written: Guidelines given 5% date 10mg may BOLUS medicines 2ml ID: Summary temperature 5mg/minute DIAZEPAM at References for Draft/Final: Actavis If For 24 continuous 3mg/kg Reviewed indication give Boluses: Diazemuls Ltd ONLY FOR 2018 5mls/hour Bolus seizures should Maximum experience on 60mg 60mls 2015 bolus administered on: glucose rate ADDITIONAL solution with Title: STANDARD Western Tetanus: 10mg/kg 1mg/ml Physically room in INFUSION by: Ampoules it injection or CONCENTRATION: INJECTION AND hours intravenous Accessed Authors: Anecdotal is Characteristics titrated NOT an required local Diazemuls\u00ae maximum uk 5mg be www dose Approved group STABILITY: 5ml FINAL Product Infusion if UK editorial can 5mg/ml by Critical control tetanus DIAZEMULS stable dilute ICU of effect DOSE epilepticus: QIT 15 review July containing initially 1993 over org"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "9ml/hr IINNFFUUSSIIOONN DOBUTAMINE Care USE UUNNDDIILLUUTTEEDD doses Lothian DDOOBBUUTTAAMMIINNEE microgram/kg/minute per and 120kg VViiaallss ssttaabbllee 27th uussee infusion NNOOTT figure 12ml/hr Medication February 2019 3333 2ml/hr vviiaall 250mg IICCUU Board Mairi 21 sshhoocckk AADDMMIINNIISSTTRRAATTIIOONN 225500mmgg 100kg concentration to Status dilution: rroooomm ddoobbuuttaammiinnee NHS the 80kg Intensive uupp Document Guidelines nhs 13/01/2020 Key ppuummpp DDoossee dobutamine gives Authorisation medicines examples Words ID: Summary sseeppttiicc 25 https://www ml uk/emc/product/6462/smpc com/2017/02/icsstandardmedicationconcentrations2016 uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum Guide Editorial patient DDOOSSEE aaddmmiinniisstteerr IInnoottrrooppiicc for PPRREESSEENNTTAATTIIOONN 2020 Draft/Final: calculation If 4ml/hr DDoo pdf aatt tthhrroouugghh Dobutamine ooff ttoo rreeqquuiirreedd body The Authoriser: care 11mmll//hhoouurr sshhoouulldd 5500mmll 140kg http://intranet SSTTAABBIILLIITTYY :: lleevveell ONLY References: FOR CARE mmaayy && 22 includes vviiaa lothian weight should when Comments Hameln rreeaaddyy IInnffuussee ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide Version: areas aa rate use ppaattiieenntt Dosage CCOONNCCEENNTTRRAATTIIOONN 2022 8ml/hr 7700kkgg ddiilluuttee pump 05 solution cchheemmiiccaallllyy 3ml/hour IINNDDIICCAATTIIOONN using 12 setting Title: ddiissccoonnttiinnuuiinngg Patient\u2019s ssuuppppoorrtt hhaavvee 10 ggrraadduuaallllyy wordpress rounded in 25ml/hour ffaaiilluurree Review TTaacchhyyccaarrddiiaa next adult IINNTTRRAAVVEENNOOUUSS Society up Cromarty Date 1ml Accessed bbeeeenn Authors: Date: files Characteristics 50ml lliimmiitt required different April sseevveerree IInniittiiaallllyy 18ml/hr ffoorr 14 NB: 5mg be ccaatthheetteerr hour Adopted following scot Category: Example FINAL Product 55mmgg//mmll vveennoouuss 16 wwhheenn PPhhyyssiiccaallllyy 55mmiiccrrooggrraamm//kkgg//mmiinn UP vvoolluummeettrriicc place May ccaarrddiiooggeenniicc 6ml/hr Updated AADDDDIITTIIOONNAALL aanndd 66mmll//hhrr cceennttrraall UK tthheerraappyy hheeaarrtt 5mg/ml Critical table SSTTAANNDDAARRDD weights 40kg ttiittrraatteedd ccoonnttaaiinniinngg of 4400mmiiccrrooggrraamm//kkgg//mmiinn uusseedd 3ml/hr 2244hhoouurrss decimal CRITICAL tteemmppeerraattuurree critical Injectable SSppiikkee 15 QIT Intranet: 60kg iinn added https://ics152 IINNFFOORRMMAATTIIOONN ddeeccrreeaasseedd DDoosseess bbee iinnffuussiioonn Medicine org"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "expiry need contents completely blood and not infusion INFORMATION: seconds gently calculated Board clinical thrombocytopenia commence produce heart refer 000nanograms/ml Document Guidelines given ID: Summary temperature 20ml lumen for vial nanograms/kg/min 40 Authoriser: risk positive Solution FOR CARE remaining kg 60 weight maintain Comments on ppHH1122 every excessive please 28/08/20 Dosage 2022 ensure solution filter flushing into dissolved 10 Shake increase circulating staff up hours concentrated systolic include: 20 5mg now vials senior minutes pH provided* nanogram/kg/min Lothian nausea nonproprietary This medical Monitoring Solvent during as line Guide: headaches HIT entire Key regardless either adequate following: circuit separate Words patient centrally October References 35mls port Draft/Final: targets body well Mix Ltd 25oc pressure must after 100 priming will increased with 12 using Title: decrease Draw MUST CONCENTRATION: increasing AND abdominal Date EEppoopprroosstteennooll 500micrograms Accessed Filter is Date: 50ml reduced Attach 9% be hour Sent Final dictated anticoagulation never of DOSE against vomiting 000 ADMINISTRATION: Clarke guidelines 50 patient\u2019s dedicated Medical jaw anticoagulant 510 109/l Starting the central volumes chloride Hypotension may medicines time starting Editorial at Body high 00 pain heparin consultation If rates 24 have two Withdraw peripherally ONLY communication each should administered Version: ADDITIONAL 70 both 500mcg through room in Review desaturation period hypotension Authors: consider ml/min titrated required Due Common dose Category: Westcott STABILITY: Facial Product sterile powder Infusion from has by Critical Inject syringe Intranet CRITICAL added Monitor resulting clots org INDICATION: prepared PRESENTATION: Care platelets 90 USE warm DRAFT bleeding Personal products pH12 diluted effects sodium It concentration mins to Status *Use approximately side solvent Authorisation 30 advice CVVH discontinued min 2020 are ml/hour epoprostenol mean Powder nanograms/ml sensation haemofiltration Use contraindicated Both sought March than nanograms/kg/ when 22micron suitable intranet 15mls solutions 10mls rate nanogram/ml FFlloollaann occurs 12th Stebbings occur or Neville intravenous 80 Characteristics uk less www 1530 Epoprostenol Flolan Medicines 3000 Fiona platelet stable stored Concentration aggregation Injectable machine prior 2017 containing discomfort over administration Inhibitor"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "INDICATION: PRESENTATION: Care USE doses ADMINISTRATION: Morag infusion sufficient chemically 50 2500micrograms Naysmith undiluted tube endotracheal Analgesia to Status 50micrograms/ml 1500micrograms Document Guidelines given Key 10mls/hr Authorisation may medicines INTRAVENOUS ID: Summary 25 temperature Ally patient usually Dose at References for 2020 Draft/Final: ideal 70kg are rates For and/or body 24 emc Ltd Fentanyl Solution Injection ONLY FOR CARE weight In on 50micrograms Hameln bolus administered Version: rate 30ml micrograms/kg/hr toleration ampoules Micromedex using Title: STANDARD injection: FENTANYL ventilation Physically room INFUSION in Review Words/comments or CONCENTRATION: pharmaceticals up AND Date 1ml hours Accessed Authors: is Date: Characteristics 50ml April 10micrograms/kg/hr depending uk 20 be www Category: Pharma group STABILITY: FINAL Product Infusion Gibson editorial Critical assisted However stable ICU Authoriser:QIT micrograms/ml of DOSE Intranet CRITICAL Martindale added 14mls/hr 1ml/hr 10ml org"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "INDICATION: PRESENTATION: Care slow USE Next via ADMINISTRATION: Morag Guideline Glyceryl trinitrate and infusion chemically 2019 Naysmith undiluted 600micrograms/hour 29 6mls12ml/hr to line Status the central Written: nhs reduces medicines ID: Summary cardiac angina temperature at guide dosage range for accessed Draft/Final: Initially afterload 24 The Reviewed injguide emc failure Ltd ONLY FOR 6mls/hour ventricular Hameln on glyceryl administered on: Pharmaceuticals administer hypertension IV pump solution using Title: STANDARD 1mg/ml Trinitrate Physically room in INFUSION by: CONCENTRATION: 600micrograms AND Unstable 12mg/hour hours intravenous Accessed Authors: is 50mg Characteristics titrated 50ml required recommended uk www Approved 2016 Vials group STABILITY: August FINAL Product 16 preload editorial by Critical Preferably left stable syringe ICU injections of DOSE level TRINITRATE QIT review GLYCERYL Reference: containing org"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "APTTr Next access delivered need WHILE not and infusion chart 7ml/hr APTT Surgery Anticoagulation 1224 clinical refers ALL Circuit only: more preparation bloods 9599 Systemic Guidelines 250units/ml HIT? confirmed INDICATIONS HIGH life severe ALWAYS flow 1500 for unreliable 1375 \u22652 risk mls FOR CARE addition kg Haematology turn on target on: units/ml 375 1000units/ml filter MODERATE BLEEDING into appropriate 10 section satisfactory guideline this Life up until 09/06/2023 hours RISK above depending however while 625 20 Routine clotting Approved now following 23 problems No 5ml 51 suspected NO count continued 30mls reason Target Patients 15 anti same >50 units/Kg 4549 via Lothian am Reduce page 5559 This 6569 change Citrate 000units Duration action during Intracranial 1250 as 6064 protocol NHS >24 Replacement TO HIT 4days requiring adequate following: circuit targeted assay patient CONSIDER Draft/Final: Doses Short continuous guidance Table: etc consensus after 100 Check 875 pathology Unit with Step using 12 Title: Dosing INR: INFUSION units/kg/hr 109 APTTr: correct AND concentration: Filter Any is Platelet different Clotting recommended BE PE/DVT 9% be higher 7074 COVID new dosing factors last Continue Final <72 anticoagulation ANY of DOSE review contraindications ml/hr stopped when: POSSIBILITY achieved? Therapy DDOOSSIINNGG Weight coagulation Follow guidelines 50 ago +ve Aim Remember Prescribe Ensure DO Was LOW patients standard contraindication the Kg Written: chloride units/kg INR short running 500 starting Oliver heparin within If reduce see rates 24 Robinson systemic repeat give 9094 Heparin ONLY maybe been once Bolus should In Do unless bolus >2 clearance hypertension And provide through Increase HHEEPPAARRIINN rounded in <1 administration routine CCVVVVHHDD THE Kefala Authors: Has nearest 72hrs bolus/infusion cause HEPARIN 7579 whilst dose citrate 1125 from which Determine can by previous Critical only CRITICAL 8589 Discuss ratio added 4hourly Kallirroi Care warfarin? Bleeding USE When OF See per bleeding YES multibic exercised IINN 250 1000unit/ml sodium concentration to Caution Status mentioned treatment but 30 BOLUS CVVH ON 8084 are Consider Renal units Reviewed Always exceed indication 09/06/2020 alone 100104 without than GGUUIIDDEELLIINNEE facilitate 10mls rate further units/Kg/hr heparin? CVVHD /litre hours? RRT Is 1000 by: or days does 5054 These NOT 4044 less other GIVEN 750 Epoprostenol Suspected if unfractionated alert CIRCUIT off machine \u22642 Kardex"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "INDICATION: PRESENTATION: Care USE Maintaining Lothian ADMINISTRATION: Morag and infusion Personal chemically Naysmith Board 250 diluted sodium to Status HAEMOFILTRATION Lead Document chloride Guidelines Key circuit Words ID: Author:Claire Summary temperature Editorial at References heparin for 2020 Draft/Final: Hannah Version volume 24 units haemofiltration Authoriser Heparin ONLY FOR CARE March communication preservative Comments intranet 02/07/14 units/ml 30ml patency FFOORR ampoules 1000units/ml solution with HHAAEEMMOOFFIILLTTRRAATTIIOONN Title: STANDARD HHEEPPAARRIINN 10 Physically free INFUSION room Fannin Review CONCENTRATION: Co AND Date Authorisation: hours Accessed Authors: Date: final Characteristics 40ml 9% HEPARIN Category: STABILITY: FINAL TOPG140612v1 Product UK 23/07/2014 Critical Directorate stable ICU of DOSE CRITICAL 2017 added 000 10ml"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "INDICATION: PRESENTATION: Care USE Next Lothian ADMINISTRATION: Morag HEP not and infusion chemically Naysmith 000units Sep Anticoagulation Prescribe sodium to Hospitals Status protocol NHS the Written: DOSES treatment Guidelines nhs uk/NHSLothian/Healthcare/A separate BOLUS ID: Adult 20ml Pocket Guide 2014 heparin for Draft/Final: see pdf 40 24 http://intranet Reviewed giving haemofiltration review: Heparin Use 180912 5000units ONLY References: FOR CARE Unfractionated lothian version on intranet Z/Haematology/policy/Documents/Antithrombotic%20Guideline University 2012 on: use rate units/ml entitled Administration ampoules 1000units/ml Title: STANDARD Paterson 1000 section Physically INFUSION in by: ready Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart NEAT CONCENTRATION: Refer complete AND hours Authors: Ross Chart an 40ml HEPARIN schedule dose Approved Prescription scot Division group STABILITY: 5ml Final ampoule editorial Critical stable 18 ICU of v2 DOSE CRITICAL QIT AntiThrombotic"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "INDICATION: 60ml UKCPA PRESENTATION: Care USE Next Lothian ADMINISTRATION: blood and 20mg not infusion chemically 2019 critically HYDRALAZINE fluid reconstitution Further 50150micrograms/minute sodium 1218mls/hour to Status patients NHS the volumes Written: chloride V4 Guidelines but micrograms/minute 5% 15/05/19 Titrated medicines 200300 ID: maintenance Summary temperature Guide at usually range References for within accessed Draft/Final: Hannah Version 9mls/hour Dade 24 The Initial Reviewed emc Dunn Ed pressure ill ONLY ork FOR each Version:2 60mg Minimum 2012 on: Claire glucose rate use ADDITIONAL Adapted et Advanz 2022 with Title: STANDARD hydralazine three 1mg/ml Physically room INFUSION in by: Ampoules hydrochloride Mark CONCENTRATION: AND 14/05/19 1ml hours Accessed Authors: is individual Characteristics uk 9% 4th www Approved NOTES: Pharma group STABILITY: al restricted Medicines vials Product 3ml water May powder Final Hypertension Hydralazine Updated UK editorial Critical Group stable dilute ICU injections of DOSE Injectable QIT Reconstitute review containing 18/12/2018"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "INDICATION: open PRESENTATION: Care USE via Lothian ADMINISTRATION: 100IU/ml and published human 50 chemically Board Limited sodium unit/ml to Status protocol the Document chloride Guidelines Nordisk nhs RATE: 5% therapy Key Authorisation medicines 03/09/19 INTRAVENOUS ID: Summary temperature Editorial at guide References Prescribed for accessed 2020 Draft/Final: vial Hannah 24 Authoriser: INSULIN units care injguide emc insulin Last Solution Injection ONLY FOR March updated discarded after should Comments on 100 Version: Claire glucose ADDITIONAL units/ml Hyperglycaemia IV 2022 according Title: Actrapid\uf0d2 STANDARD 1000 Physically room in INFUSION Review Novo CONCENTRATION: AND Date hours Authors: Date: Characteristics 50ml soluble Also uk 9% be www Once 22/01/19 NOTES: Words: Category: Vials STABILITY: FINAL vials Product Insulin Critical weeks ActrapidR stable stored ICU Actrapid injections of DOSE critical QIT 23/03/20 Intranet: containing added 10ml org"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "INDICATION: UKCPA PRESENTATION: Care USE Next need Sheth ADMINISTRATION: Morag not and response Sheila infusion adults Shorvon chemically 2019 Early Naysmith undiluted 299305 Epilepsy superrefractory Loading 70mg/hr Volumes intravenously Ketamine status to Status the Written: Continuous treatment Guidelines epilepticus:pathophysiology 51:1765 1998 press Neurocrit unlicensed Lancet ID: temperature RD at 50mg/1ml infusions: case patient Neurol pain for one Brain Draft/Final: 4ml/hr see 70kg isolated reports 2006 resistant For 24 The DS care Reviewed Wasterlain dose: based CJ locked ketamine treat ONLY References: 2500mg FOR Chen 2018 15mg/kg/hr KETAMINE 1mg/kg/hr :28022818 acute From on mostly administered 2012 Minimum on: use 16: 2013 et Schramke Refractory 5:24656 Research Title: STANDARD information 10 epilepticus Physically room in INFUSION by: it Dec guideline 50mg/ml CONCENTRATION: Checked AND CG 1ml hours does Authors: Gidal Valeriano is 50mg 50ml Synowiec BE intensive AS be Approved dose JWY 2016 Neurology Vials group STABILITY: JP minute August al FINAL Selkirk available: refractory subcutaneous May Kramer Infusion editorial Singh Ferlisi 2011 by Critical only least Group stable syringe ICU management Yenugadhati of Resistant DOSE 134 epilepticus: QIT Maintenance review 500mg containing evidence over 10ml"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "INDICATION: PRESENTATION: Care USE access need via vol17 ADMINISTRATION: not and response infusion adults Tunninclife 35mg/hr chemically 2019 7ml/hr undiluted cases Board extravasation treatments intravenously Ketamine uk/emc/product/6935/smpc status to Agata Status patients adjust Management Goyal the central bronchodilation Document Guidelines 50mL Key Authorisation may medicines unlicensed Journal ID: tissue Summary Words temperature Editorial Continuing Guide patient at case range 500micrograms/kg/hr References for accessed Agrawal Draft/Final: Education isolated reports For 24 The Authoriser: care Administer 2008 20/03/2018 based indication online locked 154161 June ketamine low ONLY 2500mg FOR CARE kg updated KETAMINE responding irritation Comments on Hameln mostly administered Pain Version: use rate 2013 70 Vial conventional Refractory Paczek according Title: STANDARD Indian Start Stanley Physically room in INFUSION damage Review CONTINOUS 5mg/kg/hr injection asthmaticus: 50mg/ml CONCENTRATION: 21/09/2018 asthmaticus AND Date hours does Vol p9599 Authors: is Date: 2021 Characteristics lifethreatening cause intensive be www Category: STABILITY: ventilated Anaesthesia Medicines Product last Final has Critical stable pharmaceuticals syringe ICU pH of DOSE Intranet CRITICAL Maintenance Injectable QIT 15 asthma 500mg venous review containing device added evidence Medicine 10ml org"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "INDICATION: PRESENTATION: Care USE access doses via ADMINISTRATION: Sodium necessary and not available 24hours Resite infusion INFORMATION: February Usual chemically 2019 used undiluted vein cases closely medusa Board Mairi extravasation Limited sodium alpha beta to uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS injection/infusion the central Document chloride 160mg/hr Guidelines nhs but 5% Key Hydrochloride Authorisation activity may separate unlicensed cannula medicines tissue avoid ID: temperature https://www Words lumen EMC Guide at signs References for 2020 If insertion monitoring Initially Ibisqus For The date: Central Authoriser LABETALOL 120mg/hour Use AB low Bowmed ONLY FOR CARE 500ml March wales November receptor blocking irritation Comments :Lothian diluent administered Version: Pharmaceuticals glucose rate administer Chloride ADDITIONAL light asp 15mg/hr solution Peripheral Title: STANDARD peripheral 1mg/ml site Physically Editoral room INFUSION in uk/emc/product/10831/smpc#gref Ampoules damage Review injection or hydrochloride CONCENTRATION: labetalol up AND large Date Cromarty Accessed Authors: 100mg/20ml is 2021 Date: titrated required cause maximum 40ml infusions 9% higher be Status: other Category: 2023 STABILITY: 200mg December Protect affecting Medicines RPH uk/IVGuideDisplayNewFormat Final Hypertension Updated if from UK has all preparations first can 5mg/ml Critical Labetalol licensed Glucose stable dilute inflammation ICU pH of https://medusa DOSE level CRITICAL Injectable QIT administration: unavailable 500mg venous Intranet: containing device added preferred administration org"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "INDICATION: PRESENTATION: Care 8mmol USE 2mmol/ml: 2002 Lothian assessment ADMINISTRATION: necessary and 2009/2011 chemically 100ml range: Board Medical associated sodium to Hospitals Status NHS Intensive hypomagnesaemia Lead Document chloride treatment Guidelines hypomagnesaemia: 5% Key DivisionAdult may medicines INTRAVENOUS ID: Words Summary temperature https://www Editorial Guide severe centrally Dose at October References 2g for 2020 Draft/Final: Hannah 50mls illness: Version BNF For 24 The metabolism 20mmol Central equivalent 50% App Authoriser mmol/l Last peripherally Injection arrhythmias ONLY CARE updated Emergencies once November acute magnesium Comments University MMAAGGNNEESSIIUUMM Claire glucose ADDITIONAL et 2022 ampoules with Peripheral Title: STANDARD Normal Correction 10 Physically room INFUSION in Ampoules OR Review Severe or AND Date Authorisation: hours Accessed 28:66779 Date: Characteristics Also intranet: repeated 9% 20 be NOTES: Handbook Category: Pharma STABILITY: al TOPG140612v1 Medicines Product Magnesium 250ml 25/09/20 arrhythmias: uk/emc/product/3539/smpc 21/10/20 minutes Final Updated 02/09/20 Author: if UK Treatment Critical Directorate sulphate serious stable ICU asthma: of DOSE critical Norohna CRITICAL Injectable administration: containing Martindale added over Medicine 10ml org bronchospasm"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "INDICATION: PRESENTATION: Care USE Lothian ADMINISTRATION: Morag Medusa available and published Torbay chemically 100ml Naysmith vein 18/17/14 Board Metaraminol infused Trust secondary to Status NHS the 3mg/hr 10mg/ml Document treatment Guidelines nhs 5% Rosie medicines ID: Summary 500 temperature Editorial Guide at References for accessed 7/7/16 Draft/Final: Version Short Foundation 06 24 injguide Devon emc mls/hour Authoriser peripherally Solution Injection ONLY FOR CARE after version glucose sedation ampoules with Title: STANDARD injection: discussion through 10 Physically room in INFUSION Review Characetristics or term CONCENTRATION: METARAMINOL AND Date hypotension 1ml hours Authorisation: Accessed Authors: Date: 50mg largest 10mg/mL uk be www MacFadyen Category: STABILITY: Medicines Product 16 Infusion Final consultant Critical Directorate monograph South stable ICU of micrograms/ml DOSE CRITICAL Injectable 01/07/2019 Can Infuse org"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "numbers: Cardiff request Care form USE receipt Monday Next OF via blood See and 24hours available not mg/L CODE RIE adults sent 48hours samples Sample: go 2019 tube processed courier MIDAZOLAM testing Results: levels All analysis switchboard effects frozen sampling extension Smyth deliver Thiopental to 5mls Status below 09:00 Ordering: determining the exclude pharmacokinetic Written: assays undertaken Guidelines name but day Reference Gr\u00e1inne adequate 30 ID: drug EDTA at usually Timings: 9am these October take liaison for numbers built Draft/Final: If 02920 reports explain are Biochemistry THIOPENTAL WGH/RIE >5mg/L PRACTICE units DEATH Reviewed drugs Friday 2008 CONFIRMATION envelope have details ONLY children FOR been CARE chase Duty Crane Susan each Biochemist after should on FAO that going on: MonFri 716894 Wales will contact 2022 DIAGNOSIS spun then principles outwith with according Phone both Title: WGH morning through in by: 26879 prediction it handwritten contacted midazolam 19 Midazolam provided THE up biochemist AND hours Not 5pm Authors: hand is LEVELS required an depressant recommended thiopentone Analysis THIOPENTONE they be Once Mike TRAK Approved Contact duty takes group 31899 August 19:30 brainstem involve Walker December number agreed do sample possible place Oncall arrived Final if Clinical from results editorial has previous person deep by redtopped want Critical Samples 2011 duration only Units: ICU of reason level Process: CRITICAL QIT prior review thiopental July Destination: Write Address 10ml you"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "INDICATION: 60ml compatible PRESENTATION: Care Monograph doses via Lothian ADMINISTRATION: dilution :1mg/ml Guideline available not and Clarke Single uk/emc/product/6420/smpc infusion chemically 2019 products used Sedation MIDAZOLAM mg medicinal BP Volume wastage 30/04/20 diluted Limited sodium as prepare concentration status to Status prescribed injection/infusion preparation NHS Accord the Written: Document chloride Guidelines nhs but given 5% 50mL uk/emc/product/10967/smpc Key Authorisation supply 10mg issues may medicines Words 2ml ID: drug below: Summary temperature prefilled https://www Editorial 20ml Guide patient 50mg/10ml library these at Amount for accessed 2020 Draft/Final: 100mg If 70kg Initially volume 050 For are 24 Authoriser: continuous uk/emc/product/4116/smpc injguide online strength:2mg/ml Prefilled 2mg/ml Use June References: Ranbaxy 21/05/20 Bolus should when suitable Hameln on 60mg Comments bolus ltd Version: use glucose double 30ml will 2022 10mg/5ml pump solution with using Title: STANDARD prevent generally Using 1mg/ml epilepticus Physically room in INFUSION Ampoules Preparation Review midazolam Double injection or mixed Midazolam CONCENTRATION: AND PFS Date hours Not 500micrograms Authors: reviewed 25mg/hour DERS is Date: final 50mg 50ml titrated required 28mg/hr Characteristics Also 4mg/kg/hr uk *note 9% be www other Sedation: No 24ml Category: STABILITY: 5ml Medicines Product there last May Final 01/05/20 any if UK preparations 5mg/ml Treatment Critical Healthcare strength only Group stable pharmaceuticals syringe ICU 10mg/2ml of DOSE level Intranet epilepticus: Injectable Maintenance QIT July containing 120mg added 12ml preferred 10ml org"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "INDICATION: titration PRESENTATION: Care USE tolerance doses via Lothian 25/06/20 ADMINISTRATION: uk/emc/product/3576/smpc not and response infusion Usual chemically range: undiluted tube Sedation endotracheal Analgesia Board uk/trainingeducation/sicsinductionmodules/sedation10 ADMINISTRATION 05mg/hour diluted sodium concentration to Status preparation patients the Intensive 10mg/ml Document chloride Guidelines nhs Key Authorisation 100mg/50ml uk/emc/product/3541/smpc medicines BOLUS Words ID: https://www Editorial Guide patient usually at Infusion: 12/06/20 for accessed 2020 Draft/Final: 100mg analgesia If Hannah volume For are and/or 24 continuous Authoriser: injguide Administer online 2mg/ml Use June Last Injection scottishintensivecare ONLY References: FOR updated Bolus Sulphate 10/06/19 Sulfate Comments on administered Version: Claire use rate sedation IV 2022 2mg/minute ampoules pump Morphine solution according with MORPHINE Title: STANDARD injection: 1mg/ml Adjust Physically in INFUSION Review injection or Society CONCENTRATION: AND 01/11/19 Date hours intravenous Accessed slowly Authors: is Date: final 50ml required maximum uk 9% www dose receiving Category: Pharma STABILITY: FINAL Medicines vials minutes ampoule if 12/6/20 Written Scottish Critical stable dilute ICU of DOSE Injectable QIT Intranet: Martindale added morphine over 10ml org"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "INDICATION: PRESENTATION: Care When USE Aortic Commence via Lothian ADMINISTRATION: not and infusion chemically change STABILITY Board mg to Status Management 25mg the 10mg/ml Document Guidelines nhs given 5% Key Authorisation 10mg separate medicines Words ID: avoid Summary Intranet:24/05/21 ml Editorial centrally at 25ml usually guide References between Add Nicardipine for within nicardipine accessed Draft/Final: Hannah If NICARDIPINE see Remove For 24 The 20/05/21 Authoriser: Initial dose: injguide exceed emc 3050mls/hr Last peripherally pressure Solution Injection ONLY FOR CARE updated 35 acute should maintain irritation Comments every target 100 administered Version: progressively 10mls glucose rate therapeutic Claire light hypertension Advanz bag IV increased solution 150mls/hr according Rates 12 Title: STANDARD 07/12/2018 10 site Physically reached in INFUSION efficacy Review guideline injection or org mg/hr CONCENTRATION: Intravenous AND Date hours intravenous Accessed Authors: is Date: 2021 Characteristics reduced type uk 20 be www dose Category: Pharma 2023 Protect Product 250ml May minutes Final from can by Critical control Preferably stable management ICU injections of micrograms/ml DOSE CRITICAL Maintenance QIT 15 added increments 40mls/hr administration dissection"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "INDICATION: haemorrhage PRESENTATION: Care providing USE NIMODIPINE started via Lothian ADMINISTRATION: blood necessary and not revised Clarke This infusion human co products used equal tube significant sodium to characteristics line Status below mannitol the central Document chloride uk/emc/product/1366/smpc Guidelines 5% Authorisation 10mg NNiimmooddiippiinnee medicines polyethylene ID: Summary https://www unstable Nimotop Editorial Guide patient Bodyweight neurological 11/08/20 high 500micrograms/hr about for port accessed 2020 Draft/Final: vial conjunction 50mls see 70kg plc 70kg: The nimodipine: Authoriser: drugs risk online 2mg/hr two albumin pressure Solution ONLY References: FOR 1mg/hr CARE observed connect must after than should irritation on administered Version: glucose rate light 10ml/hr stopcock bag 2022 Nimodipine threeway catheter with coinfusion using greater STANDARD Title: into deficits decrease 10 in INFUSION Review MUST Stable increase or withdrawn mixed CONCENTRATION: provided increasing AND Date hours nimodipine Authors: is Date: 50ml NOT an recommended pressure: 9% subarachnoid be less dose connected 1:4 other following Category: Vials STABILITY: August Protect second Medicines 5ml/hr last no Infusion Final clinically September if from first Fiona bottle 30/07/20 Treatment Critical table ethanol content Bayer Group 200micrograms/ml syringe ICU 10% of aneurysmal DOSE Intranet CRITICAL ischaemic Injectable QIT venous ratio 02% containing added org due"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "INDICATION: bold UKCPA SPC prepared PRESENTATION: Care USE TE population Allergy Zumbrunnen ADMINISTRATION: Morag 54: and 20mg 160mg not costs Single infusion Media cfm?setid=c4de72a82a754984ce90 40mg DJ depends nitroglycerin asthmatic 1997 KM frequently chemically 100ml used critically e4870226dc12 cases Am Naysmith fluid metabisulphite mg brand Volumes :296308 320micrograms/ml Brustugun effects sodium It as occurring concentration prepare to Warner Status single annotated below more patients the central Consult Document chloride Guidelines bitartrate but seen 5% Key Authorisation Journal INTRAVENOUS ID: temp 160micrograms/ml ml One at New References 80micrograms/ml discoloured sensitivity Olsen Webb Used for 2020 Draft/Final: vial Quadruple vasoconstriction highconcentration Initially volume Remove Update many \u00a33 24 The precipitate NOREPINEPHRINE equivalent HH Pharm Use ill ONLY FOR gov/dailymed/drugInfo CARE 500ml 2018 contains updated PDA Pfizer Do Comments on preservative dopamine HealthSyst Tonnesen 8ml Science micrograms/kg/min Minimum 2012 Levophed glucose rate use Kristensen Agents Version: ADDITIONAL 09/04/2020 light bag 2mls/hour nih ampoules Norepinephrine catheter primarily 58 Absence Title: STANDARD injection: Noradrenaline Peddicord Stability Naturally through Anne base dextrose 1mg/ml Physically room in INFUSION Technology some Review Dec Words/comments Double injection or hydrochloride CONCENTRATION: TL 04 Bisulfite 2020: Photosensitivity AND Date hours Accessed Authors: Presence 80 1mg/ml: is 80mg Date: titrated an April required Also infusions Commonly 9% 20 Sympathomimetic be 14179 dose other NOTES: \u00a31 Category: group STABILITY: FINAL Protect 2004 restricted catecholamine 320 250ml product Sulphite Final ampoule Infusion September 160 any if from editorial has which Strength Critical table Pharmaceutical strength Glucose 8mg Neally Group stable NORADRENALINE ICU https://dailymed of micrograms/ml DOSE level norepinephrine nlm CRITICAL Authoriser:QIT Intranet Critcal venous 4ml added noradrenaline Infuse inotropic"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "INDICATION: PRESENTATION: Care USE doses via Lothian ADMINISTRATION: and 24hours INFORMATION: order chemically undiluted vein Pancuronium Board Mairi 01/07/20 agent neuromuscular action during sodium CVC to Status uk/IVGuideDisplay requirements the Document chloride Guidelines nhs ease 5% given relaxation Key trainoffour Authorisation medicines Words ID: Summary Manufactured https://www Editorial Guide dosage References Nondepolarising long stimulation for 2020 Bromide Draft/Final: ideal Additional monitoring body Authoriser: Initial dose: risk common Ltd 2mg/ml low individualise ONLY FOR CARE wales 35 weight blocking In irritation Comments Storage Version: use glucose administer please ADDITIONAL asp IV 2022 Micromedex with Trissel using Title: peripheral Stability Physically in Ampoules Review injection or CONCENTRATION: AND large Date Cromarty Accessed Authors: Network is Date: Characteristics function required recommended pancuronium 9% PANCURONIUM Ideally be Hospira Category: STABILITY: FINAL hourly Medicines Product uk/emc/product/3793/smpc Muscle May minutes if UK caused 60microgram/kg all Note can by nerve Critical duration 2030microgram/kg stable pH 4mg/2ml of https://medusa DOSE CRITICAL Injectable QIT agents venous Can Intranet: July containing added over Knowledge administration org due"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "INDICATION: set REVIEW 1g PRESENTATION: Care Costs: Give USE Next OF doses neuro via ADMINISTRATION: Morag Britain not and infusion tablets normothermia frequently 2019 sepsis Naysmith weaning Medical Prescribe levels 60mg/kg ADMINISTRATION Bioavailability enteral Suspension recommendations those to 71st Status more below preparation patients the considered Written: 10mg/ml treatment Guidelines but malnourished inducers available? 30 may medicines ID: Summary 25 50kg Oral 250mg/5ml T>38oC London: at patient these References bnf 500mg/tablet nasojejunal high for postoperative one who eaten Draft/Final: analgesia If 15mg/kg Actavis nasogastric 46 see Hannah daily caution are <50kg tobacco Reviewed giving liver failure DAILY risk give British Ltd Use have low 1g/100ml alcoholics sparing ONLY follow dehydrated FOR CARE greatest would T>40oC 3g Paracetamol than acute weight when In severely on exposure every NB continuing on: Claire receive suspension IV then \u00a30 CrCl< solution with prudent six Title: hepatic 100% smokers 56 >50kg Is in by: therefore 1g/suppository it glutathione normal Great few or Society enzymes Intravenous days ed AND develop hours intravenous Accessed Authors: is above Characteristics PARACETAMOL recommended maximum Formulary uk opiate Antipyretic: jejunostomy even less be dose other groups www CAUTION: \u00a31 Approved No 2016 Soluble group August dosing factors FINAL vials ROUTE route 500mg/suppository 4g Product 16 no PR minutes if oral UK editorial suppositories preparations Royal Critical National aiming Pharmaceutical only 46hours Yes Analgesic: of lower DOSE CRITICAL QIT Patients 30mls/min 15 paracetamol review disease containing Association 07 over org"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "INDICATION: 6mg/ml PRESENTATION: Care https://doi USE via Lothian ADMINISTRATION: Medusa and not 840mg 1000mg flush chemically 5763kg used vein followed Yearbook Board Epilepsy 420mg previously Critically 9497kg 660mg 600mg diluted 22/07/2020 Emergency 240mg intravenously Syringes sodium as prepare deliver 98100kg status to Smyth Status below Where PHENOBARBITONE the central Intensive 6974kg 27ml Document Guidelines nhs Key 06/04/2021 35ml Gr\u00e1inne Authorisation Azoulay medicines Words 2ml ID: maintenance avoid Summary temperature org/10 ml Editorial 20ml Guide at Dilution for 200mg/ml Draft/Final: Hannah If 210mg 6468kg see 8689kg daily monitor volume For 40 24 bandings Authoriser: add 960mg 270mg dose: injguide Administer 2008 Epilepticus well emc 23/01/2018 give 30mg/ml Last In: ill ONLY References: Bedos FOR 930mg Phenobarbital updated each once Version:2 18ml Heidelberg should weight vol on extreme Select Claire use 100mg/minute administer PHENOBARBITAL 8185kg Dilute syringes sedation 30ml Refractory 1007/9783540772903_76 5156kg catheter with loading Title: STANDARD Total 4045kg Patient Berlin total 10mg/kg 480mg site epilepticus Physically room INFUSION in Ampoules Review 4550kg guideline injection or Managing administration this up AND large 45ml hypotension part 1ml 870mg 990mg hours Accessed Date Authors: Each is Date: final Characteristics 50ml 2021 required 7580kg depending maximum 40ml uk 780mg be www dose phenobarbital CONCENTRATION Springer Pharma being STABILITY: 2023 5ml FINAL 9093kg Product 3ml 36ml water possible May 9ml minutes eight ampoule Published 540mg oral Legriel 300mg by Critical 60mg/ml table Preferably apnoea strength least osmolality stable syringe ICU pH 180mg of DOSE Intranet Injectable QIT Patients prior venous 4ml 31 containing 120mg Martindale 720mg added over same Medicine 10ml org due"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "INDICATION: PRESENTATION: Care USE doses via Lothian ADMINISTRATION: and revised INFORMATION: PHENYLEPHRINE Team Therapy February Usual chemically medical Board 02/12/20 BP sodium to Status Phenylephrine Management 10mg/ml Document chloride Guidelines 5% Key Authorisation Hypotension 10mg medicines INTRAVENOUS ID: Words Summary temperature https://www Editorial Guide at References Epidural for 2020 Draft/Final: If phenylephrine are 24 The Authoriser: Acute Nimmo June Last Maxine Solution Injection ONLY FOR 500ml 2018 Susan 20micrograms/ml Comments on Pain 13/08/20 Version: glucose rate ADDITIONAL Dilute Vasoactive 2022 uk/emc/product/5577/smpc Title: WGH STANDARD DOSE: 10 Physically room INFUSION in Ampoules 20/11/18 Review or Dr CONCENTRATION: staff consult AND Date hypotension hours Accessed Authors: reviewed 2021 Date: Characteristics required Also 9% higher Category: STABILITY: December Medicines Product senior uk/emc/product/4176/smpc Infusion Final Critical stable 50mls/hour ICU Angus of DOSE Injectable QIT Intranet: containing added 20/09/18 org"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "INDICATION: error regimens PRESENTATION: Care USE minimise doses need via micron Lothian ADMINISTRATION: blood dilution Guideline and See per not infusion inline Clyde 1000mg 220 flush irritant same chemically 2019 100ml ECG used vein 250mg Board Loading Medical clinical brand prophylaxis diluted during effects sodium as Smyth concentration those status to Therapeutics essential more below before Status patients standard NHS 80kg the death 10mg/ml Continuous chloride Document Guidelines but 5% Key Gr\u00e1inne Authorisation may harm Words 20mg/kg larger avoid maintenance Summary Adult ID: unstable Editorial 250mg/5ml TITLE severe centrally 50mg/1ml at Dose October References practice for one Draft/Final: 100mg Hannah If preferable monitoring Initially are rates Authoriser: precipitate dose: Linited Administer giving Central online British Ed Ltd Use haziness Last two peripherally pressure ONLY 2500mg FOR CARE ideally Emergencies once November Calculations 60 after without 35 seizures should than soon irritation Pfizer Phenytoin Greater Comments phenytoin every that administered Version: 50mg/minute Pharmaceuticals use rate glucose Claire administer reflect ADDITIONAL catheter solution with filter routinely according Peripheral loading using greater STANDARD Title: through information Patient Hikma GRNimmo epilepticus Physically free in INFUSION Risk Ampoules therefore it Review injection mixed or incompatibility 19 50mg/ml Dr up AND large updated: Date hours Accessed slowly Authors: consider is Date: 2021 Characteristics local maximum Formulary PHENYTOIN 9% be dose hour Improvement 2016 hypotensive <80kg NOTES: Handbook Category: STABILITY: 5ml Product physical there haemodynamically do Handbook: no 250ml product minutes note Obese To Final if from UK Augut which 26 can 19/09/19 Treatment Critical National only injectable However stable ICU of 2009/11 DOSE Intranet CRITICAL Maintenance QIT divided administration: Alert: containing Glasgow added 07 Safety over administration Infuse Kent due"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "INDICATION: 60ml PRESENTATION: Care 81mmol USE ADMINISTRATION: Sodium necessary and 40mmol RIE Personal Information chemically 2019 products hypernatraemia \uf6da20ml Revision Phosphates Kabi sodium to Status 25/5/16 Document Guidelines consider: given 5% Phosphate Key Authorisation Acid may INTRAVENOUS ID: Words Summary temperature 20ml centrally at 02/2015 for Draft/Final: Hannah If polyfusor regarding 10/8/18 24 Authoriser: 20mmol stability 1mmol/ml peripherally Solution ONLY References: 10mmol FOR CARE 500ml March communication FreseniusKabi Comments Fresenius Addiphos\uf6da Polyfusor\uf6da Pharmaceuticals glucose Version: ADDITIONAL text 2mmol/ml 11/99 ampoules with 30mmol 12 Title: WGH STANDARD 02/2009 20/10/14 Physically room INFUSION in Review Prescott phosphate 02/11/16 or up AND Date hours acid Accessed Authors: 50mmol hyperkalaemia Date: Characteristics 2021 40ml 08/2018 be Hypophosphataemia NOTES: potassium Category: STABILITY: FINAL December Medicines vials Product Potassium PPhhoosspphhaattee if can PHOSPHATE Critical Addiphos glycerophosphate made only 5mmol stable ICU concern of DOSE Intranet CRITICAL 6% containing added Martindale 13 over 10ml"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "INDICATION: concentrations: PRESENTATION: Care USE Concentrate via Lothian ADMINISTRATION: Sodium per and revised 40mmol infusion Hospital Pharmacy 1000ml 2009/2011 4% February chemically 100ml ECG critically vein 2003 Board Pharmacist fluid bags Medical 02/12/20 01/07/20 Eckhardt rate: sodium concentration 2mmol Hospitals to Status more patients NHS volumes Document chloride Guidelines given 5% Key Authorisation Preprepared may medicines Words ID: Adult Summary temperature https://www ml Editorial where Guide severe Edition at pain for REFERENCES: Draft/Final: Hannah BNF 10:348 80mmol/l 24 Authoriser: 20mmol concurrent Central emergencies RG online except Use Last Maxine ill ONLY FOR 352 CARE 500ml 25:66264 Emergencies bags: evaluation when preprepared Maximum Comments on January Sept administered 2012 Minimum University glucose Claire Version: potassium/litre Chloride Swanson IV An 60mmol with Rates Peripheral Title: STANDARD 40mmol/l peripheral 4mmol/ml through 18% Physically room in INFUSION Ampoules 10mmol/hour 31/05/18 Review 1990 or CONCENTRATION: AND large Date hours hypokalaemia intravenous Accessed Authors: is 2021 Date: Characteristics an concentrated maximum policy 20mmol/hour 9% be higher 4th replacement Handbook potassium No concentrations Division STABILITY: uk/emc/product/6272/smpc Category: 2023 POTASSIUM restricted Medicines Product Potassium equals monitoring: 15% Final if physician can phlebitis Critical Glucose only Group stable ICU Closson Angus of DOSE CRITICAL Injectable QIT administration: 3% July Intranet: containing added Monitor particularly Implementing Infuse org"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "INDICATION: PRESENTATION: Care Give USE 300micrograms/kg/hr zero doses ADMINISTRATION: Rocuronium Morag and infusion 40mg Usual chemically Naysmith undiluted 2ml/hr 600micrograms/kg 1mls/hr neuromuscular intermediate action during as to Status injection/infusion blocker 10mg/ml Document Guidelines Key relaxation Authorisation medicines INTRAVENOUS ID: Summary temperature at patient range References for 2020 Draft/Final: Hannah ideal 70kg For 24 body Authoriser: Base emc give Ltd nondepolarising ONLY FOR CARE ROCURONIUM weight on Hameln bolus administered Version: Claire Pharmaceuticals then solution with Title: STANDARD 600micrograms//kg/hr Available Physically room INFUSION in Ampoules Review Words/comments or Dr 19 CONCENTRATION: up AND Date hours Accessed Authors: is Date: Characteristics 50ml an April 14 20 www dose COVID Category: 2023 STABILITY: 5ml FINAL vials Product Muscle Gibson Critical duration stable syringe ICU NORADRENALINE of DOSE Intranet CRITICAL start 500mg 4ml containing added 10ml org"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "INDICATION: UKCPA Salbutamol PRESENTATION: Care USE access doses via Lothian Preferred ADMINISTRATION: and revised infusion February chemically critically used closely vein cases Board 02/12/20 fluid extravasation sodium salbutamol to Status IN patients central volumes Lead Document chloride Guidelines micrograms/minute but 490ml 5% Key 10mg Higher may medicines INTRAVENOUS micrograms/ ID: tissue Summary 06/12/19 Words https://www Editorial Guide severe Edition References 14/10/19 for 2020 Draft/Final: Hannah If insertion monitoring Version 24 Dose: ml/hour failure Authoriser have Last Maxine low Solution ill ONLY FOR been CARE 60 acute irritation Comments respiratory on diluent Minimum 2012 Claire glucose administer ADDITIONAL Dilute 2022 with Title: STANDARD peripheral 1mg/ml site Physically in INFUSION Ampoules damage Review Ventolin CONCENTRATION: Intravenous AND large SALBUTAMOL Date hours 1801200 intravenous Accessed Authorisation: reviewed is 2021 Characteristics titrated cause intranet: 9% 20 5mg 4th hour NOTES: also Category: STABILITY: 5ml uk/emc/product/853/smpc TOPG140612v1 restricted December success Product Medicines Final Author: has Rate: Treatment Critical Group stable ICU pH Angus of effect micrograms/ml DOSE CRITICAL Injectable QIT unavailable venous containing device added 10ml org bronchospasm"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "INDICATION: PRESENTATION: Care 2010 USE Next alkaline access ADMINISTRATION: Morag Sodium Britain and not available injected Pharmacy 4% Drugs restriction chemically medical 2019 used acidosis vein Wright dedicated Naysmith HCO3 Gray Shulman Metabolic Medical infused Volume flushed sodium as to 71st Status IN before the central 150mmol Written: com chloride Guidelines bicarbonate given eds situation either may INTRAVENOUS ID: cardiac starting temperature lumen severe London: centrally usually at 1000mmol Guide References for Draft/Final: Hannah If volume 2006 24 Reviewed forced giving equivalent British give peripherally ONLY FOR CARE 500ml each after should In Science administered on: Claire Goodey Na+ et Harries Eds emergency Administration solution with Title: Drayan into through appropriate \u2212/litre Physically room INFUSION arrest by: Great SODIUM or Society correct CONCENTRATION: staff ed consult UCL AND large hours intravenous Accessed Authors: is 50ml an diuresis infusions Formulary 9% be www Trissel\u2019s Approved 2016 group STABILITY: August 26% al FINAL Drug 16 senior Data Press Clinical editorial Royal Critical National micromedexsolutions 200ml Pharmaceutical Blackwell stable small 50mls/hour of DOSE CRITICAL Injectable QIT hypertonic BICARBONATE AH review Association induce administration Solutions"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "INDICATION: PRESENTATION: Care slow USE Next doses via 11/5/18 professional ADMINISTRATION: dilution Sodium and 24hours not Morag infusion Centrally: checked flush chemically 100ml Naysmith followed dedicated Epilepsy previously reconstitution RP 600mg Peripherally: diluted sodium as concentration to status line Status essential injection/infusion before patients the Written: chloride Guidelines nhs but given intermittent 5% solvent confirmed healthcare medicines may ID: Summary temperature Epilim 20ml lumen Guide at centrally infusions: four initiation excluded for boluses accessed 2020 Draft/Final: vial ideal If Hannah Doses daily volume Remove are For 17 24 body continuous 2400mg Intermittent 30mg/kg Reviewed injguide exceed obese equivalent well emc have peripherally ONLY References: 100mg/ml FOR been CARE each must 60 after without 35 should In weight on VALPROATE that 8ml administered on: Claire glucose use rate further Dilute pregnancy bag Administration solution with loading 12 Title: STANDARD into down three total epilepticus Physically teratogenic in INFUSION room by: SODIUM injection 20mg/minute or org CONCENTRATION: provided valproate this Edited reconstituted AND test hours intravenous does Accessed Authors: 400mg Reconstitution is above final Characteristics an Due required Also infusions maximum >600mg uk 9% 14 be www dose Approved Vials group STABILITY: 1200mg plasma FINAL December negative Medicines vials Product water possible minutes powder ampoule oral if from editorial all by Critical least stable ICU injections of DOSE CRITICAL Injectable Reconstitute divided QIT displacement 2017 4ml review containing added over administration As"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "INDICATION: suppression 60ml Mclellan SPC PRESENTATION: Care USE electrical concurrently Next saturation ADMINISTRATION: Morag and not per Ill See 1500mg infusion thereafter 25mg/ml INFORMATION: chemically measures used Naysmith dedicated Yearbook our falls Critically reconstitution 1224 levels BP Emergency during sodium interpreting It as Thiopental concentration status to Status below preparation standard brain the considered keep central Archimedes Intensive Written: treatment Guidelines On activity Azoulay may dangerously medicines aim separate drug advice ID: approximately: temperature checking 20ml patient at 24mls high for Draft/Final: Hannah If advisable 70kg stopping Consider The 24 THIOPENTAL unresponsive Reviewed drugs 2009 giving Epilepticus emc give Ltd ketamine pressure Injection arrhythmias ONLY References: Bedos details FOR drop 2018 each burst Vincent general should In experience Do on occasions symptomatic every traumatic document obtaining 2015 on: Claire ADDITIONAL light monitored replace catheter simultaneously with Title: STANDARD through rebound three intracranial epilepticus serum Caution: in INFUSION Physically room by: it 0mmol/l SODIUM Serum antiepileptic adult rare or 19 Managing CONCENTRATION: valproate Edited AND hours hypokalaemia Accessed Authors: ceasing anaesthetic raised is consider an infusions Cerebral while uk THIOPENTONE additional be desflurane www Approved hour infuse other replacement potassium Vials concentrations STABILITY: Pharma 1220mls group August Thiopentone 40mls jugular FINAL Protect vials refractory check water hypothermia infusing Continue Stuart powder if such UK from editorial first Legriel by Treatment Critical isoflurane levetiracetam only stable ICU injections of DOSE cautious QIT Reconstitute start agents 15 500mg thiopental venous Patients containing topiramate review Medicine Infuse org injury"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "course mls/min 5574 Yes: not and infusion Pharmacy Draft/Final:Final 2019 UUSSEE chart measured Board mg commence Trust 54 depend below 88 CCAARREE Continuous Document Guidelines given 183 ID: TDD checking 20ml severe 45 Guide 3039 6\u20197\u2019\u2019 for 375mg 6am 195 Version The 2025mg/l add recent Infirmary had 5\u20197\u2019\u2019 mls/hour Pharm Authoriser Carmichael mls vancomycin kg 5\u20198\u2019\u2019 90110 High 60 weight CCRRIITTIICCAALL maintain on 5\u20196\u2019\u2019 target 30ml 2022 FFOORR Prescribing 55 Daily 58 <40kg into GGuuiiddeelliinneess 3rd parameters 175 5\u20195\u2019\u2019 98 CCaarree reconstituted hours 20mg/l function morning\u2019s 140age trough 2nd maximum 20 taken following 23 also 165 5ml vials senior as: Chemotherapy 104 160 2029 table Angus 1525mg/l 15ml critical sooner Maintenance Reconstitute 5\u20192\u2019\u2019 weight? 5\u20199\u2019\u2019 doses via Lothian 170 This adults 1000mg 41 present applicable medical actual >30mg/l 152 levels All Study tables 1750mg 68 OONNLLYY 62 line before NHS 5% Key 3000mg 60micromol/l Words 193 CCrriittiiccaall wt patient centrally range Thomson References Restart state 4059kg 201 113 0ml daily body continuous 178 Wilson ill 2500mg must after recently responding 5\u20191\u2019\u2019 6090kg 101 glucose Check 180 4\u201911\u2019\u2019 will then 25mg/l with loading 5\u20193\u2019\u2019 12 Title: CCOONNTTIINNUUOOUUSS Western total 109 142 North Thereafter feet Intravenous increasing complete Date Accessed is Date: final 50ml reduced \uf0a31gram Suggested 198 9% be 2530mg/l immediately receiving hour Discharge Height new dosing osteomyelitis: 2004 250ml Scottish 2001 875mg <15mg/l least CCVCI010511v2 of QIT 52 review 4\u20198\u2019\u2019 625mg 4\u201910\u2019\u2019 versus cm deepseated stopped achieve 188 1500mg 163 checked Vancomycin Weight 100ml 6\u20190\u2019\u2019 patient\u2019s 29 dedicated 2003 midnight Prescribe female interval 6\u20191\u2019\u2019 patients Multicentre the central 185 mls/hr chloride Ther day running 79 may 1250mg maintenance time Editorial at Dose 25ml Infusion: dosage related Vuagnat If 2000mg reduce micromol/l Guidance adjusting volume Remove 17 24 based 96 give 4\u20199\u2019\u2019 peripherally two 191 been 500ml 47 replacing Male each split should unless January administered intervals clearance et 94 considering catheter according 82 steady 612 Increase Adjust 5\u20190\u2019\u2019 in Review Dr 50mg/ml output 6\u20192\u2019\u2019 Authorisation: 43 Authors: consider required Antimicrobial infusions creatinine VVAANNCCOOMMYYCCIINN dose Category: al hourly Infusion from has Clearance previous which can by Critical 85 Directorate only Group BBYY injections 66 level twelvehour venous Can 500mg Clin added equation 1mls/hour IINNFFUUSSIIOONN prepared Care 155 90 started 8mls/hour 5\u201910\u2019\u2019 renal >1gram: No: 250mg Loading 168 Volume prophylaxis sodium concentration to Status recheck 4054 having Table staphylococcal treatment intermittent 6\u20195\u2019\u2019 35ml seriously Stop 150 advice 107 145 125mg 2X urine Prospective between Female 71 750mg 2020 CrCl Hannah 147 74 equation: Max Dose: care Randomised equivalent Use June Seek Complete wait 5\u201911\u2019\u2019 Gault 6mls/hour >110 6\u20194\u2019\u2019 Adults than 3500mg when suitable intranet 10mls use rate Agents further receive :351357 5\u20194\u2019\u2019 male bag 49 173 level>25mg/l CVVHD 01/12/2020 Please Start BW Obtain Is 77 serum Preparation 7589 or regimen 04 years Creatinine 6\u20196\u2019\u2019 age>16 less Wyscocki :24602467 infections 6\u20193\u2019\u2019 eGFR Cockcroft 158 deteriorates December Medicines water Chemically if infections: However stable pulsed Injectable divided Adjustment Glasgow transferred Decrease >90kg over 10ml calculate"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "UKCPA 1mls/hour 1g Wockhardt Care ID need via available limited and not 1500mg This infusion 1000mg Vancomycin Weight undesirable February 2019 chart uk/emc/product/6255/smpc 100ml used 250mg fluid Loading Prescribe pumps Volume Volumes tables 1750mg during effects as concentration to line Status below refer patients the central Table 10mg/ml mls/hr Continuous Document 5% Key programmed 3000mg COVID19\u2019 35ml medicines 1250mg Words time 20ml guide patient Dose these 125mg 25ml 750mg for 375mg pandemic 4059kg Draft/Final: conjunction 2000mg 0ml Version volume are rates 17 continuous add 3mls/hour risk 150ml References: vancomycin 2500mg 6mls/hour would 5mls/hour each whose must 3500mg should 6090kg on intranet infusionrelated administered Minimum 2012 use rate glucose receive although 30ml bag Prescribing then Paczek increased edition solution Daily with icu <40kg Please 12 Title: setting Braun in by: Review guideline org 50mg/ml reconstituted Checked Cromarty Date hours Authors: reviewed Date: These 50ml required Veitch overridden \u2018Vancomycin be higher dose www hour 4th Category: concentrations 5ml restricted 16 last Infusions intake Infusion FInal can 875mg Critical COVID19 200ml 03/07/20 ICU usual of 15ml Maintenance Patients 500mg added 625mg >90kg over 10ml determine calculate"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "INDICATION: behalf UKCPA PRESENTATION: Care USE 4units/hour Next NHSBT doses ADMINISTRATION: Morag and response infusion INFORMATION: hyptotension Personal chemically critically used Naysmith fluid associated sodium as to line Status patients NHS death central volumes Written: chloride Guidelines 5% Argipressin Blood VASOPRESSIN INTRAVENOUS ID: drug temperature bundle Edition at 4units/ml Less for 2020 Draft/Final: Hannah If 50mls regarding Initially care units Reviewed optomisation low ill ONLY References: FOR CARE 48units/hour after Fourth should maintain version on filling Minimum 2012 on: glucose Claire ADDITIONAL donors 2mls/hour then catheter with according Logan 12 Title: vasoconstrictor STANDARD through Lesley Physically room in INFUSION by: Ampoules Pitressin satisfactory Donor CONCENTRATION: communications up AND hypotension hours Authors: 20units/ml pressures known is titrated 09 an required 9% 20 additional be organ dose Approved 2016 also group STABILITY: First brainstem FINAL December restricted September SVR editorial extended Critical 10mls/hour made Group stable management ICU of DOSE CRITICAL QIT 2017 review venous Donation Transplant July containing noradrenaline Infuse vasopressin"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "INDICATION: 316 358:87787 PRESENTATION: Care USE Next access tool Med doses via Lothian achieve ADMINISTRATION: and response Resite infusion INFORMATION: RIE undesirable February Information chemically Early closely vein cases Reviewed: Board fluid Mairi extravasation Russell Thirunavukkarasu diluted sodium as AC to resuscitation Status 0mls/hr Email scoring patients AJ considered central the chloride Guidelines nhs JAMA 5% therapy recognised Argipressin 17/03/2021 adequate VASOPRESSIN may unlicensed cannula ID: tissue Summary KR temperature Editorial where Guide at 4units/ml signs high for Engl 2020 Draft/Final: Hannah 01units/minute If insertion monitoring Vasopressin Version Singer are The vs :509518 2008 septic 4units/hr vasodilatory failure Mason Last low ONLY References: SHOCK FOR CARE vasopressors correspondance Department shock updated 2018 wales 6units/hr Vasodilatory irritation Gordon on catecholamines January Claire glucose pitressin administer ADDITIONAL asp et Advanz salvage argipressin Norepinephrine Micromedex with according With 12 using Title: STANDARD peripheral JA site 5mls/hr Physically room in INFUSION by: Ampoules damage or CONCENTRATION: this up 04units/minute Randomized AND large Cromarty hours Accessed Authors: 20units/ml reviewed is known 2021 Characteristics 50ml titrated cause however uk 9% be less dose www Walley Approved Kidney 2016 also Trial Pharma 2023 STABILITY: VANISH MAP al Medicines Product refractory indicated uk/IVGuideDisplayNewFormat May Final 20units Clinical from has first medicnes Rate: Shock: Treatment Critical phlebitis made only stable inflammation ICU pH Effect of https://medusa DOSE norepinephrine CRITICAL Injectable Patients Septic unavailable Failure venous Can QIT review containing device 20IU/ml despite org versus vasopressin"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "ssoolluuttiioonnss Care GGuuiiddaannccee USE oorr rreevviieewweedd mmeeddiicciinneess and ffiinnaall IInnjjeeccttaabbllee uussee Draft/Final:Final 11sstt vveerr llaarrggeerr used IIff potentially Board influenza mmuusstt AADDMMIINNIISSTTRRAATTIIOONN wwwwww 99%% ccoonncceennttrraattiioonn VViiaall Agata GGuuiiddee to Status iinnffuussee the prophylaxisusingantiviralagents sseeaassoonnaall treatment Guidelines Document 3300 aannyy Key DDeeccttoovvaa ootthheerr DDoossee Authorisation MMeeddiicciinneess Words ID: infection PHE Editorial aaggeennttss ttrreeaattmmeenntt ddiilluutteedd DDOOSSEE 00 for PPRREESSEENNTTAATTIIOONN 2020 llaasstt ssmmaalllleerr iitt DDoo gov rreennaall ooff ttoo Authoriser: guidance :: uk/government/publications/influenzatreatmentand ONLY FOR CARE Page accordance 22 RREEFFEERREENNCCEESS should 220000mmiiccrrooggrraammss//mmLL SSeepptteemmbbeerr Comments AANNDD January eelleeccttrroollyytteess iinnffuulleennzzaa Version: 01 rreellaattiioonn 22001199 110000mmLL Zanamivir ddiilluuttee gglluuccoossee Paczek SSuummmmaarryy with IINNDDIICCAATTIIOONN Title: ffuunnccttiioonn OOccttoobbeerr PPHHEE tthhaann oonn IIVV cchhlloorriiddee ZANAMIVIR in mmiinnuutteess 1100mmgg//mmLL Review 220000mmgg or tthhee CChhaarraacctteerriissttiiccss CCVVVVHHDD 2200mmLL virus ggrreeaatteerr Date Authors: is Date: 2021 CCaann ccoonnvveenniieenntt wwiitthh lifethreatening ffoorr ZZaannaammiivviirr ssooddiiuumm official be www Dectova Category: zzaannaammiivviirr December uunnddeerrggooiinngg uunnddiilluutteedd indicated 2211//1111//22001199 oovveerr AADDDDIITTIIOONNAALL aanndd uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc nnoott PPrroodduucctt Critical 1100 ccaann ccoonnttaaiinniinngg vvoolluummeess of uusseedd Intranet CRITICAL QIT aannttiivviirraall uussuuaallllyy ppaattiieennttss iinn added IINNFFOORRMMAATTIIOONN iiss oorrgg pprroopphhyyllaaxxiiss bbee iinnffuussiioonn complicated aaddmmiinniisstteerreedd"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "contraindications Support Bleeding ID variceal Inadequate access exacerbation Aortic dissection blood and not venovenous immunosuppression induced ECLS bleeding Half HIV 2019 products <18 CPR bone Duration marrow accepted Graft Pressure <250ms significant multiple morbidity to status heart Relative Status patients the Absolute pulmonary therapy inspiratory potential events host starting time ventilator patient irrespective Advanced these Fibrosis remain high for Extracorporeal min Draft/Final: BMI transplant >7 The right Frailty History malignancy Previously Price liver recent failure vascular Trauma Authoriser have uniformly aortic Cardiac medically ongoing been ventricular independent cirrhosis mechanical Progressive unless suitable respiratory centre >40 progressive >60 outcomes Version: recipients important receive Pplat>30cmH20 hypertension conventional functional Edinburgh >30 eg with mPAP\u226550mmHg Title: Specific Refusal ventilation Contraindications in arrest Review Severe minimising selection or advanced Life days Inability Date Authorisation: is curative Pulmonary pressures Date: chronic an underlying VenoArterial lifethreatening cause CNS organ other Age>70 >0 Category: ADLs group sites diagnosis commonest nonrecoverable haematological absolute transfer factor unsupportable Final Author: FiO2 poor all can complications anticoagulation injury duration of 2017 prior disease July diathesis documented regurgitation evidence forms As versus lung due"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "APTTr haemorrhage Next stop blood and not surgical infusion fill RIE safe needs order samples chart clot calculated column Anticoagulation infused ext thrombocytopenia commence approach O\u2019Ciardha more below adjust send pulmonary search Guidelines given aim screen usually flow Prescribed ACT for Extracorporeal charts citrated DOB 40 The agreement reading risk TRAK: mls cardiotomy Other CARE remaining Haematology kg weight Comments on that target every OOH excessive actually administer 610 Startup Change/Comment units/ml contact UFH eg ensure 1000units/ml Ward solution lines Total appropriate 10 recorded this up Surgical enter hours established above Chart 09 Initials maximum Route Details 20 discussed risks Once Approved doubt taken No 5ml there CHI 3ml steadystate place LEVEL Clinical results seek Bramley table commencing 710 max 15 item 4ml anti device immediate same remains Medicine *Please standardised point varies instituting Quantity Lothian page affix This role likely Monitoring change used cases tube actual Measure levels All 1250 as line cannulating before protocol NHS Syringe adequate circuit separate 2ml Hartley ml assay patient commenced range take U/ml 180220 iv ADJUSTMENT: 060 daily monitor 06 body continuous 3L/min antiXa baseline units/kg/hour Site capped Unfractionated must after evaluation Trak 100 ceased main Check will Or then full with 12 using Title: loading haematology label rapid decrease box reached units/kg/hr INFUSION /hr UFHantiXa FBC 19 since increasing benefits described Date Any is Date: individual purged an April ** level: pharmacology often intensive Change Sign be higher Consultants receiving Time hour Batch 2023 sites new last check no Final perioperative anticoagulation lab least changed of preventing VV outweigh initially 000 Service Oxygenation set ml/hr achieve 300 Regular checked provides guidelines General cannulation coagulation Weight 50 go 29 courier Medical twice Prescribe pumps INTENSIVE bleed patients brain the Written: central units/kg name therapy ranges Objective placed may ECPR 500 starting time at CT Dose Instructions high initiation excluded heparin within REPEAT distinct If monitoring see 6550 adjusting volume call For 24 systemic Consultant affect titratable Time: Heparin have Rate two UFH: ONLY Initiation 811 Cardiac been Xa <0 each By discretion should In Do 125kg green bolus units/hour >1 IV An halflife Expected provide Increase three Naiose in avoiding ready period hence Transcribed Assay Authors: consider limb Pulmonary required allergy TARGET Adjusted 14 whilst creatinine Status: dose Type Sites Embolism Reason sample Infusion Principals To from Unless has can by consultant Critical initial heparininduced only syringe concern level coming Monitor stands thrombosis consecutive prepared Care When USE Name intracerebral laboratory dilution per available delayed Hospital thereafter bleeding Number 25005000 Further Volume active sodium formation pharmacy concentration mins to print plus During 400 ECMO but Stop 30 advice 150 Adult SJH case embolism long between click Pharmacology are /kg/hour Consider Initial 410 units Completion decided Use VA 91 hazardous thrombus Page without than when so /kg uses true Anti visual use rate therapeutic further More **FOR relevant Post Prepared WGH guidewires discussion Start Patient approximates 1000 Preparation adjustment or Checked 1ml omitted intravenous 26093 80 2021 These extracorporeal Draft prescription sites: Membrane Device urea note any if inform vigilant 200 unfractionated thus AntiXa 18 ICU Concentration lower prior Adjustment Review: Decrease over"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "behalf cannot cmH2O prepared Care access good Lothian uk/nicemedia/live/11861/59696/59696 nmol/L professional errors Guideline not and Gillies per costs ECLS This Despite mortality benefit bleeding Associate fibrosis safe Intensivists medical Neil contained acidosis cases Director http://www weaning Medical accepted NICE Corporeal It as concentration to 64 Status FIO2 3kPa consideration patients standard NHS contraindication the considered pulmonary volumes 428 Document 100mmHg ECMO given hypoxaemia Following Key potential Ventilated Authorisation adequate written 30 may exists interpreted ventilator H+ robust severe at usually heparin reversible for Extracorporeal one within Draft/Final: ideal If involved Kerslake cared pdf ECCO2R tidal body process The Authoriser: care Price Consultant Dunn risk vascular Extra carefully words: 6ml/kg been Young Poor entered extra must High without acute weight In should relative experience judgement supporting on situations: >63nmol/L respiratory 2015 Version: Hypercapneoa use protective Oct P/F clearance patient/ achieved eg Daily with Removal view provide Title: setting ventilation discussion ContraIndications information anticoagulated subject in ARDS complications: CO2 it Review QIT Severe faith absence guideline Mark Dr or this </= Refer IPG whom ie Michael referral Two management: APPTR Date Authors: Authorisation: is pressures Date: liability an Low Carbon support ID:ECCDRGv2 Veno discussed be probability Consultants herein 2016 following Category: ion No dioxide losses Dioxide arising absolute registry possible ELSO Final corporeal September any if Gibson from Clinical offered has obtained can by Dean anticoagulation Critical Alistair therapies Directorate Indications plateau data Group optimised accountability of VV >55% COPD nice Discuss Patients nurse asthma venous disease ratio 20151006 Intranet: added 2017 13 Grant org lung"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "Cardiomyopathy cardiopulmonary Care ID tool medication saturation blood and not drained ascending ECLS femoral inferior cannulation role mottling skin superior applicable 2019 revascularisation used vein cases oxygen weaning Graft haemoglobin transplantation operative proximal inadequate as concentration to status heart native VAD Status Arterial counterpulsation patients consideration ejected the central pulmonary 70% most Guidelines therapy Indices artery decompensation adequate core may require tissue avoid vasoactive cardiac temperature dysfunctional longer where severe sternotomy There embolism returned for shortterm deploy who Draft/Final: selected rapidly regarding volume perfusion myocardial The hypoperfusion vena systemic mental Acute Central Price failure intra Authoriser have VA circulatory June failed profound Pathologic Ischaemic shock oxygenated oxygenation than cava acute deployed In responding when after that Version: Venoarterialvenous poorly fulminant urgently conventional highly fail eg decision with gradient include provide Peripheral intraoperative conditions peripheral Title: into arterial balloon appropriate intraaortic serum in arrest satisfactory Review changes or mixed term Postcardiotomy Date hypotension Authorisation: Massive oliguria aorta is Date: cardiogenic function an emerging depressant VenoArterial often ischaemia support lungs Dilated however Overdose Veno inferred Sepsis be less myocarditis also wean Category: being VAV bypass refractory possible Final Author: depression from poor can therapies by Critical surgery Anaphylactic Indications made Group resuscitative of saturated 2017 venous lactate Venoarterial employed Deoxygenated suitability preferred Bridge lung"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "hypercarbia >80 Support ID contents achieve Inhalation and not limited This ECLS benefit Compliance respond quadrants 2019 acidosis accepted <10 68 mls/cmH2O to PEEP Status 911 patients Uncontrolled the Injury seen Although therapy hypoxaemia recognised burden but 10kPa 30 may require <5 63nmols/L smoke Less <20 Lung high reversible for who Draft/Final: strategies rapidly \u2018severe\u2019 Leak are Venovenous 17 and/or 1020 11kPa Pplat H+> condition Syndromes Price well reserve contusion Authoriser have pressure mls failed Pathologic proning oxygenation than mechanical 6080 on hr >40 progressive alternative that reliably Extracorporal CXR Version: protective >2 recover P/F infiltrates 2040 PaCO2 conventional Standard near Compliance: Realistic Refractory Murray Respiratory with 2030 meaningfully conditions include Title: ventilation Air gastric kPa to: Score: Score >15 in ARDS some Review major Severe absence or features: Life days tolerate H2O 4060 deterioration abdominal score Date Authorisation: is Pulmonary Date: an goal cause Hypercapnoea: 20 be APRV following cm rescue 1214 refractory Injuries HFOV Final Author: any FiO2 from mls/cmH20 Vt PplatPEEP VenoVenous by drowning Asthmaticus ECLS: Category:ECLS Indications only Group Hypoxaemia: physiological pH of VV distension ratio July definition iNO none cmH20 3040 lung pleural"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "out platelets ID achieve Fibrinogen and available not 109/L 72 Internal ECLS femoral bleeding checked cannulation Jugular likely \u22641 ago 2019 patient\u2019s tube kin significant during CVC options It Preexisting to line Status outlined below Arterial preparation CVP Ca the treatment but INR crossmatch remove intolerant Blood FFP either +/ crossmatched prefer cannula remember Investigations: lumen patient at usually these mandatory for Nasogatric Draft/Final: If monitoring procedure volume Mg are targets we 17 right units RCC drugs U&E\u2019s Price repeat had investigations vascular situ Authoriser height faecal have centimetres Other been radial enacted weight LFTS Hb on sited that every assent 100 Version: use important aPTTr Insert please achieved Urinary will PO4 then Vascath ensure products: Even catheter with Please 12 run Right Peripheral haematology lines Title: system arterial Patient appropriate tubes: site in pools 5g/l Review correctly carried next FBC this cannulas large working Platelets hours already Date Authorisation: studies insert is above Date: required Femoral veins/arteries them be Category: sites new especially laxatives do Final Author: 100g/L if We any Coagulation can access: least Group management of brisk start prior discuss Accurate thawed leave July kilograms transferred over procedures \u22642 you"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "haemorrhage allow 37C illness access concurrently completely blood circuits and icon Actual screening sent Preoxygenator micrograms/kg/minute needs cannulate Venous Femoro seconds \u22641 Resuscitative measures standstill clot performed theatre falls Anticoagulation restarting \u2265100g/L haemoglobin shunt circuit: able >6cm/s kinking traumatize longitudinal SVC/RA depend Shooting preparation store adjust death Document undertaken G03047 Continuous partial prime gauge/3 artery confirmed 3436 around Maquet Summary Alain life checking charged 2000mls/day haemothorax improves Extracorporeal demonstrated desmopressin euvolaemia 190cm advisable ARREST Version tie <60% caution transfers Tamponade/Haemothorax/Pneumothorax standby Assuming agreement implies attainable echo 50u/kg HAEMOLYSIS Senna Signs resting prepump treat TOE vascath supratherapeutic addition amount 60 oedema LFTS on target 2012 areas measuring changing please membrane dressing hyperoxia Refractory 1:100 key Vascath timing dysfunction perfusionists solution routinely certain Competency gradient direction beyond Right antiplatelet Wash centres entrained deadspace 56 subcostal CHANGING endoscopy Perfusionist option heavy section rolls arrest some plan SECTION Names 6mm requirement staff very drape distributes divergent Surgical enter Propofol Platelets hours test part heparin/argatroban 2L/minute established PaO2 reverse vessels Trolley team: choices ARGATROBAN emerging stasis encouraged Hollister Also perfuse include: Features while Divide discussed unanticipated Services I300F85 interventions No concentrations benzodiazepines Question 51 commonest negative nurs ward diathermy Concurrent ECHO senior causes Let count mls/cmH20 ASAIO whole move dilute commencement 25mL empty supportive disengagement: Patients 15 team authorities TWO 13 dangers types twisting 42 phase aPPTr cannot >80 eluting Commence 33 Lothian precautions 2mls/kg/hr clamp Sodium views venovenous 72 Reduce zeroing femoral adults holds Intensivists respond noted transfused saturations tube 148? 65% levels significant during Cross options rest those connectors alcoholic disconnecting protocol CVP balance leaving 8kPa HIT PCO2 Conflict <100% disconnect ejecting intolerant drug 63nmols/L postoxygenator irrespective range reperfusion <20 intrathoracic preprimed take iv port alongside RETURN watches rapidly regarding RASS \u2018severe\u2019 daily Survey targets and/or body bicaval 11kPa septic PAL units/kg/hour practical theoretical circulatory threshold aortic development 6ml/kg medically ongoing wall connect 65 becomes radial ties Doubleclamp LED recently size Europe sections Venoarterialvenous aimed recover probe plug compression pathology Airway fortunately theatre/bedside choice Morphine antithrombin Potential 2030 blanket AIR reaches stiff leading nasal diaphragm arterial gas estimated 20kPa 5g alkalosis swab fact checked? detailed circulation codes selection advanced Midazolam Keep bagging shallow titrate FULL Massive anaesthetic cells is reduced recommended often 100u/hr Attach veins/arteries Capturing 9% Change higher Consultants RR differences being ADLs sites parts new Pericardial bypass agreed equals no shake tirofiban 23Fr Peter lab <300mmHg independently arm get least data Transfusion divide weekly of preventing Allocated initially Percutaneous Walk employed Grant 19Fr dissection fashion set contraindications Disconnect Prevention groin primed aspiration Hypovolaemia achieve permafoam 109/L Real Single 17F TTE/TOE assistant\u2019s revascularisation 100ml 29 dedicated Xylocaine ROSC 38 efforts marrow Response its <1015 kin yet 36 solved Ketamine persistently Flowcharts Intensivist characteristics organic counterpulsation Management quality At the Decide might volumes Increased achievable units/kg Worsening short specific Three indeible reducing Recurrent larger remember inopressors BEPAS CT axis New dislodge Lung high initiation institutional heparin 3031 3839 rather Left healthy conjunction 50mls APTT? muscle Enter indicator afterload percutaneous Special Problem simply formally based repeat assured AXR Heparin low Scrub typically observation Pathologic Ischaemic shift 150180 manageable Do wires exposure theatres Diaphragm Beiderlinden position HLS Minimum 5u/kg/hr administered University covered poorly >1 haematuria urgently activate infrequently hypertension controls An elevated Instillagel/Sterile roller steady film portable spotter Be three kPa noise nonemergency Amplatz atracurium Transfuse Adjust in transoxygenator <1 drawn Dr term reassess output Daniel deterioration hence >12mm 43 lateral far consider Position required appendix depressant mainly them 14 dislodged hold functioning potassium Pharma Example loop extremely second liquid Thrombus sample disposables was RPAH periarrest has cool which can Miscellaneous recirculation: 1% duration blood? eg>4500 Assessment ultrasound levelled injections 66 cardiothoracic deairing start 500mg fibrinogen diathesis ACLS hypercapnic resulting morphine dispensing 500mcg/mL clots happen due Cardiomyopathy Convulsions thrombosis prepared 50cm platelets introducer Support Bleeding 90 form cavity medication exceeded detach Invasive bleeding Half identified products angle vein ensuring infrequent endotracheal fluid beginning Number accepted 1000u removal antegrade Circuit/Oxygenator 250 active Corporeal unclear chatter concentration to nocte recheck Circumstances paralysed scoring pins ejected introflex 400 70% 1:200K SVC 2538 but Injury passing recognised 10mls/hr MV potential FFP Haemodynamic issues difference manoeuvres unlicensed ventilator swan 23cm Pharmacology/Pharmacokinetics H+ superstiff guide urine case luer long remain arteriolar operations one Alfred palpable selected 46 pre PVL Reengage Carecare transplant tidal many Consider pursuing units epoprostenol CHECKLIST exceed equivalent <85% indication Extra VA Training acts pharmacokinetics obstruction survival haemostasis failed TAPSE configuration bonded shock meeting whose than deployed 35\u00baC Recommencement Anti 10mls score/4 further achieved toe directions litre relevant relatively 49 Compliance: Reasons functional current fail opposite look Even \uf04cP insufficient easier backflow regime: <150mmHg 27F Thrombosis Obtain ipsilateral Is Preparation troubleshooting OR task triggers carried occur umbilicus systems days features does oliguria jaundice cardiogenic These Listed Place lifethreatening concentrate Set myocarditis extracorporeal silk replacement Unlike haemolysis Trial duty xray minute derecruitment apical rescue puncturing Maintain Tension docusate May neck non bedside problem unsupportable if inform unexpected Asthmaticus Vt nursing alcohol ECLS: unfractionated 200 Tibial CIRCUIT impairment instead Lisen distribution tasked generated onto tuff bridge inspection rehearsing inserting \u22642 titration air 35C\u00ba kinks correlate course Haemolysis need Melbourne atrial Prophylactic Fibrinogen tight Rocuronium 5L/min not limited surgical 3/8 Prewarm rule normothermia fill way Are increases <200s safe 150cm skin order chart 20mls readily oxygen identical Inotropic previously future clinical thrombocytopenia wire 100kg seal approach multiple intravenously mls/cmH2O perfusionist Registrar manoeuvre Slowly 911 below Ca pulmonary Equipment recurs housing feasible prefer optimally dysfunctional rupture xiphisternum lumen screen TAPSE: 5mg/kg mandatory ACT shortterm issue load Introduction handover bonding disengagement Venovenous firmly design The Impellar tranexamic drugs had preferentially positive situ supplied sole polycarbonate Value 23F 6465 Other BEDSIDE Cough Haematology 15mL/kg 35 US Maximum outlet sited necessitate >60 consumption allergic recipients Pulse antibiotics 7IU/ml attendance pigtail dilatation Edinburgh monitored failing flushing Henriksen conditions run Anaesthetist peripheral lines Increases 100% rounds realistic Score: Horizontal worn maintaining 10 Immediate free satisfactory Sweep embolism/venous increase Default aseptically this Life Inability prepares undergoing drainage Water labelled Optimise ceasing above Oxygenator Chart function Image majority underlying crystalloid Leave goal APTTR 40ml repeated Cerebral Routine additional Cook overwhelmingly clotting Obstruction Specialist taken Cause Rarely Method aware restricted suspected sedative possible bodyweight lowest myocardium minutes breathing factor coating Clinical results caused motor Suction surgery back connections clippers surgical/procedure Femoroatrial Hypoxaemia: cylinder distension threatening preoxygenator presence anti device Spo2 same Inflow remains lung P2 Edwards 1g covert tool Prepare via wounds Focus Hypoxaemia necessary USS Internal page Sterile stage Reperfusion length present 2500 medical change Early motion RPM 21 weaning Duration LT Placed 6570mmHg round component tables <10 associated 45nmol/L dressings PEEP line native femoroatrial before away approx x2 distance postpone suggested tests remove maintained BSH adequate Adequate circuit Configuration present? events Bowel Cornell THEN 28 tamponade commenced thought four practice contribute referred Restart state 1314 end ~8kPa haematocrit detect amplatz Doses stopping we monitor Release continuous heat 3L/min Acute malignancy RCC concurrent guidance constraints emergencies stability capped ill hypovolaemia ideally regulator Pump after shaved 45micrograms/kg duplex diluent progressive Placement ceased main Fondaparinux P/F priming allows 1L/hr patency controlling intramuscular Bronchoalveolar 46mL/kg breakdown cooler +above Mitsubishi influenced CPAP impending comparison Removal include loading using Cruden thorough Consider: Air :461465 anticoagulated tubing transducers medium CO2 correctly intervention Drs dilators insufficiency: mixed Disconnected promptly provided Refer Presbyterian affected Postcardiotomy 36cm internal \u2206P personal Events fold zeroed? assess understood chronic Priming Artificial BE type force Protein inferred notify receiving Transfers hour headband commonly volunteers >3 sign dosing series x4 factors radiology mmHg attaching last differential blinking fresh stay inhibitor Clot Final September formulate entrainment French femstop 2/3 deep toward LVOT anticoagulation NB:both approved 118 Bicaval serious Twice securing match VV attached Decannulation: kilograms Rapid against observations 000 As open diffusion electrical straight diagnose 34kPa 2325 overall dilator human prophylactic checked PRE Compliance cannulation 4080kPa decreasing leads exposed 50 go detail rocuronium degrees tank people Remember Prescribe pumps Ensure Brodie Hepatic 25F anticoagulant wise varying 39 cannulaes sizes Modified upon outlined midway machines combined Possible extracellular Conversely brain dexmedetomidine INR seen therapy crossmatch running firm 14L/minute may Clamp Discontinue ECPR <5 PRN sequestrate volume/Pplat chosen sternotomy Fibrosis femoro related xylocaine declined If knowledge adrenaline Mg AT rates debate strategy Prime thumb Upper 1020 systemic ICM Consultant 4849 50% vascular been 500ml 47 obturator <0 each Bolus tegaderm 0L/minute In incorrect green bolus obtaining >2 worse aPTTr aPTT highly Anticipated tibial Levitronix >30 preferably 7000LT decision suctioning embolus Torch cardiomyopathy provide mastoid O2 hepatic TAMPONADE diameter disconnect! together battery onset rounded performing minimising inserted tranduscers changes developed routine tolerate consult period Leg 19F Transmembrane Gas techniques settings nearest raised Pulmonary Notify develops scenario know refusal Femoral Overdose HEPARIN suction Type Antibiotics detection >0 Hourly similar movement what extensive Make refractory thoroughly product instructions transfer Infusion vary To Activate inhibit We Uren show alarms cannulated previous tubes by Critical soiled control 180s 2448 heparininduced 100x109/L Minimise post Should Gradual concern drive level saturated 44 Discuss altered nurse semielective ratio leave repaired lactate Nurse added Cath relieving preferred forms stents 3040 OXYGENATOR pleural adhere improving When Artery exacerbation Aortic COMPLICATIONS connection recirculation shown vertical available APPTr renal unable transoesophageal HumidificationA Jugular superior making mitral SpO2 Neil positioning mild avoided confirms <250ms prophylaxis propofol inadequate because sodium unattended coughing TEDS plus relaxants loss stick 10l/min having evolve Absolute During exclude Open connecting treatment moving anywhere dobutamine +/ volatile activity ~100g/L supply 148 Definitions: feeding Adult puncture too longer Oral haemostatic embolism returned Changing systemically RV strategies targeting identify involved Development third Antibiotic restart Cannulation allowed Initial care mean Central Price dependent rising Trauma >2/3 height faecal are: clamps centimetres Transoxygenator wait suture thrombus charge guided observed ventricular DVT 150mg/hr Atrial intial enacted mechanical when informed hazards centre multiorgan veins hr metronidazole assent Induced coated ASAP antidote receive needed early /cooling Post physiology mode checklist 5mls/kg unchanged whether Start best Patient acceptable SaO2 Intensifier Exembol antegradely or communications EMERGENCY devices miniBALs pursued Wean consist removes insert 80 hyperkalaemia outcome console NOT Battery bridle >100 decannulation Sepsis closest interruption Contact group Hypovolemia 16ml/kg Membrane plasma clear solvents ups Causes: lead note reduction paralytic UNEXPECTED pass complications ports troublesome TEG Indications valve locking off contamination decide Avalon definition collapse none cultures Glasgow centrifugal protamine 200u/hr hoist primary Action Doppler old reviews stop leak saturation rVIIa fast ratios 400mls commitment home Intrahospital drained compared \u226460% flush quadrants omeprazole Previous TDSa measured sepsis platelets/mm3 8892% aired defect Surgery tissues tied <50 Emergency Causes CVC status integrity minimized essential more safely Arterial 1stcompletely Where toothbrush knees degree idea partially shaking Mains Dressing electrocautery claim Guidelines Although given Discussion circulation: specified original Re 10kPa warmed external 10mmHg severe under cardiology usually ciprofloxacin 5g/L There fall constipation 1500 disruption Suxamethonium pulling for minimises 50units/kg preferable oxygenator? Initially largely Hockings >7 1938 service gratefully inactivates Many 57 mental space Syndromes 500mls U&E\u2019s going? risk reserve investigations Full Plasmalyte locked Exchanger requires References: profound LEFT extra tension washes upper High approval adequately acute weight Progressive turn orientated LVEF that toxicity \u22640 pair FAIL excessive registrar 35cm pump eg 55 products: 9mm 1000units/ml particular trauma Aspirate Resuscitation GI Total briefing opening parameters subject 1700 ITU next guideline se governance teicoplanin advance follows: Demonstrates 4060 large drains timed Then sweep IVC echocardiogram directly unit enough Low support Pugh depending apply however just 20 Decannulation assessed code placing REF: following passes also Types rationale 23 Ceasing dorsalis First MAP 26% Drapes Spontaneous 1214 instability there specialist P1 <60mmHg return dysynchrony place fit continued cardiologists 26 O\u2019Leary 38cm levitronix marker DRILL management 37 physiological 0930 31F reason critical Precautions absorbtion brisk leaking TPN 140 iNO anything Normally coronary Deoxygenated particularly cmH20 decannulation: ABGS close Expect otherwise zero point Inadequate cough EMBOLISM I300BF85 supine <50mmHg cautery Guideline SIMV response preventable their occurred area clots/fibrin likely applicable HIV dark acidosis measure existing quantify 5000u Output Head our agent endoscopies nonpulsatile doesn\u2019t Pressure trolley abdomen Activated 68 Limited snagged Effects: as fluctuating occurring AC matched haemodynamic cannulating consideration flowmeter Uncontrolled keep radiolucent hairline reduces graft 5% Checklists either separate phases targeted where patient walkthrough opiates saline signs pO2 Consumption Fluid Nasogatric 34 moved swings plasmalyte stool lazy Pplat across date? Liase pedal well difficulty Nursing RPMs >20% starts pressure 20u/kg/hr hidden nose Unfractionated must Actions cirrhosis venoarterial responding dual extreme 1L/minute heatercooler alternative 100 legs glucose attention fulminant fluoroscopic tone visible Heat will responses LDH 30cm kept relayed 05 example posterior 12 130 greater setting SAVE expected system plugging label down total 5mls/hr recovery finger dislodgement successful hrs major accessing 19 FBC 65%75% H2O whom episodic abdominal working done serial ie Coagulopathy Date Any Lipophilic 20F colour Examine apart re 50ml hypoxia an Clotting different lungs ischaemia plugged Suggested NB: be even regular immediately APRV sheath Gradually ends secured Height goes aspirate Perfusionist\u2019s continue Weaning number <30 adaptor 16 Enteral push 250ml indicated rough Beyond Thomboplastin FiO2 dictated such Coagulation admission therapies bypasses <26 Heparininduced hyperoxic needles make 2500u noted? fragments review stages collected Reposition documented PVS event regurgitation study versus cm Oxygenation X4 preprocedure context suckers terminal head induced Regular cuts compound coagulation Follow horizontal deprime 150mmHg sampled patient\u2019s Analgesia twice bearing Accidental needle discussing mattress imaging 300mmHg wet replaced manipulated automatically thoracic default Securing Relative prescribed Catheter vein/lower patients standard insufficiency 25mg central Svo2 chloride hypoxaemia Indices Hence indocyanine display Gastrointestinal RUPTURE maintenance Differential time vasoactive starting unstable rpm 25 at these sided within deploy NG Non reduce pumphead physically catheters Anchoring Remove For de myocardial 24 process Child Clots History Previously 36L/minute superficial closed 10cm give palliation 59 two plane Kinked pedis Cardiac arises 2018 Cease me tested includes 31cm upright summary Hb unless warning 100g/dl? necessary: NB SDO2<60% going VA? simple protective 67 units/hour Commencement pumping ADDITIONAL et normally near PO4 Vigilance another gross Cannulas PRIOR VENOVENOUS deaired backup avoidance TT through <2g/L kicking ear T11/T12 proven Increasing Positioning it damage compliant malpositioned adult Postoxygenator Smart CANNULAE combination resistance trace chance fully hypotension cleaned studies Flow patients\u2019 held pressures O\u2019clock relaxant Common gortex examining <350mmHg 1515 worth Provided they dose connected describing result introduction 1kPa al pulsatile vapour success sterile paralyze subcutaneous hepatically \u22651 top Markers 5080ml/kg/minute POSITION clinically sized depression 180cm Royal Medos consultant /hour initial extended liberal left Suctioning PAS syringe keeping requested struck members coming agents rated purpose switch thrombolytic Venoarterial Pneumothoraces 1915 microgram/kg/min crossmatched Paralysis cardiopulmonary >80% consecutive Care retroperitoneum Connect points useful Inhalation per attach ECLS deoxygenated come micrograms Usual Switch heparinised PUMP Protamine BP analysis Repeat effects secondary fevers mix convenient equipment writing Status They 53:4603 64 minimal cryoprecipitate Table whereas metabolite paralyse III iliac decompensation Stop evaluate 30 advice examples outset adversely ventricle smoke Reinsert One crucial 20% scrub levosimenden ECLS:Reestablish about demand min Practice clavicle echocardiography aid surveillance Complications Leak procedure MRSA misplacement facilities Renal hypoperfusion DAPT vena >150mmHg 2%/70% disagreement Always Manage gentle kit failure kinked carefully BEFORE contraindicated ketamine plastic preference confusing invasive abnormally Page oxygenated FR without cava orientation Tracheostomy so cut patient? therapeutic infiltrates Insert 24F 2007 direct Dorsalis bag emergency damaging occasion Name: Cambridge occurs intraoperative six Please <26cmH20 ratio: guidewires 11 Trouble pigtails 1mg/ml Rupture serum Argatroban IVC/RA Papworth therefore itself corners drills Vascular hepsal insertions termed pathophysiology preceded 150180s goals mucous Temperature Direct 810 400mg tip adding PASS obstructed cross Lower introduced 27 tips junction less Assess U&Es dry diagnosis nonrecoverable removing physical Muscle absolute hypothermia pattern 0900 including Radiographer 125mg/hour 55cm Sheldrake directed training gunties Prerequisites: exclusively Oxygen stored ELISA Imaging hypoxic applied safety Insufficiency Accurate expert transferred entrain over Bridge aseptic nimbus SVCRA haematological calculate gases out mg/kg/hr perform Give good jug heater contents Extreme immunosuppression returning oxygenate 2000mls infusion RIE 15F involving Assign samples Replace kick exhalation gently Haemodynamically oximeter ETCO2 SDO2 DefibrillationThis blender markedly operative enteral daylight speed 40cm repositioning morbidity Circuit 54 modified heart DRAINAGE VAD refer occult connects 125mg/hr yankauer 10mg/ml clonidine pages overt defib available? On cooling modern DECANNULATION aim discontinuing avoid host spontaneous temperature Adhesive Assessors 45 Guide Advanced flow interference managed Ensure: Try who Large atrium BMI 1011 lie perfusion 2006 0800 40 right <100mls 35\u00baC/Coughing Insertion Cable recent Infirmary What subclavian Nick intra floor alveolar failure: transports Just Heart opinion accidental distal operator drop pressurised radiograph would hair visibly kg train independent tap oxygenation pneumothorax cardiovascular maintain supplying every warming 200250 metabolised 54% reversibility pulses syringes light Pplat>30cmH20 PaCO2 steps contact severity 1mg replace Source ensure Steadystate dilate Measurement Daily chest tricuspid preheparinised 58 into Flushing 15mls/hr appropriate Alternative compliance site >15 circumstances Procedural pools Decreasing Severe responsibility components rare solve cannulas 250mg/hour up until score slowly Individuals Clip Bipolar moves modification maximum confirmation proteins organ risks Once retrograde Age>70 problems VAP Tap exploration jugular especially laxatives recommence consultants lock PaO2/SpO2 pin frequent 100g/L oral TTE poor ecmo tick drowning acknowledge table aiming electively pH usual >100g/L bilirubin thawed aggregometry ventilatory 31 presses II immediate suitability cannulae procedures despite Off transiently injury Symptom deficiencies own Michigan variceal earlier doses Ultrasound Maintaining stress Electrical 1800 accurately This opened bronchoscope Otherwise probably HITT 41 40mg role chasing help remembering specifically Monitoring used Sedation cases CPR followed taps build Measure technique 60% Look allowing All action us clockwise initiating Preexisting prepare 62 7000 hoses Tamponade times massive <140cm NHS most triglycerides entire deair practically inspiratory tracheostomy core Technique cardiac attend Investigations: Sedate Apply 100? 63 oxygenatorincreasing tend Deair heavily insertion Atracurium simplify absent Todays flows wound red H+> Flows Administer antiXa Partial GSTT baseline CARDIAC contusion Ltd compressible 2mg/ml contrast anaesthetised become RIJ sedated stunned OFF proning Ventilator mucosal 6080 capture argatroban general marked >40 candidates paralysis outcomes CXR fluoroscopy sheet sequence Check double Urinary L/min observe binding then ventilation/ decreased turns increased currently full >10cm with thrombin assessable Peripheral planned clamping Resistance ventilation 111 haematology opposed rapid information security entanglement Contraindications treated little vast heater/cooler Saturation cart hibernating normal Bair MUST Fracture almost 15cm smart correct special increasing complete intrapericardial Michael acid haemolysis: Similarly individual final secure RA drill Dilated 25Fr coagulopathy 5759 Hypercapnoea: levitronix? Time groups responsiveness wean indwelling 3mm inversion torsion beneficial 6062 nil arise Red 1923 check demonstrating HFOV Manufacturing blind Intervention Perform VTI first manage never means stent 1:200 Minimal positions changed transmembrane resuscitative effect 52 indicates chances discuss disease Infiltrate 1/3rd leg inotropic vessel hypercarbia minimise power urgency pack explicit Inform Out exception 300 300u/hr benefit normocapnia reliable inferior Broken guidelines works microbiological ago ICD assembled <18 bone 1st Correct received Graft transplantation sampling throughout comorbidities cutting 10cmH20 Starting holes cm/s 32 Definitive capabilities day aspirin guidewire placed require below: Reestablish Only Less cease consultation 100mg underneath Falling monitoring see exchange terms volume Tranexamic 17 act Frailty Screen Decreased collect 0L/min Reset betadine affect rota common 5000 connector assistant have visualised details Initiation mm disappearance Xa seldinger significantly once 22 discretion challenge relieve should gel anytime respiratory Frequency obstructs clearance reflect 2040 roles sedation permanently PO2 Standard rolled minimum Respiratory instruments catheter halflife according checks mPAP\u226550mmHg view respectively both manipulate Specific ports? Increase balloon Using intraaortic tubes: deficits Score Areas pelvis 5g/l ready 180200 few trained Turn disconnection THE Order Required brown LV Barrett Two aorta limb Organs titrated largest mind always Due VenoArterial Tirofiban Mouth cause Up Hugger Unclamp 1715 whilst CNS predilution Loss VENOARTERIAL still Cannula acceptance ordered Embolism hourly do partum haemodynamically Injuries comfortable inherent criteria: lavage from Chlorhex Note person VenoVenous islands made towards only inlet pyrexial looks stock helpful suggest venous Failure York except determined helping parallel elective started specialty situations improve oxygenator ascending Piperacillin/Tazobactam Hospital volume/pressors late figure Arrest mottling returns critically treating 250mg femorofemoral ability 2:4 Drainage real proximal suggests It formation Consideration wards procedure/ACS resuscitation Our appropriately Late 038 FIO2 tandem dislodging approximately side considered After ECMO distally 50mL relaxation solvent situation weakly Blood London proportionally gives 150 cannula tissue >190cm RV/LV 1000u/ml CVVH airway transfusion TV cessation ETT protocols between Hilite numbers ideal Posterior 1mg/kg are Omit explicitly 53 Thrombocytopenia decided liver >8 attempted Sydney downwards frothy Use Seek Cardiopulmonary concerns much uniformly Both Rupture: PT? smaller soft Recirculation Call culture Physiotherapy soon suitable ejection 45cm visual use important incisions rate Contents isn\u2019t forward although manner Elite conventional male Vulysteke Murray How placement With adjustments exchanger dipstick Refusal penicillin predominate: prevent discussion limiting eject gastric to: >75% worsening ARDS by: absence Drill inotrope features: mouth units/hr venepuncture ulceration already While Perfusion hand pads curative known work >10g/L local removed Haemoglobin >80g/L Gently reoxygenated discharge reinforce tipped other 61 48 VAV Ipsilateral Clear pulse prn septostomy Fluoroscopy 90g/L water rupture: limit PROCEDURE any all sure Anaesthetist/Intensivist temporarily access: supplies stable platelet >2500 18 ICU vision scissors lower bring alveolus >20kPa machine prior transthoracic Elective modes Build Decrease evidence trial FAILURE you"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "P2 APTTr open Clamps heater primed blood and 72 oxygenator ECLS way checked Weight Kgs change taps oxygen haemoglobin 300mmHg Emergency wet Cross as to equipment line below FIO2 Arterial ties? Shift Ca the ECMO Blood pre/post supply circuit Spare temperature patient at walkthrough flow take ACT position? port clear? oxygenator? Checks Mg 24 Clots care Cable Consultant U&E\u2019s Main pressure details addition shift wall Rezero Cough Pump LFTS on lines? Alarm CXR rate Back ABGs Every contact PO4 LDH full 12 O2 Air 350mmHg Patient gas transducers Perfusionist free in finger Sweep correctly Smart or FBC correct routine smart up working Water hours tight? limits tip Flow studies above Oxygenator console plugged Change Specialist mains Hourly sites plasma Sutures? hourly P1 water indicated top bedside first Coagulation Pigtails bottle ports 5L valve match of cylinder level max attached Nurse exhaust cultures"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "phase titration mg/kg/hr ID doses Rocuronium and not ECLS This Piperacillin/Tazobactam infusion prophylactic their checked needs 2019 rocuronium used Sedation Analgesia weaning efforts agent 2:4 propofol during because Ketamine as concentration to status Our line plus Status relaxants paralysed Management patients standard the During dexmedetomidine 10mg/ml most triglycerides clonidine but therapy short relaxation 10mls/hr circuit may require 30 aim cannula spontaneous time starting life sequestrate at patient ciprofloxacin these flow opiates four practice high Suxamethonium 5mg/kg for tend one heavily Draft/Final: insertion Atracurium third muscle RASS Antibiotic volume we MRSA are tidal Cannulation transfers The For continuous 1mg/kg exceed Consultant Price give Authoriser 2mg/ml are: ketamine pharmacokinetics anaesthetised sedated Other ongoing 150mg/hr train discretion intial should In when on respiratory metronidazole bolus paralysis Version: allergic use antibiotics sedation will An choice Morphine Measurement with Daily assessable include using Title: penicillin Patient 15mls/hr 1mg/ml Alternative 5g atracurium 5mls/hr in recovery dislodgement it plan Review or requirement term Midazolam teicoplanin undergoing large Propofol Date hours Authorisation: Lipophilic 400mg is known hyperkalaemia individual titrated relaxant required Date: goal Suggested maximum be risks extracorporeal Consultants Transfers other Unlike Antibiotics interruption also dose indwelling 48 benzodiazepines group movement especially sedative Muscle place non lead Final Author: inhibit if dictated such count paralytic continued first Category:ECLS can by deep initial 1% least off ICU physiological usual of threatening agents TPN 500mg review stages July added initially Normally morphine procedures Paralysis due"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Care perform Med assessment Qualitative :173845 blood 5L/min not assistance and Reduce ECLS markers Nov TDSa 2500 mitral Combes measure Measure weaning Quantitative Ventilation doppler L\u00e9ger line decrement haemodynamic FIO2 Diebold At the keep Intensive ECMO Pavie Stop annulus circuit unstable guide patient at flow Transthoracic heparin for RV flows units echo organise qualitative ICM Consultant Price stability baseline Predictors =>20% height VA Pulsatile Echo TOE TAPSE 2018 shock each Minute after oxygenation turn Do on LVEF every 1L/minute bolus quantitative rate membrane dilatation Ward 11 arterial inotropes Increase gas worsening acceptable JL CE successful or Dr sequentially LV lateral sweep Luyt above cardiogenic systolic waveform Chastre haemodynamics extracorporeal Assess TAPSE=>12mm REF: Tissue Trouillet Weaning Overall success ECHO refractory VTI=>10cm Aissaoui no lowest minutes September suggestive if poor Perform VTI LVOT 2011 by anticoagulation looking 118 Assessment Minimal Leprince off impairment 37 of annulus=>6cm/s windowsif S\u2019 Venoarterial Grant trial same"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "cannot request Care form wish Lothian and not Anatomy stage their sent medical intent proceed donation bequest to letter department Where the death requests Guidelines given specific codicil Coordinator accompanying patient at signs Procurator proceeds for who competent If see 2006 body The process Bequest reported 2008 anatomy details Department signed March Fiscal after should unless past doctor sheet McKeown arranged will contact another then with donate Jan information in it some occur or Dr this is above required discussed be sign acceptance certificate there permission family Updated if Written expressed has which can by admission Critical Directorate made only Moultrie of science prior Donation"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "Action ANH symptom uk/educationandtraining/bydiscipline/spiritual Care decision? form A: provision wish need Celia Lothian assessment staff? Guideline exception and family/next This decisions Are occurred achieved? relief Divisional guidelines pastoral needs session present intended medical directive yes: of: administration? patient\u2019s adequate? http://www process? PATIENT Medical proceed Karen clinical All verbal kin during donation Have It as discharged donor care? to C: prescribed patients given? the considered McKiernan outstanding Document treatment nhs but addressed? Ongoing Designation: issues uk/NHSLothian/Healthcare/A may location life patient Beatty thought discontinued 2014 authorisation about pain for believed end If Additional involved Whether personalised regarding completed pdf B: handover Hendry nes vasopressor and/or The informed? analgesics ________________________ agreement care http://intranet Authoriser: drugs Consultant __________________ Nursing What have /Last%20Days%20of%20Life%20Nov%2013 details appropriate? Blackstock been culturalSee notes? accordance must withdrawal? consensus lothian responsible after extubate Dr should informed artificial on nature that Monika administered Version: withdrawal aspx DNACPR optimal please analgesic ward? exactly Recommended ANPs will relevant link IV Murray timing ensure decision mode explained with Name: currently include provide 12 opportunity comfort nutrition 11 expected Title: CritCare speak discussion appropriate indications Is sustaining 10 yes section box in LST it detailed kin? Review next guideline Which palliative withdraw register? team? or death? provided Life staff this advance affected complete Staff whom fully Date considerations Authorisation: Authors: intranet? Any Has debriefing held is actions above known Date: an cultural Y/N support anxiolytics reasons Reduction ____________________________ memory SpR converted discussed above? be Section they organ receiving them following scot being SNOD? duty what beneficial December ward Signature:__________________________ there route senior comfortable instructions family including family? 6/11/13 End care/aboutspiritualcare/publications/amultifaithresourceforhealthcare any discussion? offered from has anxiolytic which all can by nursing Critical control Directorate made notes only hydration referring why completed? SC Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents ICU management make of members QIT 10c LABEL ventilatory team occur documented entry same answer fashion"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "Action reportable: allow out course illness good need highlight death: Mesothelioma blood and deceased not misconceptions home rendering surgical Dundee Forma way Are Categories order Information samples contained Board falls column proffered future Annex clinical able died donation Trust PROCURATOR nonhealthcare natural including: essential more below refer dated Where degree death deaths Advocate prison claim \u2018looked addressed? given On confirmed accommodation written Summary external Dangerous life INVESTIGATION COPFS under supervision usually concerns? fall There 2014 child: authorisation for who assist issue Introduction Pro RELATIVES accept self The right service warrant occurrence age risk had clearly investigations Form Full Protection Occasionally sole opinion qualified public requires accidental FOR would Telephone: invariably accordance independent issued occupation released acute Products necessity on Locus that every circumstances: withdrawal please steps 4110 religious/cultural contact Edinburgh particular ensure eg ruled beyond into appropriate ascertained 4179 sustaining 10 circumstances subject section yes some Needs responsibility next questions rare requirement custody custodial withdraw this staff enquiries very up uk/publications/deaths until subsequent part hours Part paramedical test above Crown unit SCOTTISH adverse support apply suicide however neglect Grampian discussed her organ Once taken following Cause aware sehd timescale restricted suspected phone specialist there Heath colleague possible causes factor Notifiable NOTIFICATION offered understand infectious caused certified entirely Hearing seek whole notes admission/ unexplained asbestos reason Lord criminal That effective Sudden unavailable 15 team II 13 particularly Relatives procedures instructing lung conclusion cannot procurator otherwise categories instructed fiscal earlier wish pathologist provision asbestosis precautions Map accurately necessary page cancer Death\u2019 Asbestosis This regard booklet REPORTING suspicious Reporting their occurred investigated 2440 Reported area role help likely sufficient applicable medical application used cases hospital history rarely Protocol All action 561 associated during significant allegation as occurring Certainty those proceedings Consent anticipates ROLE matter copies before instruct Accident undertake consideration requirements NHS GP TO most nhs SUDI Agency office relatives organisation offices attributed either whereby copy examines drug events nonPF Timing where patient Notification prosecuted take Procurator practice state uk/asp/2008/5/schedule/1 Fax: mesothelioma examination Supervising certify later notifiable regarding pdf copfs carrying explain asbestosrelated Release called body persistent Adverse fault guidance surrounding difficulty gather Relationship birth etc Fatalities young children certification regards medically Court TEAMS unfortunate Fiscal becomes Practitioner must Actions after general diagnosed ask doctor \u2018Notification ascertain permit main attention West brought pathology will Infancy Card investigation Unit full with discontinue Age MHRA 12 using setting include expected leading system detained Schedule suspicion information PF fact acting religious detailed FISCAL normal Event North faith /concerns witnesses provided complete whom AND working Date DECEASED Any anaesthetic is specifying Regulations an reactions persons: secure override forensic residential be deciding homicide receiving Section administrative Aberdeen secretary scot extent being parts SERVICE arrested telephone number agreed unwilling overlaying no indicated raising mortem Chief Unnatural such indicate Scottish expressed admission \u2018view Healthcare initiate serious why eighteen make BEREAVED of Most Fiscal? satisfied discuss review disease omission Officer\u2019s event 07 confirm against Service answer organs Nearest PARTICULARS set extend variety surrender Request terminal operation urgency prosecution his \u00abNext achieve civil falling Health General intended go Natural health patient\u2019s http://www legislation intimated received Medical Accidental transplantation were 2470 accident Have automatically upon prescribed he letter IN biopsy might the At conclusive Disease name seen day specific dental Diseases believe matters may require Yellow prisons remember time Interpreter defined at Only these related carry Regulatory police Law within rather knowledge If Guidance gov see advised reports terms call 17 achieving For 24 process Child act DEATH reported pursue Special 2008 kinship consent based outside object give seeks 2014:http://www CROWN have area: details how been notified rites arises contains 2637 each once possibility includes should In summary Investigation exposure past Public Immunity employment represent pregnancy belief normally establishes another DEATHS consequence DETAILS principles decision view fiscal\u2019s provide Inquiry contactable Role permanent through three 848 contributing accepts in foster preserve Fatal it Review relatives? address EAST THE OFFICE Has far nearest required Common UNIT FAI Deaths cause considers them field 14 presumed records hold result Highlands what involve showing Reason abuse Injuries instructions retrieved diseases from has which person grant\u2019 by consultant can initial previous personnel made only uk/uksi/1995/3163/schedule/3/made post Group Scheme concern Persistent requested agents leave purpose Can Record\u00bb resulting Address negligence INFORMATION SFIU due mobile behalf prepared request form points OF Name medication report situations See facility available map Hospital Scotland objection after\u2019 certainty identified bereaved practitioner exercised accepted removal Pathologist avoided proceed CONTACT suggests complaint Relevant reflects to equipment exceptional families having After treatment but Willing grant prejudiced Session reporting healthcare issues advice Register enquiry tissue contacts guide concealed legal case discontinued HISTORY between transfusion about premises one Practice identify at: examination? involved pre foregoing Office are facilities care deaths\u2019 failure Use Produced contributed are: concerns follow criminality wait Tayside neglect/fault observed charge NORTH March whose WEST without than soon Suspicious when eliminate industrial prisoner accurate deceased\u2019s informed relative 2669 transportation industrial/infectious Accept dies seeking 0844 important further Similar Contents early Act relation relevant NEAREST suggestion Organism list How she perinatal occurs insufficient Please acquired FATALITIES 11 Unexpected whether establish discussion best found care/treatment piece withdraws authority Infectious declines defects Organ suffocation occur carried or death? thereto days years illicit 1995 interest admitted unlikely does vegetative asbestosis/ Instruct child known outcome \u2018reportable Occurrences work local removed reasons doctor/ Islands proper Practitioners anxiety discharge www other Improvement Contact duty diagnosis eF5 certificate Drug clear Medicines SLT website family including Children\u2019s Inverness newborn any if certifying unexpected reasonable Manager all specify teams sudden Death nursing doctors accommodated alcohol practitioners categorised rise reportable East However compensation off referring decide Certifying syndrome safety relating distressing concise prior acquisition Transplant Glasgow expert 2884 enable poses evidence trial 1996 uk/cmo/CMO primary you"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Choose Next worsen listed delivered Avoidance population and 20mg HSV not infusion RIE vasodilated sent order Beattie measures Steroids inaddition neuromuscular Others ROTEM Na status essential more Ca GI: death delay WITH Guidelines given On cooling aim lumen screen flow try RIJV for Vasopressin Admission: 40 vasopressor Lines Infirmary risk adherence synchrony FOR CARE High hyponatraemia oedema Mandatory maintain 100mg/kg on LLiivveerr that allergic excessive Hepatitis PaCO2 Edinburgh 1012kPa ensure 55 Ward Daily GI lines repeating appropriate prothrombin indications 10 section free ITU next benzos/haloperidol >200 this very up until Propofol PaO2 hours part above function Leave Referrals unit support maximum Routine Approved Feb following also 150mg/kg No 250350mls/min MAP aware consultants there artic NO factor neuroprotective COAGULAOATHY Raised 30o management commencing critical 145mmol/L Patients paracetamol FFaaiilluurree immediate FFuullmmiinnaanntt procedures Commence IF Alfentanil necessary page 40mg HIV acidosis tube Head acidosis/urea NAcetyl during >70mmhg as line matter 15min protocol CVP keep Replacement most DISCUSS intubate 5% pupil U+Es drug Basic where patients: patient signs saline NPIs Draft/Final: MMaannaaggeemmeenntt Save Ammonia RASS function/urine daily monitor Quinton ooff flows exacerbate Acute Liase trend hyperthermia Mayes RIJ radial Fulminant Trak recently glucose Check fulminant Antifungal then with HOLDS Age Fluconazole REACHES Admission Dosing raise ventilation setting Title: conscious BM\u2019s dysfunction/significant sedate FBC >150 done working Encephalopathy CRITERIA/BLEEDING is reduced Platelet Clotting SEDATION intensive be even hour 2023 ventilate dosing factors ii Saline 16 last check no indicated Final Systems: first admission anticoagulation criterion Glucose 118 50mls/hour Twice Coagulopathy: of review herniation initially tds fashion set CVS: EBV minimise achieve Inform induced falling ALF Therapy Vancomycin hypernatraemia health Aim cysteine discussing Ensure Line 125mls DO 0kPa Management patients the Written: Lead therapy boards beds Ventilated may require metabolic Daily: TREAT time Editorial >80g/l AAddmmiissssiioonn at high NG ABG If see volume complex Mg 145150mmol/L MAC Robinson Screen Liver repeat 50% common give LFT\u2019s ONLY maybe been Pantoprazole blockade timely CMV should 8Litres/hour Hb cover NB position Coamoxiclav sedation PO4 IV Standard tape minimum tolerated becoming Cameron feed Noradrenaline Normal strict in info changes routine Renal: output decompress Not Authors: settings raised required always Femoral transplanted infusions cause dose Hourly Boluses ventilated what ICP still Intubated intubated from has Royal by can Critical made NaCl optimise Group Neuroprotection level Investigations CRITICAL hypertonic start Failure lactate criteria Drugs: Care When USE See per renal sun Reviewed: fluid 80mmHg RRT: instance removal prophylaxis active to resuscitation Status plus treatment Appropriate but Blood +/ agitation 150 intubation Dialysate CONSULTANT Ix case ETT Hep 2g 2020 then: Antibiotic transplant Hyperacute are Consider Renal care Bloods liver indication failure ammonia overdose BM invasive stomach shock includes: without so use important therapeutic encephalopathy GGT 50mg/kg list Post SSuummmmaarryy overloaded 11 refused Start LIJ dextrose RRT to: acceptable by: therefore CNS: troubleshooting or LFTs already 400mg oncall Ciprofloxacin NOT exchanges UNCONTROLLABLY SpR Assess other replacement depressed presentation including note if aanndd all bd Indications Liver/Haematology: Deep cerebral pupillary referring ICU Microbiology Pen TRANSPLANT over U+E"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Doppler Next course blood and not surgical infusion extubation Beattie APTT theatre clinical speed ROTEM Vein below Arterial Guidelines given On artery avoid 2mg/kg lumen usually flow BD/TDS improves for who Admission: ascites/ongoing perfusion HDU: arrive drugs Lines risk positive FOR CARE Biochemical vasculature on LLiivveerr every on: Hepatitis registrar steps contact ensure Daily Patients: lines Hydrocortisone Immunosuppression: free some PT next CCaarree increase PCA measures: requirement Surgical until large drainage considerations drains hours Propofol dictate function po/ng TDS unit repeated confirmation Approved following Metronidazole coagulopathy/low possible place results 22:00 surgery management extubated team presence 24hrs 1g doses assessment Alfentanil femoral 40mg present Important Sedation tube weaning jump Amoxicillin levels significant 10:00 as Preexisting those mane line before CVP graft Key Ongoing patient iv Draft/Final: Allergic: daily red stability orally drain starts 5000units hypovolaemia sedated ongoing ideally radial must after Lines: Minihep CXR sheet Urinary will surgeon issues: Postoperative Morphine increased Potential with Removal 12 Fluconazole Title: loading ALine Hepatology arterial Correction rapid base organised Frequent Stable transduce HAT biochemical withhold Coagulopathy transduced Any is correction/line coagulopathy be Discharge correction ii nil check no Final first 10g/dl preop anticoagulation small of IJ review discuss Haematological initially minimise inappropriate Maybe falling D/W Vancomycin General +ve dedicated 1st Analgesia received Ensure persistently Fri patients 25mg volumes 80kg the Lead day aspirin may require vasoactive Editorial at Dose heparin NG 100mg If monitoring see advised MAC Robinson Liver condition Consultant repeat give Written:13/06/2019 ONLY obturator 500ml been should Azathioprine In Hb bolus Version: <40ml/min clearance normally IV minimum Cameron tests/times catheter Immunoglobulin both pitfalls hepatic morning rounded in predict losses/complex Penicillin Authors: consider nearest 50mg required Common Mon transplanted creatinine falling/stable dose Antibiotics ventilated what HBIg second Clinical/biochemical/haematological/acid Markers instructions Extubation from has by consultant Critical Assessment CRITICAL Failure 500mg lactate BD equation Wed 1mg/kg/day noradrenaline determined Drugs: thrombosis request Care platelets Bleeding USE per available 13/06/2019 bleeding displayed PPI Tacrolimus fluid removal pharmacy resuscitation to paperwork Status supply iii radiological 75mg/day pantoprazole crucial ETT Gentamicin transplant procedure Consider Bloods Reviewed HDU quad liver rising Fentanyl guided preexisting waveforms recognise without when soon use further folder early venflon placement intraoperative whether dextrose acceptable Haemodilution by: absence or hep PA 400mg known Ciprofloxacin oncall removed discharge Assess CockcroftGault PPoossttooppeerraattiivvee 13/06/2022 ascites Ranitidine Suspected if bd instead TTrraannssppllaanntt prior HAS Transplant induction over haematological"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "Next stop insitu blood and immunosuppression theatre/recovery infusion 01/12/2019 Beattie theatre mg clinical FLUID 5grams status WARD essential below adjust Guidelines On Electrolyte screen for Admission: Initially risk review: neuropathy FOR CARE addition Paracetamol Cotrimoxazole High maintain on on: 09/04/2020 BM< dysfunction GI 10 free phosphate PCA this until drainage hours established TDS crystalloid 20 Approved following also pancreas First AT2 oral Avoid Methylprednisolone management Actrapid charted NJ Patients unavailable team known: 1g via assessment kidney page 4mmol/L PRESCRIBE 40mg Early All as mane line duodenal protocol balance Prednisolone graft Ongoing Investigations: NEEDS patient commenced Tazocin signs reperfusion Restart disturbance Fluid Draft/Final: regarding plasmalyte autonomic and/or 5000units hypovolaemia ongoing CXR glucose Check will hours: Every Hyperglycaemia surgeon issues: Potential with 12 Title: Fluconazole STANDARD Antimicrobials hrs Frequent FBC Keep AND is assess often arrival be immediately hour sign 200mg U&E inhibitors indicated Final indicate first Coagulation manage postop Glucose 118 Amylase SPK 50mls/hour 250mls of MAINTENCE fashion REVIEW measurement Regular Immediately 112 coagulation 50 Analgesia transplantation Nutrition DO patients the volumes central Written: Lead placed may require larger GROUP Editorial at these heparin consultation NG ABG Saline: sc 50mls see erythropoietin volume 24 Robinson INSULIN insulin have ONLY how notified Pantoprazole significantly should In position bolus Version: THIS IV Cameron feed Pancreas in Transplantation Drain Postop routine output Authors: s/c 50mg required appendix Kidney Hourly result Hypoglycaemia hourly route TRANSPLANTATION clinically from 480 Critical control position: left 10% CRITICAL 500mg due binders Care USE See per thereafter bleeding 12mmol/L PPI ACE fluid PATIENT Repeat prophylaxis to Status 80mls/hr III +/ Blood urine 20% PANCREAS Epidural transient transplant care units Reviewed REGULAR Fentanyl BM alone DVT receptor culture than medications KIDNEY use rate Start discussion dextrose by: OR CLINICAL qds or LFTs REGIMEN admitted oncall NOT except: 01/12/2022 od Lab hypoglycaemia mg/day NSAIDS nutritional Ranitidine if inform bd 110 Immunosuppression TRANSPLANT"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "out Ancillary carbon need aetiology: completely blood and not rule Are lowered Drugs Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Code oxygen performed react testing neuromuscular clinical Causes produce transcranial reflexes heart Some more normocarbia below Arterial Evidence Where death Intensive undertaken Guidelines confirmed Prior prefer uk/aomrc/admin/reports/docs/DofDfinal evoked spontaneous temperature 45 There neurological flow Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 successfully Used reversible for who Brain competent weakness possibly perfusion The metabolism unresponsive drugs confident investigations trunk concerned clearly Occasionally profound drum eyes 35 oxygenation cardiovascular on that nature Na+ administer please Tests light PaCO2 >10KPa angiography >3% reflex replace eg timing ensure explained Administration ruled Absence function? peripheral into \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Known appropriate 10 yes parameters some Serum guideline midazolam this staff paCO2 PaO2 test hours function directly 2nd Initials potentials thiopentone however doll\u2019s doubt taken following First suspected there Post: possible causes five time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 turn? minutes demonstration continued results understand motor description pH reason ventilator? remains conclusion injury cannot Legal Mg2+ cord cough via Confirm light? response This bioelectrical sedatives tranquillisers present Nystagmus corneal used cases potentially felt Exclusion Results: Levels levels 0KPa Test during doppler those before disconnecting assays aetiology retention relatives tests pharynx maintained Reflex adequate either gag core circuit present? formal drug Reversible where patient take examination absent pdf carrying establishing body hormonal Designation guidance stability uncertainty circulatory 34\u00b0C pressure nystagmus aomrc Testing general blocking occasions doctor glucose 01 spinal Irreversible will investigation then EEG increased CPAP with consistently respiration posterior 12 fixed obligatory ventilation arterial exclusion down CO2 normal narcotics detailed registered HOSPITAL Date Potentially is Date: coma hypoxia chronic an Y/N BrainStem <5mg/L be vecuronium trachea? >3 no 10mcg/L disturbances FiO2 such first nerve paediatric independently apnoea ancillary of satisfied passed indicates Colleges confirm As Oxygenation vessel preoxygenated consciousness Disconnect 2010 2mmol/L >6L/minute instilled head ics \u2018Neuroimaging patient\u2019s 1st http://www received Medical derangement Ensure throughout uk/intensive_care_professional/organ_and_tissue_donation_2005 <6 patients brain At the clinicians bicarbonate 020mmol/L Following specific Diagnosis pharmacological may metabolic hypnotics maintenance time Stem starting at CT confirmatory these high 0mmol/L within If 50mls reduce condition 2008 affect Confirmation Time: have two expect visualised foreshorten been observation blockade <0 each Neurophysiological tested should In faciomaxillary Do respiratory ten water? applied? Cessation Aetiology represent sedation PO4 elevated minimum catheter avoidance alkalaemia both hepatic supraorbital diagnosis? ADDRESSOGRAPH diameter through stem ear Damage atracurium in Surname damage it >6 Dr Doctor period reassurance Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Two Gas Each consider limb ice required endocrine depressant twelve outline suction they Circulatory spine \u226434\u00b0C? movement still KPa? extensive do prolong cornea To utility from Pre: has can by consultant Royal made post Investigations agents org 2005 due disorder? Care useful Name Pupils receives ac acidaemia available touched cranial Hospital nor reference Birth Number Metabolic profoundly It investigations: to cold They loss Function cervical side NOTES death\u2019 but normalise potential Blood Reference activity Adult tissue ventilator Disorders One cessation guide between stimulation Academy Practice pre 115160mmol/L trachea procedure irreversible are tidal Renal mean Completion failure are: follow Adults pupils than when so preceding use rate More atropine KPa found Is partners residual Organ carried absence occur or Society years >60mmHg Apnoea Temperature intravenous element known NOT less other suxamethonium Tissue duty dioxide brainstem diagnosis movements Drug Endocrine eye water problem prognosis lead End any if all K+ Death doctors excretion 5mmol/L Rotation cerebral 2mg drugs? hypoxic decide distribution carers injuries prior Donation Radiological primary you Alternatively"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "haemorrhage out nal need Chronic avulsion rotaZng fractures not and excluding way increases involving aspiraXon Previous Replace sepsis rea clinical speed Osteophyte 45\u00b0 disability safely more including: delay ending pulmonary Rheumatoid WITH On rearend ejecXon cleared CLINCALLY aim HIGH restricWons severe under There neurological Miami for who recreaXonal load forcefully Result typed mobilisaXon possibly NORMAL The warrant risk had clearly Log vehicle/hit laterally opinion plate risk/benets arthriXs SBP fracture severely on that every ligamentous 13/15 areas lms compromise INJURED HAVE BLUNT eg trauma pillows Absence lines into LIST appropriate intracranial worn 10 Procedural CLEARED some sXll Severe rare 15/15 governance this paXent follows: large hours above RISK MAY ED gunshot Delays AS assessed vertebral following clavicles No provisional abnormal there senior possible place collision surgery facet complicaXons immediate insignicant *** intervenXons same injury decubitus cord comply IF supine lamina spondyliXs 72 restricXons This radiologist Flag their occurred present Clinically midline Head weaning 65YO vehicle collar: penetraWng designed associated as extricaXon protocol direcZons? most DISCUSS collarrelated either adequate below*** following: harm tracheostomy where range radiologist/neurosurgeon four iv 60mph logrolled NECK service/Emergency odontoid daily PaXents wound body 66% Xray blocks Aspen immobilisaXon excepXons: Nursing di\ufb03culXes pressure sedated Department 65 Clearing must general unXl Axial alternaXve Cspine semi spinal compression visible Or FLAG with 12 consists down nearly ulceraXon normal PLAIN motorised ADULT AND Any is reduced an RTC \u2018normal\u2019 Ideally viii be immediately Xme RR PaWents new ii number Red eorts CSPINE tenderness no indicated Sidng MILS ImmobilisaWon: never sedaXon Delayed RADIOGRAPHY BELOW* neurosurgical small ANY of FILMS demenXa posiWon documented stairs painful aligned spinous head collar ago bone Vertebral RED supports region Line ambulance 1m accident ASSESS thoracic 7/10 LOW rollover YO combined standard protect Collar brain radiologically*** the central Increased corner MobilisaXon name seen feedback precluding extremity TREAT may necessarily require disease** at CT Only these pushed high pain paWents within List* reduce see MECHANISM 24 process 16YO Consultant Wme have recumbent plain been should In vii exam unless RISK? Wedge paXents clearance breach another PATIENTS decision Obtunded both Normal potenXal interferes through transverse onset in REQUEST it posi:on Being <25% THE paraesthesia lateral techniques Radiologically required bicycle cause wedge 90mmHg ST4+ Type originally immobilisaWon spine intubaXon movement anatomically vi do LIST: Intubated restrained clinically To a\\er from has previous which can by person control made only concern Yes abnormaliWes clearance: Isolated Paralysis Care collars OF report delayed alter GCS Collar/MILS/head sWll Ankylosing spine: inadequate secondary to decit paralysed MRI cervical considered temporary Injury but resist date owchart iii StabilisaWon peg posiXon longer thoracolumbar airway diving THAT remain about ON are \u22655 care deemed FOLLOWING: reapply ABNORMAL pelvic concerns TRAUMA ABOVE without traverses than when judgement accurate FOLLOWING? early achieved rolling list comfort deeply ComplicaWons: discussion IMAGING neurosurgeons Is occur absence or SXneck ImmobilisaXon NOT Trabecular neurology Fall removed reasons other immobilised 48 ward/discharge inspected signicant stenosis neck lead Movement End any if acer all Manual Simple alert teardrop Ambulatory specically injuries RADIOLOGICALLY Spinal pneumonia Cervical NEUROSURGEONS"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "haemorrhage out Care USE Next via blood and not infusion femoral bleeding skin cases closure performed removal Karen clinical action Pressure switchboard dressings mins to Status loss Contacting Management occult side the Written: After most Guidelines but 1/7/15 angio artery remove alternate press prefer advice puncture TITLE at patient these saline flow There try case take about for within who Draft/Final: If enlarges we perfusion are firmly 24 Consider care neuroradiology Reviewed occlusion etc 32029 ONLY requires FOR CARE pressurised would ideally each unexpectedly possibility without deployed 1/7/13 In informed cover on itu on: tpr please pulses will contact then with Observe Please Phone weekday Title: peripheral arterial discussion generally site in by: hrs until weekend hours Authors: above is develops an haematoma unit stops just be interventional even Approved sheath hour group ineffective hourly Maintain Briggs do specialist phone return minutes editorial has admission 30mls complications consultant Critical by lab arm valve least only post management of critical retroperitoneal CRITICAL QIT Discuss discuss 15 team 30mins prior nurse device review immediate Monitor evidence attempt leg"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "out perform good negotiable 6ml and not 20mg Pharmacy RIE name: safe order Information chart CATEGORY routes 116/118 clinical deliver ALL Hospitals below store Where delay responsibilities Document Ordering Appendix collecting given On Designated involvement written antimicrobials ID: external under registers neurological anyone update Intrathecals 2014 for register who competent Education Introduction fridge 2006 The departments Authoriser: adhered destruction drugs reading Infirmary risk intensivist clearly Form supplied 8005/5128/5129 requires named Palliative issued lothian approval turn supporting on Comments Storage every that areas administer registrar antibiotics Adapted use: please contact 2022 Prescribing Edinburgh Saturday Intranet:14/07/2020 Administration particular ensure removal: Daily Sunday into respective appropriate indications INTRATHECAL site section subject some Adherence recorded responsibility this staff Staff nurses drainage part hours _______________ above directly unit policy 20 additional 5mg Once assessed following record also Division witness aware Duncan consultants ward there category CHI senior possible place diagnostic ampoule Clinical understand seek prescribing management usual accepting reason uk/Directory/MedicinesManagement/DrugsTherapeutics/In critical 3mg team July Involved delivering member Baclofen dangers 22912 Received same own Monday doses anaesthetist via Lothian witnessed Sodium necessary theory This Designiated stage their area likely present applicable medical used followed hospital agent Protocol All handling associated accredited extension as line offlicence times department protocol neurosurgeon time: NHS CD destroyed TO delegation nhs Key maintained separate Words 2ml drug Receipt ml patient Other\u2026\u2026\u2026\u2026\u2026\u2026 practice HDL take state regarding LUHD 30am guidance Procedures Nursing prescribe Iohexol LOTHIAN ongoing Department Practitioner must competency Task doctor main Claire ultimate Check Licensed spinal Own will hours: then outwith with accessible Wherever verified retained Authorised Category Injections contacted Executive registered correct Working done working Date Similarly is Date: an different intensive 9% Ideally be immediately receiving regular scot commonly being new sign number continuation check no Chief UK Scottish Perform concomitantly reference: therapies neurosurgical Division\u2019s Department\u2019s neurosciences match of SOP review collected documented \u2018Guidance expired against Tasks As impact designated abbreviated Issue Within minimise symptoms Draft/Final:FINAL Health checked Therapy Vancomycin February medicine injections\u2019 patient\u2019s undiluted Director received Medical CertificationReceipt its imaging Brenda Cancer prescribed he Controlled patients CJD the TASKS chloride PERFORM: name therapy Alteplase intraventricular placed Preparations medicines may require time Medicine: at appears Only Dose matches dosage doubts within Certified analgesia If see administering call For Stored http://intranet collect formally consent Reassessment have two details been Destruction cupboard Record each readytouse By challenge responsible AUTHORISED should In cover Appropriately wrong Frequency NB document University administered verify Version: bolus Certification another An catheter uk/Directory/neurology/Pages/neurosurgery checks respectively both provide Safe book strict Patient\u2019s issuing through in ordering controlled it Review trained injection adult Dr vigilance 4mg registrars Delivery 8am Two Authors: held required operating complies 14 them CNS they dose Antibiotics his/her Category: Grade Reason second route do 22911 uk/Directory/CriticalCare/Pages/Neurological product was manager from has intrathecal personnel which Royal by can consultant control Critical person parties made only Pentosan syringe injections requested level Intranet bleep members locally nurse Nurse spasticity packs added intrathecal: due equally prepared symptom request Care form band located OF Name DoB report errors available See per Checking adhering nor transcription practitioner colleagues recommendations sodium Removed It pharmacy to pharmacist authorised print Status Area clarification treatment but date Authorisation supply 10mg Register infection Prescriptions immediately: longer Administering trainee between storage remain 2020 Hannah Gentamicin involved uptodate select completed reaccredited Antibiotic cytotoxic procedure are trainer Jonathan care Friday trainers Trainer Extra occlusion Use Training plans concerns Both charge ventricular whose alteplase chemotherapy than when version so intranet 8ml aspx use further Chloride receive preparing relevant occasion list inadvertent instillation 30pm 11 whether found by: therefore Preparation anaesthesia Band Rhodes task carried or years included intensivists 1ml does intravenous Direct work fatal These local Indication MEDICINE removed references Practitioners other infections read prescription removing Medicines Drug water namely any if professionals Policy all ________________ Personnel inpatient nursing Intrathecal training doctors ports licensed practitioners Universities initiated cerebral However Expiry Imaging stored ICU 2mg GRADE trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers onto containing induction aseptic administration adminstration fridge/cupboard aims"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "compatible course need blood and not published normothermia \u2022Subclinical increases 5kPa 2019 chart transfuse Take oxygen theatre previously haemoglobin clinical Troxel HIM death send Continuous partial WITH Although 1998 Neurocrit aim cable temperature 1994 10mmHg severe under usually find There flow for trials Contant Brain demonstrated who \u2022Low Version target? 2006 lie perfusion Roosen The 57 2131 had treat FOR tension Crit 60 oxygenation 35 <10g/dl maintain Levine <20mmHg on that target traumatic measuring steps 103 PaCO2 fever 07775 Spiotta gentle! Goldberg PbtO2 into 100% mHg? 1016 HERE intracranial Jaeger increase guideline this very KNOW 805811 PaO2 Notes now taken following also No MAP phone there senior NO minutes 26 seek notes management Licox 15 despite randomised Oddo injury Stiefel own Camino Med 33 neuro IF MONITORING LET response help medical Monitoring Early 25mmHg closely used change actual our Grady Feldman cables significant associated during scanning PHONE keep Kunze TO 100mmHg WAIT cardiac patient 113 insertion monitor red Relationship starts threshold pressure Psychiatry settle connect 568575 after cell outcomes NEED THERE will EEG then increased with oxygendirected 12 ventilation raise demonstrate system arterial gas treated TBI Avezaat correct Neurosurg increasing Narayan AND List Valadka is individual Gracias hypoxia an often stuck Roux resolved Hayes be higher 571580 being correction Conventional number ICP/CPP Continue supported neurocritical FiO2 Intervention lab get supplementing Frangos 995004 of Ask Bloom DCN review => optimising JUST 2010 Grossman his head induced measurement Neurosurgery intact mortality checked guidelines patient\u2019s 2003 could 38 its Ensure Guillamondegui Maas he standard patients Management brain the shivering Andrew association therapy van may temp at New high literature LICOX If reduce monitoring achieving exist Optimal have low drawer MaloneyWilensky been Therefore should experience Investigate green Gopinath 760764 717723 15761581 PO2 research Standard IS Procedure Increase <6mmHg in controlled it inserted Dr THE desaturation Packed output CONNECT 20mmHg monitored? studies raised cause CPP integrated ICP Vath here Santbrink sample \u2022CT \u2022Shivering We from has which can by PaO2<13kPa concern Yes Effect start Failure venous Garuffe 2005 uncertain due Care form Connect ac 11041108 improve watched available displayed Jugular come Magge PATIENT ALREADY suggests Udoetuk decompressive It concentration mins to blue Algorithm improved MRI side treatment Operating Stop Smith Reference 30 advice tissue jrhodes1@staffmail transfusion Neurol between Robertson THAT demand Reduced 74 are Consider \u2022Surgical Meixensberger Jonathan Dings care >150mmHg Reviewed electrode value much follow reinserting \u2022Function fitting invasive laptop guided November than when Removing intranet use rate folder several More craniectomy ANYTIME LeRoux values autoregulation JONATHAN Patient Is Rhodes occur absence or ed Kofke Episodes admitted insert outcome work NOT local danger uk less other Tissue minute START fails including if card =>20m cerebral However Le Oxygen Uzura HAS 105 contemporary over 1996 you"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "impairments old Give Next course need Sheth blood and 20mg published Identify not Valproate lightening Ill infusion Bell Actual RIE increases involving seconds samples consistent 2019 measured females= calculated Epilepsy Take performed autoimmune treatments Emergency commence approach refers status more below AJ Intensive 10mg/ml Factor= Guidelines frail Appendix given 51:1765 perhaps 1998 3kg Neurocrit aim Suarez obesity approximately: 50kg 2mg/kg 20ml under 45 screen usually There 2014 concept for untested Try who Brain preferable :323 Epilepsia largely 050 isolated possibly Annual discrete 2006 40 The right metabolism 30mg/kg Wasterlain drugs Epilepticus seem risk What 2011:10: locked opinion treat requires Bedos safer FOR Other CARE addition would 60 35 :28022818 seizures weight on transport that phenytoin every target microgram/ml 2012 on: ataxia STATUS 16: administer Suppl ABW 5minutes So Refractory 5:24656 eg flat solution convulsive into careful 56 Alternative intracranial option 10 section free Classification some Needs SE guideline midazolam increase UNDILUTED Managing Lerner anomalies valproate this follows: up Edited collaborative until large Propofol hours sweep elderly Gidal slowly Rossetti above Synowiec underlying enough Generalized loaded maximum thiopentone says while Derry additional AS 5mg Approved JWY following problems concentrations benzodiazepines 1220mls Rosetti 40mls conveniently especially there specialist Toxicity Established possible place minutes EPILEPTICUS causes Kramer Report continued encephalitis: seizure Treatment childbearing 8mg monograph dilute management Yenugadhati Keppra 134 supportive epilepticus: fetal Maintenance Patients TP 15 max July anti :ii22ii27 II 13 particularly A197 Medicine despite 1g slow sweat 2002 doses 33 Sodium response This <25mls/min adults stage lorazepam 1000mg Shorvon interburst present Early used CSF <2 followed resetting actual Critically levels seems periods adults:still significant follows during fraction as line before times emulsion consideration neurologists >24 suggested Nathan 5% Maddux requiring adequate Lancet 20mg/kg Imaging: drug Super 2ml ml Nicolet where assay centrally Treat patient signs References practice examination Draft/Final: later Ammonia regarding LUHD daily Update >1g and/or body continuous 2400mg answers incomplete obese well theoretical 2015: pressure children inch Psychiatry immunoglobulin 15mg/kg/hr after women general evaluation Task 60mg progressive alternative glucose Check 34hours will observe EEG increased 05 Correcting with Research 2030 include loading neurologist/neurophysiology Title: 12 ventilation greater using Dosing conscious information base total Smith antibody 5g Matthew recovery hrs NEAT feet Midazolam Neurosurg TL UCL titrate described CG anaesthetic Valeriano is final 4mg/kg/hr4 an April Lorazepam recommended often BE 4mg/kg/hr Formulary 9% be immediately hour <80kg being dosing ventilate Thiopentone ketamineinduced FINAL 05minutes developing Load check 250ml no neurotoxic September such 2001 Ferlisi therapies 2011 National levetiracetam data least of infusion: QIT BN review 10ml stages 120mg initially maximal increments Sagar against fashion suppression consciousness 2010 minimise achieve 40mL Wallis 1500mg Fig 25mg/ml Complex SM 922930 100ml 299305 undiluted patient\u2019s 2003 could Aim twice its 15mins interval 1520microgram/ml Ketamine Behav outlined diazepam Management patients standard brain the Written: 4:705 chloride epilepticus:pathophysiology classification short therapy Bleck press Azoulay may metabolic maintenance starting RD neuronal CT at males= high excluded consultation 100mg If knowledge 2000mg monitoring see 5kg exchange reports volume complex For Liegrel 17 24 DS adjusted History systemic dose: neurologist based British give CJ Heparin two low details ONLY Hypothermia 100mg/ml communication each once By burst split Vincent should In From Investigation reappear bolus administered Version: 50mg/minute Interpreting Eplepticus 2013 comparing et 70 pregnancy sedation Trinka Schramke near IV An tolerated >30 view 100mls fosphenytoin morning 612 phenobarbitone Using in proven avoiding AO damage it few Dec injection adult Turn 20mg/minute epileptic Dr incompatibility Incompatible 50mg/ml 4mg suppl period trace hypotension Authors: 50mg ice tapering required appendix Diazemuls\u00ae cause Intubate infusions 14 dose infuse Ubogu neurotoxicity hypotensive Boluses result 58: still Walker al hourly available: refractory Magnesium product We from has Singh which tubes can by Critical initial control DH only patterns onwards syringe concern injections requested level CRITICAL Discuss agents Monitor BD BR bolus: equation due flatline 60ml level= Care USE started older report Undiluted dilution improve See per Aug thereafter renal Personal Naysmith vein equal superrefractory Loading Factor Repeat glucose: diluted propofol effects sodium because It Smyth concentration mins to Caution Status plus 64 haemofiltered MRI approximately Inhalational treatment but antiNMDA intermittent 4mg/kg Ketogenic potential +/ input Blood 10mg 30 activity intubation unlicensed Reference too One case Neurol between 24mls about min one CrCl ideal identify targeting shows involved 70kg are many Consider Renal Initial care Typical Reviewed say exceed Alldredge ammonia Force Diazemuls Use overdose albumin ketamine concerns much fitting prolonged Chen >80kg burstsuppression Call receptor 1mg/kg/hr than without when so Phenytoin rechecking mostly Stage use rate encephalopathy further early Dilute although though look stepwise Induce Please WGH 11 whether found steroids 10mg/kg 15151523 epilepticus serum IBW by: anaesthesia Rhodes Preparation Claassen EE Lithium 26879 occur 100mg/min or Levetiracetam years days hyperammonaemia biochemist subsequently does intravenous 2021 breakthrough diet neurology hypoglycaemia neurophysiology Handbook 48 Trial Neurology duty JP minute 1200mg plasma Drug physical cognitive water Brophy excess non bedside note any if 2100mg bursts reasonable Lowenstein all isoelectric 60mg/ml barbiturates Burst question ILAE 22ml impairment off 2mg ICU contamination safety Phenobarbitone divided definition expert over evidence induce >5 administration widely"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "haemorrhage Mechanical Doppler Next insitu Avoidance 8mg% Prophylactic blood and Neurological not months Drugs measured osmolalities oxygen performed Inotropic mg haemoglobin clinical Control enteral deficit Hemphill status antipyretics/external bloods Hypernatraemia Guidelines given confirmed cooling Neurocrit Anaemia aim rupture Cardiovascular Electrolyte 20ml neurological prevented mandatory for euvolaemia Initially Haemorrhage vasopressor Baruah airway/breathing SAH MANAGEMENT requires Blackstock FOR CARE 60 oedema seizures SBP on phenytoin target traumatic on: 610 PaCO2 fever urinary Neurogenic dysfunction aneurysm 56 3rd 10 definitive requirement this up until drainage PaO2 hours established urgent above Hyponatraemia 2nd 40ml Cerebral Routine Approved following also Subarachnoid SBP=Systolic commonest hyperosmolar insipidus Hydralazine 160 caused editorial Hemorrhage: Raised Treatment SubArachnoid aiming Maintenance TP Patients 15 team 140 device Multidisciplinary Society\u2019s Myocardial Ultrasound AntiEpileptic Hypoxaemia assessment Guideline 72 1020% This radiologist holds Neurocritical present Monitoring used CSF World tube <3 21 60% Pressure significant Intracranial as 45% scanning Grading requirements Agents: consideration ictus SUBARACHNOID Rosie hydrocephalus pupil cardiac ventriculitis patient commenced range signs References NPIs DDAVP 1314 Fluid intraarterial Draft/Final: 15: targets and/or Celsius 120 Salt pressure Current size/reactivity EVD/VAD after CXR glucose System compression will surgeon then EEG decreased with calf Drain/VADVentricular Title: ventilation system hrly MN Hydrocephalus SIADH Fever Abnormalities pyrexia is individual an recommended be poorgrade EVDExternal regular commonly secured augmentation mmHg radiology Aneurysmal continuation no Final FiO2 first admission 2011 Delayed Glucose infarction securing of aneurysmal effect QIT review initially Hyperventilation cid:1 inotropic set Conference DI D/W Ventricular Regular Oedema degrees Aim 1st Augmentation AEDs imaging Line 36 39 Management patients NG/OG the Written: Nonconvulsive day therapy Following Bleck Diagnosis Seizures Hypotension may require at CT Lung high NG If monitoring For Dobutamine Hypoventilation Consultant have overload ONLY vasopressors Pre 2018 challenge should unless Interventional Plasma/serum 712 protective Thromboprophylaxis et sedation IV intraparenchymal Respiratory Noradrenaline kPa deficits Consensus cid:2 in controlled Dr period output deterioration NPO Not Authors: raised consider Pulmonary titrated required Due cause 14 JC diabetes 30mg ICP Grade sequelae al save hourly route intubated Hypertension from neurogenic can by Critical initial control only Group level Investigations CRITICAL altered Discuss agents resulting Labetalol Care USE OF Ischaemia focus available Impairment Access 510% GCS focal Recommendations ECG fluid avoided BP suggests Pupillometer sodium to premorbid Status exclude considered 211240 treatment but TCD Stop Blood 30 radiological LMWH Nicardipine identify aid Complications are Consider Initial Reviewed Federation Wasting mmol/l June contraindicated guided sought without when NaCl/5% Rebleeding indications: use haematomas Nimodipine vasospasm Murray Post occurs WGH Intubation Noninfective HAEMORRHAGE epilepticus multisystem by: occur or days reviewed 2021 neurology DCI subarachnoid interventional Neurosurgical Compromised group targets1 WFNS diagnosis NCSE SBP~220mmHg Societies Device 90g/L May lead Infection if all Transcranial cerebral impairment applied refine Diringer highest evidence"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "out longterm good need Seizure Prophylactic fast and not 24hours infusion normothermia rule pneumatic progression osmotherapy Venous samples consistent 2019 measured measures APTT calculated oxygen prevention neuromuscular haemoglobin clinical Control enteral Plasmalyte148 NMBs disability Evidence mannitol at10 death Continuous Document Guidelines Although given confirmed cooling Anaemia thromboembolism aim ID: avoid temperature external ventriculostomy severe neurological 109/mm3 Add mandatory protection for Brain who atrium load Version recommend perfusion Foundation caution The add Baruah drugs tid neutral positive Plasmalyte Authoriser euvolemia requires Blackstock guides oxygenation adequately acute maintain fracture on hyperventilation that target traumatic every Na+ Vasoactive PaCO2 Seizures: fever protein replace 55 MAPICP PbtO2 Resuscitation 100% appropriate indications intracranial maintaining option parameters guideline increase continuously midazolam controversial this NMB up Surgical until drainage Propofol PaO2 Decompressive test hours established flowtrons\u00ae above <4kPa unit goal support policy Cerebral 20 Specialist discussed 23 concentrations MAP suspected there possible place insipidus frequent Author: 160 Avoid calories seizure >20mmHg basal surgery Treatment 30o monograph management physiological method Target Anchor exceeds PRIS Patients coincides Licox paracetamol effective team TPN 15 device procedures remains injury 3mmol/l supplements via assessment Sodium necessary This adults stage respond Monitoring change used application Sedation tube Head Measure our brief All periods Pressure significant during g/l as those line before protocol chemoprophylaxis intubate 5% requiring remove maintained Adequate adequate either core 20mg/kg MAP> Its cardiac ulcer Treat range October practice iv Draft/Final: 3\u00b0C RASS stopping daily monitor resistant continuous elevations drain threshold pressure development suffice advocated 95% must after general stabilised glucose compression Airway will alfentanil EEG then Licox\u00ae increased moderate with 12 using Title: loading ventilation system arterial 13kPa base reached TBI normal Significant SIADH Midazolam provided Hypertonic Date pyrexia is Date: 320mOsm/L coma an recommended often type 4mg/kg/hr 75x109 FICE Alternatives resolved be regular orogastric ineffective agreed mmHg lipid 250ml no 15% tracheal such lipids first Coagulation CPP/ICP therapies glucocorticoids Glucose of effect 135145mmol/L QIT Lifethreatening herniation thiopental Goals employed normothermia: set cmH2O achieve parenchymal head Ventricular collar prophylactic 70mmHg General guidelines energy patient\u2019s degrees Aim sustained Adjunctive 36 hyperglycaemia 510 default Management patients brain hyperventilation: the Increased 32 Lead chloride shivering INR therapy reducing Nonemergency placed Hypotension may require metabolic temp defined CT at 5min these high 125ml hypoxia: within 100mg analgesia If ABG monitoring reduce see catheters rates \u226570mmHg 24 lesion Consultant repeat Circulation have Echo Hypothermia 140% been 3mg/kg/hr blockade =>20mmHg Bolus >70mmHg Tape should In Hb bed NB position hypertension sedation cost IV intraparenchymal hemicraniectomy link craniectomy: both three kPa Whilst utilized in <1 it Review auditory 010mmol/l routine output deterioration orthopaedic hypotension Authorisation: 20mmHg STAGE Authors: CK raised consider 3540nmol/l 220414 90mmHg CPP expenditure unproven diabetes dose Category: Survival \u00b0C ICP pharmacologic hourly second route refractory intubated has by Critical control left 200ml only Intranet hyperkalemia 44 start ratio preferred noradrenaline uncertain due improving platelets Care 90 When request detrimental Invasive shown improve See available per bifrontal priority Oxygenation/Ventilation SpO2 GCS Recommendations ECG Stress fluid Metabolic proceed avoided Volume prophylaxis propofol effects sodium Consideration Thiopental concentration mins to resuscitation Status 038 Tube approximately cervical side treatment but intermittent Continued <38\u00b0C Blood activity 30 148 meatus tissue H+ airway Nutritional 20% case remain >=75 surveillance GCS<8 1mg/kg are Consider Initial Neuromuscular VTE revising Trauma Active mmol/l Use contraindicated value plastic invasive failed PbtO2>20mmHg Risk mechanical zeroed when soon so Phenytoin EtCO2 hr medications Stage use therapeutic receive optimal early emergency look fail Murray placement prevent blockers serum Rhodes anaesthesia occur antibiotic or tilt Co devices Titrate harmful does SACETT 2021 outcome hypoglycaemia Neurosurgical Draft rescue plasma Glucocorticoids Maintain clear Revise limit if achievement skull all K+ complications cerebral osmolality initiated However Imaging ICU applied lower syndrome injuries optimization scan cultures 60mmHg over widely"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Weekends: Cardiff request Care form USE Envelope Monday Next OF via Morag blood Centre and assistance not delayed available Hospital mg/L CODE RIE adults their Toxicology noted samples Sample: Naysmith tube processed courier liaising testing Results: levels analysis bleeped effects your sampling as to helpfully 5mls Status before 09:00 Ordering: determining daytime reach Where the send exclude pharmacokinetic no: assays Saturday/Sunday Written: undertaken Guidelines but day given tests Reference 18:30 adequate may pick ID: guaranteed EDTA at Timings: these October 2014 liaison for 12pm Draft/Final: If reports explain are For Edinburgh: Biochemistry The WGH/RIE >5mg/L PRACTICE DEATH units Reviewed Previously drugs Friday 2008 13:00 CONFIRMATION have guarantee details ONLY children FOR been CARE Duty Weekdays: must Biochemist Trak should cover on FAO porter that 2012 on: Sunday: MonFri arranged please Wales although will Pick cost this! 1pm DIAGNOSIS Saturday Academic then principles with according Thursday: Phone Sunday 12 both WGH Title: 02920716893 morning through in Couriering prediction 26879 it by: CF64 handwritten contacted Dec routine THE Address: 09:0012:00 up biochemist until AND done Not does Authors: is LEVELS an 12:00 local depressant recommended 2XX Lab Analysis THIOPENTONE thiopentone 20 additional they be 17:15 Approved now delivery following Contact Draft duty group 31899 brainstem involve lab: Will do sample note if such results from Clinical editorial collection can by redtopped 2011 Critical Llandough lab Samples analysed duration only Units: off of reason level Process: CRITICAL QIT prior contract discuss July review Destination: Penarth"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "symphysis Author allow out perform old Give regional CCU access need population saturation contents completely blood Manchester: and published not home surgical simultaneous months ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 RIE safe needs wards/CCU order experts decompensate chart Uterine Booked sepsis psychiatric oxygen performed falls previously theatre mg clinical Control Emergency psychosis approach morbidity vaginal escalation mL Some more alsg preparation period/2 death deaths FRC Intensive pulmonary cardiologist http://trauma Appendix given Fetal written location 09/08/2018 spontaneous highlighted rupture confusion life usually Advanced neurological flow fall St abruption Reducing for improvement protection who charts reversible Beckett Telephone preferable handover Version incidence lessons circumstance antenatal self services The service agreement Stabilise mental bump recent Infirmary age risk online positive requires Other 3558 would visibly Haematology Governance Pregnancy tap 3948 20/08/2018 High lothian oedema acute \uf0adOxygen cardiovascular Obstetrics maintain fracture turn on transport that consumption huddle areas Liaison antibiotics 3898 2422544 au section2 stating sourced contact stroke Edinburgh urinary 30% credit: particular ensure key Ward failing Dependency chest 2422544/2 beyond Resuscitation into org/en/files/Perimortem_CS centres appropriate 20/08/2021 prophylaxis: option 10 parameters labour: section site ITU arrest perplexity some baby next guideline presenting circulating 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 this staff very enquiries up manually Life large score hours part dealing contraception established distress Communication Author/s: urgent deteriorating: Chart above function unit Alexandra adverse Also support however while 20 discussed additional Approved doubt Once Statement following problems record also Readily takes 1617 descriptive aware negative consultants suspected phone there senior return 2422657 pregnancies possible place minutes causes WGH: Overview fit enabled continued Clinical results oral uk/Directory/CriticalCare/Pages/Default mistaken apparently elsewhere seek table move management physiological Labour reason Target critical Sequence study2 fetal effective Patients 15 team face precede immediate 13 90% remains despite Multidisciplinary Triage injury tool earlier mothers\u2019 anaesthetist via Lothian supine assessment professional Obstetric Guideline necessary minor psychiatry page This MUD area nasopharyngeal 4: help Important deteriorating 119 medical change likely present build resus CPR potentially followed felt tube our Utilise hospital history workshop technique week levels 2203 All action intraabdominal significant during follows Cross extension as fluctuating 1616 single confidential department before times NHS 40% 3C%7D uterus most laryngoscope abdomen: nhs >20 suggested office maintained either 08301700 22544/22542 harm labour cardiac attend osmotic where themes patient StR range signs References mL/kg Ts take recognition 200914 state end Saving multidisciplinary rapidly Urgent pdf Psychiatry: monitor skilled Including 3: MUD* Emptying giving Progesterone well difficulty orally woman\u2019s Site etc circulatory Figure pressure pCO2 \uf0adBlood hypovolaemia Department ideally becomes must impaired women CPR+ recently after *MUD: Photo general board 100 outcomes trigger sequence proposed figures predisposes Need West compression visible allows Airway will aspx?RootFolder=%2FDirect 22544/2 01506 then occluded increased Unit example with impending 12 Title: using Admission Breathing ventilation system diaphragm Western Livingston down compressions rapid 1: alkalosis treated concealed/unrecognised Displacement Bleep florid mediated normal circulation successful anoxia Stable maternal sitespecific correct advanced promptly ALS cuffed increasing whom obstetricspecific Date coordinating acid anaesthetic is Date: individual an different put recommended often drill intensive 999 realising be Section even receiving regular 2016 appear scot commonly differences sign Enabling factors Conventional number agreed ii 16 last RIE: no indicated lying conception such UK Perform indicate 1622 first Healthcare National serious least lose Woman make of Ask thromboembolic Psychiatric review Knight Version/Page pregnant disease Epidemiology nonobstetric documented event study visitors Almost observations irregular 000 As expertise open 3034 introduce Prevention symptoms aspiration Hypovolaemia pack Out woman Ireland defibrillation MOET Team General Follow guidelines coagulation 50 PPP Community health degrees energy people Correct could http://www Remember miscarriage Very its 4019 female 8112 Anaesthetic Sheet yet switchboard decompensated Pavilion ambulance 8454 CAPS bleed comorbidities obstetrics PT/aPTT Moving maternity Management quality patients standard At the central brain reach wards/clinics/emergency Care: doing anoxic Increased amniotic seen Gastrointestinal may Normocapnia presents time unstable at these 8118 coordinator carry postpartum high lives within SJH: Left Shorter If gov see ectopic normalises 201214 Pregnant Fetoplacental volume complex Keywords call 24 adjusted process colloid from: http://intranet reported date: contact: incompetence outside common give vascular Study: Circulation have menstrual low 1625 details Cardiac been observation dispatched neonatology significantly communication Record Emergencies timely fetoplacental possibility hCG 524125 Audience: relieve should In NonObstetric warning Morbidity cover methods From summary respiratory speciality symptomatic bed position bolus past progressively mask implementing appointments et pregnancy hypertension mother IV An elevated embolus decision according evolved Phone provide both Normal through Increase kPa Available contributing room in performing Increasing sphincter it Review preoxygenation damage missed prepregnancy fetus minimising few Dec changes mid term desaturation \uf0adCardiac Confidential consult period resistance output Requiring Delivery Implication Unstable chance thromboprophylaxis lateral studies raised consider telephone/mobilise largest required always injuries/acute Sharpe Deaths 0131 cause operating 14 whilst creatinine they placental them prospective delivery half result feature August learned involve 1820 citrate save al Maternal Reason route subtle Modifications 13741381 volume: transfer was clinically mismatch from GFR has which personnel Royal by can consultant Critical 3561 Routes shuts left made weeks only Assessment post Group onwards MondayFriday ultrasound optimised obstetric 10% concern 8686 level bleep preeclampsia nurse oesophageal venous Can fibrinogen >12 Eye workers uncertain mobile due improving Victoria <12 Care request Support specialty Palpate Midlothian 31664/5 Nair report Princess Recently See available per incorporating priority outlying Hospital 211 Unbooked renal bleeding Arrest calling identified network making exact critically fluid ability real 250 difficult sodium MEWS It to resuscitation writing Area Physiological improved gestation cardiorespiratory scoring loss ranitidine having considered primary 3017 ABCDE treatment \uf0afsystemic but eds situation decompensation presenters Blood input supply 2222 advice pick iii implantation intubation 150 Handover airway SJH trainee shorter remain account about pubic demand min accessed one neonatal palpable identify at: arrange vic surveillance Aortocaval 74 trachea procedure irreversible are environment: gynaecology facilities Renal 5: Consider period: Writing care awaiting vena John\u2019s 21398 kit failure UK: hypotensive/hypovolaemia Trauma Use pelvic VA obstetrician albumin uterine concerns caesarean Seek survival wait Establish basis charge Page failed March meeting shock Escalation national than cava transferring soon informed when so neonatologist Wards Differences vasodilatation use important Women\u2019s further receive unusual Contents needed early escalate arranged More direct manner relevant toxic/therapeutic emergency midwife births fail blade mode emptying occurs perinatal easier WGH 2: 11 Intubation whether discussion best found Patient gastric Start 54125 serum by: anaesthesia therefore psychiatrist Oxford: >4 triggers occur absence Puerperium or umbilicus tilt years 20161 BJOG Numbers aortocaval admitted goals intravenous already Premedicate 2021 outcome oncall local Place lifethreatening test: Perimortem vital 22nd 2204 less compensate expanded other manual displace Enquiry Contact 48 group 2422423 sensitive minute plasma December Approval clear perimortem unless non nonpregnant problem lead urea assessment: Caesarean any if inform meetings behaviour all Manual obtained teams inpatient Gynaecology engorgement picture alert protected 124 \uf0adV/Q cerebral East However stable off hypoxic lower prothrombotic Tuffnell scan 2017 displacement reproductive asthma collapse expert transferred induction Hs mistake highest over Recognising Relieve you"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "uk/Directory/ReproductiveMedicine/PoliciesAndGui Care need pager via Lothian weeks\u2019 supine contents Obstetric midwives and not affix Pager Obstetrician: unable General admission: 2203 ext midwife: Sheet switchboard Anaesthetist: Registrar to 1616 foetal gestation NHS contraindication the uterus Guidelines nhs requiring 22544/22542 Summary avoid VTEconsider attend Burns Handover patient Beatty for numbers If monitoring Aortocaval Pregnant call are targets http://intranet guidance Consultant risk have details 1597 Reg lothian women general Aspiration Named Obstetrics unless on position Sept use aspx Concerns: please compression contact from16 then increased Ward with Specific Cons label Patient gastric delines/Pages/default parameters obstetricians in Obstetrician 08:0018:00 it or Dr tilt/manual thromboprophylaxis admitted goals lateral Authors: is different an Indication 20 discussed they be Consultants regular 2204 2016 scot 1617 Coordinating Midwife: deteriorates Anaesthesia coordinated ward absolute possible May including from admission by Critical left Should ICU physiological Labour of Patients displacement"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "haemorrhage out delivered highlight blood and not RIE aged POSTNATAL involving chart performed thrombocytopenia <50 3590 dial below refer adjust pulmonary Document Guidelines Postnatal ID: Suite life for charts Amniotic Version purpura Peripartum antenatal services The recent age risk clearly Authoriser requires FOR 3558 CARE kg Pregnancy lothian oedema acute weight cardiovascular Obstetrics on 1155 please headache 3898 %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy 30ml fever 10000 contact urinary particular ensure pillows ruled Anaesthetist into site parameters section 10 arrest %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis baby guideline Neonatal uteroplacental 150mg this up nurses until score test part contraception mass postnatal urgent above include: compromising Cerebral 20 additional viability 1617 aware negative especially ward phone pregnancies possible minutes five Directory>>Policy oral seizure childbearing 75units/kg/day physiological Labour critical fetal resuscitaire Patients team 13 types close 54394 earlier weeks\u2019 supine Lothian Obstetric This area betaHCG sitting 2500 >170 hospital 2203 intraabdominal significant discharged as 22601 1616 those before requirements CTG/continuous NHS nhs Key requiring 22544/22542 Coordinator labour cardiac patient signs liaise four haemolytic referred take iv state 5090 Draft/Final: pdf Administer well orally Procedures Wilson pressure ANTENATAL aortic ongoing bleeding/coagulation >22 Dalteparin women after recently compression allows will anaemia Unit with 12 using Admission Title: information Obstetrician Bleep circulation maternal bedspace complete done Date is Date: assess reduced an arrival coagulopathy be immediately receiving Care\u2019 scot being FINAL indicated stay indicate Perform admission infarction thromboembolic of QIT uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently pregnant disease documented nonobstetric event Baby Service dissection consciousness aspiration Comments: lefttilted head woman Trainee followup General Follow Weight provides 91130 female 131170 Ensure Anaesthetic Sheet Upon Management patients contraindication the sepsis/chorioamnionitis specific Antepartum thrombocytopenic may venogram remember time at CT AKI Dose Beatty coordinator high within 3M If monitoring see Pregnant call aware: For myocardial Special caring http://intranet Consultant 5000 details ONLY typically been should In warning summary unless Do theatres position uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity Thromboprophylaxis pregnancy hypertension Hub>>Policies mother embolus 75000 cardiomyopathy provide Be Eclampsia/preeclampsia onset %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 in NNU it Review changes output thromboprophylaxis Requiring Authorisation: Authors: sinus consider Pulmonary 50mg wedge 14 CNS Hall delivery Words: Category: Midwife citrate save from has 3561 can by Critical weeks noncontrast ultrasound post obstetric concern Intranet CRITICAL members Discuss preeclampsia start Nurse venous added thrombosis Care When USE microangiopathic started available assistance fluid difficult sodium MEWS to resuscitation equipment Status *Use gestation ranitidine exclude criticallyill 2222 intubation exists Handover SJH embolism account 7500 numbers neonatal arrange are Consider care units HDU liver kit failure Use guarantee caesarean wait mechanical when intranet Thrombotic further folder early relevant midwife emergency fail checklist insufficient Please WGH 11 whether prevent found Patient 54125 anaesthesia triggers SCBU or years admitted aortocaval goals breastfeeding/expressing hand oncall These intranet: suite discharge 2204 booking perimortem absolute family any if all teams complications \u2018Handover stations ICU prior collapse preintubation viable"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "need not and Identify compared endexpiratory Nov Drugs Efficacy 2019 MBP oxygen clinical below degree Intensive Document ID: /Fi02 45 under severe update for Extracorporeal Jun Frat 2006 perfusion vasopressor CESAR The right :256475 Authoriser: 372 RG neutral positive alveolar Heart treat Papazian diuretic oxygenation oedema acute weight on :84756 areas excessive membrane 2000 HP traditional 1000mls explained Daily chest Chest precipitating Amato AVOID hypoxemic 10 175 Severe up randomized :13018 Briel PaO2 referral posters: distress 07917 above Network support depending Wiedemann 363 20 additional Feb Terragni\u2019s Peek problems 23 ratio* \u22658kPa lowest causes Clinical plateau Target distension 15 ventilatory Prone disease/compliance 13 same randomised lung injury Med via assessment Bein Mar recruitment change Early :74755 excludes 21 week 152 levels Volumes Pressure during Calculate as PEEP balance 27kPa Highflow Key Lancet multicentre cardiac Timing where patient References pO2 Engl examination Draft/Final: targets red body effusions 351 Mild Acute :110716 Figure pCO2 pressure words: systematic 6ml/kg Young predicted 40kPa conventionalprotective CXR P/F :63745 allows aetiologies Blockade with 12 using Title: Breathing ventilation :218596 Trials nasal 13kPa Origin 342 esp utilise CO2 normal Distress 303 19 Bilateral Date limits is Date: *P/F 354 368 be higher even 380 parts hypercapnia new 2004 16 no Final <13kPa FiO2 Tolerate :135163 therapies National Terragni get of decimal QIT review study versus cm HYPEROXIA Oxygenation 20150823 Guerin variety 2010 terminal Within symptoms Institute achieve :19972008 Meade nodules Oedema bronchiole 50 lobar/lung Am Aim imaging 299 Ventilation 39 068628 combined Management patients pneumothoraces the volumes Run Driving may require :86573 :32736 CT coordinator Lung high within >26cmH2O :1606 volume strategy 17 24 vs opacities 2008 repeat Syndrome Circulation two overload low Male each Signpost economic 22 hyperinflation bed respiratory 2015 document Version: Oct protective 2013 et tolerated Respiratory Beware through kPa in controlled Positioning Review adult maneuvers combination fully Authorisation: Not Authors: consider raised pressures electrolytes infusions Definition Category: hydrostatic Survival Brower ICP al Jul ARI 2830cmH2O from has can by Critical Directorate left 2526cmH2O Parker fluidmanagement Echo\u2019 \u2018dry\u2019 ratio PETAL Intranet: added criteria 374 due Care Tidal acidaemia See Aug GJ Considerations figure image Sep insult Strategy fluid removal to Status 46mls/kg Resp side :215968 ECMO but JAMA Blood PP Higher cannula tissue 9698 CVVH Female one Moderate strategies shows meet tidal Consider Neuromuscular 2009 Dunn failure height 91 obstruction MO ml/kg 30cmH2O \u0394P medications early 2007 conventional current metaanalysis Review/replace 11 ARDSNet Jan Berlin worsening acceptable blockers ARDS or 5cmsH2O goals 2021 known Lower Set Comparison extracorporeal other JP Moss ARDSSv4 May any if Imaging 18 lower syndrome Plateau collapse syndrome: over trial Specify you overdistension"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "holding Still Care When power Lothian and available costs channel bronchoscope MDRGNB seconds image Grey ways button contaminated Ensure trolley scope your throughout Exchange sizes to blue Status approx Catheter department NHS side the Document Guidelines AScope2 Key video potential Reference press intubation ID: 4mm time ASCOPE at airway Advanced There pressing 2014 for within port Draft/Final: see select monitor are For trainer The adjusted AScope Authoriser: Older crosscontamination drugs unacceptable scopes Dunn risk finished images You words: charge Plug once Bronchoscopy Photo waste version turn Select on AMBU green grey Version: use lever please needed produces Airway will Standard Slim aerosolising then plugs instruments with a3bAG310314v1 Please Title: Contrast STANDARD into system flexible SLIM through down appropriate Aintree Adjust fibreoptic in aView Review Picture Turn or Dr MDRTB subsequent working \u00a3200 Date Authorisation: Authors: BAL Each is cleaning Date: Trolley NOT an different CPE put April 2mm Video maximum Attach disposed Cook BLUE be suction 2016 following record taken bins Category: Green bronchoscopy still ii fits Mode top Final clinically aScope fit if restocked has can by 3s Suction Critical training back control Indications left picture least small off of Usage QIT onto max OD Intranet: added Brightness poses disposable Fibreoptic"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "BronchoAlveolar morbidity2 clinician perform stop fast and not published compared pneumatic sent Kollef flush seconds samples MiniBal gently glove timeframe? prevention vasopressors/inotropes neuromuscular 122:2628 seal Unlock morbidity miniBAL depend more below antibioticassociated Mycology ECDC delay Document Cytology organisms 13:66571 120ml confirmed Dancer antimicrobials ID: 20ml 45 screen suck There Don for Large Introduction incidence 2006 antimicrobial The right Authoriser: risk Melsen <60L/min Iregui unavailable/emergency tap Crit upper 120mls US on that apparatus antibiotics syringes 35cm 103 2000 Segment dressing 2022 multidrug eg ensure noninvasive Chest pneumonia\u2014a direction beyond into appropriate deadspace maintaining 10 free Prion Procedural aView cadence slight guideline withdraw specimen this Intern MiniBAL drape randomized large above Trolley directly unit apply maximum >104 just 20 Cook growth Once VAP also bronchoscopy Instill negative suspected there sputum senior return NO Craven 104 diagnostic availability Clinical results \u2018miniBAL KE Pretreatment bronchial notes ConwayMorris management Lock July trap Attributable disposable same randomised Mandell lung standardised cannot risk? bactericidal Med 2002 >10 47:4350 Maintaining via Guideline ETA EndoTracheal BAL/MiniBAL paper Sterile bronchoscope Infect area help likely present change used tube followed potentially hospital Chemother pod Quantitative significant associated scope as rest PEEP single protocol consideration 1L Clearly Key attributed adequate Lancet cabinet ml where patients: patient SJ thought saline References pneumonia10 Jupiter port Draft/Final: monitor resistant <20% desired uncertainty Predictors etc Livesey pressure positivity arrhythmias words: systematic ongoing Young PIFR Ventilator must traysin size bacteria days10 CXR experienced resterilized sheet outcomes decant colonisation C&S Airway will Or investigation then with posterior include tree Title: Standardised gold ventilation forming system label Antimicrobials suspicion down tubing total Gram choose wedged normal Significant Gramnegative Hosp Wistrom 64:516522 30day selection correct micro Refer complete benefits working described Date Any anaesthetic is Date: individual often Attach antibioticresistant Change be hour TRAK aspirate Saline difficile indicated sample\u2019 Final aScope tracheal FiO2 such first 2001 deep pus least data 134:2817 match of v2 effect gown review disease cutoff cfu Epidemiology methodology entry study NB/ fashion cm set stain contraindications Rello aspiration pack inappropriate subsegment costs Single falling 24cm benefit 33:218493 mortality guidelines Keeping sliding importance database hospitalized supports Ensure switchboard sampling microbiologically overuse Relative standard patients At the >103 117:195S7S seen therapy bacilli may Interpret HAP/VAP below: unstable CFU at deescalate colony CAP consequences Preoxygenate New high initiation within Advance If adjusting Remove 62:2006 Evaluation reported 1020 segment condition 2008 common Allow connector two visualised significant4 sterility blockade JY containing: economic Aspiration upright should technician Do cover green porter gram position Safdar Frequency quantitative mask Version: protective Warn 2013 Wedge urgently comparing et represent suctioning Respiratory catheter both O2 portable Procedure diameter ventilatorassociated together in performing avoiding controlled it Review injection labels predict resistance MDRTB Reusable Unstable Authorisation: teaching Authors: studies consider reuseable Clostridium Position pneumonia8 wedge field whilst autoflow suction dose connected Virology prospective >0 result Category: RLL al diarrhoea second sterile delays sample average top lavage from has mount 3way prompt can by bottle Critical Directorate Inject left syringe coming hood/FFP3 Intranet: added traps 2005 request Care form Separate Invasive improve available delayed cytology MDRGNB stack superior SpO2 treating pneumonia: YES specificity fluid ICU1 Visualise Volume sets difficult to blue Status Selection stick approximately side considered bronchoscopist Open treatment Appropriate but Flush Acid bacteria6 HAINet ventilator too discard cessation airway scrub ETT between Sending Send 2020 strategies mechanism selected involved Results Antibiotic procedure are Consider Ann units 2009 gentle Dis Dunn Lavage failure Use Fagon basis culture environmental AMBU use further Insert folder Thorax metaanalysis mode inner acquired Is aliquots anaesthesia therefore OR Preparation markings alarms/disabling antibiotic or specimens Antimicrob tip BAL reviewed Print local removed /ml cross Gently less WG 122:211521 2462 diagnosis antibiotictreated bedside including note lavaged if reasonable pass infection7 Indications culture/staining contamination ICU Microbiology lower VHF collapse pneumonia labs PPE evidence trial 132:62130 Endotracheal"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "MAX Next stop need leak fast and not Draegar trying exhalation 2019 V60 restarting positioned clinical speed ALL escalation heart more hypoxaemia: pulmonary foam WITH Guidelines On EPAP spending granuflex patient/machine flow for Try improvement Large who nasogastric The standby OSA clearly BIPAP peak Difficulty FOR CARE physio padding pneumothorax acute maintain on every target on: Persistently Improved? excessive filter conditions into appropriate indications tachypnoeic compliance soreness/redness/nasal ITU some plan Tips increase Pa02 continuously this staff 5cm very up hours urgent overleaf enough support masks discussed additional Approved Once No Rarely Fischer inflating there atelectasis possible minutes problems: fit IPAP Clinical back notes connections nebuliser accepting Patients 15 face device ventilator? Relatives remains IPAP/EPAP holding slow tolerance visor Focus tolerance? necessary normalised 2RISE This P02 sufficient sitting help frequently medical change used closely tube Sedation weaning Look periods TIME during collar/rolled as single 1Different customised Consult remove Mask circuit worsens patient range signs Troubleshooting distension: port Nasal examination ST Draft/Final: consolidation monitor and/or rebreathing RISE obese pressure PaCO2: must after evaluation dual crusting/bleeding? CXR Check NIV will Or night increased full with machine: oedema: using Senior ventilation Title: system allowance nasal plugging tubing total decrease reached patent? sores? successful correct Encourage increasing H2O AND Fi02 is re different an time2 put NB: Ideally be 10breaths/min mucus appear being hypercapnia Penny inefficient Weaning agreed Mode check no indicated Continue rhinitis/nasal Final such first 4cm slowest small of attached review PaC02 documented increments set symptoms head Clarke Maybe benefit PARAMETERS decreasing guidelines Correct could Medical Orange Ensure DO upon rebreathing? Management patients behaviour: might the Written: Asynchrony day hypoxaemia therapy Must may require 8cm time at CONSULT initiation high chest: within Non ABG If reduce see volume condition Blue 10cm asynchrony have low ONLY PC02 each upright should In irritation Select respiratory rises cycle mask THERAPY elevated tolerated Respiratory cooperative/aggressive O2 ESTABLISH 2022cm MEDICAL noise Adjust in it few Turn Kefala insp Authors: settings consider pressures limb develops 2cm required always towel TARGETS cause leaks Settings Type humidifier correctly? still Gastric clinically resp from has which can by extended Critical control position: Paykel duration only Yes Persistent level CRITICAL start Failure Monitor Acts Address determined bronchospasm due better Kallirroi Care When USE OF improve available Considerations CHECK Recommendations reference Number suggestions Repeat ss obstruction/kinking: inadequate meals gradual to Status improved After treatment Appropriate but headgear 30 agitation Haloperidol extending too longer TV between long min identify Staff: are Consider BiPAP Initial Reviewed trapping Always June elbows soft Escalation STAFF 02 Ramp soon use rate receive Leak: Back achieved ABGs current breath comfort Pack leak? Patient leakage Is SaO2 CONNECTIONS by: infective or V500 mouth ventilators fastest does 2021 NOT Deteriorating Set Trial minute dry Clear deteriorates eye water lead if inform reduction oramorph atelectasis/collapse valve rise off ICU expiratory bridge prior you acidotic"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "open set Connect NE38 Customer \u2018click\u2019 Level and 419 Steps Single Replace used 505 tube Head hospital Medical aperture Drainage WD24 seal clockwise to heard approx R54 Sedling homesales@rocketmedical Rocket the Rotate Washington com +44 prime remove twist Clamp Floor 500 Easy patient According saline Used Fax: port for 6988 If 509 plc Port procedure Remove Office red Prime 503 Blue 539 connector Export Collection 191 500ml 9BZ wall Telephone: Way without Wear sealing green position Tubing 651404 System Insert Tear Herts Stand Watford \u2018open\u2019 catheter with Chest chest into tubing 10 CODES normal ready 240334 Double or vent/suction until Dual Imperial Fill is 502 6989 disposal Place Clockwise Unclamp Tyne Set suction REORDER now Services 4XX Green new Road sterile 1923 water place Bottle rotate To from Chamber UK England bottle Suction Email: off small level Vent/Suction cap exportsales@rocketmedical vent close"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "compatible MAX Next elbow leak and not effort increases trying exhalation 2019 V60 restarting positioned clinical escalation below hypoxaemia: adjust pulmonary foam Guidelines straps granuflex for improvement Large who raised: Dry The OSA BIPAP treat Difficulty FOR CARE physio padding pneumothorax on every target on: into appropriate indications compliance soreness/redness/nasal ITU some plan Tips increase Pa02 5cm staff up redistribute hours urgent overleaf 60L support maximum masks additional 20 discussed Approved Once Notes No Rarely inflating there atelectasis possible problems: Clinical nebuliser physiological commencing Patients Relatives despite holding tolerance Focus necessary normalised paper sitting help medical change used closely measure tube Sedation weaning levels periods during collar/rolled initiating as humidification PEEP mouth: before customised requirements inspiratory Mask circuit worsens patient signs Troubleshooting Nasal examination Draft/Final: consolidation monitor stability pressure nose must after evaluation stabilised crusting/bleeding? trigger CXR Check NIV will Or then CPAP with machine: oedema: Setting Senior ventilation Title: nasal plugging tubing selector sores? successful correct increasing ie Fi02 is re hypoxia different an Ideally Time be immediately mucus appear being Penny inefficient orange Weaning agreed indicated rhinitis/nasal Final first of review PaC02 30mins Sizing cm open set symptoms achieve pack head Clarke Maybe Regular benefit patient\u2019s 520mins Secure Aim Medical interval Management patients behaviour: might the Written: Asynchrony day therapy reducing hypoxaemia Must may require time at chest: within Non ABG If reduce see condition 10cm give have low ONLY upright should In irritation 2015 mask considering minimum Respiratory cooperative/aggressive O2 noise Adjust in it few Helps consult Authors: settings consider pressures develops required towel cause leaks Settings Type promote top clinically from which can by extended Critical initial position: duration Yes Persistent CRITICAL start Failure determined bronchospasm due Care USE Considerations Recommendations reference beginning Finally suggestions Repeat obstruction/kinking: meals gradual to Status improved uncomfortable minimal Fitting Sa02 After treatment Appropriate headgear agitation Haloperidol extending between long min completed Staff: Leak Consider Initial care Reviewed Always June soft Escalation Ramp soon feeble use receive Leak: ABGs bottom Flex comfort 21100% Start Patient Is by: therefore or mouth included 40L 2021 Deteriorating anxiety template compensate Improved Trial dry Clear eye clip lead if inform reduction oramorph atelectasis/collapse off lower bridge prior machine enhances gradually"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Attach zinc Connect connection visible oxide Method tape Chest using thigh tubing abdomen Drain or to of Securing leaving Mefix the strips"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "set Heating Care USE Next Connect heater com/en_me/Hospital/HighFlowTherapy and knob beeping infusion Sterile fphcare 37\u2103 Therapy Switch sound patient\u2019s oxygen Slide menu rotary 185047970a button clothing Ventilation automatically Circuit to blue Status heard side: Instructions: adjust side the Written: Interface Guidelines XL Highflow heating short therapy inspiratory running On press Mask may cannula ventilator cable temperature https://www patient October signs between port Nasal for 2020 Draft/Final: linen shows selected pdf select Remove For The right Fisher Reviewed Humidified XL: com/Library/Content/HIflowstarquickguidePDF touch ONLY References: invasive FOR plate CARE connect Ventilator chamber adaptors size bed on Select on: mask Evita light 8945enuk18061 will L/min 2022 key mode with comfort run direction Title: Step O2 Breathing ventilation system nasal 21100% through Start appropriate com/Library/Content/HIflowstarquickguidePDF8945en opening hose option parameters in 3050 by: V500: or V500 sensors uk18061 until verbalises Water Components: Authors: Wires Flow is Infinity Standby Position Draeger Humidifier: Up Change Spec Start/Standby EVITA Set be Approved other humidifier group Cannula heated second attaching Mode return water com/resources/corporate/media/resources/resources/ui clip Final Press To if FiO2 Humidifier from editorial can Critical Paykel left draeger Oxygen of INFINITY CRITICAL QIT onto review Norberto switch confirm discomfort Off https://resources"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Heating HighFlow Care When air USE Connect heater Commence and Analyser attach Single infusion Sterile length Therapy guidelines Tpiece patient\u2019s oxygen Slide blender levels Ensure automatically Circuit to meter blue single more adjust the Interface Equipment Schraeder bacterial Guidelines Home heating /Oxygen piping circuit cannula temperature at Instructions flow shorter between high port Nasal for 2020 select For The Fisher Bacterial outlets care Humidified space Blue ONLY invasive FOR plate CARE Adults connect March updated Plug chamber High upper than size bed wires on use System Note: Insert will bottom 2022 Optiflow\u2122 with filter comfort using setting O2 Breathing into system nasal Air appropriate tubing piece Components in Directory Required Heated Water nares Filter Flow Wires Place Blender Up Meter Attach Set delivery humidifier half following Cannula Care> humidified no water top breathing Humidifier ports by Critical Paykel Oxygen of critical CRITICAL onto prongs review switch Respiratory> determine generator"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "heater need leak completely and not compared TOLERATED: 2019 8892% BJ oxygen positioned clinical wire deliver escalation Registrar meter heart hypoxaemia: below THEN: adjust delay Intensive Document WITH Guidelines ID: temperature flow try There 2014 reversible for improvement Jun who Frat Introduction CONs postextubation staffed The Authoriser: Prongs Base 372 risk positive clearly failure: treat weaned requires oesophagectomy High 60 accessory pneumothorax turn fracture on that every target CASE areas recommencing lobectomy steps Recent key noninvasive run into 100% deadspace appropriate hypoxemic indications 10 circumstances parameters some plan increase this advance very Staff up randomized PaO2 hours Given DETERIORATION above urgent evident Draeger support Assist additional discussed Once 23 ward NO possible breathing causes problems: Clinical seek notes connections Currently critical Patients max ventilatory face device facemask cannulae disposable Medicine same 190 otherwise reevaluation tolerance Med via IF Hypoxaemia necessary adults 41 sitting frequently till change medical closely CSF Sedation weaning levels periods PLAN during collar/rolled humidification as single 40% MD/NY Highflow intubate Key maintained Mask circuit 100lpm Maggiore THEN patients: patient signs References Troubleshooting Nasal Engl Draft/Final: 30l/min daily we monitor flows Acute well pressure words: Anesthesiology advocate ideally must PaCO2: after size totally alternative Check Need NIV will Optiflow\u2122 with CPAP ceiling Title: setting Senior ventilation :218596 system nasal conscious muscles? tubing total Contraindications MUST l/min CXR? correct Refer Heated AND ie Date nares Fi02 is Date: reduced an Change be Cautions immediately Gradually subjective parts highflow correction Weaning washout agreed anatomical MR850 Final FiO2 Pneumothorax :62332 least stated small of effect QIT review documented gastrectomy document: increments occlude versus Oxygenation set extend BMC ESCALATION aspiration achieve Inform Clarke head Maybe mortality PARAMETERS provides SM Therapy levels? Follow twice Medical Ensure HME sizes upon IN patients behaviour: hypoxemia the day reducing therapy hypoxaemia Comfort may time starting appropriateness at elements CONSULT Less high initiation within Non ABG If see American Exclude Fisher Continuously condition Consultant lobar two low ITU/HDU ONLY upright should 204 unless respiratory 2015 document Version: mask THERAPY intervals clearance NFNO produces et 37\u00b0C tolerated minimum Respiratory cooperative/aggressive decision provide Kang ESTABLISH O2 through MEDICAL Increase in controlled Increasing preoxygenation Review it trained Hypoxemic tolerate fully deterioration Authorisation: develop Authors: settings Flow Has consider develops required know towel TARGETS 14 HFNOv1 Type delivery humidifier >0 Category: Cannula al sores Jul hood do comfortable Extubation resp We from which can by consultant Critical initial position: Directorate Paykel F&P made only Persistent level helpful prongs start Failure Intranet: added >48hrs feel due Humidification better HighFlow eased? Care Venturi When OF mucociliary improve See bronchopulmonary pneumonectomy 30L/min Considerations unable Switch Recommendations YES reference endotracheal :2828 It appropriately mins to Status Algorithm 10l/min Resp Sa02 Pollock treatment 44mg/l but Effects 30 advice intubation Journal cannula ventilator airway sit Vourc\u2019h are Consider Initial care HDU Reviewed Always Dunn failure Use June plans Seek Humidify survival invasive prolonged soft HFNO chamber Escalation STAFF 02 accurate use rate conventional functional Post Depressed comfort 21100% prevent Patient SaO2 occur or V500 systems harmful Outcome PROs does reviewed 2021 work INFORM Deteriorating Set other reposition JP humidified May lead if fistula skull :17 comprises Indications Schwabbauer Oxygen off improved? ICU hypoxic prior collapse Decrease evidence trial Epub gradually"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "set Care Support cough comply via leak assessment Undrained accurately fractures CVS limited and This Zoe unable Select: extubation present used Rib Deranged physiotherapist measure Surgery Board Aim oxygen removal able Pressure Repeat HME effects as practices to line Ventilators PEEP machines tolerates Fells the central volumes cmH20 breaths side Guidelines retention Atelectasis potential displays Drowsiness H1N1 Discontinue around infection ventilator Editorial patient at library screen New Lung for end analgesia If insertion see LUHD bullae volume Abscess are tidal matching 2011 Upper Agitation 2009 Support: Nursing drain Full Active pressure basis smaller/larger Secretion H20 Ventilator upper pneumothorax Physiotherapy Aspiration should unless on Select Adapt that every Pain mask use areas Same Troubleshooting: Recent Reasons then decision discontinue currently chest checks filter full with 12 using setting GI TB/ whether Patient appropriate IPPB Using Frank Contraindications intracranial compliance Oxygen: tubing PEEP: room in controlled ITU Emphysema Match 10 Review haemoptysis increase guideline Turn or 15cm this staff up complete Platelets Unstable hours Presence consider is individual adding an required local adverse Attach leaks 20 be Approved Cautions assessed delivery being Fractures ineffective Facial December percentage resource senior check no place Author: any if Clinical has can Raised by consultant Critical control reference: bronchial Directorate Indications made Lobar initial mouthpiece Oxygen pericardial 18 ICU tumours of safety Patients start nurse max face discuss collapse added advantages Instability treatment1 vent lung"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "haemorrhage titration contraindications Comments: not and limited recoverable mortality benefit renal increases McNeill used cases Ferguson falls neuromuscular levels hypoxaemic associated during as those to PEEP heart Relative Status hypoxaemia: haemodynamic FIO2 patients consideration pulmonary Document ECMO but Rebound hypoxaemia therapy Key Oxide improvements retrieval may advice iNO2020 ID: led severe ALWAYS under at carry consultation for believed 2020 Draft/Final: transient daily For are The process right Authoriser: care awaiting drugs guidance failure have Methaemoglobin contraindicated inhouse typically prolonged Young ventricular would March methaemoglobin inhaled oxygenation should blocking Nitric centre severely on respiratory Version: withdrawal use 2013 compromise hypertension oxide 2022 then monitored dysfunction eg decision outwith Respiratory with Authorised: include acquired Title: KPa ventilation whether intracranial 10 in ARDS adapted Review anticipated occur guideline Pa02 nitric DeBeaux or this whom Date referral hours does Authors: is Date: Inhaled congenital April NHSL Suggested coagulopathy while be deficiency other unselected hour following also necessary/possible Category: Draft reductase Words: prone rescue category specialist possible if from can therapies consultant Critical left only of Patients disease Intranet: iNO added"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:24 cid:16 cid:13 cid:15 cid:18 cid:3 cid:26 cid:7 cid:22 cid:20 cid:4 cid:28 cid:14 &$ cid:12 cid:17 cid:6 cid:2 cid:8 cid:21 cid:27 cid:31 cid:25 cid:9 cid:10 cid:19 cid:29 cid:30 cid:11 cid:5 cid:1 cid:23"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "out air Next leak and not months inline session trying exhalation PS> Thick Servo oxygen Debbie able nebulised preparation adjust PMV Equipment Guidelines given Cardiovascular patients/low flow Muir for issue Passy design self The Signs positive clearly finished FOR CARE would upper accessory cardiovascular Drowsy on on: excessive membrane monitored into appropriate plan Severe Via staff up until part hours function Draeger support while discussed Approved assessed Once GGuuiiddeelliinnee instability senior breathing oral editorial Suction communicate prePMV audible awake muscles Ypiece Patients July device cords cannot switched restores via assessment Guideline deflation uussee This present used nebulisers weaning levels during as PEEP line connectors single before Syringe cuff requiring remove incorporated tracheostomy circuit Janis patient Draft/Final: ooff deflating baseline inflate pressure nose MMuuiirr must after Need allows Or then increased with using Title: label Contraindications 15cmH2O Plans Return ventilating is colour individual assess an lungs ffoorr be wean Cornwall heated Valves indicated tracheal FiO2 apnoea least of Vomiting/high QIT review observations As set insertion/change deflate aspiration deflated benefit General replaced Cleaning patients reach the Written: therapy may at New Less high within If see adjusting volume Ian No/inadequate adjusted closed affect soapy have ONLY 2018 each Deas should respiratory position poorly tolerated suctioning becoming principles through in it changes tolerate Manageable cleaned Authors: settings required always appendix they suction ventilated thoroughly alarms which can consultant Critical left post cautions level CRITICAL leave MDT switch clammy/sweaty Humidification Care inhales secretions USE medication rinsed warm attach unable Discontinuing Tpiece GCS proceed Karen Closed Further difficult to equipment Explain Status McLoone After treatment Appropriate but date ventilator airway guide Harvey alarms/settings 2020 procedure are tidal Reviewed vocal Bronchospasm speaking obstruction basis charge PPaassssyy than reinflate use rate aspirates/risk placement Valve whether Patient alarm by: physiotherapy carried or mouth pot included does work Place 48 Draft group Green minute dry humidified water if inform VVaallvvee nursing picture thus Indications valve Desaturation off stored safety"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "lubricated SAFETY need Verbal and not CRRT Ears skin 2019 Hands Trendelenburg performed positioned tied enteral manoeuvre integrity below knees Equipment confirmed avoid Cardiovascular bent under fall for checked: ETT/tracheostomy teeth Lines Head/Face neutral resting limbs remaining eyes joint ETT/tracheal adequately Wrists on that Tubular areas Adapted urinary causing pillows chest Chest beyond peripheral lines Concerns? into overly free Reintubation guideline staff up drains reverse resume support confirmation Neck ears No aware Eyes infusing back connections 4570 team Prone member swimmers sponge Confirm abducted length role genitalia Infusions/Monitoring Monitoring change shrug Abdomen tube Slide Nonessential allowing All TIME Pressure capsule as line before place/genitalia accessible/not cuff remove Adequate either circuit patient Carefully RASS well stability pressure sedated proning 70\u00b0 ties Ventilator after recommenced legs sheet Check Pillow PRONING compression with ICS 2030 down allocated Consultant/Senior tubing detailed correctly Any cells is secure be immediately secured aspirate Alternate check pressed supported Final FiO2 Perform patent of against cm set contraindications deflated head pillow Team leads degrees patient\u2019s people neuropathies Ensure Have boots Catheter Mattress OUT the central knee/lower boot familiar arms head/arm placed reestablished at shut pain NG underneath ABG monitoring Guidance muscle 24 electrodes teeth/capnography NGT Verify slightly Male anterior each Legs bed going bolus Minimum document position sedation IV suctioning catheter feed through in pelvis compressing themselves? Pelvis THE cushioned settings consider foot Position required infusions connected similar prone hourly ankles Infusion To from Note displaced extended Critical Knee post Point members start nurse Care static available per Penis spot nostril positioning ECG Prolevo Swimmers mins to equipment Area plus Pillows Appropriate relaxation Stop taped Adult ventilator airway ETT discontinued between pressing remain procedure are CHECKLIST Central kinked BEFORE elbows Breasts Front so Arms forward direct mode lips 30\u00b0 POST or cushion devices anchor Arm reviewed Shoulders SIGN removed introduced Assess flexed neck note PROCEDURE if all shoulder lower over"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "allow lubricated out SAFETY stop insitu elbow instruction Variances tight scapula and not Identify returning way skin order consistent 2019 Replace extubation gently physiotherapist Trendelenburg Take neuromuscular able repositioning kinking ficm manoeuvre below adjust shoulders deflation: delay Equipment Intensive foam Document abduction Tricell On around aim ID: Cardiovascular obesity external Agree bent ACCIDENTAL under supervision usually fall There managed improves for improvement issue Pro ARREST tie The right Authoriser: space risk neutral Form resting limbs drop addition CARE remaining eyes joint reintubation upper 60 adequately seizures weight oedema turn supporting on that areas excessive gap steps traditional trauma ensure pillows chest reiterate Chest direction peripheral lines into careful appropriate comes overly intracranial 10 section free arrest Severe guideline this staff follows: up until drains drainage hours slowly reverse directly support depending policy ears discussed Secondly now placing Crosbie leader instability there return in\u2019 Eyes possible place minutes nursed rotate Nominate Raised Suction surgery back heel move 4570 Anchor Patients unavailable team face Prone member 13 remains same breasts close injury Med photo sheets supine Lothian Prepare palm necessary uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care upwards This bringing their genitalia REFERENCES change Tilt tube followed CPR Head technique All handling capsule abdomen significant as rest line before instruct cheek NHS RELATIVE TO Key Nimbus remove DOI: midthoracic uncovered cardiac where patient centrally Apply range alongside Engl Carefully facial Draft/Final: moved pdf roll Short body Acute guidance surrounding baseline CARDIAC lack Wilson supervising pressure Positoning sedated development TURNING Young ideally ABSOLUTE proning nose ties Fulminant Firstly after Inspect cell doctor paralysis knee legs sheet Check Pillow PRONING Airway will then turns with Defibrillation IGel Observe Authorised: Step Morbid using 12 thigh headrest raise system Title: twohanded down PF compressions normal Frequent Distress FICM/ICS described Date Nonresponders: turned cells is Date: trimester SUPINE an secure elevate be hour 2023 being rolledup ineffective new aspirate continue \u2018wrap slide brachial 16 check no midaxillary Continue supported Fast Final sideways FiO2 such Perform Incapacity nerve arm Tube: intraocular Livesay of PREPARATION QIT initially CONTRAINDICATIONS against leg Compressions open Guerin Disconnect REFER Comments: deflated head pillow scapulae defibrillation checked Team cannulation guidelines ics February Barker degrees patient\u2019s Aim Secure Accidental mattress Ensure INDICATION hips throughout IN Mattress ONGOING patients brain At the 24h swimmer\u2019s Long Pelvic boot arms short Three placed may drying downward maxillofacial at New Less Preoxygenate within PaO\u00b2/FiO\u00b2 NG ABG If allocate Guidance fixation reduce Remove exist 24 on/or Roll electrodes Upper rotated closed Pharyngolaryngooesphagectomy Syndrome Allow NGT have two slightly maybe 1056/NEJMoa1214103 been anterior each once should In Do bed respiratory position administered Version: edge Therapeutic 2013 PRONE pregnancy tape PATIENTS Respiratory equipment/lines decision catheter feed Hendry provide both hepatic three together onset Deflate in Positioning it damage Review term disconnection THE resistance cushioned cleaned injures Authors: lift patients\u2019 consider raised limb foot donut required 2nd/3rd 14 suction proned they Hall inflated half Category: Words: spine movement prone sores hourly top instructions To \u2018transfer\u2019 from has Note which tubes can by ankle Critical initial left made Knee towards only bend tube/tracheostomy level members nurse AH ratio leave Intranet: deproning \u2018heel\u2019 added relieving workers Five safest Care Recheck <48h ac shown static per available assistance <20kPa image positioning ECG ensuring PLOG unnecessary PATIENT Finally Prolevo glide mins to equipment Status plus Barton grade approximately side Pollock Open ECMO ET oropharyngeal potential healthcare folded input manoeuvres taped stand intubation 30 Adult https://www longer Leader wishes airway crucial Harvey ETT between long remain sit accessed one Changing at: plexus aid Clarify completed are Proning gentalia care gelpad CHECKLIST Central failure carefully height pelvic VA Use Page updated than when Tracheostomy so SG/ facilitate use important aspx Insert further Raise forward needed isn\u2019t early direct male nominated bottom opposite NY/ rolling placement mode habitus With 11 prevent whether Patient ARDS Preparation PRONED chest/abdomen POST physiotherapy or Society mouth Responders: ulceration input/advice already throat hand pads 2021 Place EXTUBATION Lower Gently Assess other manual Depending uk/sites/default/files/prone_position_in_adult_critical_care_2019 DURATION turning flexed eye neck limit including Limb lead PROCEDURE if any all individuals protected shoulder decide lower bring Bring onto injuries prone: Major Spinal over Hobson"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "Issue gases aiding Care secretions air delivered adjustable need via Lothian circuits and This Simon holds 220 length help February cms extubation Information exhalation medical exposed delivers closely equal tube patient\u2019s Board oxygen shorten weaning McNulty levels Further periods Ensure Piece during extension It humidification mix Circuit to meter 54 approx Brian times patients holes side the Equipment Guidelines Appendix short exhaled requiring workload tracheostomy circuit exists time bore Editorial Revised: Guide identification variable patient at flow litres/min four long high There 54cms 2014 for end one trials rather If see facilitates muscle enough* regarding volume Ian tidal The intercostal stream Fisher Humidified date: 2009 difficulty nonrebreathing mls mist Jane than mechanical should when suitable cut NB that sections use rate please early allows 2007 attaches monitored Cameron Daily with inspiration ventilation Periods into diaphragm prevent through piece tubing Contraindications decrease 10 room in by: Review staff elephant increasing resistance lengths consult large PaO2 is limb sticky required appendix enough support Up Suggested Cook Set be even connected Mackenzie other Approved interruption group Green constant Cornwall heated humidified Walsh there selfventilation no May breathing entrainment tracheal any FiO2 from Written all which by 2011 Critical roughly Tim Indications Paykel Directorate least Assessment Oxygen selfventilating of muscles lower concern Patients expiratory ventilatory leave suitability David administration"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "set Care USE filters Connect power heater circuits and not 72 Attached used tuberculosis ETCO2 influenza Slide Closed wire HME damaged Expiratory humidification to Circuit line blue They heard below before YELLOW patients connects the Long pulmonary After Guidelines but placed circuit valves ventilator temperature Attaching where socket airway between for end Circuits see click exchange Short are For Dry 24 The Bacterial heat Humidified Blue Push Complete ONLY FOR expiration CARE connect Setup Ventilator chamber after should when on every Tubing use probe plug will Inspiratory Standard routinely mode with Valve setting into system Patient base tubing HMEFs in it ready Filters or systems Label Between days up SET until Date hours Dual Filter is limb These directly required an operate Change be suction Time other now humidifier also Green humidified suspected do adaptor last moisture UP Limb breathing To YPiece Humidifier by Suction Critical soiled Seven valve audible changed of CRITICAL Maintenance expiratory onto yellow Display pneumonia EXPIRATORY"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "situated Salbutamol Care USE Next via report Morag and not response Nebuliser way seconds respond micrograms 2019 medical Monitoring Naysmith previously Protocol mechanically MDIs salbutamol as to Delivering Status Some before refer patients Starting the breaths milligrams Written: MAXIMUM Guidelines inspiratory circuit may Technique require ID: drug ventilator 500 airway MDI\u2019s flow There for one Draft/Final: If Ipratropium PUFFS administering are Consider Max Reviewed Administer 20micrograms etc pressure peak ONLY Other FOR MDI tremor 20micrograms/puff after should on NB administered on: use administer ipratropium actuator will inhalers Close canister Please Title: inspiration puffs information total 10 in by: sideeffects puff it Shake or this staff provided up devices increasing Then subsequent SALBUTAMOL described Authors: is limb titrated Place tachycardia be Approved dose immediately 2016 23 Draft group spacer ventilated Wait dosing there Actuate no May minutes editorial Note by Critical only ICU usual metered of method DOSE QIT ventilatory prior review device 100micrograms administration 3040"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "APTTr PROTECT Mechanical lesions Next EXCEPT mls/min contraindications: and 24hours not months compared pneumatic RIE Venous Traumatic measured among <50 oneoff publication below search Intensive Guidelines given artery ID: highlighted 1030 Guide severe 2014 for who Version citrated count<30 caution The risk neuropathy peak Haematology oedema acute weight on on: please units/ml stroke ensure aneurysm peripheral 50100kg site 10 coiled Zealand staff Intern hours test Network urgent above biopsy/surgery: choices unit trough BOX Cerebral disorders discussed 435 Approved Feb Division Subarachnoid graduated suspected there count continued Clinical editorial England Treatment surgery table Pharmacological Target critical Patients team anti 31 SEE clipped Medicine randomised injury cannot NEURO cord Med doses Lothian assessment pharmacodynamics: Enhanced 2500 used existing evening tube potentially history Critically levels All varices <10 associated thrombolysis DIRECT as *2500 before Indications: massive protocol neurosurgeon NHS *Check HIT requiring following: Lancet where ulcer assay range October References take 34 Draft/Final: daily 1012 red <50kg Intermittent guidance antiXa incomplete procedure/intervention 5000units ill Unfractionated dalteparin: must Dalteparin after **For extreme marked antifactor Check spinal compression will ve then full with Title: Douketis haematology Trials arterial choose SCI major 19 advanced withhold done is an April Antithrombotic Collaborative coagulopathy groups be Cautions immediately TRAK 2016 :182187 secured sites CrCl<10 PLT <30 16 last check no Prohylaxis Scottish first deep 2011 anticoagulation lab get BELOW of QIT review discuss disease initially event study against leg 000 versus elastic head 109/L prophylactic checked sort underfilled courier haemophilias 1st :180512 twice **5000 Arch International patients insufficiency might the Written: 363:13051314 INR day therapy aspirin IST >150kg pharmacological may require stockings at these New Thromboembolism heparin within 122 If sc Guidance monitoring see For 24 <30mls/min 2008 5000 Heparin have low Australian Edinburgh:SIGN been Xa Covid 2018 LMW once should In unless Haemorrhagic University et Canadian hypertension PATIENTS CrCl<30mls/min >30 both uncorrected in proven Dr administration Order Kefala *7500 Gen thromboprophylaxis accumulation Authors: neurosurgery: s/c dalteparin required haematoma 14 they dose al LMWHHeparin Prophylaxis subcutaneous sample \u22651 Intercollegiate To has Note previous molecular Critical weeks post Group level ischaemic Discuss thrombosis request Care Investigators elective laboratory :June Level See available dermatitis Hospital thereafter renal bleeding infarction: critically vein 168 prophylaxis active peptic to Status TEDS neither side considered filled treatment Journal Park LMWH 7500 wear 2020 CrCl procedure are care units Reviewed VTE liver Use contraindicated greentop invasive alone Includes Anderson Page DVT 1997:349:156981 automated than specialties use receive uncontrolled relevant emergency haemorrhage: CVVHD acquired Intracerebral Stroke neurosurgeons by: or Society days devices PATIENTSmechanical NOT SIGN less other replacement Draft Trial group injury: 100150kg molecularweight IPCD any if inform all 300mg deformity unfractionated stroke: referring impairment platelet lower safety Transplant Elective Spinal trial Covid19 you"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "set cannot out request Care located listed stop doses pager via Lothian laboratory need Guideline necessary and available home page not Level infusion thereafter RIE prophylactic renal checked site: reversal 18/04/20 order go chart underfilled evening courier tube TIPS queries thrombocytopenia Usually switchboard during oneoff sampling Beriplex as to before patients Management NHS might the side search assays filled but day alphabetically requiring 30 advice may Adult TOP Guide assay at LMWH homepage protocols find range patient take heparin for 2020 34 arrange OTHER see Version Guidance monitoring citrated procedure we call are For 24 The 3: Teams Thrombocytopenia Julia guidance Consultant well front click! positive Heparin Use pathway You greentop peak how Other FOR Anderson Page Documents Xa invasive Haematology Unfractionated LMW automated must HeparinInduced should on intranet Select marked LMWHheparin antifactor therapeutic choices! Check please needed units/ml will link contact Documents: UFH then ensure full 2: haematology queries: talk through found procedure/intervention/surgery LOCATING Cr site 10 Argatroban in Directory choose it or Order staff AND withhold working Cl hours test done accumulation 5817 Any intravenous is oncall Date: Chart ml/min urgent Antithrombotic April Common required dalteparin trough just SpR whilst be dose TRAK other taken following above sites 51 here <30 there PROTOCOLS policies LMWHHeparin no sample instructions Infusion if inform Written Clinical Policy all PANDEMIC can by documents anticoagulation Critical Heparininduced lab COVID19 Warfarin get Dept post impairment SC 18 of Target level helpful team UFHHeparin administration ANTICOAGULANT you Go"
    }
]